ࡱ> ) 3  }yLz|~rYd n O z S f`f?!` bjbj\\ &>>3CqD 1Da---DDDD<OD R _$dhzflU`]4-"-443`"/`,5554lD54D55-=o, {08 QAu `Ѷ5R@&C`<aAJfS5@fLQAQAfeA - /v5\1,2cR!---3`` 5---a4444t#Jm Rx PROvisions, Inc. One Sixty Six Main Street, Suite 3 Lincoln Park, New Jersey 07035 (973) 305-8105 f& FAX (973) 305-8108 Paragraph 1. Founded: 1995 Vendor Name: Rx PROvisions, Inc. Federal Tax ID: 22-3390483 Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 TOLL FREE Number: 1-888-921-1211 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. E-mail: jpisano@rxproinc.com Paragraph 2. Rx PROvisions, Inc. was founded in 1995 as a provider of medical forms and services for the medical and pharmaceutical markets. One of our programs for pharmaceutical marketers is our One to One"! Prescription Pad Program. The program uses prescription forms as a medium to deliver pharmaceutical advertising to practitioners and to provide those practitioners with medical forms they use in conjunction with patient care. The forms are provided as a complimentary service to the practitioner who sees prescription drug messages as the forms are used. In order to produce Rx forms the practice will use, the practice sends their current Rx form to Rx PROvisions, Inc. Rx forms are then reproduced in their original format as directed by the physician, and stored as electronic documents which can be retrieved, updated and used for print production. The information on the Rx form is reproduced with the same practice logos, logotype and design preferred by the physician or by the practice. The signature lines are produced to comply with the State Board of Pharmacy guidelines. Rx pads are perfect bound with a wrap around cover. The cover is printed as directed by the pharmaceutical sponsor. Rx Forms are printed on tamper resistant stock, 2-part stock, regular and colored stock, as directed by the physician. Rx PROvisions, Inc. also receives prescription pad orders directly from health care providers. The practice completes an order form and mails or faxes the order form to us. If the order is new, a proof is sent to the practice for approval before the order is produced. If the order is for Rx forms we have done before and there are no changes, the order is entered into our database and then it is sent to production for printing and shipping. Paragraph 3. Rx PROvisions, Inc. has been in business since 1995. In 1996, the first order for prescription pads came from a pharmaceutical company that wanted to use our Rx pads as a medium to deliver advertising for a product used to treat diabetes. In 1996, our Rx forms were printed entirely with blue thermal sensitive ink that reacted to touch and served as a test for validity. In 1997, Rx PROvisions, Inc was approved to provide the new security Rx form in New Jersey which was initiated to address Medicaid prescription fraud (approval letter enclosed). These Rx forms are printed in blue with a State logo on the front and in green with a State logo on the back (see blank NJ Prescription Blank, enclosed). All of these forms must be produced and shipped with a tracking number to prove delivery directly to the practitioner. Rx PROvisions, Inc. has been providing these Rx forms to health care providers in New Jersey for the last ten years. Historical data on any physician orders for prescriptions produced and shipped by Rx PROvisions, Inc. can be provided on demand. Paragraph 4. We continue to enhance our tamper resistant Rx forms by adding features to stop the fraudulent use of prescription forms. Our Rx forms currently use the following features on the front side; a void pattern appears if copied, a thermal sensitive ink Pharmacy Rx Symbol in the corner, a micro print signature line that will not be legible if Rx form is copied, a six quantity check box to confirm the quantity prescribed, and a unique batch number that identifies the production date, the practitioner or health care facility and the order number. On the back we have the following features; a description of the safety features, thermal sensitive blue ink in our One to One"! logo and a security watermark that is seen at an angle. A representative sample of our current product is enclosed. Since 1997, the paper we have used and continue to use to produce tamper proof prescriptions is made by Rx PROvisions, Inc. Our tamper proof paper starts with 50# or 60# opaque white stock and then the following are applied to the front side of the paper; 1. A latent "VOID" pattern is applied to paper. This pattern will appear when the prescription is copied or faxed. 2. A second screened "blue" color ink is applied over the "VOID" pattern. This ink coat covers the "VOID" pattern and also serves to identify erasures and chemical alterations. 3. A third ink is applied to the paper. This is the "thermochromic" blue ink that serves as a validity test for the pharmacist. The blue thermochromic ink will fade to colorless when touched and will reappear when cooled. 4. Under the "Address" line we print, "Prescription illegal if not blue background with thermal sensitive blue Rx square in corner. Resists erasures or alterations. VOID appears on front when copied. Security features listed on back with watermark copy and blue thermal Rx that will fade to colorless when warmed". 5. The "signature line" on the front of the prescription is printed in "microprint" with the words" Rx PROvisions, Inc. Security". The microprint is too small to remain legible if copied. 6. Our name "Rx PROvisions, Inc." and a "unique" batch number, beginning with the letters "RXP" are printed in the bottom corner. The "batch" number identifies the production date, the prescriber and the order that generated the prescription. On the back of the paper, we apply the following: 1. First we apply the "watermark that is faint but can be seen at an angle. 2. A second printing pass applies our TOLL FREE phone number, our name, a list of the security features that make the prescription tamper proof and our thumb print "One to One logo which also represents Prescription Security as the core of our mission. 3. A third press pass applies the "thermochromic Rx" letters with blue ink that is part of our patented logo and serves as an additional validity test for the pharmacist. The features listed above make our prescription forms tamper resistant and these features meet and exceed the Federal guidelines for State Medicaid tamper-resistant prescription forms. Paragraph 5. The batch number methodology is used to identify and to track every prescription form we produce. Several States, including the State of New Jersey require that all Rx forms have a unique batch number. Actually, we also print a unique batch number on all Rx forms we distribute nationwide. The batch number starts with three letters, RXP that identifies Rx PROvisions, Inc as the producer of the document. The RXP is followed by six digits that represent the year, month and day (yymmdd), or the order date. The order date is followed by four digits (1234) that refer to the practitioner or health care facility and serve as a locator number for our database. The last two digits (01) refer to the number of orders produced for the healthcare provider so far that year. Paragraph 6. We currently provide our services to pharmaceutical companies and to health care providers. We receive payment from the pharmaceutical companies by check and we also accept American Express, MasterCard, Visa and Discover credit cards for our health care provider accounts. Paragraph 7. The paper stock used by Rx PROvisions, Inc. for tamper resistant prescriptions is 50# or 60# offset opaque white stock. Paragraph 8. We will offer several tamper resistant prescription blanks for both single product entry and for multiple entries (samples enclosed). Our standard single sheet Rx form is trimmed to 4.25 x 5.5. Our computer sheets are 8.5 x 11. We will respond to and produce any other custom size for any client that orders them from us. Paragraph 9. Samples of prototype prescription blanks for the State of Maine are enclosed and meet the requirements of the Department of Public Safety, Maine Drug Enforcement Agency Requirement for Security Prescription Blank for Schedule II Drugs (16, 230, Chap 1.). Paragraph 10. In our twelve years of existence we never had any security breech of any kind. A convenient flow diagram of the companys operational processes and safeguards for manufacturing our tamper resistant stock is provided below. Additional comments about the security of our facilities are also provided. Tamper resistant stock is produced exclusively at one facility and that facility has the original printing plates, thermal sensitive ink and electronic files used in the tamper resistant stock production process. The facility is protected by external and internal security systems and alarm that monitor and protect the building and the safety of the stock we produce. One person at that facility has the authorization to access the printing plates, the thermal sensitive ink and the production material needed to produce our tamper resistant stock. Tamper resistant stock inventory is produced and stored exclusively at this facility. When tamper resistant stock is needed to produce prescriptions, the contact person at Rx PROvisions, Inc. is notified via e-mail from the prescription form production facility. We use separate facilities to provide additional security and control. Each plant is physically separated by communication, location and distance. Our on-demand production process controls the use, inventory and security of the stock we produce. Orders for prescription forms from our clients are received by our Main Street location where the orders are processed and sent to our prescription form production facility. Orders for tamper resistant stock required to produce these prescriptions are directed to our Main Street office. Then, the tamper resistant stock production facility is notified to provide the required inventory for the prescription production facility where the prescription pads are printed and packed. Then the tracking numbers and shipping labels are affixed to each order. Orders are picked up at the end of each day at this facility for delivery to our clients. The prescription form production facility sends the shipping information to our Main Street office where the orders are closed out and invoiced. Paragraph 11. The following describes, the record keeping and database methodology Rx PROvisions, Inc has used successfully for the last twelve years to comply with operational requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwide. Upon receipt of an order for prescription forms via mail fax or e-mail, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by healthcare provider. The entry includes the order date, practice name and practitioner, complete address, phone (fax if applicable) payment method (check, credit card), the prescription form quantity and type and the assignment of a unique RXP number or Batch Number, that corresponds to each order. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 10 years. All electronic data is secured with a daily scheduled back up. Two back up copies of the electronic back-up data are produced and kept in two separate secure locations. The hard copy (order forms from clients) is filed by physician, bound and stored for a moving 5 years as hard copy. These records are kept in a secure dry site Rx PROvisions, Inc. will make available on demand to the Department of Professional/Financial Regulation any and all data (electronic and or hard copy) relating to any order from any MAINE health care provider. In the event of a recall or any other emergency, these data can be used to reach all healthcare providers who have received prescription forms from Rx PROvisions, Inc. Reports will be produced on demand in an electronic format to reflect the practitioner, order dates, prescription form quantities ordered, tracking number information and any additional information we have in our database from orders received from MAINE healthcare providers. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est.). All electronic records can be produced within 24 hours. Paragraph 12. Rx PROvisions, Inc. has been producing prescription forms for the past twelve years. If the sample prototype is acceptable by the Maine Board of Pharmacy, Rx PROvisions, Inc. is ready to produce tamper resistant prescriptions for MAINE healthcare providers. Orders will be entered as described above and prescription forms can be produced in 24 hours. Paragraph 13. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. We also request their current prescription form which is also used to verify, update and to format their prescription form. Our order process also requires the name and phone number of the person who is placing the order for tamper resistant prescriptions on behalf of the Prescriber, if applicable. Rx PROvisions, Inc. will use the Maine Board of Licensure website (http://www.docboard.org/me/df/mesearch.htm), to verify the practitioners license status to prescribe controlled substances in Maine Rx PROvisions, Inc also uses DEA Lookup.com to verify DEA numbers. The DEA database contains over 1.2 million records and is updated monthly by the DEA. Paragraph 14. Our current business model is designed to handle up to 200,000 healthcare providers. Our production capacity is designed to be perfectly scalable to satisfy demand. We receive an average of two or more orders each year from over 100,000 physicians in our database. We have additional plant capacity right now to produce tamper resistant prescriptions for an additional 10,000 physicians each month. The average time from receipt of order to shipment of the product is from 24 hours to 48 hours. Paragraph 15. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized tamper resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our tamper resistant stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary te(*r    < ̷yjy]P]C3hMfh5@\^JaJh5@\^JaJhV5CJOJQJ\huW5CJOJQJ\hQh#LCJOJQJaJhQh#L6CJOJQJaJ,hQh#L6@B*CJOJQJaJph3,hQh#L6@B*CJOJQJaJph3(hQh#L6B*CJ OJQJaJ ph3+hQh#L6>*B*CJ OJQJaJ ph39jhQh#LB*CJ OJQJUaJ mHnHph3u *r    G s D E T  x@gdA $da$gd*@]^JaJhMfh6@]^JaJ  % D E R T f  . b d ˻vpjdjWK?hmhA@\^Jhmh*CJaJhUFhq>*CJaJhTCJaJhUFCJaJhqCJaJhqhmCJaJh CJaJhG<CJaJhAhm5CJaJhAhm5CJOJQJaJh 5CJOJQJaJ(} "*|4>RThjRTXǿDZ|o^!h`9h`9@B*^JaJphh`9h`9B*aJphhJjhJj\aJhJjhJj6\]aJ hJjaJ hDMaJ hwaJ hYaJ h]MIaJ h aJhSCJaJhwCJaJh CJaJhAh 5CJaJh 5CJOJQJaJhAh 5CJOJQJaJh\CJaJ#  VX*+$ !!!!("'###$$$%% x@gd gd`9 Q[$\$gd X'PQtu :[hq~!!!!!!O"Y""ʿʬ󞓞}ʬsshM@^JaJh >*@^JaJhU>*@^JaJhn>*@^JaJh`9h`9>*@^JaJ$h`9h`96>*@\]^JaJh`9@\^JaJh`9h`9@\^JaJh`9@^JaJ!h`9h`96>*@]^JaJh`9h`9@^JaJ&""Z#[#]#e#$$B$[$p$$$$$$$$%%?%C%J%K%N%Q%i%t%%%%%%㼬vgggvVg h`9h7>*B*CJaJphh`9hZ 8B*CJaJphh63oB*CJaJphh`9hDMB*CJaJphh`9h7B*CJaJphh`9h 5CJaJh`9h 5CJOJQJaJh`9h B*CJaJphh63oh63o@^JaJh[F@^JaJh`9h`9@^JaJh`9h`96@]^JaJ %%&T&U&&&&&&&& ' '':'N'R'q'z'''''''''((((((ؼشؠؼجؓvjbvjZh1yCJaJh"CJaJhAh"5CJaJh"5CJOJQJaJhAh"5CJOJQJaJhh?5CJOJQJaJh-h75CJaJh63oCJaJhDMCJaJh]MICJaJhDMh75CJaJhZ 8CJaJh7CJaJh`9h7B*CJaJph h`9h75B*CJaJph!%8&9&''''(((R)S)b)***+++,, Q[$\$gdp* x@gdp* Q[$\$gd0z- x@gd0z- Q[$\$gd" x@gd" Q[$\$gd (( )),)3)7)>)E)K)Q)R)S)^)_)`)b)x))))))))***********+ȸȗȗȇznf^fh6CJaJhp*CJaJhAhp*5CJaJhp*5CJOJQJaJhAhp*5CJOJQJaJh4CJaJhAh0z-5CJaJh0z-5CJOJQJaJhAh0z-5CJOJQJaJh0z-CJaJh"CJaJh3:CJaJh-CJaJhh?CJaJh1yCJaJh:eRCJaJ$+++++++,,,--*-6-@-i----.!.(.J.....//!/2/9/Y/e/}////0'0*000000001 1"11ǿhvbCJaJhCJaJhuCJaJh3CJaJh CJaJhFCJaJhwCJaJh CJaJhAhp*5CJaJhp*5CJOJQJaJhAhp*5CJOJQJaJhp*CJaJh"CJaJ3,,, /!/w/x/)0*0!1"11133;4<4K4r5s5D7E789:: @gdEM x@gdeV Q[$\$gdp*1111112 2D2E2G2I2J2N2_222222233 3330313B3E3M3f3}33<4F4H4I4K4Y4b4c4h444s55|hEM^JaJhE^JaJh~^JaJhh^JaJhEMhEM^JaJhAheV5CJaJheV5CJOJQJaJhAheV5CJOJQJaJh3CJaJhFCJaJhuCJaJhwCJaJhvbCJaJheVCJaJ.5556+6Y6p6y66666779999999: :(:V:c:h:z:{:::::::::;;;F;I;R;W;v;;;;;;⫶⫶ʎʶʶʆh6^JaJ"h@SB*OJQJ\^JaJphhEMh^JaJhEMhC i^JaJhC i^JaJhEMhEM>*^JaJh^JaJh=j^JaJhEM^JaJhEMhEM^JaJh~^JaJh~h~^JaJ1;;$<,<[<\<<<<=*=:=E=T=Y=o=p=r=;>?>C>R>z>|>>>>>? ? ??%?N?^?_?q?v???·৚~vnhS^JaJhw^JaJhc_h6hc_^JaJhAhE5CJaJhE5CJOJQJaJhAhE5CJOJQJaJhEMhS^JaJhEMhE^JaJhEhE^JaJh6^JaJhE^JaJh=j^JaJh^JaJh|`^JaJ':[<\<q=r={>|>>???4A5AAABBLCMC\CCC @gd}C x@gd] @gd| @gd  x@gdE @gdE @gdEMgd@S???????@A2A3A5AAAAAAABB BB!B*BTBZBaBBBBBBBBLCMCɿynjbZhC i^JaJh+^JaJh+hHhc_^JaJ h h h hc_h6hc_^JaJhS^JaJhw^JaJh^JaJh4^JaJhHh|^JaJhHh|5aJhAh|5CJaJhH5CJOJQJaJh|5CJOJQJaJhAh|5CJOJQJaJ#MCWCYCZC[C\CCgDiDDDDDDDPE[E\E]E^EoErEFFļzfUJ>hb[hf>*CJaJhb[hfCJaJ hM-hfCJOJQJ^JaJ&hM-hf6>*CJOJQJ^JaJhuWhf5CJOJQJ\hS5CJOJQJ\hf5CJOJQJ\hS^JaJhw^JaJh4%^JaJh]^JaJh}C^JaJhHh]5aJhAh]5CJaJh]5CJOJQJaJhAh]5CJOJQJaJChDiDOEPE^EhGiGIIJJفځ9: x@gd- Q[$\$gdf x@gdf @gd]FFFFFiGHIJJJJ}K؁ف89:hi X! X!߶߮ԛԈ|mieZS hSD>*CJhSDCJmHnHuhuWhnhM-hfCJOJQJaJhfCJOJQJaJh"m^JaJhb[h:^JaJhf^JaJhb[h(CJaJh(CJaJUhSCJaJhwCJaJhb[hf>*^JaJhb[hf^JaJhb[hfCJaJhb[hf>*CJaJhS>*CJaJ rms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. We continue to search for new security features we can add to our Rx forms and we will keep you informed of the success we have in our perpetual effort to save healthcare dollars lost to prescription fraud each year. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title____________________________________ X!X!X!X!.X!4X!5X!6X!gX!uX!X!X!X!X!Y!Y!'Z!(Z!Z!Z!Z!Z!Z!Z!Z! x@$ x@a$$a$ x@gd-(/ =!"#8$8% npaӜyPNG  IHDRqqgAMAPLTE3f3333f333ff3fffff3f3f̙3f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙333333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffffff3fffffff3fff̙ffff3fffff3f̙3333f33̙3ff3ffff̙f3f̙3f̙̙3f̙3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3f (((555CCCPPP]]]kkkxxx pHYs&? IDATx]Z,!'߿LBȥ{]bl^iYrim ^b3Ӕ9M2/Qh7z %PK9~i ex4󆰮ɯ >-S_w?fěw>'zZ<5|HZ?GrGn`\-U>ɹiuaṈ|ׄ(J >kigZS *c9ؕ3@%&t_{w a,7g8j >1;٫y^6[*wfu ^kO?pūԔJ˹KVN'e$jfw79us.|}xdC0e'P̹d(4/N:K[aۿmS|S'[j)MiF4sTF'g-RrWs9t4!1׵ZSw,n.']<şv,maTVIX*^ɭ 6Zc3IQ@Ei9d8cA}c+5$$ˆZ ݃Sl,i"KrWBkq3gEE䅽LtpP[{o;/dA8ON*' `#k3SQ-/b~͹4\=*ڙ;eq 3főJgZI,ooQ";oW7k~PKAEf&L`T㿐 qC,l6Njs=/[܎'G:F/esd.9֎nܹ9lV~G#0?-~ i5=rS;Qn.% Fՠf?ᅓݭbGׯq[0_t2c@g.=vY-dh%οrޠ?/BQTL@YI@"^*7=lxa_x^Fo &o'WlңA:kl-o1ˇ4[P@~ūJukӯ DouP+KB7Y[w~Љ&My0oQ -gkBр HIYTXOyviJCY,^aҕĞGIdzi"ʤed'ЕP,d{2z$FWe7Yߨ+Ф^+p/q!+WV vٟ4?s$|yfS'*a&&jnp8;v1c"csiWBVX-O8 ]}y0̃Dlls&yAw9=FgeKV,[Y,IOv^qvBc-=IU,GٰA*Cz@%;)Ȃw @a}oi&|bǯ_p0xX {54;ZlEl+yn4!JK^972fIK]G=w_?Z(J>kQ^pI|4:_^Dcq8*-c"[@ !8D|07u~7v_~Rg_{Y\6"s['!# rut-Brbk瀣 HF@x¿Yo.꽺[ܲƔqR|ljzYnyJNϚ]hg6tS`Zq!?|qCrYQ(|FԍjT~nL@&e'5[DV $(CˋEo2.~ѧ?ko ɴώt <~c%S xk4f4#?F"T>rIkYgwC ]=7]tNqe.O_:]gKk>[X,N |$u3³L'3{u ?xz+'9s}<_ڭ+B7x2-1=a*h9Ap+XM7 -!,#YEzy)EPaed_#mE+bI⸹?ǴsK{} AO.$/RԨnGa!NF=z~~Okb)ީ!"˝'*LQ'HCCiK]񻍋ҠQjZ[So^vè.ߜiBVJz' ?Cݜ#`@'/}r0EUJO!nϻӎMžb{{-NU T:"ED6+'P"œaB盰%J{/6 S-"k@Dj\h٠.Ym9{֬62?{1DΓ0'o55&1 9yDUd$Ps*]gmhq#gA7>"20$K3^Ζ|=7UFswzg54=3kT-_fvy3i@]ΡxsqE;XM[`7~dܵ9?XZIGƈ?/PшYeIS(eu4hG.CKeM5ߒ{@bХ't~c#kˆg6~ E6wZ; ؎gnM O# wa9(x壽UbkMP5dT`Mxȡ?/[YAL`23W,m4s$փC;̓'mw[aK>eխjqTv‘=?B!zBh چ$1"8,@fhz{"m}4B{ز ,Hnȿݴ0{v羜#n~ܝ3Lr..qxKYXUu l5ذ0zd;|6bxΌ M)#$2# ļ(*,<e doH 3n$>2ǰW,+~J!!'hs;W_*!MyDKniq+q6~Ucn`~(@`-}^L̨}~_rf{CY-.2S!kA?:gE))g&ʐ'bH?7=KEv:yNE rව<_ai/)=|_ޟJ/ 2=G檜09 n$"Z]KEI0tu{~#h&Q;F蜼+埇(-#XwYa .ł&ν}zu AD9l/2TI`L>ǑG޷B#WEVmi. 7j~μ*|X+MW\'feuI"! no=C8q\sȪ^8aI[m \^Dlv>❭?'n1IJ%+h 8 Ғ܈IEMLitcn+G6K~1ۍs m݋'9 ?ڸ^8Z0f8> (WB4uH8^nAK@}\(`TK=a;*e\T>gŝ&&Z&+X>\@K~FB?1j"o || K "|έJٛVXPZ!!U'-g!WsNEݻs^E"%%sCQԫlbOvq`81OD  &+n &( LlEnI~r(}]\v{ArVy>]N'{/{|8<`U;j^rOX0}~BsKxn+2I+SpbSotb1jg?qC\Q~#,[Ĭw)ć&@`1u}3ժZoZIGb,|//pRP?mIQ*=&9طF&N}=JeB$g wAZo[| 5VU)tfB# ZuݘMBDuacmٺk56N--2TK~0t< {@7nZ^7i%rn[$bAh]V&{do;1?F 0'"1ü֨4L] B-x^|u%[ho%Nn3#Wj0앮ۼK8 }.+DpbtB \(QABG5PrvQvt0)r|%(5fEUB,U74HvsBjԇKQ8ZR%.0j ŸBdo8'C0ʞ>|>{kewgGt^]}̌A o(]1HQ.Ȝ O؅ CЄEQE~!? )j! -헻^I) /Ѣ3+p9=#7ߡjK9)#trUxs` y "gWN,x΋Ēk"R@M>Ȝ!#fˢ>3bH+ 8@ni.+Y ,<$c$ee_a>LX̳H J*1t;{Z8B[ؐ/1%T6V7$}\}08!"}HU1o6(҉Bɫ[^r@tF7D 7 `Hj*s<ݸ1J nw=+Uo[v؉cvd5޷'V؍[bBFp@MO`&+Y I<9sNX)MWDtrʪ>9A߆-x%; 촧-:<݅jԧZqݑfwȀ h`3C)BFMbWA&b+8+*b5+6_z%r3ɭHZ2O( ~+Tr/WMY]\̐hrUT86m~dv _x\yB p#r(V$TծPfN@|$XpȪ•4\2(PNfԅs}d TG8^&}iYpzDOvEƓ%vBL(9WGy MJ@ʱ8 F?~B0``nqyU QtuQxVrΜjU +/6^(o24vL%Y oZ(Ylp㥈ٹDkg_ܭܲx\Ƚ!л GVD.!ͮ[`c\Ny>:!Ev&IP-TxU9S2-⬧mGw21=x IDATg^V8Q5prU%EMHA{H/J|4>(<-f!NE (8ZK]OYI%wK<+) ]ԪycLGFǏH-T#$#(0%A>[i$!ҲA$n] aMʷ&+rZ+z l"un;xyxUqr<>ݎo^s5 N@)pXl8 pV^íb R|' :pOǵsm4(!av@a$KOwdY,t>'}S=Upy.iDeDzZ WҦЖ.u&s(t?Es \?׸?hE:o^9'5mjxݴ) U$A0BXI,IGlyVJ9r߬ozcΎ1+KB7A;s %q54v'4y(-6Ԟ2rԫiZ8i6BL3[ih(;BDJ%L\J&t=ojr7{v3CcĬwB9MOۯ[k]ai%-O!pK)}NU3̱bv '0 N\|kg'f8 v"V89oɍC_׭U@dԙI4{K]5A!꤃26۰9]թ s xX8@\KoOv-T-X4B=*5Y_xG3zEDMZZq`~"_\E,jVмL5כq./~)'6R-U%DkpY_߲t6/Uz&(MT9TT6s塚tȚ`MpCs{AxmVB3Xn6W/agOqX1m, lɀ{u!ݪJP$>_X{|yZ3͏Y;{7+ 鉘U"9&';Ո*PlΝ $>iQ;m%u*F,o6΀V:~\t5D?6-w ͉+4^ 9+b{zeVX 9^ ;!`x#9=m]Be^a7` lia+Y$Q+ 0W^dȤh]q# (UL%R.FQQW5V!7B }y"C-f%A*hٷ47NSBh]ԽƄ"n4OjYGog<~6ݲx^aD0 U!i!V8p$W$-[df=U "| %i^H8h2]ރ;B_ߟsg_nX0,bn?1 53hLpC}fJBάzDm rhpH{3UpETaHێR:֜t+_Q># CCD3oP1*kƵ"Uw$ nI [hȲ=֝QJt9 t*1/.y%?H?V-3fxs$#&P b4pJٛ!r$F9I=G }.<}$)u♛@,$K֭nL󽻏gv@x޹ahoxc& A3"@m;GCŷTfllqXӋ0(A>A*8S?s[q*&`VCΩIH74 Ƭ IpFLk|0YW$+Kܣr{ d3AjS|N"wfe&hH':Q|$k_]>l%57W;gڌd%3wDB ڼ`qP|vK:8pnCjڽSgg y!8p䱲R&kĴ&q̍,L:<)r&h=Myp; XBI"m)z=.mjݚC8*u7ÞP f >5V\W-&%EV5jƜ"Z%$xU.܀D9sL5 ~ $Jo R2^oB4>뺶x' }L%Z^`A(( ؉ rlR[.gc7qٖ=.$T"iRsu4UT2,89S c̗?vm* ShxLM ;q"(8qCޣ>oٵḳgj5jDvc3gE-Yi8-m{!*'jdep5ͬHZ;F.Hu k ިV)dF]m-f}ہPqEjEv4hv~v Xk{.n׵;O!ӌR[mgB>!jt"C=BMN4XZH'b XKE4( nɲ7@'[H/NS s4_nV?=#>lgP"LSI&1gT\\#<B!X)hg9D i5},,LpcNs\E= MT,f;WOK2j*TqH"*IQ4$a#3yGJ=a$ra.0;,aB vKn |Ж9[tj>9Y6vj'mJpC9g'(sPBM'P=bE<Ϣv"#VbZT3d}KTXFcp%מ"Nү_:+~Qsl"JzDHVB]G ۠li>Q{$1 ޹z%'//)uږȱm#uCҞ,A{~9̴ڪ+9mfc_'TKi[rƃ#9C8#$ U𚜤e+?MQĹ5PYIqewX-/,-"t"E0WNZ$b o'+y /4i'@5DJY5f Y>AvQpeB3LU6)úJ=iu!ND' ɟ uB$e;ụ*m?ռR1GɆB}P$ M*d3iu2Cg_tz|,)׫= Pñ]u56&=݁LPa5ͤ :aUS-R)TbyAZ5Bh>PaLk5_u_E)Y_7Rٜ F$餜D83fkR+W{ܸ]H@ 0l<}PP)ҍr5PMܨG2QBvײl#5PCxMj gr]yƫvHH+8 濭dEkR8CKKgpuDҡosM"1!vj]0 Sg@P/DG7L&CFn_f>ޡ O[Iל k:mrV5(D0_ Y4_SM-""t@Jh1v\{CHj~8x@u)0j3` Z| ṱQOlId HT\ÏH,d; sCJZ:Nyj} 24@laJ#" 7FW5iD'*PJG| }EA_㉍q!H} ;0 b,i?zuWJ9qʼnNKHj4E[{_T,e͆I-K>ٍ^F>PJLNn@&a4}6#b3o-iTc"iY'!ޯ0zUOUS Cj$> V" (]!#L3yq ʳyDKrJ1Qof?2zeAe,R 8 4&D[K+^zE9$=lԊ# .6-y"*V=WuCoa7*0qݷo/fjCݒ$srN/C|"j}AT]) Nԁ$7R~fs'gd#/[fs;>v{n .{ڬM ax`i~@UbcKs 2]A4M gϊ%TDL[Gͨhsع'ߘk [!}BsUr`&}epP&!=/_sc1:p⅞o#05ٜȝDŽ@|7*bh!P vY_}u63r̕'_ a /̙3!NI@`Pr9\P/S?\T\ UV pUmxݗṣFwkV^&1'A8謮ՉbVf$ Ss1bv9S>a qxq+m_EF71ȨWQV5,RrOU(dtjw qX9NXaj< W!Jj#5*ɱZ-jSgaFha7f4qo2 SS{ŁH`dLEj2x"=xLՒpOdȑ-KX < n4`CUCW= -ZtQ_օORM :n|;\,HoߥA^ Z?9miR2tp}HY~6VP_ 2-' ጄqrxլg\l iZ.}<21EWѽǖ*-HP@B3&oJ\R(\ 7?Aݏ c~Q}?06v}o]?;}bv _Q:k(hnx`hpa,Vڔ8y9AR­"we_Voٛ@sq ׫ {X'jDž]6׳=)?K;.K:}tUy7}z!!I 7k98^2pTLgrRgB,rDo NNtsֈ^i7Q0ஆ1%nNC1vW;r+kgJVNuh2H3nk+G#U[ %IY"!WqtT?6V!N(evXgvJĠʏ-/8(E$XrШh>N9۾@,leVeҀ?rphȴ^Ԟ9Z"3߶xpLE@IIсnTUy' e:g*h4¡6d7?57/HZXPr#s;rٔKR#]g'g[vcwD춎QYv19Vnj;OW-i™'3ǞHɏh(NYf{cI q&f*hz wciuv!/lb@*b@RӬW߳5䴪d8\h vZqTXGM$@?x6്E4pٶ9?B(ᢃԘDLc0:2EvWU F G6Bv:kIJM*?cV軛Gsa1]Ge)Z<\{7Y#WGt&~C^}Tk)<~e<,+7yǮZF1פ_1Ӊ%oGj@yh?qK~T86SJCn\RѥŃ3˅͒G;"P+q$)ȡAͷcIgCEh|g OLX8"3O$-Uo~s~{u,F(*~**fRc Տ=aT@ey-H[: [?up?{~97хPZ6t XDJ"B*`8p;A \(!gs(:{S`{A+Nebh/Cy|Nx,EoDQ,Yҫ~<ШļIͮ-dɚd$*B,ԤSbAusp\'j-)!N qtaJ{S6Bh) ݷM~l$\eX7`gW7[8l`ީ>A YoRRo4) O3k9ԉNkQɓυU(yGNŊk4qxV\:0ey [O3>~ZkCwyhBF˹' qBV |ԛYKJh-(b 7쉕My)N!h6Fa À@E#;$&tRfw^pKx|wپ#\?QпIpfy=)NV j^[3!P̎r3,!5A{?;(Wk{hnǽvp\E&VWuz$;ɱ=lR O]V 0 !0e;KhDō_\ڍkd`,4P'[~k}w/:LRDir_ˍ"E,%)Hȳ:P<0;$7|¹e3oAFסrD۬ 6?tt.cԺzQZsOZNFLk|EۉB|? Y&Ѐ>&sX[S{/jy"m^ m-̪eܲz1 "jmᅀ^%uΚ;Gye7t<36fx}P;0S/2_@53^lIJ ,La\ Z\k Ccz-NUdn`q0cQqWRiCfq:&>i{r6I2G k+Wb߶]Ѕ鍖-$}Rvèv |4j,1x*C8Cda$&tΆ GgI6RJp!ˑKH])t0SQ OpstZwCdH9";$RCA)aBUJ<gw߇vc#H.[&nDR(ǯkxƩq2v%U~?YLo"|JPETL@TJ:+wmqt>g1|60 pgWxºDH..Q<@\Ө^v>n7?< B2T= r$I9#D5M/ Ƹf1={9RԜ/3~Dq/LqwvS'Ŕ~ص?W[j.K|.>MDh`\.'TAp վl$TʚD^"2 n) "D ٗ1Bul@Hl?bZL~>.v%s 3&-|܍-/(͝o"pF[ūy0+d&;`Ót4AxQ≲e#j#GlٽaSh޴YᷛCY<ql)kE3'g&M 97W"|8 S^eB[c:W:B6Mc:VuĻ&=+=+B$l}g^v35pvЧr6^M?>8 ,e3X'l7"RdO'gdZ:W2l+8̒eI4Jȗy*7bDr F%Us1d `paEðk8= glw§߰xlϙ@A ocy?“eO^q6H3ThC7+Ww$N6[LF P5^rxq wnjøN̍%zasߪCGIdI&bJ\hsZT@Ǫ83WW917+PPㆮj[xǦO:7=a|~ Ήkapw ?w};Ċ ˮCnygAx;Cߡ#'yF9r (>7)Lv1)m| 9,4gA俴8I-⧂+(;+%l*R6șEhm\#84Ar؏Lÿ7/^?g'lCCh-T //оDk?v1[^X B3olbϸCXsmqt]Q>-G1(iC \[5 'cř!JII8eUpl7A":*M$]'(Sd)p^y ,U).{0m?;h[BY))KeF5wzCiZOփ^EmtyaApSC$J(.kq7ڳAٕ#D-篥2QvoO;؜PBlxZ 'rd=qᵱ8Ek˹8)x~̭O07YeKm|q$7Wtks2;m3D\Fb|$^YXn[yb+!_9rI 6}ZD] :(f;_?*8 8 Ҫђ 4Q0ABS2ǟg+d,&( d  UԵ.tHb/[|Z 8=8 0kU9Y*LHlHVԏnEHA<>gj$$RO켮Op E UhAXN ?X~jq\f?Y  u,p 4R%G*a!0# | Fg{9Knoׂt.Hr--FMrHdbj㌓WԟFԋLU Xk!K$:`qKxg"/ $@P[Z3!F:Oo.%M7YMt6fgҫxheNs]އ&3j6醛sWje6ZPAEs] 9GgNRS@;A5-Qy9/92AĈ i':X[sO_eykl*HP+:/m:<^~T?)h'EmW7Y!::`2 V|biLqwٜ͛CN?j! ]Z@):$]C/\MDC1і}zWAN pYg<3f>o_P4**NM x$ NH,~`J%Qeۅ?9:;! <+:l\cgIz ZU$XCnR>YT]thP).1tUʘ|uo]o:k9AJJ ڸ`yC_6'I`fT#JQ*J=ml7.1.j+!=[eU%4E?ؾ,AaK[ _ʿjQKE݆^qA*jKp۔:MK!zmWbyI5l&I7 bhhbgڗT eê8dDGtn$y'5#@,^^<% ѩ.7q8E\Ps NI8]$iG\wU f@ [3'vYr ` w5νI:W18UJGo)kxƶ #^'Kii?7Ž|{<ř/GIUP8* vY|BB'rMl0 Z9 Zӄt8ݲxr8+3+(oX?7~wr:pBOġ8V d4V܉; CD>BrÍ>~SbOʊ.LV# d h&'jϷZ G(( (YiiOMzͯBGHҭ > "HT> wشkX3j(P\o|qWp!`InI-9X}'ќp#Ta<#yY\ cҒ;Re dW,h4גdq5PwM=P 所@%%P-TĘa2V=PuG-'RQ71X,y3$XG] s8Cbq \OM;( Ik1'W59-Y&\m꾠b(G,ׯX˕8J99'd'᫢*fHJe)|0/(> 7HDS,8p;mT1#jPD¸̒Qy~հFod:T=-XЯY!RdlͬI''K#8Y6g\|3kRD |ngׯY\ND06r9YғK'S5]}:yInu[koh.;>5*7X9LC!:6<X1V?p"TT3k8nqJ֕?z-v(0+ML1Ez<'9?D\0|pкl=nFofasmԎzIm<&19A)\i墓jA I۞ϊgޑ`sϙ(6k{ֱyKI .P=|Jݷ߱xh^&+4g&ǴEr꨻ h1\!TH&UI!i{ZYԾx3j`Q3O~\r̥hTTj n'(Ƭtk_LCVph[w^$H;-߭ўj`rxi|q9aLKC`3GYbixmrf?ȥCrNԶv-|Ax'-AY [i֭Eɕ(\h<4(dx:0 A>\k$Hju߰%gt3(TYQZb.s0)J%9l0X ݭf?-kq7)8Kx$r9'5 R5/4ҕKx۹ E)B%n [ !)yÇ\"eofx` cWiqm+wQz5# Ƙb ŲKq;^_TSZOm }B T(@R{ȉ}5@Wk޲dzC8q}q.>$5KRsa@C'Yed,fq;Z)9\Xs SXUX5^9㉸(;X<6OX &1!6v -|FOHݓk*Jt CW \4] Ռ>hzA E3Sɹ2Z\b?vB+@f&IAAw5bUV&ǽI\Cp?iBAeҁu(;(\G-Πh OԹD:-ᵈCÄI \K=rA+@Z̹ǻYv=QA{lkج-+)lVD|xg  Zsdj:pvbպ<:px̻"݉Gwsէi5O [YL/Jt@GN)esWPgu"Yu{+i4U*,QZ!~ƌ۸\ִ~PIi#a(da #k!y`v L nv>C&l6tRJf}k"yC:@|U[$ix^*W!dF9?Wb`azT"3mNa'n;&;\"*)Xg",rSKjCJ"xViDHbjC&ߜ[ekˇ}{s6ym`(J`qU4r̓{_ϖa>q /0j͞B¦@i oYcw)4ptL&3;54cPT}"<,uPI,Ҽ!pD=\-+S ~ZTdX'"2pP俍Y!ǯ ^x,NQ+B !5<&l,a&$=,=neĈ8#%# G.+\օmO,c=~>~oxsdtf,e}KݮO ~jbd{j9x=aCF62=B+O>Hpeٻ\jΏ> a[ߝJTwCPq~ߴ}̲xK mM8᯼CV\0[' \ J& |)= Qcu{=Nqf؎dΠY$IŠٕv$0l1)߭_nۧlO0'vGk5j{=4PS5ΰ,{fWCO!3Go!bQ-FGo}NOեM$l ѫ %-,bvU vbjnܗdH 8A\ous~+cB n^2{*cbEݦpv5-wd`aM{LM|=NCo1FTmT|`s*J܅OHiOIxG:UP?;.4͎@(NZ +uS3γl*3M-*BԳO#1V; uSl$XomVxP h *6fN5$.Ev֤E8gzԨө)Df#~)Һ5 &9QtL E&YVU<4;ە L"D%S<0_78{t; 63N -KaHos qrz>gY)ҴgdsVc;%CW!YcϹ 6h0ECi:rPfR PYh|c7=]R}yNVhb͚7U_G$m/~c4;׸Hecѯh ~9n|6 nրM'͂@"2PIs8'ѻ $ޛZ"4zaf"Ō>g@e+ϢQ$TFRvݻȾ-F݀RD^ۗG^m[◊䓴x yV;|+gKFͳQ9,Rjt<;?UUx6ReoAㅹmo 3|yweQ͢ʚe@ca9s:Hs~e=qoXh ;a>^5[Nh^I$9DL/4}]Ǹ|<%((@Ulu$V"SKMe KzW]4%ns4~ &{2j-vv0 "q"v&_yTCt;ª8DuuYzK:| ]}JP+TryJ8" bhC,!_d5Xe؋pEgza2W)bQ}WȬXE=Do6aW6|gU3i% | 3FExK wLa1HFVM!ThF.'3ԤP''j4YEm1*T O[[:-({/x!e&%,{zY"[cI=eӍz©9K#ځ`ΦbpI&ŕfYeW!H cU~14YA7P|9vm{0\џDlhSF^W)JIG^JdݗI,SS*rO1{^厨bTe,gB.kx3t(^[jL8{"űy9jc" Y[1C+0O_Z$*[%>>= i;'=L$Vj8G^Vx2%;s]iԨbFnQkPH?[riP~뾪/`~lTS]fk\v F[4"'s?~Bjڊ|[96sM4!^18Rf(vӆ̷*޵M2cmqaeh b 2Hڵj;)T#iLg1~'r't#2scEJTQ%X`qE݀#>%9VdN?Fmucq@{2=VYpc!l>v3)n%W58ϗ玿QefrOf\ȡ7IQ{ Mfk:e"OyW V-<5DC 1aqDbaYvޙ_]7"5KbVLT~60%H*`ŊW_+FJ Sleܮ8="Gۣ7-!eMOo-fܲ*`AջL/@B.5{@q>Ūֿhk<[濿PT a|fL"TʌFC}yU KėB &̔*=p7rƳ;oj[vy5b )'B*d?k4n/3xVH3"ͻCl|WU鯾\,$^idTFWwgȎƁ [>Q FE#LJSmF D> w5w\9.jSJ#,Sf)֏_iÁbG=K\B㭬|k094VErƭyiXȟ5*S[W˷Ưo_-Z5~|kjO5wl IENDB`]R}yNVhb͚7U_G$m/~c4;׸Hecѯh ~9n|6 nրM'͂@"2PIs8'ѻ $ޛZ"4zaf"Ō>g@e+ϢQ$TFRvݻȾ-F݀RD^ۗG^m[◊䓴x yV;|+gKFͳQ9,Rjt<;?UUx6ReoAㅹmo 3|yweQ͢ʚe@ca9s:Hs~e=qoXh ;a>^5[Nh^I$9DL/4}]Ǹ|<%((@Ulu$V"SKMe KzW]4%ns4~ &{2j-vv0 "q"v&_yTCt;ª8DuuYzK:| ]}JP+TryJ8" bhC,!_d5Xe؋pEgza2W)bQ}WȬXE=Do6aW6|gU3i% | 3FExK wLa1HFVM!ThF.'3ԤP''j4YEm1*T O[[:-({/x!e&%,{zY"[cI=eӍz©9K#ځ`ΦbpI&ŕfYeW!H cU~14YA7P|9vm{0\џDlhSF^W)JIG^JdݗI,SS*rO1{^厨bTe,gB.kx3t(^[jL8{"űy9jc" Y[1C+0O_Z$*[%>>= i;'=L$Vj8G^Vx2%;s]iԨbFnQkPH?[riP~뾪/`~lTS]fk\v F[4"'s?~Bjڊ|[96sM4!^18Rf(vӆ̷*޵M2cmqaeh b 2Hڵj;)T#iLg1~'r't#2scEJTQ%X`qE݀#>%9VdN?Fmucq@{2=VYpc!l>v3)n%W58ϗ玿QefrOf\ȡ7IQ{ Mfk:e"OyW V-<5DC 1aqDbaYvޙ_]7"5KbVLT~60%H*`ŊW_+FJ Sleܮ8="Gۣ7-!eMOo-fܲ*`AջL/@B.5{@q>Ūֿhk<[濿PT a|fL"TʌFC}yU KėB &̔*=p7rƳ;oj[vy5b )'B*d?k4n/3xVH3"ͻCl|WU鯾\,$^idTFWwgȎƁ [>Q FE#LJSmF D> w5w\9.jSJ#,Sf)֏_iÁbG=K\B㭬|k094VErƭyiXȟ5*S[W˷Ưo_-Z5~|kjO5wl IENDB`VȪ$$-$$F $$$$$  Ȫتڪܪ&8:<FXZ\hz|~$$$  $$Ȫتڪܪ&8:<FXZ\hz|~«ΫЫҫ &(*4FHJTfhjt$4̫૵B*OJQJhnH 5B*OJQJhnH B*CJOJQJhnH  5B*hnH 5B*CJOJQJhnH  B*hnH B*CJ$OJQJhnH 5B*CJ$OJQJhnH C«ΫЫҫګ &(*4F$$  $$-$$F $$FHJTfhjt-$$F $$$  $$$468BTVXbtvx$$  $$$$468BTVXbtvxĭ֭حڭ5B*OJQJhnH  B*hnH B*OJQJhnH ĭ֭حڭܭޭ$$  $$ 3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p          x\L<, tdT D ( h xb((&xb(3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p                    -  U$   "FAX""TO: Sylvio":"PLAIN AND PRE-PRINTED njpb'""NJPB'""MESSAGE:"$" sulvio, thank ""Sy"Z" you for speaking with me about the program" "providing the "^"selected Schering physicians with pre-printed"^"using Rx PROvisions, Inc. as a vendor to supp""NJPB'"^"value added strategy to help you build a stro""make budget."*"yo3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p                    -  U$   "FAX""TO: Sylvio":"PLAIN AND PRE-PRINTED njpb'""NJPB'""MESSAGE:"$"3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p                    -  U$   "FAX""TO: Sylvio":"PLAIN AND PRE-PRINTED njpb'""NJPB'""MESSAGE:"$" sulvio, thank ""Sy"Z" you for speaking with me about the program" "providing the "^"selected Schering physicians with pre-printed"^"using Rx PROvisions, Inc. as a vendor to supp""NJPB'"^"value added strategy to help you build a stro""make budget."*"your product sales " "s. "^"NJ physicians must use these new Rx forms, so""NJPB'""easy "^". And as an additional incentive to support "@" which will add value to your "@"the service you are already op""providing."bRJ                       ] e   uu6D6D--~~drdr$$9!G!9!G!^!l!^!l!~!!~!!<#J#<#J#P"And we are also a vendor for Schering.""your "^"1.88 per pad of 100 Rx forms per pad. The pr"^", 6% Tax). The minimum number of Rx pads is ""per order "6"Pre-printed Rx pads are r"8"provided at no additional ""cost."^"The price break on the enclosed order form we""will pay ""37.60""Plain and " "/or""approp[riate " "maa"*"nger you designate."" if you wish" "PAYMENT OPTION"\n (u Bom /z @B r$! ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ss0sss spsss`?G@B/z!:xr$!\=I}}.x3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p    3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p    npaӜyPNG  IHDRqqgAMAPLTE3f3333f333ff3fffff3f3f̙3f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙333333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffffff3fffffff3fff̙ffff3fffff3f̙3333f33̙3ff3ffff̙f3f̙3f̙̙3f̙3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3f (((555CCCPPP]]]kkkxxx pHYs&? IDATx]Z,!'߿LBȥ{]bl^iYrim ^b3Ӕ9M2/Qh7z %PK9~i ex4󆰮ɯ >-S_w?fěw>'zZ<5|HZ?GrGn`\-U>ɹiuaṈ|ׄ(J >kigZS *c9ؕ3@%&t_{w a,7g8j >1;٫y^6[*wfu ^kO?pūԔJ˹KVN'e$jfw79us.|}xdC0e'P̹d(4/N:K[aۿmS|S'[j)MiF4sTF'g-RrWs9t4!1׵ZSw,n.']<şv,maTVIX*^ɭ 6Zc3IQ@Ei9d8cA}c+5$$ˆZ ݃Sl,i"KrWBkq3gEE䅽LtpP[{o;/dA8ON*' `#k3SQ-/b~͹4\=*ڙ;eq 3főJgZI,ooQ";oW7k~PKAEf&L`T㿐 qC,l6Njs=/[܎'G:F/esd.9֎nܹ9lV~G#0?-~ i5=rS;Qn.% Fՠf?ᅓݭbGׯq[0_t2c@g.=vY-dh%οrޠ?/BQTL@YI@"^*7=lxa_x^Fo &o'WlңA:kl-o1ˇ4[P@~ūJukӯ DouP+KB7Y[w~Љ&My0oQ -gkBр HIYTXOyviJCY,^aҕĞGIdzi"ʤed'ЕP,d{2z$FWe7Yߨ+Ф^+p/q!+WV vٟ4?s$|yfS'*a&&jnp8;v1c"csiWBVX-O8 ]}y0̃Dlls&yAw9=FgeKV,[Y,IOv^qvBc-=IU,GٰA*Cz@%;)Ȃw @a}oi&|bǯ_p0xX {54;ZlEl+yn4!JK^972fIK]G=w_?Z(J>kQ^pI|4:_^Dcq8*-c"[@ !8D|07u~7v_~Rg_{Y\6"s['!# rut-Brbk瀣 HF@x¿Yo.꽺[ܲƔqR|ljzYnyJNϚ]hg6tS`Zq!?|qCrYQ(|FԍjT~nL@&e'5[DV $(CˋEo2.~ѧ?ko ɴώt <~c%S xk4f4#?F"T>rIkYgwC ]=7]tNqe.O_:]gKk>[X,N |$u3³L'3{u ?xz+'9s}<_ڭ+B7x2-1=a*h9Ap+XM7 -!,#YEzy)EPaed_#mE+bI⸹?ǴsK{} AO.$/RԨnGa!NF=z~~Okb)ީ!"˝'*LQ'HCCiK]񻍋ҠQjZ[So^vè.ߜiBVJz' ?Cݜ#`@'/}r0EUJO!nϻӎMžb{{-NU T:"ED6+'P"œaB盰%J{/6 S-"k@Dj\h٠.Ym9{֬62?{1DΓ0'o55&1 9yDUd$Ps*]gmhq#gA7>"20$K3^Ζ|=7UFswzg54=3kT-_fvy3i@]ΡxsqE;XM[`7~dܵ9?XZIGƈ?/PшYeIS(eu4hG.CKeM5ߒ{@bХ't~c#kˆg6~ E6wZ; ؎gnM O# wa9(x壽UbkMP5dT`Mxȡ?/[YAL`23W,m4s$փC;̓'mw[aK>eխjqTv‘=?B!zBh چ$1"8,@fhz{"m}4B{ز ,Hnȿݴ0{v羜#n~ܝ3Lr..qxKYXUu l5ذ0zd;|6bxΌ M)#$2# ļ(*,<e doH 3n$>2ǰW,+~J!!'hs;W_*!MyDKniq+q6~Ucn`~(@`-}^L̨}~_rf{CY-.2S!kA?:gE))g&ʐ'bH?7=KEv:yNE rව<_ai/)=|_ޟJ/ 2=G檜09 n$"Z]KEI0tu{~#h&Q;F蜼+埇(-#XwYa .ł&ν}zu AD9l/2TI`L>ǑG޷B#WEVmi. 7j~μ*|X+MW\'feuI"! no=C8q\sȪ^8aI[m \^Dlv>❭?'n1IJ%+h 8 Ғ܈IEMLitcn+G6K~1ۍs m݋'9 ?ڸ^8Z0f8> (WB4uH8^nAK@}\(`TK=a;*e\T>gŝ&&Z&+X>\@K~FB?1j"o || K "|έJٛVXPZ!!U'-g!WsNEݻs^E"%%sCQԫlbOvq`81OD  &+n &( LlEnI~r(}]\v{ArVy>]N'{/{|8<`U;j^rOX0}~BsKxn+2I+SpbSotb1jg?qC\Q~#,[Ĭw)ć&@`1u}3ժZoZIGb,|//pRP?mIQ*=&9طF&N}=JeB$g wAZo[| 5VU)tfB# ZuݘMBDuacmٺk56N--2TK~0t< {@7nZ^7i%rn[$bAh]V&{do;1?F 0'"1ü֨4L] B-x^|u%[ho%Nn3#Wj0앮ۼK8 }.+DpbtB \(QABG5PrvQvt0)r|%(5fEUB,U74HvsBjԇKQ8ZR%.0j ŸBdo8'C0ʞ>|>{kewgGt^]}̌A o(]1HQ.Ȝ O؅ CЄEQE~!? )j! -헻^I) /Ѣ3+p9=#7ߡjK9)#trUxs` y "gWN,x΋Ēk"R@M>Ȝ!#fˢ>3bH+ 8@ni.+Y ,<$c$ee_a>LX̳H J*1t;{Z8B[ؐ/1%T6V7$}\}08!"}HU1o6(҉Bɫ[^r@tF7D 7 `Hj*s<ݸ1J nw=+Uo[v؉cvd5޷'V؍[bBFp@MO`&+Y I<9sNX)MWDtrʪ>9A߆-x%; 촧-:<݅jԧZqݑfwȀ h`3C)BFMbWA&b+8+*b5+6_z%r3ɭHZ2O( ~+Tr/WMY]\̐hrUT86m~dv _x\yB p#r(V$TծPfN@|$XpȪ•4\2(PNfԅs}d TG8^&}iYpzDOvEƓ%vBL(9WGy MJ@ʱ8 F?~B0``nqyU QtuQxVrΜjU +/6^(o24vL%Y oZ(Ylp㥈ٹDkg_ܭܲx\Ƚ!л GVD.!ͮ[`c\Ny>:!Ev&IP-TxU9S2-⬧mGw21=x IDATg^V8Q5prU%EMHA{H/J|4>(<-f!NE (8ZK]OYI%wK<+) ]ԪycLGFǏH-T#$#(0%A>[i$!ҲA$n] aMʷ&+rZ+z l"un;xyxUqr<>ݎo^s5 N@)pXl8 pV^íb R|' :pOǵsm4(!av@a$KOwdY,t>'}S=Upy.iDeDzZ WҦЖ.u&s(t?Es \?׸?hE:o^9'5mjxݴ) U$A0BXI,IGlyVJ9r߬ozcΎ1+KB7A;s %q54v'4y(-6Ԟ2rԫiZ8i6BL3[ih(;BDJ%L\J&t=ojr7{v3CcĬwB9MOۯ[k]ai%-O!pK)}NU3̱bv '0 N\|kg'f8 v"V89oɍC_׭U@dԙI4{K]5A!꤃26۰9]թ s xX8@\KoOv-T-X4B=*5Y_xG3zEDMZZq`~"_\E,jVмL5כq./~)'6R-U%DkpY_߲t6/Uz&(MT9TT6s塚tȚ`MpCs{AxmVB3Xn6W/agOqX1m, lɀ{u!ݪJP$>_X{|yZ3͏Y;{7+ 鉘U"9&';Ո*PlΝ $>iQ;m%u*F,o6΀V:~\t5D?6-w ͉+4^ 9+b{zeVX 9^ ;!`x#9=m]Be^a7` lia+Y$Q+ 0W^dȤh]q# (UL%R.FQQW5V!7B }y"C-f%A*hٷ47NSBh]ԽƄ"n4OjYGog<~6ݲx^aD0 U!i!V8p$W$-[df=U "| %i^H8h2]ރ;B_ߟsg_nX0,bn?1 53hLpC}fJBάzDm rhpH{3UpETaHێR:֜t+_Q># CCD3oP1*kƵ"Uw$ nI [hȲ=֝QJt9 t*1/.y%?H?V-3fxs$#&P b4pJٛ!r$F9I=G }.<}$)u♛@,$K֭nL󽻏gv@x޹ahoxc& A3"@m;GCŷTfllqXӋ0(A>A*8S?s[q*&`VCΩIH74 Ƭ IpFLk|0YW$+Kܣr{ d3AjS|N"wfe&hH':Q|$k_]>l%57W;gڌd%3wDB ڼ`qP|vK:8pnCjڽSgg y!8p䱲R&kĴ&q̍,L:<)r&h=Myp; XBI"m)z=.mjݚC8*u7ÞP f >5V\W-&%EV5jƜ"Z%$xU.܀D9sL5 ~ $Jo R2^oB4>뺶x' }L%Z^`A(( ؉ rlR[.gc7qٖ=.$T"iRsu4UT2,89S c̗?vm* ShxLM ;q"(8qCޣ>oٵḳgj5jDvc3gE-Yi8-m{!*'jdep5ͬHZ;F.Hu k ިV)dF]m-f}ہPqEjEv4hv~v Xk{.n׵;O!ӌR[mgB>!jt"C=BMN4XZH'b XKE4( nɲ7@'[H/NS s4_nV?=#>lgP"LSI&1gT\\#<B!X)hg9D i5},,LpcNs\E= MT,f;WOK2j*TqH"*IQ4$a#3yGJ=a$ra.0;,aB vKn |Ж9[tj>9Y6vj'mJpC9g'(sPBM'P=bE<Ϣv"#VbZT3d}KTXFcp%מ"Nү_:+~Qsl"JzDHVB]G ۠li>Q{$1 ޹z%'//)uږȱm#uCҞ,A{~9̴ڪ+9mfc_'TKi[rƃ#9C8#$ U𚜤e+?MQĹ5PYIqewX-/,-"t"E0WNZ$b o'+y /4i'@5DJY5f Y>AvQpeB3LU6)úJ=iu!ND' ɟ uB$e;ụ*m?ռR1GɆB}P$ M*d3iu2Cg_tz|,)׫= Pñ]u56&=݁LPa5ͤ :aUS-R)TbyAZ5Bh>PaLk5_u_E)Y_7Rٜ F$餜D83fkR+W{ܸ]H@ 0l<}PP)ҍr5PMܨG2QBvײl#5PCxMj gr]yƫvHH+8 濭dEkR8CKKgpuDҡosM"1!vj]0 Sg@P/DG7L&CFn_f>ޡ O[Iל k:mrV5(D0_ Y4_SM-""t@Jh1v\{CHj~8x@u)0j3` Z| ṱQOlId HT\ÏH,d; sCJZ:Nyj} 24@laJ#" 7FW5iD'*PJG| }EA_㉍q!H} ;0 b,i?zuWJ9qʼnNKHj4E[{_T,e͆I-K>ٍ^F>PJLNn@&a4}6#b3o-iTc"iY'!ޯ0zUOUS Cj$> V" (]!#L3yq ʳyDKrJ1Qof?2zeAe,R 8 4&D[K+^zE9$=lԊ# .6-y"*V=WuCoa7*0qݷo/fjCݒ$srN/C|"j}AT]) Nԁ$7R~fs'gd#/[fs;>v{n .{ڬM ax`i~@UbcKs 2]A4M gϊ%TDL[Gͨhsع'ߘk [!}BsUr`&}epP&!=/_sc1:p⅞o#05ٜȝDŽ@|7*bh!P vY_}u63r̕'_ a /̙3!NI@`Pr9\P/S?\T\ UV pUmxݗṣFwkV^&1'A8謮ՉbVf$ Ss1bv9S>a qxq+m_EF71ȨWQV5,RrOU(dtjw qX9NXaj< W!Jj#5*ɱZ-jSgaFha7f4qo2 SS{ŁH`dLEj2x"=xLՒpOdȑ-KX < n4`CUCW= -ZtQ_օORM :n|;\,HoߥA^ Z?9miR2tp}HY~6VP_ 2-' ጄqrxլg\l iZ.}<21EWѽǖ*-HP@B3&oJ\R(\ 7?Aݏ c~Q}?06v}o]?;}bv _Q:k(hnx`hpa,Vڔ8y9AR­"we_Voٛ@sq ׫ {X'jDž]6׳=)?K;.K:}tUy7}z!!I 7k98^2pTLgrRgB,rDo NNtsֈ^i7Q0ஆ1%nNC1vW;r+kgJVNuh2H3nk+G#U[ %IY"!WqtT?6V!N(evXgvJĠʏ-/8(E$XrШh>N9۾@,leVeҀ?rphȴ^Ԟ9Z"3߶xpLE@IIсnTUy' e:g*h4¡6d7?57/HZXPr#s;rٔKR#]g'g[vcwD춎QYv19Vnj;OW-i™'3ǞHɏh(NYf{cI q&f*hz wciuv!/lb@*b@RӬW߳5䴪d8\h vZqTXGM$@?x6്E4pٶ9?B(ᢃԘDLc0:2EvWU F G6Bv:kIJM*?cV軛Gsa1]Ge)Z<\{7Y#WGt&~C^}Tk)<~e<,+7yǮZF1פ_1Ӊ%oGj@yh?qK~T86SJCn\RѥŃ3˅͒G;"P+q$)ȡAͷcIgCEh|g OLX8"3O$-Uo~s~{u,F(*~**fRc Տ=aT@ey-H[: [?up?{~97хPZ6t XDJ"B*`8p;A \(!gs(:{S`{A+Nebh/Cy|Nx,EoDQ,Yҫ~<ШļIͮ-dɚd$*B,ԤSbAusp\'j-)!N qtaJ{S6Bh) ݷM~l$\eX7`gW7[8l`ީ>A YoRRo4) O3k9ԉNkQɓυU(yGNŊk4qxV\:0ey [O3>~ZkCwyhBF˹' qBV |ԛYKJh-(b 7쉕My)N!h6Fa À@E#;$&tRfw^pKx|wپ#\?QпIpfy=)NV j^[3!P̎r3,!5A{?;(Wk{hnǽvp\E&VWuz$;ɱ=lR O]V 0 !0e;KhDō_\ڍkd`,4P'[~k}w/:LRDir_ˍ"E,%)Hȳ:P<0;$7|¹e3oAFסrD۬ 6?tt.cԺzQZsOZNFLk|EۉB|? Y&Ѐ>&sX[S{/jy"m^ m-̪eܲz1 "jmᅀ^%uΚ;Gye7t<36fx}P;0S/2_@53^lIJ ,La\ Z\k Ccz-NUdn`q0cQqWRiCfq:&>i{r6I2G k+Wb߶]Ѕ鍖-$}Rvèv |4j,1x*C8Cda$&tΆ GgI6RJp!ˑKH])t0SQ OpstZwCdH9";$RCA)aBUJ<gw߇vc#H.[&nDR(ǯkxƩq2v%U~?YLo"|JPETL@TJ:+wmqt>g1|60 pgWxºDH..Q<@\Ө^v>n7?< B2T= r$I9#D5M/ Ƹf1={9RԜ/3~Dq/LqwvS'Ŕ~ص?W[j.K|.>MDh`\.'TAp վl$TʚD^"2 n) "D ٗ1Bul@Hl?bZL~>.v%s 3&-|܍-/(͝o"pF[ūy0+d&;`Ót4AxQ≲e#j#GlٽaSh޴YᷛCY<ql)kE3'g&M 97W"|8 S^eB[c:W:B6Mc:VuĻ&=+=+B$l}g^v35pvЧr6^M?>8 ,e3X'l7"RdO'gdZ:W2l+8̒eI4Jȗy*7bDr F%Us1d `paEðk8= glw§߰xlϙ@A ocy?“eO^q6H3ThC7+Ww$N6[LF P5^rxq wnjøN̍%zasߪCGIdI&bJ\hsZT@Ǫ83WW917+PPㆮj[xǦO:7=a|~ Ήkapw ?w};Ċ ˮCnygAx;Cߡ#'yF9r (>7)Lv1)m| 9,4gA俴8I-⧂+(;+%l*R6șEhm\#84Ar؏Lÿ7/^?g'lCCh-T //оDk?v1[^X B3olbϸCXsmqt]Q>-G1(iC \[5 'cř!JII8eUpl7A":*M$]'(Sd)p^y ,U).{0m?;h[BY))KeF5wzCiZOփ^EmtyaApSC$J(.kq7ڳAٕ#D-篥2QvoO;؜PBlxZ 'rd=qᵱ8Ek˹8)x~̭O07YeKm|q$7Wtks2;m3D\Fb|$^YXn[yb+!_9rI 6}ZD] :(f;_?*8 8 Ҫђ 4Q0ABS2ǟg+d,&( d  UԵ.tHb/[|Z 8=8 0kU9Y*LHlHVԏnEHA<>gj$$RO켮Op E UhAXN ?X~jq\f?Y  u,p 4R%G*a!0# | Fg{9Knoׂt.Hr--FMrHdbj㌓WԟFԋLU Xk!K$:`qKxg"/ $@P[Z3!F:Oo.%M7YMt6fgҫxheNs]އ&3j6醛sWje6ZPAEs] 9GgNRS@;A5-Qy9/92AĈ i':X[sO_eykl*HP+:/m:<^~T?)h'EmW7Y!::`2 V|biLqwٜ͛CN?j! ]Z@):$]C/\MDC1і}zWAN pYg<3f>o_P4**NM x$ NH,~`J%Qeۅ?9:;! <+:l\cgIz ZU$XCnR>YT]thP).1tUʘ|uo]o:k9AJJ ڸ`yC_6'I`fT#JQ*J=ml7.1.j+!=[eU%4E?ؾ,AaK[ _ʿjQKE݆^qA*jKp۔:MK!zmWbyI5l&I7 bhhbgڗT eê8dDGtn$y'5#@,^^<% ѩ.7q8E\Ps NI8]$iG\wU f@ [3'vYr ` w5νI:W18UJGo)kxƶ #^'Kii?7Ž|{<ř/GIUP8* vY|BB'rMl0 Z9 Zӄt8ݲxr8+3+(oX?7~wr:pBOġ8V d4V܉; CD>BrÍ>~SbOʊ.LV# d h&'jϷZ G(( (YiiOMzͯBGHҭ > "HT> wشkX3j(P\o|qWp!`InI-9X}'ќp#Ta<#yY\ cҒ;Re dW,h4גdq5PwM=P 所@%%P-TĘa2V=PuG-'RQ71X,y3$XG] s8Cbq \OM;( Ik1'W59-Y&\m꾠b(G,ׯX˕8J99'd'᫢*fHJe)|0/(> 7HDS,8p;mT1#jPD¸̒Qy~հFod:T=-XЯY!RdlͬI''K#8Y6g\|3kRD |ngׯY\ND06r9YғK'S5]}:yInu[koh.;>5*7X9LC!:6<X1V?p"TT3k8nqJ֕?z-v(0+ML1Ez<'9?D\0|pкl=nFofasmԎzIm<&19A)\i墓jA I۞ϊgޑ`sϙ(6k{ֱyKI .P=|Jݷ߱xh^&+4g&ǴEr꨻ h1\!TH&UI!i{ZYԾx3j`Q3O~\r̥hTTj n'(Ƭtk_LCVph[w^$H;-߭ўj`rxi|q9aLKC`3GYbixmrf?ȥCrNԶv-|Ax'-AY [i֭Eɕ(\h<4(dx:0 A>\k$Hju߰%gt3(TYQZb.s0)J%9l0X ݭf?-kq7)8Kx$r9'5 R5/4ҕKx۹ E)B%n [ !)yÇ\"eofx` cWiqm+wQz5# Ƙb ŲKq;^_TSZOm }B T(@R{ȉ}5@Wk޲dzC8q}q.>$5KRsa@C'Yed,fq;Z)9\Xs SXUX5^9㉸(;X<6OX &1!6v -|FOHݓk*Jt CW \4] Ռ>hzA E3Sɹ2Z\b?vB+@f&IAAw5bUV&ǽI\Cp?iBAeҁu(;(\G-Πh OԹD:-ᵈCÄI \K=rA+@Z̹ǻYv=QA{lkج-+)lVD|xg  Zsdj:pvbպ<:px̻"݉Gwsէi5O [YL/Jt@GN)esWPgu"Yu{+i4U*,QZ!~ƌ۸\ִ~PIi#a(da #k!y`v L nv>C&l6tRJf}k"yC:@|U[$ix^*W!dF9?Wb`azT"3mNa'n;&;\"*)Xg",rSKjCJ"xViDHbjC&ߜ[ekˇ}{s6ym`(J`qU4r̓{_ϖa>q /0j͞B¦@i oYcw)4ptL&3;54cPT}"<,uPI,Ҽ!pD=\-+S ~ZTdX'"2pP俍Y!ǯ ^x,NQ+B !5<&l,a&$=,=neĈ8#%# G.+\օmO,c=~>~oxsdtf,e}KݮO ~jbd{j9x=aCF62=B+O>Hpeٻ\jΏ> a[ߝJTwCPq~ߴ}̲xK mM8᯼CV\0[' \ J& |)= Qcu{=Nqf؎dΠY$IŠٕv$0l1)߭_nۧlO0'vGk5j{=4PS5ΰ,{fWCO!3Go!bQ-FGo}NOեM$l ѫ %-,bvU vbjnܗdH 8A\ous~+cB n^2{*cbEݦpv5-wd`aM{LM|=NCo1FTmT|`s*J܅OHiOIxG:UP?;.4͎@(NZ +uS3γl*3M-*BԳO#1V; uSl$XomVxP h *6fN5$.Ev֤E8gzԨө)Df#~)Һ5 &9QtL E&YVU<4;ە L"D%S<0_78{t; 63N -KaHos qrz>gY)ҴgdsVc;%CW!YcϹ 6h0ECi:rPfR PYh|c7=]R}yNVhb͚7U_G$m/~c4;׸Hecѯh ~9n|6 nրM'͂@"2PIs8'ѻ $ޛZ"4zaf"Ō>g@e+ϢQ$TFRvݻȾ-F݀RD^ۗG^m[◊䓴x yV;|+gKFͳQ9,Rjt<;?UUx6ReoAㅹmo 3|yweQ͢ʚe@ca9s:Hs~e=qoXh ;a>^5[Nh^I$9DL/4}]Ǹ|<%((@Ulu$V"SKMe KzW]4%ns4~ &{2j-vv0 "q"v&_yTCt;ª8DuuYzK:| ]}JP+TryJ8" bhC,!_d5Xe؋pEgza2W)bQ}WȬXE=Do6aW6|gU3i% | 3FExK wLa1HFVM!ThF.'3ԤP''j4YEm1*T O[[:-({/x!e&%,{zY"[cI=eӍz©9K#ځ`ΦbpI&ŕfYeW!H cU~14YA7P|9vm{0\џDlhSF^W)JIG^JdݗI,SS*rO1{^厨bTe,gB.kx3t(^[jL8{"űy9jc" Y[1C+0O_Z$*[%>>= i;'=L$Vj8G^Vx2%;s]iԨbFnQkPH?[riP~뾪/`~lTS]fk\v F[4"'s?~Bjڊ|[96sM4!^18Rf(vӆ̷*޵M2cmqaeh b 2Hڵj;)T#iLg1~'r't#2scEJTQ%X`qE݀#>%9VdN?Fmucq@{2=VYpc!l>v3)n%W58ϗ玿QefrOf\ȡ7IQ{ Mfk:e"OyW V-<5DC 1aqDbaYvޙ_]7"5KbVLT~60%H*`ŊW_+FJ Sleܮ8="Gۣ7-!eMOo-fܲ*`AջL/@B.5{@q>Ūֿhk<[濿PT a|fL"TʌFC}yU KėB &̔*=p7rƳ;oj[vy5b )'B*d?k4n/3xVH3"ͻCl|WU鯾\,$^idTFWwgȎƁ [>Q FE#LJSmF D> w5w\9.jSJ#,Sf)֏_iÁbG=K\B㭬|k094VErƭyiXȟ5*S[W˷Ưo_-Z5~|kjO5wl IENDB`3#  @  Z"Prices include UPS shipping but not 6% tax."<,$,@@    - `@     -  u%p  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ 5  !"#$%&'()*+,-./01256789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|~Root Entry F4 WordDocument&1Table2gData :                    -  U$   "FAX""TO: Sylvio":"PLAIN AND PRE-PRINTED njpb'""NJPB'""MESSAGE:"$" sulvio, thank ""Sy"Z" you for speaking with me about the program" "providing the "^"selected Schering physicians with pre-printed"^"using Rx PROvisions, Inc. as a vendor to supp""NJPB'"^"value added strategy to help you build a stro""make budget."*"your product sales " "s. "^"NJ physicians must use these new Rx forms, so""NJPB'""easy "^". And as an additional incentive to support "@" which will add value to your "@"the service you are already op""providing."bRJ                       ] e   uu6D6D--~~drdr$$9!G!9!G!^!l!^!l!~!!~!!<#J#<#J#P"And we are also a vendor for Schering.""your "^"1.88 per pad of 100 Rx forms per pad. The pr"^", 6% Tax). The minimum number of Rx pads is ""per order "6"Pre-printed Rx pads are r"8"provided at no additional ""cost."^"The price break on the enclosed order form we""will pay ""37.60""Plain and " "/or""approp[riate " "maa"*"nger you designate."" if you wish" "PAYMENT OPTION"\n (u Bom /z @B r$! ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ss0sss spsss`?G@B/z!:xr$!\=I}}.x0naiBom(u9) x<`b@hh. @hh. @hh., 2@hh.| 6@hh.` @hh.` @hh.l` @hh. GTimes New Roman5Symbol3& Arial"sALES "" ""20 Rx pads ""plain and/or ""20""plain or"". "$"a minimum of 20 ""will be ""1.88 per pad"(u Bom /z @B r$! .V(= ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo( hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. sssss(sxsssh?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=h`b@hh. @hh. @hh.4 2@hh. 6@hh.` @hh.$` @hh.t` @hh.Q [8@8Normal@CJOJQJkHmH 4@4 Heading 1 dCJ,@, Heading 2d.@. Heading 3h@2@2 Heading 4@CJ2@2 Heading 58@CJ2@2 Heading 6@CJ2@2 Heading 7@CJ2@2 Heading 8p@CJ2 @2 Heading 9  @CJ<A@<Default Paragraph FontNON Heading Base$$$@KHOJQJkH4B@4 Body Text$d<O< Footnote Base $dCJJI@"JMessage Header$$0x @>O2>Block Quotation $4OB4Body Text Keep$0"@a0Captiond6CJ&OR&Picture$JOJDocument Labeldx@CJl@O!"@Message Header First6*@6Endnote ReferenceH*,+@, Endnote Text( @(FooterXCJ<O< Header Base$ !8&@8Footnote ReferenceH*.@. Footnote Text$@$HeaderX@O@Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ$/@"$List "h0@!2 List Bulleth# & F>Th1@!B List Numberh$ & F>T8h.>-@R> Macro Text %$d OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5](p>Th.LOLMessage Header Label@CJOJQJkH&L@&Date *$0$:@A List Number 2]+8>T8h.;@A List Number 3],>Th.$5@!$List 5-$4@!$List 4.$3@!$List 3/8$2@!$List 200X@0EmphasisCJOJQJkH,?@",Closing 2$d,@2, Comment Text36'@A6Comment ReferenceCJ8C@R8Body Text Indent5h2@b2 Normal Indent6:D@!r: List Continue76E@q6List Continue 2886F@q6List Continue 396G@q6List Continue 4:6H@q6List Continue 5;prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbObReturn Address,=$&d /#$0$ P @CJ0O0 Enclosure >$$BOBReference Initials ?$$4@@4 Signature@$$BOBSignature Job Title A$8O8Signature Name B$DO!DMessage Header Last C@&d`$@B`Envelope AddressD&@ /+D6CJOJQJ6%@R6Envelope ReturnE6<@Ab List Number 4]F>Th.29@1r2 List Bullet 5Gp26@12 List Bullet 2H827@12 List Bullet 3I28@12 List Bullet 4J(U@( Hyperlink>*B*.P@. Body Text 2LCJDR`DBody Text Indent 2Mh 8T`8 Block TextN @@S`@Body Text Indent 3 O.Q`. Body Text 3PGTimes New Roman5Symbol3& Arial?& Arial Black5"Geneva7Tms Rmn?5 Courier New." ""20"9)!,"CLARITIN -d " -     "CLARITIN SYRUP" -   -   ~ ,$, K <,$,"7."^" Charge Order to my credit card: AMEX MAS"$" VISA DISCOVER"".."<,$,,".....EXPIRATION DATE"<,$,   "7. ""8."sk       "FAX TO"8":_________________________" "FAX":" TO:_______________________" "for:"  -  u%     -  u%     -  u%     -  u%     -  u%`     - 0!u%`    "FAX" "FAX"<,$,  !! !-! ! ! ! ! ! !-!PL  ! !-!PPL  !:"___________________________""TO FAX #"" " " " " ___________""_____" "______________"2":______________________"@" COMPANY:_____________________""MESSAGE","COVER PLUS ALL PAGES"&"TOTAL PAGES FAXED"": ___________"^":____________________________________________"  -  U$  <"DATE:_______________________" " "(u Bom /z @B r$! .V(= ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo( hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ssshsssXsssH?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=$`b@hh.t @hh.ą @hh. 2@hh.d 6@hh.` @hh.` @hh.T` @hh.Q [8@8Normal@CJOJQJkHmH 4@4 Heading 1 dCJ,@, Heading 2d.@. Heading 3h@2@2 Heading 4@CJ2@2 Heading 58@CJ2@2 Heading 6@CJ2@2 Heading 7@CJ2@2 Heading 8p@CJ2 @2 Heading 9  @CJ<A@<Default Paragraph FontNON Heading Base$$$@KHOJQJkH4B@4 Body Text$d<O< Footnote Base $dCJJI@"JMessage Header$$0x @>O2>Block Quotation $4OB4Body Text Keep$0"@a0Captiond6CJ&OR&Picture$JOJDocument Labeldx@CJl@O!"@Message H  !#Oh+'0  FMicrosoft Word Picture MSWordDocWord.Picture.89q &FMicrosoft ClipArt GalleryMS_ClipArt_GalleryMS_ClipArt_Gallery9qHealthcare & MedicineC:\MSPUB\Clipart\doctor2.wmf. eader First6*@6Endnote ReferenceH*,+@, Endnote Text( @(FooterXCJ<O< Header Base$ !8&@8Footnote ReferenceH*.@. Footnote Text$@$HeaderX@O@Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ$/@"$List "h0@!2 List Bulleth# & F>Th1@!B List Numberh$ & F>T8h.>-@R> Macro Text %$d OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5](p>Th.LOLMessage Header Label@CJOJQJkH&L@&Date *$0$:@A List Number 2]+8>T8h.;@A List Number 3],>Th.$5@!$List 5-$4@!$List 4.$3@!$List 3/8$2@!$List 200X@0EmphasisCJOJQJkH,?@",Closing 2$d,@2, Comment Text36'@A6Comment ReferenceCJ8C@R8Body Text Indent5h2@b2 Normal Indent6:D@!r: List Continue76E@q6List Continue 2886F@q6List Continue 396G@q6List Continue 4:6H@q6List Continue 5;prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbObReturn Address,=$&d /#$0$ P @CJ0O0 Enclosure >$$BOBReference Initials ?$$4@@4 Signature@$$BOBSignature Job Title A$8O8Signature Name B$DO!DMessage Header Last C@&d`$@B`Envelope AddressD&@ /+D6CJOJQJ6%@R6Envelope ReturnE6<@Ab List Number 4]F>Th.29@1r2 List Bullet 5Gp26@12 List Bullet 2H827@12 List Bullet 3I28@12 List Bullet 4J(U@( Hyperlink>*B*.P@. Body Text 2LCJDR@DBody Text Indent 2Mh 8T@8 Block TextN @@S@@Body Text Indent 3 O.Q@. Body Text 3PGTimes New Roman5Symbol3& Arial?& Arial Black7Tms Rmn1"Helv?5 Courier New"973) 778-2268""": March 6, 1998" "Liz."": Immedu""icenter""J. Pisano ."": NJPB" "The order for "^"5877. As a contingency, an additional 1,000 "^"for each office location and will be shipped "2"n Mondau March 9, 1998."4"CC: Dewpt. Cons. Affairs""29" "4690""08""11"" rob Freeberg""Schering"*"Rx PROvisions, Inc."P"Tracey Sears, Doug Conetta, Derek Kish"^"Thank you for meeting with me today to discus"6"-printed program started."^"following 4 pages is a summary of the meeting"^") that needs to be taken inorder to move ahea"6"ollow up in order to keep""with you "2"when you are available." "...""1998 "" Robert"""M. Raleigh, Jr."0"Braintree Laboratories" "Pre["J"printed Program Proposal follows..."^"Let me have your comments at your earliest...""___________""____________" " __"""_______________"$"________________""781-843-7932""March 1""27, 1998""R.""Raleigh " "BRAINTREE Labs""L. Fetherbay"," rob, thank you for "^"speaking with me about the remaining orders w""bruary 25th."^" complete these orders and when they are comp"&"to arrange for hi"^"for him to arrange pick up of these orders. "$" "D"any orders we have not completed"." " " "" " " " " ""today ""oduction"<"Please let me know if the in"*"following invoice a"@"when the invoice will be paid."". Regards...""____________""S. Diamond" "Georgian Press""212-255-5303""K. Olender"^"Stu, thanks for speaking with me today about "^"work I will need. The following is a Confide""have been"^"When we meet next week on Wednesday April 1st" "3rd,"^" I will bring a Completed Confidentiality Ag""with me ""I'""who you may " "use"" to producce"B" some or all of my production. "" needs."^"n and I look forward to speaking with you soo""732-919-1425""April 5, 1998""R. Vossler" "Schwarz Pharma"$"We recently prov"6"cessed 9 orders for Bryns"L"aEdgington and 7 orders for Ron cure" ". "V"Bryna called recently because her physivi"@"s had not received their order"^"pre-printed Rx pads. So I called production "^"printted but that the porders had not yet bee"4"areas of responsibility ""to Bryna'"@"left a voice mail message for "," yet because you mau"^"y wish to advise your NJ Sales Representative"" and invoice.""an"."to follow up for her "" and "^"When our production department provides the t""send to "^"we will prepare a monthly report for you for "@"to reflect order activity foir"."r the month of March.""An invoice an"^"Then an invoice will be sent to the home offi" "ob ""Frteeberg""Schering""Rob, "^"RE: Payment for the Re-Orders sent to Clariti"^"thanks for spealing with me this afternoon ab"^"ment for the Re-Orders we sent to Claritin Ph" "100"*"998 follow. thanks "^"sent to Rx PROvisions, Inc. thanks and best r" ": 908-298-4690""x4071"" Sears""June 23, 1998""414-238-" "0961"$"Suzanne Schuetze" "5445""warz Pharma"D"Invoice June 8, 1998 # SP-980608"" dated "^"Suzanne, just a message to remind you to send""Lauren"&"Dr. M. De Antonio"""Order for NJPB'"^"Lauren, thank you for your follow up call yes""Friday, "P"for the status of your order, I contat"^"cted the poroduction manager who told me all " "Duer"^"ing a meeting today, I learned that your orde"^"a complimentary order for your office so that"" ":"Please let me know if this "^" because I need approval fom you in order to " "for" "UPS "4"The order will ship via "\"and UPS says there is a one day turn around " "tells us that "" today"&"service gives us ""time.""201-439-1208" "ly ""215-238-8495""29""Melanie Fagan"0"W. B. Saunders company""Letter"H" Dated July 29, 1998 and Enclosure"D"Our Telephone conversation this " "morm" "ning"@"Melanie, three pages follow..."^"Please call me with any questions you may hav"\"rights for the purposes we intend to persue.""that " "the","Rx PROvisions, Inc. "&"September 3, 1998""Craig Barbaro":"C. B. Printing and Graphics"(u Bom /z @B r$! .V(= ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo( hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ss|s@}s}s}s0~s~s~s ?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=|`b@hh.L} @hh.} @hh.} 2@hh.<~ 6@hh.~` @hh.~` @hh.,` @hh.Q [8@8Normal@CJOJQJkHmH 4@4 Heading 1 dCJ,@, Heading 2d.@. Heading 3h@2@2 Heading 4@CJ2@2 Heading 58@CJ2@2 Heading 6@CJ2@2 Heading 7@CJ2@2 Heading 8p@CJ2 @2 Heading 9  @CJ<A@<Default Paragraph FontNON Heading Base$$$@KHOJQJkH4B@4 Body Text$d<O< Footnote Base $dCJJI@"JMessage Header$$0x @>O2>Block Quotation $4OB4Body Text Keep$0"@a0Captiond6CJ&OR&Picture$JOJDocument Labeldx@CJl@O!"@Message Header First6*@6Endnote ReferenceH*,+@, Endnote Text( @(FooterXCJ<O< Header Base$ !8&@8Footnote ReferenceH*.@. Footnote Text$@$HeaderX@O@Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ$/@"$List "h0@!2 List Bulleth# & F>Th1@!B List Numberh$ & F>T8h.>-@R> Macro Text %$d OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5](p>Th.LOLMessage Header Label@CJOJQJkH&L@&Date *$0$:@A List Number 2]+8>T8h.;@A List Number 3],>Th.$5@!$List 5-$4@!$List 4.$3@!$List 3/8$2@!$List 200X@0EmphasisCJOJQJkH,?@",Closing 2$d,@2, Comment Text36'@A6Comment ReferenceCJ8C@R8Body Text Indent5h2@b2 Normal Indent6:D@!r: List Continue76E@q6List Continue 2886F@q6List Continue 396G@q6List Continue 4:6H@q6List Continue 5;prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbObReturn Address,=$&d /#$0$ P @CJ0O0 Enclosure >$$BOBReference Initials ?$$4@@4 Signature@$$BOBSignature Job Title A$8O8Signature Name B$DO!DMessage Header Last C@&d`$@B`Envelope AddressD&@ /+D6CJOJQJ6%@R6Envelope ReturnE6<@Ab List Number 4]F>Th.29@1r2 List Bullet 5Gp26@12 List Bullet 2H827@12 List Bullet 3I28@12 List Bullet 4J(U@( Hyperlink>*B*.P@. Body Text 2LCJDR@DBody Text Indent 2Mh 8T@8 Block TextN @@S@@Body Text Indent 3 O.Q@. Body Text 3PGTimes New Roman5Symbol3& Arial?& Arial Black7Tms Rmn1"Helv?5 Courier New6"Confidentiality Agreement"^"craig, a confidentiality agreement follows fo"" Let'"."at the Phoenix diner "R" to discuss the printing that my client" "business requi" "res."^" and I look forward to hearing from you soon "*"onfirm our meeting.""production " "973-""201-847-0899""Dave corby"""ACTION Graphics""973-872-9494":"SICPA Thermal sensitive Ink"^"Dave, see the attached info on SICPA, 800 num"J"I can provide any other assistance.""next ""21""335-6094"" diane","Order Form for NJPB'"^"Diane, your phone was busy this morning when "^"you today. We will be in the office until 12""610-695-1162" "Kurt""ASTRA"" Graves""oe"*"Additional Thoughts"^"Kurt, just had some additional thoughts about"$"to shar with you">". I will call you on friday "" page 2. "N"ey are in the waiting room and at tha"^"e same time allow them to interact with the p"4"ll share with you later."8"Thanks and best regards..." "new "B" and to build consumer contacts"$"It vcan do alot "8"Meeting On Friday Oct.2nd " "1pm"^"Mike, I spoke with John and he said he is ava"\"s to the questions I sent to you and John I'"^"s we can discuss a little more about your ser"("on Friday morning "" as well"""? Let me know.""..""(Willy'""973-884-2487"""October 9, 1998" " Matt McKenna","thomas ferguson Assp" "oc." "SPECIFICATIONS"T"Matt, the specifications you requested a"^"follow on the next page. When the new materi""________""production ""13""410-672-3293" "bEN ""NOVO NORDISK""INFORMATION"^"Ben, three pages follow. Just let me know ho" "1-864-292-3883""22""Vickie Currin"&"Regional Diabetes"^"Vickie, no problem. Your order was formatted"^"o find out if William F. Price had a title. "("change in location""also "*" office location. "^"format the prescription exactly the way it is">"? Let us know when you can. ""We""414475-7327"&"February 23, 1999" "YUHAS Graphics""Colyr"."te Flavor Packs Logos"^"Thank you for sending the Colyte Flavored Log""However, wew"" use PC'""__________""March 3, 1999""Dr. Manoukian""Pre-printed ""ed NJPB'"^"We called yesterday and requested that you fa"^"actice information correctly. When we receiv""732-235-7792"" "(u Bom /z @B r$! .V(= ?G \=I 0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo( hhOJQJo(hh. hhOJQJo( hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ss#ss$ssT$ssX6ssHssssss8s?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=#s`b@hh.$s @hh. 6s @hh.s 2@hh.Ts 6@hh.s` @hh.s` @hh.Ds` @hh.Q [8@8Normal@CJOJQJkHmH 44 Heading 1 dCJ,, Heading 2d.. Heading 3h@22 Heading 4@CJ22 Heading 58@CJ22 Heading 6@CJ22 Heading 7@CJ22 Heading 8p@CJ2 2 Heading 9  @CJ<A@<Default Paragraph FontNN Heading Base$$$@KHOJQJkH4B4 Body Text$d<< Footnote Base $dCJJI"JMessage Header$$0x @>2>Block Quotation $4B4Body Text Keep$0"a0Captiond6CJ&R&Picture$JJDocument Labeldx@CJl@!"@Message Header First6*@6Endnote ReferenceH*,+, Endnote Text( (FooterXCJ<< Header Base$ !8&@8Footnote ReferenceH*.. Footnote Text$$HeaderX@O@Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ$/"$List "h0!2 List Bulleth# & F>Th1!B List Numberh$ & F>T8h.>-R> Macro Text %$d OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=A List Number 5](p>Th.LOLMessage Header Label@CJOJQJkH&L&Date *$0$:A List Number 2]+8>T8h.;A List Number 3],>Th.$5!$List 5-$4!$List 4.$3!$List 3/8$2!$List 200X@0EmphasisCJOJQJkH,?",Closing 2$d,2, Comment Text36'@A6Comment ReferenceCJ8CR8Body Text Indent5h2b2 Normal Indent6:D!r: List Continue76Eq6List Continue 2886Fq6List Continue 396Gq6List Continue 4:6Hq6List Continue 5;prr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbbReturn Address,=$&d /#$0$ P @CJ00 Enclosure >$$BBReference Initials ?$$4@4 Signature@$$BBSignature Job Title A$88Signature Name B$D!DMessage Header Last C@&d`$B`Envelope AddressD&@ /+D6CJOJQJ6%@R6Envelope ReturnE6<Ab List Number 4]F>Th.291r2 List Bullet 5Gp2612 List Bullet 2H82712 List Bullet 3I2812 List Bullet 4J(U@( Hyperlink>*B*.P@. Body Text 2LCJDRDBody Text Indent 2Mh 8T8 Block TextN @@S@Body Text Indent 3 O.Q. Body Text 3PGTimes New Roman5Symbol3& Arial?& Arial Black7Tms Rmn1"Helv?5 Courier New"your office "  -  U$     - #@    "April 19, 1999""Candance"$" "" "^"April 15, 1999 Meeting with Glenn Parker and "^"Candance, the following was sent to Lewis vi":" letter addressed to Glenn "" last week."". ""I was vw""very thorouth"""gh and helpful."("Kindest regards..." "856""482-6053"("September 20, 1999""Nicole Foard""Targeted Medi""arketing"B"Tel Con request for information""Nicole, "^" thank you for taking my phone call. I had a"^", which will be used to prepare proposals fo"^"And, if you can send a sample of a For the Re""" above address." "dent""aNGELA""Angela" "617""577-3101","Computer Ready NJPB "$"Angela, the 8 x "" 1/2 ""four "^"The white margin on the left and on the right"L"health care provider will print drug"("prescription is be" "bek"^"low the address line and above the Substituti"("Hope this helps...""Kindest""information "<" near the bottom of the form""212) 598-6950"$"January 31, 2000"""Matthew McKenna"4" "("Sudler & Hennessey"." "T"COPY OF 1/31/00 LETTER TO REBECCA OBERUC"^"Matt, thank you for calling today. If you ha"^"xt two pages. I am scheduled to meet with Ne""Feb.8th "^"and I will keep you informed of the outcome. "^"y initial meeting with Norm went well and it ""said ":"should follow up with Neil.""You may want "^"Mo Beard started their renovation project and""and the"^"Grant Hall and other buildings scheduled for "^"removal or renovation will be completely rest""February 2, """COMPARISON DATA""The in"L"competitive information was provided"^"comparison data on the next three pages was r""equested.""Thanks ""I'" "We often get b"^"very close to getting business at the client ""always ""_____________"J" Any feedback will be appreciated.""01""994-1832""March "", ""Lisa " "ino"""Ferndale Pharms"B"COPY FOR PRAMOSONE and ANALPRAM"^"Lisa, the revisions you provided appear on th""today "(". Let us know whe"^"When you have final approval from your physic" "609""588-3543""Pat DeMarx""zo""NJ Div. of ""tance"^" ""NJPB'"^"Pat, please let me know when the NJPB Commite"J"orm you faxed to me today, on file."."Phone: 1-888-479-7768" "7828""730-2148"""Loretta Rathert""EISAI"^"MEETING with Rob Fahey and Jose Fojas March 2"(" at 2pm at Janssen" "Here"^"Loretta, here is some background for Rob to r""as requested "^"After attending the Vendors Fair last August,""presented ""During ""and then "^"Our One to One Programs are tactical and supp""ACIPHEX "" Inc.""information ""in nature ""will "" "$" (see next page)" "as "("One to One Program":"and maximum share of voice """customized and " "to "&"be customized to "^"ACIPHEX Marketing Team to select and to adjus" "tar"H"the physicians they want to targer""t and to "^"target in response to their changing market. ""PM"B"us here at Rx PROvisions, Inc. " "The ""to us "4"We further reviewed the "^"and prepared our proposal and mock-ups of the""tactical ""that " "to "$"some background "Z"a brief overview of our One to One Program."F"to you for arranging the meeting.""sent "$"David Fabbri and"Z"for distribution to the Team, as requested.""(10) " "six " "So, ""the a""that ""begin to show" "how "(" will support the "". "" However, ""(and Jose) ""So the pr"0"meeting on March 24th " "to "^"is a continuation of the interest Eisai and J"<"using the One to One Program" "to ""ctually a""ir"$"________________""And, ""sponsored "V"to the precise physician target audience ")1HOHO$+$+, 3 , 3 B I B I SZSZ 4;0"support the strategies"""accomplish the "^"address the ACIPHEX Strategies and will accom"^"A brief One to One Program Overview follows o""n the next " "eight pages..." "ECOMMENDATION:""Page 3."0"March 8, 2000.........""~(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hhOJQJo( hhOJQJo(hho(.hh. hhOJQJo( hhOJQJo(hh. hhOJQJo(o(. hhOJQJo(@hh. hhOJQJo(hh.o(.@hh56>*CJOJQJo(. ss^?s _?sp_?s_?s?sh?s?s??G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM^?`b@hh.,_? @hh.|_? @hh._? 2@hh.$? 6@hh.t?` @hh.?` @hh.?` @hh.Q [8@8Normal@CJOJQJkHmH 4@4 Heading 1 dCJ,@, Heading 2d.@. Heading 3h@2@2 Heading 4@CJ2@2 Heading 58@CJ2@2 Heading 6@CJ2@2 Heading 7@CJ2@2 Heading 8p@CJ2 @2 Heading 9  @CJ<A@<Default Paragraph FontNON Heading Base$$$@KHOJQJkH4B@4 Body Text$d<O< Footnote Base $dCJJI@"JMessage Header$$0x @>O2>Block Quotation $4OB4Body Text Keep$0"@a0Captiond6CJ&OR&Picture$JOJDocument Labeldx@CJl@O!"@Message Header First6*@6Endnote ReferenceH*,+@, Endnote Text( @(FooterXCJ<O< Header Base$ !8&@8Footnote ReferenceH*.@. Footnote Text$@$HeaderX@O@Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ$/@"$List "h0@!2 List Bulleth# & F>Th1@!B List Numberh$ & F>T8h.>-@R> Macro Text %$d OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5](p>Th.LOLMessage Header Label@CJOJQJkH&L@&Date *$0$:@A List Number 2]+8>T8h.;@A List Number 3],>Th.$5@!$List 5-$4@!$List 4.$3@!$List 3/8$2@!$List 200X@0EmphasisCJOJQJkH,?@",Closing 2$d,@2, Comment Text36'@A6Comment ReferenceCJ8C@R8Body Text Indent5h2@b2 Normal Indent6:D@!r: List Continue76E@q6List Continue 2886F@q6List Continue 396G@q6List Continue 4:6H@q6List Continue 5;prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbObReturn Address,=$&d /#$0$ P @CJ0O0 Enclosure >$$BOBReference Initials ?$$4@@4 Signature@$$BOBSignature Job Title A$8O8Signature Name B$DO!DMessage Header Last C@&d`$@B`Envelope AddressD&@ /+D6CJOJQJ6%@R6Envelope ReturnE6<@Ab List Number 4]F>Th.29@1r2 List Bullet 5Gp26@12 List Bullet 2H827@12 List Bullet 3I28@12 List Bullet 4J(U@( Hyperlink>*B*.P@. Body Text 2LCJDR@DBody Text Indent 2Mh 8T@8 Block TextN @@S@@Body Text Indent 3 O.Q@. Body Text 3PGTimes New Roman5Symbol3& Arial?& Arial Black7Tms Rmn1"Helv?5 Courier New " 11""ACIPHEX ""that will ""target "2"a select and receptive "" audience""se" "to ""enough ""that "6"Implement an exclusively ""31"*"Samantha Karr, RPh." "MOPN","ADDRESS TO SEND LOGO" "248""858-6718"^"Samantha, please send the diskette and a prin""April 3, ""Nancy"("Mal B. Isaac, D.O." "908""213-1218"6"License # Needed to print"^" Complimentary NJ Rx Forms Pre-printed with C"<"Nancy, please fax Dr. Isaac'"."umber to us. We must" "nss"^"eed it to print the complimentary NJ Rx pads "F" Our address also shown above is:":"Please fax his license numv" "ber to us at: "^" These NJ Rx forms are paid for by Schwarz P""May 2, ""73""383-6929""Bill Sisco""SUNRISE HOUSE"*"NJPB (RxPAD) ORDERS""bI"^"Bill, please complete the following form for "^"Fill in the License Number for the physician." "781""778-1024""LINDA GREGORY""FLEET BANK">"FIRST PAGE OF 1999 TAX RETURN"^"Linda, the following page is the information " "you requested.""you need ""seph " "262""238-0961"": cAR" "THY " "Race"("FR: Joseph Pisano""MESSAGE: "" ""W"" isr'""S."6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss\/es/es 0esd0es0es1esl1es1e?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMh/e`b@hh^h`./e @hh^h`.0e @hh^h`.p0e 2@hh^h`.0e 6@hh^h`. 1e` @hh^h`.x1e` @hh^h`.1e` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?5 :Courier New" "6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss\/es/es 0esd0es0es1esl1es1e?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMh/e`b@hh^h`./e @hh^h`.0e @hh^h`.p0e 2@hh^h`.0e 6@hh^h`. 1e` @hh^h`.x1e` @hh^h`.1e` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?5 :Courier New !-!PL  ! !-!P  !<"..........._________________""14"F" PAGE 1" !bN@!P ! ! ! !f" " !T@@!X ! ! ! ! "ISR'""s" "973""696-5104""31"0" IRWIN GOLDSTEIN, M.D."L"RE: CORRECTED PHONE NUMBER ON NJPB'""s (Rx Forms)""2""nURIA ""Swaby">"PRE-PRINTED RX PAD ORDER FORM"" Nuria, thank you for calling us today regarding your need for pre-printed Rx Forms. We print Rx forms for p""all healthcare providers, not only in New Jersey but also in every other State.""and/o"" your collegues need any Rx forms, just complete the Order Form on the following page and mail or FAX it to us. We would apprec"Z"x them to us, especially non-NJ Rx forms. ""m"" c"""me at any time."J"___________________________________" "732""972-5334""June 2, 2000""1" "609""399-1572" "Tara" "njp""NJPB ORDER""Tara, "8"your order for 5,000 NJPB,""'"0"s for Darlene Flamini."", RN, MSA""N, NP-C.""pLEASE ""review the copy, below and fax to us your comments/approval. We will use your approved copy to print your order."2" on the following page."h"ce for your order will be $94.95 plus 6% tax. UPS"L"There is no charge for UPS shipping.""provide an u"P"on file, however the date has expired,"". Please provide a current Card and/or expiration date we can keep on file:"&"372847990361002 ">"Thanks and kindest regards...">"_____________________________""2"" "8"OCEAN CITY FAMILY PRACTICE"" ""10"" "&"_________________""1""201-871-4005""4" " ""3""212-717-9634","TO: Alice Kosterich"*"FR: Joeseph Pisano"", MEDICIS"z"MESSAGE: Alice, thank you for calling us today for informn""rmation about ordering pre-printed Rx pads for your physicians. Our order form follows on the next page. The order form is for"" The SAMPLE on page 3 shows an example of the layouts we do in both portrait and landscape. The signature line at the bottom of"""s for New York."L"Sales representatives and physicians"" ""R"" their physicians nation wide, we have the appropriate signature line for each state.""." "Rx " "We "" print most of our Rx forms on white paper and have on occasion printed Rx forms on yellow and on pink stock. However, the turn""order " "so "".""'"D"Since we will be off next week, " "let'""s try to "0"speak with each other "0"the week of June 26th "D"to discuss the service you need.","____________________""Rx form "", President ""ly 12" " 1""908-688-6565" "3161" !-!Y :  ! !\H@!)  : ! ! ! !"201-994-1832""973-450-95" "395""July 12, 2000"" "2" ""3" "909""8-688-3161"7"9""7""3""-""4""0""2""-""0""5""0""8""3""T""O"":"" "" ""L""O""R""I"" ""U""T""T""E""R""F""R"":"" "" ""J""O""S""E""P""H"" ""P""I""S""A""N""O""R""E"":"" ""N""J""P""B"" "REQUE"S""T"" ""F""O""R"" ""N""J""P""B"" ""O""R""D""E""R"" ""F""O""R""M""L""O"ME"S""S""A""G""E"";"" "" ""L""O""R""I"","" ""T""H""A""N""K"" ""Y""O""U"" ""F""O""R"" ""R""E""Q""U""E""S""T""I""N""G"" ""A""N"" ""O""R""D""E""R"" ""F""O""R""M"" ""F""O""R"" ""N""J""P""B""'""S"" ""F""O""R"" ""D""R""."" ""K""E""A""T""I""N""G"" ""A""N""D"" ""F""O""R"" ""D""R"" "." ""S""T""A""C""K"".""O""U""R"" ""O""R""D""E""R"" ""F""O""R""M"" ""F""O""L""L""O""W""S"" ""O""N"" ""T""H""E"" ""N""E""X""T"" ""P""A""G""E""."" "" ""P""L""E""A""S""E"" ""C""O""M""P""L""E""T""E"" ""T""H""E"" ""F""O""R""M"" ""F""O""R"" ""E""A""C""H"" ""P""H""Y""S""I""C""I""A""N"" ""A""N"" ""F"D "F""A""X"" ""T""H""E"" ""F""O""R""M"" ""T""O"" ""U""S"" ""A""T"":"" ""9""7""3""-""3""3""5""-""1""5""9""1"".""K""I""N""D""E""S""T"" ""R""E""G""A""R""D""S"".""."".""P""S      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxz{|}~"":"" ""T""H""E"" "YOUR" ""F""O""R""M"PRAC"T""I""C""E"" ""N""A""M""E"" ""A""C""K""N""O""W""L""E""D""G""E""M""E""N""T"" ""F""O""R""M"" ""F""O""L""L""O""W""S"" ""O""N"" ""T""H""E"" ""3""R""D"" ""P""A""G""E"" ""O""F"" ""T""H""I""S"" ""F""A""X"".""27""1""473-5958""9""3""575-3377"" m waitinf"Z"g for final approval of the Rx form layout.""ga" "RARY" "GARY" " / ""."|" The want special Rx forms printed with their 2-color logo "("Pads printed with "" on the Rx forms in each pad. They have 550 physicians in the group and each physician will red"@"ceive 24 personalized Rx pads."<"eaturing the 2-color Rx form""Rx pads t""with the "", and sample pads in both portrait and landscape format with my 2-color fingeerprint logo on the Rx pad covbers""."" (MOPN) " " ANS""D on the "&"ir Rx pad covers."" MOPN ""."" All of the MOPN sample Rx pads will be personalized with the same name."" "" ""One to One "F". These sample pads are the same""have my 2-color logo on the front cover and rx forms printed with black ind""k ""R"B". The 4-color ads on the insic"2"de front cover and the "" for the ""are the same ads that run as ad inserts in all of the Rx pads."`" from the Chairman of the MOPN physician group" "..."&"one or in person.""K""_____________""y" " I'"R"m not sure about the re-order rate yet.""ir""are the same for all the Rx pads for MOPN and for the samples. ""h""fiver"" ("")"". "" "~"The ad on the inside front cover will rotate among the 5 ads ""." " T""5 ""will "" Ad insee"X"rts will be placed after every fifth (5th)"4" Rx form in each Rx pad." ". ""just " " So"" "<" all in the landscape format""."6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssЬs(ssحs0ss஫s8?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMܬ`b@hh^h`.4 @hh^h`. @hh^h`.䭫 2@hh^h`.< 6@hh^h`.` @hh^h`.쮫` @hh^h`.D` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?1 Courier New"."".""."6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssЬs(ssحs0ss஫s8?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMܬ`b@hh^h`.4 @hh^h`. @hh^h`.䭫 2@hh^h`.< 6@hh^h`.` @hh^h`.쮫` @hh^h`.D` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?1 Courier New"."6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssЬs(ssحs0ss஫s8?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMܬ`b@hh^h`.4 @hh^h`. @hh^h`.䭫 2@hh^h`.< 6@hh^h`.` @hh^h`.쮫` @hh^h`.D` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?1 Courier New"."6(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssЬs(ssحs0ss஫s8?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMܬ`b@hh^h`.4 @hh^h`. @hh^h`.䭫 2@hh^h`.< 6@hh^h`.` @hh^h`.쮫` @hh^h`.D` @hh^h`.Q iD@D Normal$@CJOJQJ_HkHmH sH tH 4@4 Heading 1 dCJ,@, Heading 2d2@2 Heading 3 h^h@6@6 Heading 4 ^@CJ6@6 Heading 5 8^8@CJ6@6 Heading 6 ^@CJ6@6 Heading 7 ^@CJ6@6 Heading 8 p^p@CJ6 @6 Heading 9  ^ @CJ<A@< Default Paragraph FontPOP Heading Base$$$a$@KHOJQJkH6B@6 Body Text$da$<O< Footnote Base $dCJVI@"V Message Header'$$ @0x^`0a$FO2F Block Quotation$]^4OB4 Body Text Keep$0"@a0 Captiond6CJ&OR& Picture$NON Document Labeldx^@CJl@O!"@ Message Header First6*@6 Endnote ReferenceH*,+@, Endnote Text( @( FooterXCJ<O< Header Base$ !8&@8 Footnote ReferenceH*.@. Footnote Text$@$ HeaderX@O@ Lead-in EmphasisCJOJQJkH*(@* Line NumberCJ,/@", List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^@-@R@ Macro Text%$da$ OJQJkH*)@* Page NumberCJ*Oq* SuperscriptH*=@A List Number 5a(p>Th.^pLOL Message Header Label@CJOJQJkH*L@* Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^(5@!( List 5 -^(4@!( List 4 .^(3@!( List 3 /8^8(2@!( List 2 0^0X@0 EmphasisCJOJQJkH,?@", Closing 2$d,@2, Comment Text36'@A6 Comment ReferenceCJ<C@R< Body Text Indent 5h^h6@b6 Normal Indent 6^FD@!rF List Continue7]^`:E@q: List Continue 2 88^8:F@q: List Continue 3 9^:G@q: List Continue 4 :^:H@q: List Continue 5 ;p^prOr Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHbOb Return Address,=$&d /#$0$ P @CJ4O4 Enclosure>$$a$BOB Reference Initials ?$$4@@4 Signature@$$DOD Signature Job Title A$a$:O: Signature Name B$a$DO!D Message Header Last C@&dd$@Bd Envelope Address!D@ &+D/^@ 6CJOJQJ6%@R6 Envelope ReturnE6<@Ab List Number 4aF>Th.^69@1r6 List Bullet 5 Gp^p66@16 List Bullet 2 H8^867@16 List Bullet 3 I^68@16 List Bullet 4 J^(U@( Hyperlink>*B*.P@. Body Text 2LCJHR@H Body Text Indent 2M h^h@T@@ Block TextN @]^HS@H Body Text Indent 3O]`2Q@2 Body Text 3 P]G:Times New Roman5Symbol3& :Arial?& Arial Black7Tms Rmn1"Helv?1 Courier New"Gary/"" "" "0" on britht white paper""g""all of " "of "" pads""all of the ""s""208-8106""1 0f 3"q      "August 9, 2000""Sandi"@"PRE-PRINTED INFORMATION REVIEW""sANDI,"*" pre-printed inforn"N"mation for PLEXION, DYNACIN AND TRIAZ" "and"t" follow on the next two pages for Dr. Masessa to review."" "4" as soon as you are able""Thanks and ""k""18""2""770-682-7045""2" "TO :""ALTERNARTE " "COLYTE SCRIPTS""HERE ARE SOME EXAMPLES OF ALTERNATE PRE-PRINTED COLYTE SCRIPTS WE HAVE CREATED IN THE PAST. WE CAN ADD ANY MEDICATIONS THE DOCT""WANTS"" ""24""973-402-0508""o"" ""Lori Utter"$"NJPB ORDER FOR d""DR. FILLION""Lori, thank you for calling us for an order form to order NJPB'"("s for Dr. Fillion."."price for 1,000 NJPB'"J"s is $35.68 (please see next page)."J"s NJPB, just fax the changes to us ""." "ose"" "" as well"("Kindest regards..."" 973-335-1591""1""732-683-0253""Chris Penza"N"Pre-printed LUXIQ Information On File"j"Chris, we have the copy, below, on file from othe ""r CONNETICS sales representatives who use us for their pre-printed Rx Pads.""Single "V"37.60 and our price for NCR 2-part NJPB'""s is #""$72.33"".""Please review the pre-printed information above and fax to us your approval to""commenta" "s / "6" proceed with your orders"6" for Dr. L. Robert Smith.""(""_"")""9""3""3""206-8106""8""tRACEY""Tracey"""Spironolactone "", Dynacirc""Plexion and ""NJPB'""s"d"Tracey, thank you for ordering pre-printed NJPB'""s for """Spironolactone ""each office."N"pre-printed NJPB Rx Pads (1,000 NJPB'""s) is $35.68 plus tax which includes printing packaging, handling and UPS delivery.""," "We ""ith approved pre-printed copy from you, we will print one order fr your Newfoundland Office and one order for your Rockaway Offi"4"at your rockaway office.""and PLEXION copy on page 3 of this fax. The DYNACIN and PLEXION NJPB'"&"s are complimenta""s of MEDICIS." "wE "P"will produce your orders as soon as yo"N"we receive approval from Dr. Masessa."" "" cc: Al Fuchs""o""s""R""in""September 7""6""2""212-717-9634""2""Alice"@"PRE-PRINTED RX COPY FOR REVIEW""Alice, our people had a difficult time reading the information of""n the fax you sent recently. So, before we print the three orders you sent to us, please review and correct the copy. ""If you can, please mail an original Rx form to us. Or, if you fax""prefer to fax orders to us, perhaps the copy can be enlarged and darkened before you send it.. "6"duce your orders for you."" 973-359-0158""William Delfs">"Bill, the following page cona"p"tains the copy you requested for review by Dr. Berlin.""s comments / approval, please contact us again so that we can begin to set up your account with us and to process our order.""12""973-208-8106""Sandi"4"Request for Approved CDS"8"DEA Number for Mark Evans""Sandi,"" ""1""428-5390""1"""October 4, 2000"&"Eduardo Arriagada""" COMMERCE BANK"("ORIGINAL DOCUMENTS""Eduardo, I need the original documents I gave you when we openr"R"ed our checking account this afternoon.","Phone: 973-335-7832""."T !# ! !!3#  @  2"VENDOR APPLICATION FOR ""POLICIES AND PROCEDURES FOR THE PRODUCTION OF CALIFORNIS SECURITY PRESCRIPTIONS"`"General Statement: supporting documentation a""addressing each of the vendor requirements on the Policies ans Proceedures section of the security printer application are enclo""d""A""S""i"" "".""iformn":"nia State board of Pharmacy""B"4" and corresponds to the "J"is enclosed in numbered paragraphs "".":", which correspond to the m">"numbered requirements on the "".","Rx PROvisions, Inc. ""medical documents used by practitioners during the practice of medicine in ""."""On July 14, 200"t"1997, our firm was approved as a licensed vendor in the "f"to provide New Jersey uniform prescriprion blanks""tion "B" in response to the new law rwe"&"equiring physicia""ians "@"to use security prescriptions."" "\"The NJ Department of the Treasury estimated " "In June 1996, ""t"@" that the NJ Prescription Blan""security " "NJ ""prescriptions would save the State approximately $1.5 million annually by reducing r""fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disablerd, and general publivc"0"c assistance programs.""The supporting documentation is similar to the NJ Prescription Blank Program""requires""d "", " "and ""es""in scope "&"required for the ""this ""application ""."", ""outlined "".""enclosed ""s""guidelines ""nation wide "^"When New Jersey adopted a security Rx for law" "the State of ""prescription "j" to reduce prescription fraud, Rx PROvisions, Inc. "&"and was approved ""o" "cop"N"mpleted and submitted an application "" vendor"".""O" "the ""fisacl ""impact of the new law was highlighted in an earlier report from the Treasury Department""in June 1996 " "by ""." "h (u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. sstTsTs$Ts|TsTstTsTs$T?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMT`b@hh^h`.T @hh^h`.0T @hh^h`.T 2@hh^h`.HT 6@hh^h`.T` @hh^h`.T` @hh^h`.0T` @hh^h`.QL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]HH          Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New"" and uses the """fingerprint""L" trademark to communicate our safety"N"security position in the marketplace." "Rx ""F" "an "P"example of the NJ Rx form is enclosed."("An example of the ","our security Rx form""original "n" printed with blue thermal sensitive ink is enclosed." "h (u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssssPsUs 0sd0ss ?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM`b@hh^h`.P @hh^h`.P @hh^h`.U 2@hh^h`.0 6@hh^h`.` @hh^h`.` @hh^h`.,` @hh^h`.QL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]HH          Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New" nationwide"","";"&"_________________" "h (u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss s sP sL s s s s ?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM `b@hh^h`.  @hh^h`.  @hh^h`.X  2@hh^h`.  6@hh^h`. ` @hh^h`. ` @hh^h`. ` @hh^h`.QL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]HH          Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New" "$"is the trust we " "our"" ""."j" (u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssx|!s0}!s~!s\~!s~!s !s!s!?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM|!`b@hh^h`.}! @hh^h`.~! @hh^h`.h~! 2@hh^h`.~! 6@hh^h`.!` @hh^h`.!` @hh^h`.!` @hh^h`.RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^`\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphHH          Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New"O" "is ""a""."", which " "in ""terms""also in "4"To preserve that trust, "H"as part of the production process "j" (u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss!s!s!sм!s(!s!sؽ!s0!?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM̴!`b@hh^h`.$! @hh^h`.! @hh^h`.ܼ! 2@hh^h`.4! 6@hh^h`.!` @hh^h`.!` @hh^h`.@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^`\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphHH          Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New"."4"Reactive ink properties ""help to ""original "" forms "" ""In 11" "997 ""w"3: e p e p " "" "2"Agency for Helth Care s" "Administration""a"" (PAAD)""VENDOR APPLI""vendor"" application"4"AHCA Vendor Application."J" beginning on page five (5) of the "("that correspond th"R"o the sixteen (16) numbered paragraphs ""b""of the AHCA "r"The inks reactive qualities also serve as a quick test ""validity "D"for the dispensing pharmacist. "N"on the front and on the reverse side ""side "" (approval "("letter is enclosed"("see enclosed copy)""Paragraph16."" "("several security r"*"features including ""Our security stock is produced exclusive for our use in the production of prescription forms. "*", which we produce ""ly" "our"0" with this application" "Date"h"__________________________________________________"B"_______________________________"".""________"" "."_____________________"6"created and patented the " "our","in conjunction with ""patient care,""tries to "H". Our security stock is produced "" "("is our design and ""prescription "r"features which we will announce to you at a later date.""Currently, ""w">" when they have been approved""we have "".""that a" "re "";"6"of thermal sensitive ink "4"copy of approval letter)"" ""Vendor Name:"" " "x PR""."2"66 Main Street, Suite 3":"Federal Tax ID: 22-3390483"$8#(u Bom /z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. sss4sss<sssD?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnM`b@hh^h`.@ @hh^h`. @hh^h`. 2@hh^h`.H 6@hh^h`.` @hh^h`.` @hh^h`.P` @hh^h`.RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphHH          Gz Times New Roman5Symbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New" " " 2."0". was founded in 1995 "" as a provider of medical forms and services for the medical and pharmaceutical markets. "" Our """We offer severa"N"One of our programs for marketers is ""o"". "Z" The program serves as a medium to deliver ""for the ""to practitioners and to provide those practitioners with medical forms they use in conjunction with patient care.""practitioner who sees prescription drug messages as the forms are used.""Our Rx forms ""In order to produce Rx forms the practice will use, the practice sends their current Rxc">" form to Rx PROvisions, Inc. ""then "", and stored as electronic documents which can be revised and reproduced"P"updated and used for print production.""retreived,"" ""The signati"~"ure lines are produced in accordance with that State Board of"*"to comply with the "." Pharmacy guidelines."2"pharmaceutical sponsor."6"counterfeit-proof stock, "@", as directed by the physician"."their original format" " as ""s"b" also receives prescription pad orders from the""directly from physicians. The practice completes an order form and mails or faxes the order form to us. If the order is a f""new, a proof is sent to the practice for approval before the order is produced. If the o""if the order"" is for Rx forms we have done before and there are no changes, The order goes to production for printing and shipping."j"rescription pads came from a pharmaceutical company"x" that wanted to use the Rx forms to promote a product for " "uses","d to treat diabetes.""touch."J" and served as a test for validity.""Rx PROvisions, Inc was approved to provide the new security Rx form passed into law durin"x"in New Jersey which was initiated to address fraud in the ""m"<"Medicaid prescription fraud."L"We continues to enhance the features"" These Rx forms are printed in blue with a State logo on the front and in green on the back with a State logo. All of these for"l"with a tracking number directly to the practitioner."" During the last ten years we have been providing these Rx forms to health care providers in New Jersey"8"used in our other Rx forms"$"We can retreive ""current or historical data on any physician we have produced Rx forms for sisce":"at least the last 10 years.""W"$"counterfeit rese""istam"."nt Rx forms by adding"" "."features to stop the ""fradulent " "usr"X"e of prescription forms. The forms we hav"L"Our Rx forms currently feature five ""have five "."the following five fr""eatures;"" "<" a unique batch number to tr""that ""a void pattern on the front side if copied, a thermal sensitio""ve ink "" "Rx""" on the front, a micro print signature line that will not copy, a six quantity check box to confirm the quantity prescribed, sta""description of safety features on the back, thermalsensitive ink in our logo on the back"" "" "P" and a security watermark on the back."," on the front side; ""appears " "in the corner,"" ""and a unique batch number that provides the date and the prescriber"" and the order. On the back we have the following features; a "","" "","" number"B"identifies the production date,""3""3"`"The company has been in business since 1995. " "our""4"" and shipped "6"rrentproduct is enclosed."" "" ""a"" ""5"r"The State of New Jersey requires that each Rx form be ""has a unique batch number. We also print a unique batch number om"X"n all Rx forms we distribute nationwide. ","s with three letters"&"on the left with ""; RXP. "N", followed by the year, month and day"j" that identifies Rx PROvisions, Inc as the producet" "r f"&" of the document.""The "" "RXP""`" is followed by sis digits that represent the "&" (yymmdd). Follo""The date ""productio ""da""order date is followed by four digits that refer to the practice"4"invoice and the practice"". The"" (1234)"" last 2""two digits (01) refer to the number of orders for the practice so far that year." "The "r"The batch number methodology is use to to identify the "h" and to track every prescription form we produce. " "all"" ""s""ve"" "",""x"$" or practitioner"H"actitioner or health care facility"" ""d"".""6""We currently provide our services to pharmaceutical companies and to health care providers. We receive payment from the pharmac"8"Express, MasterCard, Visa,"" and Discover credit cards for our health care provider accounts.""7""8"L"We will offer several counterfeit re""-proof prescription blanks. Our standard sisgle sheet form is trimmed to 4.25""" x 5.5""". It is available as a single sheet and as a 2-part set. Our large Rx forms are trimmed to 5.5"" " x ""standard " "8.5"" ". "$"If any other six"f"We will produce any other custom size based upon "T"for any client that orders them from us.""n"F"Our computer sheets are 8.5 x 11""". """respond to and "" 9""P""samples "d"of prototype prescription blanks are enclosed. ""10" "An overview of"@"A flow diagram of the company'""s operational processes and safeguards for manufacturing our counterfeit-proof stock and the security features of u"@"our facility are provided belo"\"is provided below. Additional comments are "F"In our twelve years of existance "2"we never had any breech""security " " of any kind. ""convenient "("are also provided " "to ""about the "\"security of our facilities is also provided.""Securi""Counterfeit-proof stock is produced by one facility. That facility has the original printing plates and is dedi""cated to "" and that "", thermal sensitive ink and electronic files used in the production process. The facility is protected by external and internal""fety of the stock we produce. One person has the sole responsibility""at that facility has the authorization to access the printing plates and production material needed to produce our stock"*"counterfeit stock. "h"Inventory is produced and stored at this facility.""-"," prescriptions, the "P"contact person at Rx PROvisions, Inc. "",""is notified via e-mail from the facility that will use the stock to produce prescriptions.""the security "*"use, inventory and "4"of the stock we produce.""By divid""separating the stock production process from the actual prescription form production ""physically "H"process by facility and distance, ""additional "0"security and controll ""is pri""ovided by "D"We use separate facilities to a""provide ""a"&". Each plant is " "ed "6"by location and distance "". " "Our ""o""process "" ""Orders for stock are directed to our Main Street office. The request for stock is forwar""then ""the stock productionfacility is notified to send stock to the prescription production facility."" """communication, ""by us "" ""Orders for prescription forms are received by our Main Street location. the ""orders are processed there and sent to our prescription form production facility. As the ""c"&"fron our clients " "ose""m"" where the ""As the "6"to produce prescriptions "" ""i""i""C""is needed "P"prescription form production facility ""nedded ""required"" these""T""orders for "."are then sent to the "J"production facility is notified top"R" provide the required inventory to the ""n," "the "" where the prescription pads are printed packed and shipped. Each order is given a tracking number""," " and"" "z". A label and tracking number are assigned to every order "L". The tracking number, a tearsheet "" ""r ""taken fro""shipping information is sent to our Main Street office where the orders are closed out and invoiced.""The shipping " "and ""and affixed ""T"" ""sends the "" ""c"<", the thermal sensitive ink ""exclusively "" Orders are o"`"picked up at this facility and are delivered. "&"for delivery to u""our clients.""1"B'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssFslFsFsGstGstdsds$e?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP F`b@hh^h`.xF @hh^h`.F @hh^h`.(G 2@hh^h`.G 6@hh^h`.d` @hh^h`.d` @hh^h`.0e` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier NewB'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss(wswsws0xsxsxs8ysy?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP4w`b@hh^h`.w @hh^h`.w @hh^h`.@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier NewD"The following addresses the metn""hodoly""logy ""Rx PROvisions, Inc has used successfully for the last twelve years."(" to comply with re">"operational information needs""requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwi","healthcare provider."("prescription form ""10""a" "All ""e""daily "," from clients, faxes"" to reflect the practitioner, order dates, prescription form quantities, "h" ordered and tracking number information can be re"("also be retreived "*"and sent on demand.""provided "" and type"" "."name and practitoner,"" " " and" "DHL"" ""stored."".""."" "J"of the electronic back-up data are ""separate""a moving " "and "",""Rx PROvisd"B"ions, Inc. will make available ""to the AHC any order form from and Florida health care provider ":"data relating to any order ":"(electronic and or hard coy" "py) ""r" "any ""."".""shipper"" ""label""'""complete "" and all "" Any "" These data can be used to reach all healthcare providers who have been sent prescription forms from Rx PROvisions, Inc."""All electronic "D"Reports in an electronic format "f"In the event of a recall or any other emergency, ""t""received""t"V" will be produced in an electronic format"$"or any other cri"" on demand""."","" "b" and anyadditional information we have from ore" "ders"" "\" received from Florida healthcare providers."$"in our database "6"record keeping, database " " and"" ""2"Z"If the sample prototype is acceptable, the ""Rx PROvisions, Inc. is ready to produce counterfeit-proof prescriptions for Florida healthcare providers. Orders are entered an"" "<"can be produced in 24 hours." "now ""will " "be "*"as described above ""Rx PROvisions, Inc. has been producing prescription forms for the past twelve years, so "" by AHA""."v'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. sspܞsܞs ݞsxݞsݞs(ޞsޞsޞ?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP|ܞ`b@hh^h`.ܞ @hh^h`.,ݞ @hh^h`.ݞ 2@hh^h`.ݞ 6@hh^h`.4ޞ` @hh^h`.ޞ` @hh^h`.ޞ` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial BlackWTms RmnTimes New RomanE" HelvHelvetica?5 z Courier New"3""s""internet"" to verify ""tH""The Florida Medical License search provides the current license number for s"|"each healthcare provider and will be used to verify license " "Specifically, ""t" "the ""numbers of " "for "B"who orders prescription forms. ""T""confirmed.""Rx PROvisions, Inc also uses DEA Lookup.com to verify DEA numbers."P" and to format their prescription form"".""conterfeit-""proof"" "v". We also request their current prescription form which ""is use t"H"also used to verify and to format "", update""4"<"We receive an average of 2 o""two or more orders from over 100,000 physicians in our database."" each year"" ""We have additional plant capacity to handle an additional 100,000 physicians. "P"Our production capacity is perfectly d":"scalable to satisfy demand."""designed to be "" "" "*"produce couterfeit-""proof prescriptions for an additional 10,000 physicians each month. " "rit" "ght " "now ""The current " "Th      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~e average to"X"ime to from receipt of order to shippment "\"of the product is from 24 hours to 48 hours.""5"("Listed below are f">"references for you to contact"&" for our company'"|"s experience and qualifications with the production of fraus"8"d resistant prescriptions.""6"v'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssܕ>s4>s>s>s<>s>s>sD>?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP>`b@hh^h`.@> @hh^h`.> @hh^h`.> 2@hh^h`.H> 6@hh^h`.>` @hh^h`.>` @hh^h`.P>` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial BlackWTms RmnTimes New RomanE" HelvHelvetica?5 z Courier New"."("counterfeit-proof "" security ""." "Pharmaceutical"" ""s"<"in response to approval fron"$"m the physician."$"and complicated "B'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. sspss sxss(ss?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP|`b@hh^h`. @hh^h`., @hh^h`. 2@hh^h`. 6@hh^h`.4` @hh^h`.` @hh^h`.` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontViV  Table Normal :V 44 la (k(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier Newn"facilitate the pharmacists directions to the patient.""frequentlu" "y used and or ""'""t"<"is entered into our database""" and then sent "V" pads as a medium to deliver advertising " "for " "Our ":" (approval letter enclosed)"". "" (see NJ ""blank "@" Prescription Blank, enclosed."*"to prove delivery ">"Rx PROvisions, Inc. has been "4" for the last ten years."" " "prescriptions "4"orders for prescriptions"" "f"by Rx PROvisions, Inc. can be provided on demand."" ","be legible if copied""use the "6" that is seen at an angle"*", or the order date"0" locator number for uo""our database."" ""produced "Z"The quality of the fraud resistant paper is"4"The Rx PROvisions, Inc. " "the ","papar stock used by "b"for fraud resistant prescriptions is 60# offset""opaque "" ""whit "" stock""e"".""e""it is "")"<"entirely and exclusively at """and alarm that "H" and protect the building and the " "the ""-proof" "for ""Then the ""s""s" "ach"2"the end of each day at ""describes"4" via mail fax or e-mail,"V", which will be used for billing purposes"."health care providers""'"" "B'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss<s8<s<s<s@<s<s<sH<?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP<`b@hh^h`.D< @hh^h`.< @hh^h`.< 2@hh^h`.L< 6@hh^h`.<` @hh^h`.<` @hh^h`.T<` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"@a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*@> Endnote ReferenceH*4+@4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@@ Footnote ReferenceH*6@6  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5Symbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New "We are continu""continue to search for new security features we can add to our Rx forms and we will keep you informed of the success we have."" "4"in our perpetual effort " "to "F"dollars lost to prescription frau""d each year."."health care providers""In 1996, ""o""blue """pharmaceutical "B"uses prescription forms and dia""Pharmacy """"" Symbol"."Rx form is lightened,"" ""copied""."",""blue " "the "*"Rx PROvisions, Inc."" "B'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssus$vs|vsvs,wswsws4x?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMPu`b@hh^h`.0v @hh^h`.v @hh^h`.v 2@hh^h`.8w 6@hh^h`.w` @hh^h`.w` @hh^h`.@x` @hh^h`.         RL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New"50 or ""#" "are"" "" ""50# or "" ""Prescription "$"blue background "F"Resists erasures or alterations. ""on front "<"Security features listed on " ". ""H"" with ""h""that "Z" for single products and for multiple presc" " entry or for ":"entries (samples enclosed)." "Rx " ..//1144"watermark ""Rx Se""PROvi""sions, Inc ""with ""watermark"""""TOLL FREE ""letters ""x"'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss8sss@sssHs?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMPD`b@hh^h`. @hh^h`. @hh^h`.L 2@hh^h`. 6@hh^h`.` @hh^h`.T` @hh^h`.` @hh^h`.         SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier NewD" and the Federal guidelines for ""S""resistant"" ""resistant"" "," prescription forms."8"Several States, including ""t""Actually, w" "ans""d serve as a "*"healthcare provider""tamper ""tamper"" resistant""both ""and for"" ""for the .S "$"tate of Wyoming "$"tamper resistant"$"Tamper resistant"$"Tamper resistant"" "S#c#%%%%"&4&"&4&2222-5?5-5?5G8Y8G8Y8X@j@X@j@   r!!""" "" "" "" "" "" "" "" "" "" "" ""5""tamper"" "'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssa sa sDb sb sb sLc sc sc ?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMPa `b@hh^h`.a @hh^h`.Pb @hh^h`.b 2@hh^h`.c 6@hh^h`.Xc ` @hh^h`.c ` @hh^h`.d ` @hh^h`.         SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New " the"","'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ssa s@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New" ""will use"" "F"to confirm practitioners who are "" "" """OLL FREE Number" "1-888-921-1211"": "." jpisano@rxproinc.com""E-mail: "" "" " " "" " " "   ////1111S3Z3S3Z33333N6U6N6U66666" and meet the requirements of the Department of Public Safety, Maine Drug Enforcement Agency Requirement for Security Prescripti""Licensure "'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. sss(ss`ssshs?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP`b@hh^h`.4 @hh^h`. @hh^h`.l 2@hh^h`. 6@hh^h`.` @hh^h`.t` @hh^h`.` @hh^h`.         SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New" "@0(,@@ ""'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss's's'sD'sl'ss@s?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP'`b@hh^h`. ' @hh^h`.' @hh^h`.P' 2@hh^h`.x' 6@hh^h`.` @hh^h`.L` @hh^h`.` @hh^h`.         SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New@0(,"" ##'%(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss>'s|ss,sss4s?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMP0`b@hh^h`. @hh^h`. @hh^h`.8 2@hh^h`. 6@hh^h`.` @hh^h`.@` @hh^h`.` @hh^h`.         SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>Th]^1@!B List Numberp$ & F>T8h.]^H-RH  Macro Text%$da$ OJQJkH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>Th.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8h.^8;@A List Number 3a,>Th.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>Th.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJphLL           Gz Times New Roman5RSymbol3& z Arial?& Arial Black7Tms Rmn1" Helv?5 z Courier New3# #"##$4DTdt  , 0 48<LPTdt ,<L\l| $!!4""D##T$$d%%t&&' (()),**<++L,,\--l..|/001122.33>44N55^66n77~899::&;;6<<F==V>>f??v@@ABBCC.DD>EENFF^GGnHH~IJJKK&LL6MMFNNVOOfPPvQQRSSTT.UU>VVNWW^XXnYY~Z[[\\&]]6^^F__V``faavbbcddee.ff>ggNhh^iinjj~kllmm&nn6ooFppVqqZrr^ssntt~uvvww&xx6yyFzzV{{f||v}}~.>ƂNփ^n~&6F΋Vތfv&6FΔJҕZjn~ *:¡JҢZ֣^n~"2BʭFήVޯfv.>ƶNַ^n~&*.26:>NRbfjnr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr .>N^n~  &  6  F  J  Zjz"2BRbr *:JZj  z!""##"$$2%%B&&R''b((r))* ++,,*--:..J//Z00j11z23344"55266B77R88b99r::; <<==*>>:??J@@ZAAjBBzCDDEE"FF2GGBHHRIIbJJrKKL MMNN*OO:PPJQQZRRjSSzTUUVV"WW2XXBYYRZZb[[r\\] ^^__*``:aaJbbZccjddzeffgg"hh2iiBjjRkkbllrmmn oopp*qq:rrJssZttjuuzvwwxx"yy2zzB{{R||b}}r~~ *:ƒJ҄Zjz"2BʌRڍbr *:”JҕZjz"2BʝRڞbr *:¥JҦZjz"2BʮRگbr *:¶JҷZjz"2BʿRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr   *  :  J  Z  jz"2BRbr *:JZjz !!"""##2$$B%%R&&b''r(() **++*,,:--J..Z//j00z12233"44255B66R77b88r99: ;;<<*==:>>J??Z@@jAAzBCCDD"EE2FFBGGRHHbIIrJJK LLMM*NN:OOJPPZQQjRRzSTTUU"VV2WWBXXRYYbZZr[[\ ]]^^*__:``JaaZbbjcczdeeffgg&hh6iiFjjVkkfllvmmnoopp.qq>rrNss^ttnuu~vwwxx&yy6zzF{{V||f}}v~~.>ƃNք^n~&6FΌVލfv.>ƔN֕^n~&6FΝVޞfv.>ƥN֦^r *:­JҮZjz"2BʶRڷbr *:¾JҿZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"  2  B  R  b  r *:JZjz"2BRbr  !!""*##:$$J%%Z&&j''z())**"++2,,B--R..b//r001 2233*44:55J66Z77j88z9::;;"<<2==B>>R??b@@rAAB CCDD*EE:FFJGGZHHjIIzJKKLL"MM2NNBOORPPbQQrRRS TTUU*VV:WWJXXZYYjZZz[\\]]"^^2__B``Raabbbrccd eeff*gg:hhJiiZjjjkkzlmmnn"oo2ppBqqRrrbssrttu vvww*xx:yyJzzZ{{j||z}~~"2BʂRڃbr *:ŠJҋZjz"2BʓRڔbr *:>ƜN֝^n~&6FΥVަfv.>ƭN֮^n~&6FζV޷fv.>ƾNֿ^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&  6  F  V  f  v.>N^n~&6FVfv !!"".##>$$N%%^&&n''~())**&++6,,F--V..f//v0012233.44>55N66^77n88~9::;;&<<6==F>>V??f@@vAABCCDD.EE>FFNGG^HHnII~JKKLL&MM6NNFOOVPPfQQvRRSTTUU.VV>WWNXX^YYnZZ~[\\]]&^^6__F``Vaafbbvccdeeff.gg>hhNii^jjnkk~lmmnn&oo6ppFqqVrrfssvttuvvww.xx>yyNzz^{{n||~}~~&6F΂Vރfv.>ƊN֋^n~&6FΓVޔfv.>ƛN֜^n~&6FΤVޥfv.>ƬN֭^n~&6FεV޶fv.>ƽN־^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.@P`p(8  H  X  h  x  0@P`p(8HXhx   !!0""@##P$$`%%p&&'(())(**8++H,,X--h..x/0011 22033@44P55`66p77889:: ;;0<<4==8>>H??X@@hAAxBCCDD EE0FF@GGPHH`IIpJJKLLMM(NN8OOHPPXQQhRRxSTTUU VV0WW@XXPYY`ZZp[[\]]^^(__8``HaaXbbhccxdeeff gg0hh@iiPjj`kkpllmnnoo(pp8qqHrrXsshttxuvvww xx0yy@zzP{{`||p}}~(8HЃXhx 0@ȋP،`p(8HДXhx 0@ȜP؝`p(8HХXhx 0@ȭPخ`p(8HжXhx 0@ȾPؿ`p(8HXjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *  :  J  Z  j  z"2BRbr *:JZjz  !!"""2##B$$R%%b&&r''( ))***++:,,J--Z..j//z01122"33244B55R66b77r889 ::;;*<<:==J>>Z??j@@zABBCC"DD2EEBFFRGGbHHrIIJ KKLL*MM:NNJOOZPPjQQzRSSTT"UU2VVBWWRXXbYYrZZ[ \\]]*^^:__J``Zaajbbzcddee"ff2ggBhhRiibjjrkkl mmnn*oo:ppJqqZrrjssztuuvv"ww2xxByyRzzb{{r||} ~~*:J҂Zj|$4D̊T܋dt ,<ĒLԓ\l|$4D̛Tܜdt ,<ģLԤ\l|$4D̬Tܭdt ,<ĴLԵ\l|&6FνV޾fv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>  N  ^  n  ~ &6FVfv.>N^n~  &!!6""F##V$$f%%v&&'(()).**>++N,,^--n..~/0011&22633F44V55f66v77899::.;;><<N==^>>n??~@AABB&CC6DDFEEVFFfGGvHHIJJKK.LL>MMNNN^OOnPP~QRRSS&TT6UUFVVVWWfXXvYYZ[[\\.]]>^^N__^``naa~bccdd&ee6ffFggVhhfiivjjkllmm.nn>ooNpp^qqnrr~sttuu&vv6wwFxxVyyfzzv{{|}}~~.>ƀNց^n~&6FΉVފfv.>ƑN֒^n~&6FΚVޛfv.>ƢN֣^n~&6FΫVެfv.>ƳNִ^n~&6FμV޽fv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N  ^  n  ~   &6FVfv.>N^n~&  6!!F""V##f$$v%%&''((.))>**N++^,,n--~.//00&11622F33V44f55v6678899.::>;;N<<^==n>>~?@@AA&BB6CCFDDVEEfFFvGGHIIJJ.KK>LLNMM^NNnOO~PQQRR&SS6TTFUUVVVfWWvXXYZZ[[.\\>]]N^^^__n``~abbcc&dd6eeFffVggfhhviijkkll.mm>nnNoo^ppnqq~rsstt&uu6vvFwwVxxfyyzz{{||"}}2~~BRڀbr *:‡J҈Zjz"2BʐRڑbrv.>ƙN֚^n~&6F΢Vޣfv.>ƪN֫^n~&6FγV޴fv.>ƻNּ^n~&6FVfv.>N^n~(8HXhx 0@P`p(8HXhx 0@P`p(8HXhx 0@P `  p       (  8  H  X h x    0  @  P  `  p       (  8  H  X  h  x       0 @! ! P" " `# # p$ $ % & & ' ' (( ( 8) ) H* * X+ + h, , x- . . / / 0 0 01 1 @2 2 P3 3 `4 4 p5 5 6 7 7 8 8 (9 9 8: : H; ; X< < h= = x> ? ? @ @ A A 0B B @C C PD D `E E pF F G H H I I (J J 8K K HL L XM M hN N xO P P Q Q R R 0S S @T T PU U `V V pW W X Y Y Z Z ([ [ 8\ \ H] ] X^ ^ h_ _ x` a a b b c c 0d d @e e Pf f `g g ph h i j j k k (l l 8m m Hn n Xo o hp p xq r r s s t t 0u u @v v Pw w `x x py y z { { | | (} } 8~ ~ H  X h z   " 2 B ʇ R ڈ b r  * :  J Ґ Z j z   " 2 B ʘ R ڙ b r  * :   J ҡ Z j z   " 2 B ʩ R ڪ b r  * : ± J Ҳ Z j z   " 2 B ʺ R ڻ b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r       *  >  N  ^  n ~   & 6  F  V  f  v       .  >  N  ^  n  ~     &  6  F V! ! f" " v# # z$ % % & & "' ' 2( ( B) ) J* * Z+ + ^, , b- - r. . / 0 0 1 1 *2 2 :3 3 J4 4 Z5 5 j6 6 z7 8 8 9 9 ": : &; ; 6< < F= = V> > Z? ? j@ @ zA B B C C "D D 2E E BF F RG G bH H rI I J K K L L *M M :N N JO O ZP P jQ Q zR S S T T "U U 2V V BW W RX X bY Y rZ Z [ \ \ ] ] *^ ^ :_ _ J` ` Za a jb b zc d d e e "f f 2g g Bh h Ri i bj j rk k l m m n n *o o :p p Jq q Zr r js s zt u u v v "w w 2x x By y Rz z b{ { r| | } ~ ~   * :  J ҂ Z j z   " 2 B ʊ R ڋ b r  * : ’ J ғ Z j z   " 2 B ʛ R ڜ b r  * : £ J Ҥ Z j z   " 2 B ʬ R ڭ b r  * : ´ J ҵ Z j z   " 2 B ʽ R ھ b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B  R  b  r       *  : J Z j z     "  2  B  R  b  r       *  :  J  Z  j  z    "! ! 2" " B# # R$ $ b% % r& & ' ( ( ) ) ** * :+ + J, , Z- - j. . z/ 0 0 1 1 "2 2 23 3 B4 4 R5 5 b6 6 r7 7 8 9 9 : : *; ; :< < J= = Z> > j? ? z@ A A B B "C C 2D D BE E RF F bG G rH H I J J K K *L L :M M JN N ZO O jP P zQ R R S S "T T 2U U BV V RW W bX X rY Y Z [ [ \ \ *] ] :^ ^ J_ _ ^` ` na a ~b c c d d &e e 6f f Fg g Vh h fi i vj j k l l m m "n n &o o 6p p Fq q Vr r fs s vt t u v v w w .x x >y y Nz z ^{ { n| | ~} ~ ~   & 6 F ΂ V ރ f v   . > Ɗ N ֋ ^ n ~   & 6 F Γ V ޔ f v   . > ƛ N ֜ ^ n ~   & 6 F Τ V ޥ f v   . > Ƭ N ֭ ^ n ~   & 6 F ε V ޶ f v   . > ƽ N ־ ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . >  N  ^  n  ~     &  6 F V f v      .  >  N  ^  n  ~     &  6  F  V  f  v    ! ! ." " ># # N$ $ ^% % n& & ~' ( ( ) ) &* * 6+ + F, , V- - f. . v/ / 0 1 1 2 2 .3 3 >4 4 N5 5 ^6 6 n7 7 ~8 9 9 : : &; ; 6< < F= = V> > f? ? v@ @ A B B C C .D D >E E NF F ^G G nH H ~I J J K K &L L 6M M FN N VO O fP P vQ Q R S S T T .U U >V V NW W ^X X nY Y ~Z [ [ \ \ &] ] 6^ ^ F_ _ V` ` fa a vb b c d d e e .f f >g g Nh h ^i i nj j ~k l l m m &n n 6o o Fp p Vq q fr r vs s t u u v v .w w >x x Ny y ^z z n{ { ~| } } ~ ~ &  6 F ΁ V ނ f v   . > Ɖ N ֊ ^ n ~   & 6 F Β V ޓ f v   . > ƚ N ֛ ^ n ~   & 6 F Σ V ޤ f v   . > ƫ N ֬ ^ n ~   & 6 F δ V ޵ f v   . > Ƽ N ֽ ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . > N ^ n ~   & 6 F V f v   . > N  ^  n  ~     &  *  : J Z j n ~     &  *  :  >  N  ^  n  ~     &  6  F  V  f  v ! " " # # .$ $ >% % N& & ^' ' n( ( r) ) * + + , , *- - :. . J/ / Z0 0 j1 1 z2 3 3 4 4 "5 5 26 6 B7 7 R8 8 b9 9 r: : ; < < = = *> > :? ? J@ @ ZA A jB B zC D D E E "F F 2G G BH H RI I bJ J rK K L M M N N *O O :P P JQ Q ZR R jS S zT U U V V "W W 2X X BY Y RZ Z b[ [ r\ \ ] ^ ^ _ _ *` ` :a a Jb b Zc c jd d ze f f g g "h h 2i i Bj j Rk k bl l rm m n o o p p *q q :r r Js s Zt t ju u zv w w x x "y y 2z z B{ { R| | b} } r~ ~   * : ƒ J ҄ Z j z   " 2 B ʌ R ڍ b r  * : ” J ҕ Z j z   " 2 B ʝ R ڞ b r  * : ¥ J Ҧ Z j z   " 2 B ʮ R گ b r  * : ¶ J ҷ Z j z   " 2 B ʿ R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z   " 2 B R b r  * : J Z j z  "2BRbr   *  :  J  Z  jz"2BRbr *:JZjz !!"""##2$$B%%R&&b''r(() **++*,,:--J..Z//j00z12233"44255B66R77b88r99: ;;<<*==:>>J??Z@@jAAzBCCDD"EE2FFBGGRHHbIIrJJK LLMM*NN:OOJPPZQQjRRzSTTUU"VV2WWBXXRYYbZZr[[\ ]]^^*__:``JaaZbbjcczdeeff"gg2hhBiiRjjbkkrllm nnoo*pp:qqJrr      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~Zssjttzuvvww"xx2yyBzzR{{b||r}}~ *:‚J҃Zjz"2BʋRڌbr *:“JҔZjz"2BʜRڝbr *:¤JҥZjz"2BʭRڮbr *:µJҶZjz"2BʾRڿbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *  :  J  Z  j  z"2BRbr *:JZjz  !!"""2##B$$R%%b&&r''( ))***++:,,J--Z..j//z01122"33244B55R66b77r889 ::;;*<<:==J>>N??R@@bAArBBC DDEE*FF:GGJHHZIIjJJzKLLMM"NN2OOBPPRQQbRRrSST UUVV*WW:XXJYYZZZj[[z\]]^^"__2``BaaRbbbccrdde ffgg*hh:iiJjjZkkjllzmnnoo"pp2qqBrrRssbttruuv wwxx*yy:zzJ{{Z||j}}z~"2BʃRڄbr *:‹JҌZjz"2BʔRڕbr *:œJҝZjz"2BʥRڦbr *:­JҮZjz"2BʶRڷbr *:¾JҿZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"  2  B  R  b  r *:JZjz~&6FVfv  !""##.$$>%%N&&^''n((~)** ++,,*--:..J//Z00j11n22~34455&66677F88V99f::v;;<==>>.??>@@NAA^BBnCCrDDE FFGG*HH:IIJJJZKKjLLzMNNOO"PP2QQBRRRSSbTTrUUV WWXX*YY.ZZ>[[N\\^]]n^^~_``aa&bb6ccFddVeefffvgghiijj.kk>llNmm^nnnoo~pqqrr&ss6ttFuuZvvjwwzxyyzz"{{2||B}}R~~br *:…J҆Zjz"2BʎRڏbr *:–JҗZjz"2BʟRڠbr *:§JҨZjz"2BʰRڱbr *:¸JҹZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr     *  :  JZjz"2BRbr *:JZ  j!!z"##$$"%%2&&B''R((b))r**+ ,,--*..://J00Z11j22z34455"66277B88R99b::r;;< ==>>*??:@@JAAZBBjCCzDEEFF"GG2HHBIIRJJbKKrLLM NNOO*PP:QQJRRZSSjTTzUVVWW"XX2YYBZZR[[b\\r]]^ __``*aa:bbJccZddjeezfgghh"ii2jjBkkRllbmmrnno ppqq*rr:ssJttZuujvvzwxxyy"zz2{{B||R}}b~~r *:„J҅Zjz"2BʍRڎbr *:•JҖZjz"2BʞRڟbޠfv.>ƧN֨^n~&6FΰVޱfv.>ƸNֹ^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv     .  >  N^n~&6FVfv.>N^  n!!~"##$$&%%6&&F''V((f))v**+,,--...>//N00^11n22~34455&66677F88V99f::v;;<==>>.??>@@NAA^BBnCC~DEEFF&GG6HHFIIVJJfKKvLLMNNOO.PP>QQNRR^SSnTT~UVVWW&XX6YYFZZV[[f\\v]]^__``.aa>bbNcc^ddnee~fgghh&ii6jjFkkVllfmmvnnoppqq.rr>ssNtt^uunvv~wxxyy&zz6{{F||V}}f~~v.>ƄNօ^n~&6F΍Vގfv.>ƕN֖^n~&6FΞVޟfv.>ƦN֧^n~&6FίVްfv.>ƷNָ^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv    .  >  N  ^n~&6FVfv.>N^n  ~!""##&$$6%%F&&V''f((v))*++,,.-->..N//^00n11~23344&55666F77V88f99v::;<<==.>>>??N@@^AAnBB~CDDEE&FF6GGFHHVIIfJJvKKLMMNN.OO>PPNQQ^RRnSS~TUUVV&WW6XXFYYVZZf[[v\\]^^__.``>aaNbb^ccndd~effgg&hh6iiFjjVkkfllvmmnoopp.qq>rrNss^ttnuu~vwwxx&yy6zzF{{V||f}}v~~.>ƃNք^n~&6FΌVލfv.>ƔN֕^n~&6FΝVޞfv.>ƥN֦^n~&6FήVޯfv.>ƶNַ^n~&6FοVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv  .  >  N  ^  n~&6FVfv.>N^n~ !!""&##6$$F%%V&&f''v(()**++.,,>--N..^//n00~12233&44655F66V77f88v99:;;<<.==>>>N??^@@nAA~BCCDD&EE6FFFGGVHHZIIjJJnKK~LMMNN&OO6PPFQQVRRfSSvTTUVVWW.XX>YYNZZ^[[n\\~]^^__&``6aaFbbVccfddveefgghh.ii>jjNkk^llnmm~noopp&qq6rrFssVttfuuvvvwxxyy.zz>{{N||^}}n~~~&6F΄Vޅfv.>ƌN֍^n~&6FΕVޖfv.>ƝN֞^n~&6FΦVާfv.>ƮN֯^n~&6FηV޸fv.>ƿN^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~&6FVfv.>N^n~  &  6  F  V  fv.>N^n~&6FVfv  !""##.$$>%%N&&^''n((~)**++&,,6--F..V//f00v1123344.55>66N77^88n99~:;;<<&==6>>F??V@@fAAvBBCDDEE.FF>GGNHH^IInJJ~KLLMM&NN6OOFPPVQQfRRvSSTUUVV.WW>XXNYY^ZZn[[~\]]^^&__6``FaaXbb\ccldd|effgg$hh4iiDjjTkkdlltmmn oopp,qq>L??\@@lAA|BCCDD$EE4FFDGGTHHdIItJJK LLMM NN0OO@PPPQQ`RRpSSTUUVV(WW8XXHYYXZZh[[x\]]^^ __0``@aaPbb`ccpddeffgg(hh8iiHjjXkkPll`mmpnnoppqq(rr8ssHttXuuhvvxwxxyy zz0{{@||P}}`~~p(8HЅXhx 0@ȍP؎`p(8HЖXhx 0@ȞP؟`p(8HЧXhx 0@ȯPذ`p(8HиXhx 0@P`p(8HXhx 0@P`p(8HXhx 0@P`p(8HXhx$4DTdt ,<L\l|$4DTdt    ,  <  L  \l|$4DTdt ,<L\l  |!""##$$$4%%D&&T''d((t))* ++,,,--<..L//\00l11|23344$55466D77T88d99t::; <<==,>>N^n    (  8  H  Xhx 0@P`p(8HXh  x!""## $$0%%@&&P''`((p))*++,,(--8..H//X00h11x23344 55066@77P88`99p::;<<==*>>:??J@@ZAAjBBzCDDEE"FF2GGBHHRIIVJJfKKvLLMNNOO.PP>QQNRR^SSnTT~UVVWW&XX6YYFZZV[[f\\v]]^__``.aa>bbNcc^ddnee~fgghh&ii6jjFkkVllfmmvnnoppqq.rr>ssNtt^uunvv~wxxyy&zz6{{F||V}}f~~v.>ƄNօ^n~&6F΍Vގfv.>ƕN֖^n~*:JҞZjz"2BʦRڧbr *:®JүZjn~&*:¸JҹZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr *:JZjz"2BRbr     *  :  JN^bfv&b((&b((&|b*&Eb((&6b(X(&b(X(&^^b(;&b(;&b(X(&WWb(X(&b(+&53b(X(&b(X(&b(n&[[[[[b(X(&| { {b(s&,  b(+&, , b(+&, , b(+&, , b(+&, , b((T$Fckb((T$F ,# { {b(nU$F{{|b*U$F{{{b(0U$F{{|b*0U$F{{{b(0U$F{{|b*0U$F{{{b(U$F{{|b*0U$F{{{b(:U$F{{b(X(b(|b*0b(0|b*06b(X(G&b(:G&b(X(G&b(X(G&b(X(H&77b(X(H&""b((H&b(X(H&b(X(H&b((H&b(X(H&b((H&b(X(I&+b(:I&b(X(I&Ab((I&[[b((I&[[b(X(I&g[[b(X(I&qb(X(I&b(X(J&OCCOOOb((J&NOOOOOOOb(X(J&OrOOOrrrb(X(K&O8888b((K&888888888b((K&8888OO888888b((K&8888OO888888b((K&8888PP888888b((K&8888OO888888b((K&8888OO888888b((K&8888OO888888b((K&8888PP888888b((K&8888OO888888b((K&8888PP888888b(X(K&b((K&vb(X(M&b((M&b(X(M&b(X(N&====b(X(N&/;/0//;;;/b(X(O&=4G4444GGG4b(X(O&iMQMM00MMQQQMb(X(P&wQQQQMMb(X(P&44b((P&b(X(P&b(X(Q&b(X(Q&b((Q&b(X(R&L]]LLLb(X(S&WLjLLLjjjb(X(S&eeevveeeb(X(Z&b(X(Z&LMLLLLMMMLb(X(Z&3e z,n`&w&S@w&w&w&w&~ z.`&S@w&w&w&w&w& z,n`&!"C@y&y&y&x&w&w&w&w&b(+`&b(a&[>#b(X(c&b((c&&b((c&b(X(d&&&&&b(se&vQQb((e&          b((e&          b((e&          b((e&          b((e&          b((e&          b(X(e&%      b((e&6Wb((e& b((e&RRb((e&QQb((e&QQb((e&QQb((e&QQb((e&QQb((e&RRb((e&QQb(X(f&b((f&U%b((f&b(X(f&BCBBBBCCCBb((g&DDD\DDDDDDb(+g&_______b(+g&b(+h&*000b(X(i&     b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  zz   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&  {{   b((l&     b((l&  {{   b(X(n&5 5  {{ 5 5 5 b(X(o&0 j 0 0 0 0 j j j 0 b(X(o&Z d Z Z @@Z Z d d d Z b(X(p&.q q t t   q b(X(p&r r r r r   r b((p&    b(X(p&G    b(X(p&     b((p&I  u    b((p&.      b(X(q&q r q q q q r r r q b(X(r& w   w w w b(X(r&  SS   b((r&     b((r&  {{   b((r&  {{   b((r&  {{   b((s&    b((s&    b((s&    b((s&    b((s&    b((s&    b(X(s&     b((s&       b(X(s&  '*  // b(X(s&  ''   b(X(t&3  [[   b(X(t&?    b((t&      b(X(t&_  WW   b((t&  gg   b(X(t&k  gg     b((t&          b((t&    HH      b((t&    GG      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    GG      b((t&    HH      b((t&    HH      b((t&    HH      b((t&    HH      b((u&o9b(X(u&NZNN!!NNZZZNb(X(u&--|b*u&b(u&b(X(v&|b*v&b(v&b(X(v&?%b((v&b((v&b(X(w&%%%%b((w&7(((^$((((((b((w&((((((((((b(X(w&()(((()))(b((w&E(lkk__kkkkkkb((w&(kkkkkkkkb(X(w&Q%kmkkkkmmmkb((w&Ub((w&b((w&b(X(x&[%b((x&b((x&..b((x&..b((x&..b((x&..b((x&..b((x&..b((x&..b((x&..b((x&..b((x&--b((x&--b((x&..b(X(x&w%b((x&b((x&b((x&b((x&b((y&SSSSSSSSSSb((y&SSSSSSSSSSb((y&SSSSSSSSSSb(X(y&%SUSSSSUUUSb(X(y&%ckcccckkkcb(X(y&cdccccdddcb(X(y&%PPb((y&b(X(y&%ddb((y& b(X(z&%wwwwwwb(+{&b(({&b(({&b(({&b(({&b(({&b(X({&%b(({& b(-{&?yycyyyyyb(+&?PPQQPQQb(+&_|b*&&4 @ 4 4 4 @ 4 4 (&KL4 @ 4 4 4 @ 4 4 b((&( ( 4 @ 4 4 ( ( ( ( b(X(&B* ? * *  * * ? ? ? * b(X(&     b(X(&C""""""""""b((&""""""""""b((&"""#""""""|b*&C"#"""""""b(X(&UC""""""""""b((&""""""""""b(X(&"#""""###"b((&#####"###"b(0&%"#""""###"|b*0&sC""""###""b((&""""RR""""""b(X(&""""RR""""""b(X(&C ## # # # #### #b(0&""""" #""" #|b*0&D""" #""" # #b(0&"""""#"""#|b*0&D"""#"""##b(&"""""#"""|b*&E"""#"""b((&########|b*&E######b(&""###"""|b*&E###"""b(X(&/Ff#h#f#f#f#f#h#h#h#f#b(-&f#i#f#i# f#f#f#i#f#f#b(X(&9Fh##h#h# h#h####h#b((&####OO######b(X(&F####vv######b(+&"##########b(X(&##########b((&Hf##########|b*&F#########b(&"##########b((&"##########b(X(&####99######b(X(&##########b(X(&F##########b(X(&####33######b(X(&##########b(&##########|b*&F#########b(X(&G##########b(&##########|b*&?G#########|b*&Gf#f#f#f#f#f#f#f##b(&"f##f#f#f#f#f#f#f#f#b(X(&Gf#j#f#f#f#f#j#j#j#f#b((&##########b(X(&G##########b((&##########b((*%%|b**G%b(*W^^(^b(X(lc&Hb((lcb(X(mc8Hb((mcb(X(mcb(X(mcb((mc b((nc1b(X(ncrHb(+ncb(.ncb(-ncb(X(nc~H b(;ncb(X(ocb((ocb((ocb((ocb((ocb(X(ocHb((ocb((ocb((ocb((ocb((ocb(:ocb(0pc|b*0pcHb(0pc|b*0pcKIb(0pc|b*0pcIb(0pc|b*0pcQJb(0pc|b*0pcJb(0pc7>=>=|b*0pcWK=>=b(X(pcKb((pcb(X(pcKb(qc|b*qcKb((qcb(0qc|b*0qc2Lb(qc|b* 0qcLb(0qc|b*0qcAMb(0qc|b*0qcMb(X(rcb(X(rcb(;rcb(X(rcGNb(X(scNsb(3sc$b(-sc b(.sc b(X(scb(X(scb(X(scNb((sc%%b((sc((b((sc,,b((sc00b((sc44b((sc77b((sc;;b((sc??b((scb((scb(X(scb((scb((scb((scb(X(scNb((tc#b(3tc b(3tc b(X(tcNb(3tc b(3tcb(3tcb(3tcb(3tcb(3tcb(3tcb(X(ucNb((ucb((ucb((ucb((ucb((ucb((ucb((ucb((uc  b((ucb((ucb((ucb((ucb(X(ucNb((ucb(X(ucb(X(ucb(X(vcb((vcb(X(vcb(X(vcO  b((vcb((vcb(X(vc    b((vcVVb(X(vcb(X(wcCO +    +++ b((wc**********b(X(wcO*1****111*b(;wcb(X(xcOb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb((xcb(X(xcOb(-xcb(.xcb(X(ycO!!b(X(zcPNgNNCCNNgggNb(X(zcghgggghhhgb(nzchhhhgb(X(zcb(nzcb(n{c99999b(n{c99999b(n{cb(n{cCCCCCb(n{cCCCCCb(0c7?>?>[ [|b*0coP>?>[ [[b(X(,4!FPb(X(,4!Fb(X(,4!Fb(X(,4!Fab(X(,4!F0Qb(+-4!F(``:`````b((-4!F:b(X(-4!Fb(X(-4!Fb((-4!F<b(X(-4!Fb(X(-4!Fb((-4!F>b(.4!Fb(.4!Fb(.4!Fb(/4!Fb((/4!Fb(/4!Fb(/4!Fb(04!F|b*04!F>Qiiiiiib(04!Fiiiiiib(04!Fjjjjjjb(14!Fb(14!Fb(14!Fb(14!Fb((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!F##b((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb((24!Fb(24!Fijhjjjhjjb(*'!Ab(X(2#mb((2#b((2#b((2#b((2#b((2#  b((2#  b((2#b((2#b((2#b((2#b((2#b((2#b((2#""b((2#''b((2#++b((2#00b((2#55b((2#99b((2#>>b((2#CCb((2#GGb((2#LLb((2#QQb((2#UUb((2#ZZb((2#__b((2#ccb((2#b((2#mmb(X(2#DDb((2#2b(X(2#n//b((2#b(X(2#Anb((2#b(X(2#VVb((2#b((2#2b(X(2#22b(X(2#NNb(X(2#OnOOb((2#b(X(2#enb((2#b(X(2#yn 77   b((2#)b(X(2#XXb((2#b(+2#b(-2#b(X(2#n%VV%%%b(X(2#n!/!!dd!!///!b(X(2#3433334443b((2#3444434443b(X(2#444433b(X(2#33b(X(2#n33b(X(2#+o((((b(X(2#o)@))))@@@)b((2#0000bb000000b(X(2#0100bb001110b(X(2#@A@@@@AAA@b(;2#ABAAA@AAA@b(X(2#ANAAA@NNN@b(X(2#o////b((2#77b((\#f**b((\#fb(X(\#fo33b(X(\#foLLb((\#fb((\#fccb((\#fhhb((\#fmmb((\#fb((\#fb(X(\#f pb((\#f??b(X(\#fDDb((\#fjjb(X(\#fpjjb(X(\#f!pb((\#fb((\#fb((\#fb((\#fb(X(\#fb((\#fXXb((\#fXXb((\#fXXb((\#fWWb((\#fWWb((\#fWWb((\#fWWb((\#fWWb((\#fWWb((\#fWWb((\#fWWb((\#fWWb(X(\#fApXXb((\#f!!b(X(\#f!!b(X(\#f66b(X(\#fWp0\\000b(X(\#fp5[55""55[[[5b((\#f[[[[[5[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[QQ[[[[[[b((\#f[[[[PP[[[[[[b((\#f[[[[PP[[[[[[b(X(\#fpgggddgggb((\#fb(X(\#f5q      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~b((\#fb(X(\#fb(X(\#fb(X(\#fmqC##CCCb((\#fBBBBBBBBBBb(X(\#fqBBBBBBb((\#fyyb(X(\#f-ryyb((\#fyyb(X(\#f''b(X(\#f]^]]VV]]^^^]b(X(\#ferb(X(\#f}rb((\#fb(X( \#fb(( \#f          b(( \#f8Kb(: \#fb(X( \#f))))b(X( \#frDDb(( \#fb(X( \#fb(( \#fb(X( \#fb(X(!\#frb(X(!\#f3433  334443b((!\#f5555555555b((ׂ#&??b((ׂ#&ssb(X(ׂ#&ssb((ׂ#& Ob((ׂ#& b(X(ׂ#&WWb((ׂ#&'FQb((ׂ#& +*******b(-؂#& + +   +  b(+؂#& + +   +  b(X(؂#&b(X(؂#&b((؂#&b((؂#&b((؂#&Lb(X(#&MMb(X(#&rb(X(#&rb(X(#&sXb(X(#&WWb(X(#&9sDHDDeeDDHHHDb((#&GGGGGGGGGGb(X(#&GsGjGGGGjjjGb((#&ghjjjGhhhGb(X(#&hnhhhGnnnGb((#&hhhohhhhhhb(X(#&shhhhhhb((#&hhb(X(#&hhb((#& b(X(#&KKb(X(#&b(X(#&hihhhhiiihb(X(#&YYb(;#&b(X(#&sb((Q#HHb((Q#b(X(Q#t88b((Q#b(X(Q#-tb(X(Q#;tb((R#b(X(R#_tXXb((R#\556665555b(X(R#ABAAAAAABBBAb((R#,6BBBA6666b(X(R#6866668886b(R# ,688868886b(R# ,688868886b((R#8988867777b((R#7777776666b((R# ,655``555555b(X(R#5;55``55;;;5b((R#;<;;;5::::b(X(R#:<::::<<<:b(X(R#<D<<<:DDD:b(X(R#DMDDD:MMM:b(X(N#t99b(X(N#DDb((N#b((N#b((N#RRb((N#VVb((N#[[b((N#``b((N#ddb((N#iib((N#mmb((N#rrb((O#eeb(X(O#iib(3O#ub(X(O#t7@EEb((O#jjb(X(O#tjjb((O#b((O#b((O#b((O#b((O#b((O#b((O#b((O#b((O#b((O#b((O#b(X(O#t&&b(X(O#b(X(O#tb((O#b((O#b((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#xxb((O#b(X(O#tXXb(X(P#u(4((##((444(b(X(P#-u>R>>``>>RRR>b(X(P#?@??ee??@@@?b((P#@@@@@?@@@@b(X(Q#[uRRRRRRb((Q#b(X(Q#ub((Q#b(X(Q#b(X(R#u6666b((R#b(X(R#b(X(S#9v7H7777HHH7b(X(T#av777777b(;U#&rb(:U#~~~~~~b(X(U#v\\b((U#b(X(V#uuuub(X(V#vddd&&dddb((V#db((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b((V#77b(X(V#88b(-V#G???????b(X(W#-wb(:W#b(:W#b(X(W#]wb(X(W#kwb(;W#b(:W#b(X(W#wb(X(W#b(X(W#b(X(W#b(:W#b(X(W#wb(:W# b(;W#b(=X#555555b(;X#&jb(=X#&Zb((X#kkb(X(X#vvb(3Y#ub(X(Y#kkb(3Y#xb(X(Y#6766667776b(X(Y#wekeeeekkkeb(X(Z#wb((Z#b((Z#33b((Z#88b((Z#==b((Z#AAb(X(Z#wC_CCCC___Cb(X([#x]p]]!!]]ppp]b(X([#/xVtVVVVtttVb(([#tttttVttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(([#ttttttttttb(X([#tuttttuuutb(X(\# SS   b(X(\#qx      b((\#  b(X(\#  b(;\#  b(X(\#x$ $$$ b((#&&b(X(#x&&b((#b((#~~b((#}}b((#}}b((#~~b((#}}b((#~~b((#}}b((#}}b((#WWb((#WWb((#XXb((#XXb((#WWb((#WWb((#WWb((#WWb((#WWb((#WWb((#WWb((#WWb((#WWb((#WWb(X(#xXXb(X(#xb((#b((#::b((#b((#CCb((#FFb((#KKb((#OOb((#TTb((#WWb((#[[b((#``b((#eeb((#iib((#kkb((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b((#''''""''''''b(X(# y'1''##''111'b(X(##y<z<<dd<<zzz<b(X(#yxxx__xxxb(X(#yDDb(X(#yb((#b(X(#    b(X(#[z   55 b((# b(X(#jjjjb(X(#Y\YYYY\\\Yb(-#<[<[==<[==b(X(#izZZZFFZZZb(X(#ziqiiiiqqqib((#b(X(#b((#aab(X(#zb((#b(X(#b((#IIb(X(#OOb(X(#z!b(X(#{nnb(X(#{    b((#          b(X(#1{ +    +++ b(X(#u{)1))))111)b((#11111)1111b((#1111111111b(X(#{<x<<aa<<xxx<b((#uvxxx<vvv<b(-#wwwb(X(#vvb(X(I-${b((I-$ Bb((I-$ggb((I-$iib(X(I-$qqb(X(I-$|77b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b((I-$b(X(I-$'|&&b((I-$b((I-$ssb((I-$ssb((I-$ssb((I-$ssb((I-$ssb((I-$ssb((I-$ssb((I-$ssb((I-$ssb(X(J-$A|WWb((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b((J-$&&&&""&&&&&&b(X(L-$c|1A11``11AAA1b((L-$@@@@@@@@@@b(X(L-$|@Y@@@@YYY@b((L-$XXXXXXXXXXb(X(L-$|X|XXXX|||Xb(X(L-$YZYYYYZZZYb((M-$yyyyyyyyyyb(X(M-$yzyyyyzzzyb(X(M-$}}}}}}}b(X(M-$}}}b((M-$++b(X(M-$++b(X(N-$s}99b(X(N-$}!!!!b(X(O-$~WWWWb((O-$MNWWWWWWb(X(Q-$WEWWWEEEb(X(Q-$8988889998b((Q-$9999989999b((Q-$b(X(Q-$b((Q-$b(X(Q-$u~ 8    888 b((Q-$88888 8888b((Q-$8888888888b((Q-$8888888888b((Q-$8888888888b((Q-$8888888888b((Q-$8888888888b((Q-$8888888888b((Q-$8888888888b(X(R-$STSSSSTTTSb(X(R-$SkSSSSkkkSb(X(R-$~ktkkkStttSb((R-$sttttStttSb(X(R-$t}tttS}}}Sb(X(S-$~aaaXXaaab((S-$ab((S-$kkb((S-$==b((S-$CCb((S-$KKb((S-$TTb((S-$\\b((S-$ccb((S-$iib((S-$<<b((S-$BBb((S-$CCb((S-$KKb((S-$b((S-$hhb(X(S-$ppb((S-$b(X(U-$3bbbbb((U-$abbbbbbbb(X(U-$bbbbb((U-$b(X(V-$b((V-$jjb(X(V-$llb((V-$b((V-$b((V-$b((V-$b((V-$b((V-$ b((V-$|b*8W-$CCCCCCCCb(8W-$CDCCCCCCCCb(W-$'DCCCCCCCCb(X(W-$b(+W-$SAAAb(-W-$06079000700b((W-$****##******b(X(W-$99b(X(W-$PQPPyyPPQQQPb(-X-$(((((((b((X-$b(X(X-$b((Y-$b(X(Y-$&+&&&&+++&b((Y-$+++++&++++b((Y-$++++++++++b((Y-$++++++++++b((Y-$++++++++++b(X(Y-$+,++++,,,+b((Y-$))))))))))b(X(Z-$)*))))***)b((Z-${{b((Z-$b(X(Z-$b(X([-$b(X([-$eb(X(\-${H  HHHb(X(\-$ۀ7U77  77UUU7b(X(\-$ShSSSShhhSb((\-$hhhhhShhhhb((\-$hhhhGGhhhhhhb((\-$hhhhIIhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhEEhhhhhhb((\-$hhhhFFhhhhhhb((\-$hhhhGGhhhhhhb((\-$hhhhFFhhhhhhb((\-$hhhhGGhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhEEhhhhhhb((\-$hhhhFFhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhEEhhhhhhb((\-$hhhhFFhhhhhhb((\-$hhhhFFhhhhhhb((\-$hhhhGGhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhHHhhhhhhb((\-$hhhhIIhhhhhhb((\-$hhhhIIhhhhhhb((\-$hhhhIIhhhhhhb((\-$hhhhIIhhhhhhb((\-$hhhhJJhhhhhhb((\-$hhhhEEhhhhhhb((\-$hhhhEEhhhhhhb((\-$1iii~iiiiiib(X(\-$MiviiJJiivvvib(X(]-$miiiKKiiib((]-$ib((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((]-$++b((3$&jb(X(3$&b((3$&iib((3$&b(X(3$&b((3$&]]b(X(3$&]]b(X(3$&́22b(X(3$&فb((3$&b((3$&b((3$&b((3$&b((3$&b((3$&b((3$&b((3$&b((3$&b(X(3$&XXb(X(3$&$__$$$b((3$&#b(X(3$&JJJJb(X(3$&b(X(3$&wZZZZZZb((3$&b(X(3$&ׂb((3$&b(X(3$&PPPPb((3$&OOOOOOOOOOb(X(3$&7OROOOORRROb((3$&PPPPPPPPPPb((3$&PPPPPPPPPPb(X(3$&CPcPPPPcccPb((3$&\]cccPcccPb(X(3$&ccccPPb((3$&b(X(3$&ob((3$&b(X(3$&((3$&b(X(3$&ijiiiijjjib((3$&jjjjjijjjjb(X(3$&  b((3$&((((ff((((((b(X(3$&()((ll(()))(b((3$&7777777777b(X(3$&7877778887b((3$&EEEE00EEEEEEb(X(3$&EFEE00EEFFFEb(X(3$&^`^^^^```^b((3$&llll\\llllllb(X(3$&b(X(3$&qqb(X(3$&σ22b((3$&YYb((3$&YYb(X(3$&YYb(X(3$&b(X(3$&b(X(3$&.4....444.b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&          b((3$&         b((3$&          b((3$&          b((3$&          b(X(̻&F--b((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&Fb((̻&F!!b(X(ڻ&F3b(X(ڻ&FIb((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&F  b((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&Fb((ڻ&Fb(X(ڻ&F''b(X(ۻ&FWb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb(X(ۻ&F}b((ۻ&Fb((ۻ&Fb((ۻ&Fb((ۻ&Fb(X(ۻ&F))b((ۻ&Fb((ۻ&Fxxb((ۻ&Fxxb((ۻ&Fxxb((ۻ&Fxxb(X(ܻ&F2S2222SSS2b((ܻ&F5SSSTSSSSSSb(sܻ&F:RGSGG:E::b(X(ܻ&FELEEEELLLEb(-ܻ&F\d\eG\\\e\\b(X(ݻ&FeeeNNeeeb((ݻ&Feeb(X(ݻ&Feeb((ݻ&Fb((޻&Fhdb((޻&FSSb((޻&FZZb(X(޻&F<<b(:޻&F \ \\\ \\b(X(߻&Fb((z'fiib(X(z'fqqb(X(z'fa&&b((z'fb((z'fYYb((z'fZZb((z'fYYb((z'fYYb((z'fYYb((z'fYYb((z'fZZb((z'fZZb((z'fZZb((z'fYYb((z'fYYb((z'fYYb((z'fZZb((z'fZZb((z'fYYb((z'fZZb((z'fZZb((z'fYYb((z'fYYb((z'fYYb((z'fYYb(X(z'fsWWb((z'fb((z'fb((z'fb((z'fb((z'fb((z'fb((z'fb((z'fb(X(z'fb((z'f2b(X(z'f'6''""''666'b((z'f56666'666'b(X(z'f67666'777'b((z'f77777'7777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b((z'f7777777777b(X(z'fDDD``DDDb(X(z'fb(X(z'fmmb((z'fb(X(z'fb(X(z'f5JJb((z'fGGb(X(z'fCFFCCCb((z'fb(X(z'fBDBBggBBDDDBb(X(z'fDHDDDBHHHBb((z'fFFFFFFFFFFb(X(z'fGGGGGGb(X(z'fb(X(z'fUOOb((z'f&b((z'fb((z'fddddddddddb((z'fddddddddddb(X(z'fdgddddgggdb(X(z'fggggggb((z'fgb((z'fb((z'fb((z'fb((z'fb((z'fb((z'fb((z'fb(X(z'fHHb((z'fb(X(z'fb((z'f''b(X(z'fb(X(z'f11b(X(z'f[b((z'fb((z'fb(X(z'fgb(X(z'fub(X(z'fccb(X(z'f b((z'fb((z'fb((z'fb((z'fb((z'fb(sz'f"$b(X(z'fb(X(z'f+b(X(z'f=""""b((z'f"""""""""b((z'f""""BB""""""b((z'f""""BB""""""b(X(z'fe8=8888===8b(X(z'fub((z'fb((z'f88b((z'f==b((z'fAAb((z'fDDb((z'fIIb((z'fMMb((z'fRRb((z'fUUb((z'fYYb((z'f^^b((z'fccb(X(z'fIIb((z'fb(X(z'fb((z'f 3b((z'fb((z'fDDb(X(z'fb(X(z'fb((z'fb((f'fb((f'fb((f'f  b(X(g'fb((g'fb((g'fDDb((g'fIIb((g'fMMb((g'fRRb((g'fUUb((g'fYYb((g'f^^b((g'fccb((g'fiib(X(g'fqqb((g'fYYb((g'fYYb(X(g'fYYb(X(g'flj&&b((g'fb((g'fb((g'fb((g'fb((g'fb((g'fb(X(g'fWWb((g'fb((g'fDDb((g'fb((g'fb((g'fDDb((g'fb((g'fb((g'fDDb((g'fDDb((g'fb((g'fEEb((g'fDDb((g'fDDb((g'fDDb((g'fDDb((g'fDDb((g'fDDb((g'fb(X(h'fb(X(h'f3933""339993b((h'f9999939999b((h'f9999QQ999999b((h'f9999PP999999b((h'f9999PP999999b((h'f9999QQ999999b((h'f9999QQ999999b((h'f9999QQ999999b((h'f9999PP999999b((h'f9999QQ999999b((h'f9999QQ999999b((h'f9999PP999999b((h'f9999PP999999b((h'f9999QQ999999b((h'f9999PP999999b((h'f9999QQ999999b((h'f9999PP999999b(X(h'f+9[99QQ99[[[9b(X(h'fu3S33""33SSS3b(X(i'fSTSS**S3TTT3b(X(i'fSWSS66SSWWWSb((i'fVVVVTTVVVVVVb(X(i'fɊVZVV__VVZZZVb((i'fZZZZZVZZZZb((i'fZZZZttZZZZZZb((i'fZZZZzzZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZmmZZZZZZb((i'fZZZZssZZZZZZb((i'fZZZZwwZZZZZZb((i'fZZZZzzZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZrrZZZZZZb((i'fZZZZssZZZZZZb((i'fZZZZyyZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZmmZZZZZZb((i'fZZZZnnZZZZZZb((i'fZZZZnnZZZZZZb(X(i'f׊eee``eeeb((i'feeb(X(i'feeb((i'fb((j'fb(X(k'fb(X(k'fy1111b((k'f**********b(X(k'f*+****+++*b((k'f1114 111111b((k'f1111111111b(X(k'f1211112221b(X(l'f׋!ee!!!b((l'fb((l'fb((l'fb(X(l'fb(X(l'f!5!!!!555!b((l'f55555!5555b((l'f5555555555b((l'f5555555555b(X(l'f;<;;KK;;<<<;b(X()!--b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()b(()      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}b(()b(()b(()b(()b(()b(X()Ib(X()ib(()b(()66b(()66b(()77b(()66b(()66b(()77b(()66b(()66b(()66b(()66b(()66b(()66b(()66b(()66b(()66b(()66b(()77b(()66b(()66b(()66b(()66b(()rrb(X()rrb()b()67jjb()67b()67b(()|b*);;;;;;;;b().6;;;;;;;;b(X()d;T;;;;TTT;b(()TTTTT;TTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(()TTTTTTTTTTb(:)TUTTTTTTTTb(X()___MM___b(()b(();;b(X();;b(()b(X()b(X() b(()b(X()b(X()<     b(X()b(X()b(()b(()b(()b(()b(()b(()b(()KKLKLLKKKKb(X()K}KK88KK}}}Kb(()||||||||||b(X() ||||||b(()|b(()LLLL<<LLLLLLb(()LLLL<<LLLLLLb(()LLLL<<LLLLLLb(()LLLL<<LLLLLLb(()____MM______b(X()_`__MM__```_b(()b(X()b(X()Lxxb(()b(()b(()b(()b(()b(()b(()b(()b(()b(X()hb(X()vb(()b(()b(()b(()b(()b(()b(()b(()b(()  b(()b(()b(()b(()b(()b(()  b(()b(X()b(()BBb(X()AAb(()eeb(()ddb(()eeb(()eeb(()eeb(()eeb(()eeb(()eeb(()ddb(()eeb(()eeb(()ddb(()eeb(X()b(()b(()UUb(()UUb(()VVb(()UUb(()UUb(()VVb(()UUb(()VVb(()UUb(()UUb(()VVb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()UUb(()VVb(()VVb(()VVb(()!!b(X()''b(X()ҫb(()b(()b(()b(()b(()b(()b(()  b(()b(()b(()b(()b(()b(X(),G,,,,GGG,b(()GGGGG,GGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(()GGGGGGGGGGb(X(),RRRMMRRRb(X()DDb(()b(()b(()b(X()ج#(####(((#b(s) #,#'##',''b((d)& Kb((d)&*b(X(d)&qqb((d)&b((m)&-b((m)&b((m)&!!b(X(m)&''b(X(m)&b((m)&b((m)&b((m)&  b((m)&b((m)&b((m)&b((m)&b((m)&b(X(m)&b((n)&b(X(n)&b(X(n)&,,,,b((n)&+,,,,,,,b(X(n)&,-,,,---b(X(n)&H888MM888b((n)&b(X(o)&b((o)&b(X(o)&,,,,b((o)&ttb(X()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()F  b(()Fb(()Fb(()Fb(()Fb(()Fb(()F!!b(X()F''b(()Fyyb(X()Fyyb(X()F&b(()Fb(()F44b(()F33b(()F33b(()F33b(X()F4b(X()FD44b(X()FX66b(()Fb(X()Fb$7$$$$777$b(()F77777$7777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(()F7777777777b(X()FBBBMMBBBb(X()Fyyyyyyb(X()Fb(X()FVVb(X()FVVb(()Fb(X()Fb(()Fb(X()Fb(X()FT????b(()F>>>>>>>>>>b(X()Fl>c>>>>ccc>b(()Fbbbb44bbbbbbb(X()Fbbb44bbbb(()Fbbb(X()Fbbb(()Fbbb(X()Fbbb(()Fb(X()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fvb(X()FRb(()Fb(X()Fb(X()Fb(X()Fްb(()Fb(X()Fb(()Fb(()F [b(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb((t)F Ab((t)Fb((t)Fb((t)Fb((t)Fb((t)Fb(X(t)F----b((t)F*,------b((t)FRRb((t)FRRb(X(u)F>RRb((u)F...C......b(X(u)F.0....000.b(X(u)FJ9w99MM99www9b((u)Fpqwww9www9b(X(u)Fwwww99b((u)F++b(X(v)F,,b((v)Fb(X(v)F****b((v)F))))))))))b(X(w)F))))))b(X(x)Fh00b(X(x)Fb((x)Fb((x)Fb(X(x)Fb((x)Fb(X(y)Fb((y)F66b(X(y)F66b(n(z)F"""""b(X({)Fb(({)Fzzzzzzzzzzb(X({)Fz{zzzz{{{zb(X({)Fz{zzzz{{{zb(X({)FJKJJJJKKKJb(X({)F̲llb(({)F((((((((((b(X({)F()(((()))(b(({)F"2""""""""b(({)F"2""""""""b(({)F"2""""""""b(({)F"2""""""""b(({)F"2""""""""b(X()Fֲ.5....555.b(()F45555.555.b(X()F57555.777.b(()Fb(()Fb(()Fb(()Fb(()F)sb(()F)sb(()F)sb(()F5sb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(()Fb(X(J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*  b((J*b((J*b((J*b((J*b((J*b(X(J*--b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b((J*b(X(J*,b(X(J*Nb((J*ggb(X(J*|ggb((J*b(X(J*b((J*b(X(J*b(X(J*4B4444BBB4b((J*BBBBB4BBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb((J*BBBBBBBBBBb(X(J*MuMMMMMMuuuMb(X(J*t tt//tt   tb((J*     t   tb(X(J*     t   tb((J*         b((J*q   |      b(X(J*   ll   b(;J*  b(X(J*`  b(X(J*vb((cl*F__b(X(cl*F__b((cl*F!!b(X(cl*F''b(X(cl*Fb((cl*Fb((cl*Fb((cl*Fb((cl*Fb((cl*Fb((cl*Fb((cl*F  b((cl*Fb((cl*Fb((cl*Fb((cl*Fb((cl*Fb(X(dl*Fb((dl*Fb(X(dl*Fb((dl*Fb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb((dl*Fddb(X(dl*Fȴb((dl*Fb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb((dl*FRRb(X(dl*F)4))))444)b((dl*F44444)4444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b((dl*F4444{{444444b(X(dl*F4544{{445554b(X(dl*F?@??MM??@@@?b((dl*F????MM??????b(X(el*F???MM???b((el*F??b(X(el*F??b((el*F??b((el*FXb(sel*F2zzzzb((el*F Ab(X(K*bb((K*b((K*b((K*b((K*b((K*  b((K*  b((K*b((K*b((K*b((K*b((K*b((K*""b((K*!!b(X(K*''b((K*ppppppppppb((K*rrrrrrrrrrb((K*nnnnnnnnnnb((K*__b((K*__b(X(K*__b(X(K*b((K*b((K*jjb((K*jjb((K*jjb((K*jjb((K*jjb((K*jjb((K*jjb((K*jjb((K*jjb(X(L*+=++++===+b((L* ===I======b(X(M*ֵGGGMMGGGb((M*b(X(N*6    b((N*      b(X(O* E   EEEb(X(O*?Q????QQQ?b(X(O*1611116661b(X(P*жM~MMLLMM~~~Mb(X(P*tttnntttb(X(Q*\ggb((Q*b(X(Q*b((Q*fb((Q*lb((Q*b((Q* b((Q*b(X(R*EEb((R*b((R*IIb(X(R*II(X(]2F((]2F (X(_2F(X(_2F(X(_2F(X(_2F((_2F!!(X(_2F''(X(_2F·,,((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2F((_2FA((_2F(X(_2F(X(`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F((`2F G(X(`2F $)$$$$)))$((`2F((((88(((((((X(`2F(=((99((===(((`2F=====(====((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========((`2F==========(X(a2FLHHHMMHHH(X(a2F(X(a2Fʸ((a2F(X(b2F>>>>,(b2F/bS@>>>ccc(X(c2Fcpcccppp((c2Fmnpppnnn(X(c2Fnpnnnppp(c2F3/b/b///b//(+c2F3/b/b///b//(+c2Fooo(X(c2Fopoooopppo(;c2Fpqpppopppo(X(d2Fp{pppo{{{o((d2F op{{{opppo((d2Fqrqqqpppp(X(d2Fosoooossso((d2Fsssssossss((d2Fstssssrrrr((d2Frsrrrrqqqq((d2Fqqqqqqpppp(X(d2Fpsppppsssp|t(X(3F33|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t(X(3F|t(X(3F|t(n(3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t(X(3F:* ***|t(X(3FX7?7777???7|t((3F>????7???7|t(X(3F?@???7@@@7|t((3F@@@@@7@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t((3F@@@@''@@@@@@|t(X(3FnKKKYYKKK|t((3F|t(X(3Fι____|t((3F___z______|t(X(3F|t(X(3F.|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F  |t((3F  |t((3F|t((3F|t((3F|t((3F|t((3F|t((3F|t((3F$$|t(X(3FL|t((3F|t((3F##|t(X(3F**|t((3F__________|t(X(3F_e____eee_|t((3Fabeee_eee_|t(X(3Feeee__|t((3F|t((3F|t((3F|t((3F|t((3F|t(+3F|s*3FVTTxxTTTTxxTTs(3F TTxxTTTTTT|t(X(3FT`TTTT```Tu((*4&u((*4&u((*4&u(0*4&|u*0*4&3u(0*4&|u*0*4&u(n(+4&u((+4&u((+4&u((+4&u((+4&u((+4&u((+4&u((+4&u((+4&u((+4&  u((+4&u((+4&u((+4&u((+4&u((+4&u((+4&  u((+4&u((+4&!!u(X(+4&''u(X(+4&9%%u((+4&u((+4&mmu((+4&nnu((+4&mmu((+4&mmu((+4&nnu((+4&mmu((+4&nnu((+4&nnu((+4&mmu((+4&mmu((+4&mmu((+4&mmu(X(,4&[u((,4&u((,4&LLu((,4&MMu((,4&MMu((,4&MMu((,4&LLu((,4&LLu((,4&LLu((,4&LLu((,4&LLu((,4&LLu((,4&LLu((,4&LLu(n(,4&     u((,4&MMu(X(,4&qLLu((,4&++++ff++++++u(X(,4&+3++ee++333+u(X(-4&UUUUUUu((-4&Uu((-4&RRu((-4&SSu((-4&SSu((-4&SSu((-4&RRu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&RRu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&SSu((-4&44u(X(-4&44u(X(.4& @@u(X(.4&mu((.4&||u((.4&||u((.4&||u((.4&||u((.4&||u((.4&{{u((.4&||u((.4&{{u((.4&||u(X(.4&u((.4&u(X(/4&4444u(X(/4&3533mm335553u((/4&2222jj222222u(X(/4&2322jj223332u(X(/4&6>66yy66>>>6u(X(/4&<I<<<<III<u((/4&HHHH$$HHHHHHu(X(/4&HYHH%%HHYYYHu((/4&UYYYYYYYYYu(X(04&)YkYYYYkkkYu((04&hikkkYiiiYu(X(04&iliiiYlllYu((04& lmlwCllkkkku(+04&lllu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu((04&nnu(X(04&nnu(X(04&*+****+++*u((04&      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~????ee??????u((14&MMMMMMMMMMu(X(14&MNMMMMNNNM(X(v9&S((v9&((v9&((v9&(X(v9&_((v9&((v9&  ((v9&((v9&((v9&((v9&((v9&((v9&  ((v9&!!(X(v9&''(X(v9&u--((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&((v9&(X(w9&((w9&((w9&ff((w9&ff((w9&ff((w9&ff((w9&ff((w9&ff((w9&ff(X(w9&LL(X(w9&((w9&((w9&((w9&ss((w9&ss(X(w9&((w9&,)((w9&(X(x9&:Y::::YYY:((x9&YYYYY:YYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY((x9&YYYYYYYYYY(X(x9&7dlddMMddllld((x9&llllldllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll((x9&llllyyllllll(X(y9&MlTllyyllTTTl(X(z9&SSSSSS((z9&(X(z9&((z9&((z9&(X({9& (X({9&mnn(X({9&,,,,((9&++++++++++(X(9&+/++++///+((9&((9&&l((9&kkkkvvkkkkkkd,(˳9fC@yyd(X(˳9fyyd(X(˳9fd((˳9fd((˳9fQQd((˳9fPPd((˳9fPPd((˳9fQQd((˳9fPPd((˳9fPPd((˳9fPPd((˳9fPPd((˳9fPPd((˳9fPPd((˳9fPPd((˳9fd((˳9fd((˳9fd((˳9fd((˳9fd((˳9fd(X(˳9fd((˳9fd((˳9f!!d(X(̳9f''d((̳9fd((̳9fd((̳9fd(X(̳9fd(X(̳9fd((̳9fd((̳9f  d((̳9fd((̳9fd((̳9fd((̳9fd((̳9fd((̳9f  d(X(̳9f#7####777#d((̳9f77777#7777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d((̳9f7777777777d(X(̳9fBRBBMMBBRRRBd(X(ͳ9f9OTOOOOTTTOd((ͳ9fPQTTTORRROd(X(ͳ9fRRRROOd((ͳ9fOOd((ͳ9fd(X(ͳ9fId(X(ͳ9fd((ͳ9fd(X(ͳ9fd((ͳ9fd(X(ͳ9fd((ͳ9fd(X(γ9fd(X(ϳ9fYd(X(ϳ9f4444d(X(г9f0B0000BBB0d(X(г9f1@C@@@@CCC@d((г9fBBBBBBBBBBd(X(г9f=BBBBBBd((г9f8d(X(г9fd((г9fd(X(ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd((ѳ9fd(X(ѳ9fd(X(ѳ9f=I====III=d(X(ҳ9fbbd((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d(X(PA&7d((PA&!!d(X(PA&''d(X(PA&W--d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d(X(PA&}d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((PA&d((QA&d((QA&d((QA&d((QA&d((QA&d((QA&d(X(QA&d(X(QA&++d((QA&++++++++++d(X(QA&+@++++@@@+d(X(RA&1bbbbbbd((RA&bd((RA&\\d((RA&]]d((RA&\\d((RA&\\d((RA&\\d((RA&\\d((RA&\\d((RA&\\d((RA&]]d((RA&\\d((RA&\\d((RA&\\d((RA&]]d((RA&\\d((RA&]]d((RA&\\d((RA&]]d((RA&]]d(X(SA&ZMMZZZd((SA&YYYYYYYYYYd(X(SA&YYY~~YYYd(X(SA&G..d((SA&d(X(TA&d((TA&d(X(TA&d(X(TA&]d((TA&d(X(TA&    d(X(TA&        d(X(UA&      d(X(UA&-4 444 d((UA&-.444 444 d(X(UA&4W444 WWW d((UA&VWWWW WWW d(X(VA&WWWW  d((VA&  d(X(VA&  d((VA& d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&d((VA&)d(X(VA&d((VA&d(X(VA&d((VA& d(X(VA& d(X(VA&d(X(VA&id(X(WA&[[[[d((WA&WX[[[[[[d(X(XA&[[[[d(sXA&ZVVfVVd((XA&ffffCCffffffd(X(XA&fmffCCffmmmfd((XA&mmmmmfmmmmd((XA&mmmmoommmmmmd(X(XA&HHd((XA&d((XA&LLd((XA&KKd((XA&KKd((XA&LLd((XA&LLd((XA&KKd((XA&KKd((XA&LLd((XA&LLd((XA&KKd((XA&KKd((XA&LLd((XA&LLd((XA&LLd(X(ZA&**d(X(ZA&]D11DDDd((ZA&DDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd((ZA&DDDDDDDDDDd(X(ZA&d((ZA&d(X(B--d((Bd((Bd((Bssd((Bssd((Bssd((Bssd((Bssd((Bssd((Bssd((Bssd((Bssd((Bssd((B!!d(X(B''d(X(Bbqbbbbqqqbd((Bqqqqqbqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd((Bqqqqqqqqqqd(X(Bd(X(B--d(X(B_=--===d(X(B<G<<<<GGG<d(X(B7877ZZ778887d((B8888878888d(X(B8988889998d(X(BHOHHHHOOOHd((BHHHHHHHHHd((BHHHHHHHHHHd(X(BHJHHHHJJJHd((BIJJJJHJJJHd(X(BJQJJJHQQQHd(X(BHVHHHHVVVHd((BUUUUPPUUUUUUd(X(BUUUQQUUUd(X(BUUd((B/* d(X(Bd((Bd((Bd((Bd(X(Bwd(( B}DEDDDCCCCd(; BCDCCCCCCCCd(X( BCPCCCCPPPCd(( B""d(X(!BFiFF@@FFiiiFd((!B"FFHhHHFFFFd((!BFFFF??FFFFFFd((!BFFFF@@FFFFFFd(X(!BFGFF@@FFGGGFd,(CC@d((Cd(X(Cd(X(Cd((Cd((C  d((Cd((Cd((Cd((Cd((Cd((C  d((C!!d(X(C''d(X(C,,d(X(Cd(X(C)d((Cd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd((Cccd(X(C3d(X(Cd(X(CCd((Cd((CSSd((CSSd((CSSd((CSSd((CSSd((CTTd((CSSd((CTTd((CSSd((CTTd((CSSd((CSSd((CSSd((CSSd(X(COd((CUUd(X(CUUd((Cd((C\\d((C\\d((C]]d((C\\d((C\\d((C]]d((C]]d((C]]d((C]]d((C\\d((C\\d((C\\d((C\\d((C]]d((C]]d((C\\d((C\\d(X(CsVuVVVVuuuVd((CuuuuuVuuuud((Cuuuu++uuuuuud((Cuuuu++uuuuuud((Cuuuu,,uuuuuud((Cuuuu,,uuuuuud((Cuuuu,,uuuuuud((Cuuuu++uuuuuud((Cuuuu,,uuuuuud((Cuuuu++uuuuuud((Cuuuu,,uuuuuud((Cuuuu++uuuuuud((Cuuuu,,uuuuuud((Cuuuu,,uuuuuud((Cuuuu,,uuuuuud((Cuuuu,,uuuuuud(X(CMMd(X(C  d(X(C)VVd(X(CS``d((Cd((Cd((Cd((Cd((Cd((Cd((Cd((Cd((C-Fd((Cd,X(SCCfC@d((SCCfd((SCCfd((SCCfd(X(SCCfd((SCCfd((SCCf  d((SCCfd((SCCfd((SCCfd((SCCfd((SCCfd((SCCf  d((TCCf!!d(X(TCCf''d((TCCfUUd(X(TCCfUUd(X(TCCfd((TCCf[[d(X(TCCfZZd((TCCfd((TCCfiid((TCCfd((TCCfhhd((TCCfiid((TCCfhhd((TCCfiid((TCCfhhd((TCCfhhd(X(TCCf  d((TCCfd(X(TCCfd((TCCf!!d(X(TCCf d((TCCf]$        d((TCCf]$        d(X(TCCf          d(X(TCCf   }}   d(X(UCCf%S SSS d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^II^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^HH^^^^^^d((UCCf^^^^II^^^^^^d((UCCf^^^^HH^^^^^^d(X(UCCfd((UCCfd(X(UCCfd((UCCf d((UCCfd(X(VCCf MM   d((VCCf       d(X(WCCf    d(X(WCCfd((WCCf;vd((WCCfd((WCCf]d((WCCfd(X(XCCfAd(X(XCCfqd(X(XCCfd(n(ZCCfSMMSSSSd(X([CCfd(([CCfd(([CCf  d(([CCfd(([CCfd(([CCfd(([CCfd(([CCfd(([CCf  d(X([CCfd(([CCfd(([CCfssd(([CCfssd(([CCfssd(([CCfttd(([CCfssd(([CCfttd(([CCfssd(([CCfssd(([CCfttd(([CCfssd(X([CCfd(([CCfd(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(([CCf77d(X(\CCfQQQQQQd(X(\CCfwww&&wwwd(X(\CCf)yyd((\CCf d((\CCfd(X(]CCfd(:]CCfd(X(]CCfSMMd(X(]CCfaMMd((]CCfd(X(]CCfd(X(]CCfd(X(^CCf}}d(X(_CCf      d(X(_CCfA[e[[33[[eee[d(X(`CCf[      d((`CCf d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d((`CCf%%d(X(`CCfo\e\\??\\eee\d(X(aCCfvvv--vvvd(X(aCCfd(aCCf>>LLd((aCCf::d(n(aCCf=====d(sbCCf5>t t >>>d(n(bCCf=>====>>>>d(X(bCCf77d(X(cCCf ood(X(cCCf::d(:cCCfd((cCCfd(n(cCCfd(X(dCCf+d(X(dCCfEd(X(dCCfHHd(X(dCCfUd(X(eCCf_//d(X(eCCfd((eCCf]]d((eCCf\\d((eCCf\\d((eCCf\\d(X(eCCf\\d((kCCf$>d(X(lCCfPcPPPPcccPd((lCCfcccccPccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd((lCCfccccccccccd(n(lCCfZ[ZZZZ[[[[d(X(lCCfPQPPPPQQQPd(X(mCCfd(X(mCCf\\d((mCCfd((mCCfd((mCCfd((mCCfd((mCCfd((mCCfd((mCCfd(X(mCCfd(X(mCCf"%""""""%%%"d((mCCfU%%%xR%%%%%%d(X(nCCf';L;;zz;;LLL;d(X(oCCfOd(X(oCCfd(X(oCCfd((oCCfccd(X(oCCfccd((oCCfd((oCCfd((oCCfd((oCCfd((oCCfd((oCCfd((oCCfd(X(pCCf$Q$$$$QQQ$d((pCCfQQQQQQQQQd(X(pCCf----d((qCCfd((qCCfd(X(qCCf}d(X(rCCf      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~d((rCCfggd((rCCfggd((rCCfggd(X(rCCfd(n(rCCfd(X(rCCfd((sCCfTTTUxTTTTTTd(X(sCCfTUTTTTUUUTd(X(tCCfouoooouuuod(X(tCCfd((tCCfd(X(tCCf__d((tCCfd((tCCfccd((tCCf__d((tCCf__d(X(tCCf![[d(X(uCCf1211ll112221d(X(uCCf#{{###d((uCCfttd(X(uCCf:?::::???:d((uCCf?????:????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d((uCCf??????????d(X(uCCf:=::::===:d((uCCf=====:====d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((uCCf==========d((vCCfIIIIIIIIIId((vCCfIIIIIIIIIId((vCCfIIIIIIIIIId((vCCfIIIIIIIIIId(X(vCCf\\\\\\d(X(vCCfd(X(wCCfd(X(wCCf7 tt   d((wCCf         d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((wCCf    $      d((xCCf    $      d((xCCf    $      d((xCCf    $      d((xCCfooooooooood((xCCfooooooooood((xCCfooooooooood((xCCfooooooooood((xCCfooooooooood((xCCfooooooooood((yCCfd((yCCfd((yCCfd((yCCfd((yCCfd((yCCfd((yCCfd((yCCfd(X(yCCfZZd((yCCfd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfwwd((yCCfAAd((yCCfAAd((yCCfAAd((yCCfAAd((yCCfBBd((yCCfAAd((yCCfAAd((yCCfBBd((yCCfAAd(n(yCCfAAd((yCCfd((yCCfd((yCCfd((yCCfd(X(zCCf'7''~~''777'd(X(zCCf4_4444___4d((zCCf_____4____d((zCCf____??______d((zCCf____??______d((zCCf____@@______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____@@______d((zCCf____??______d((zCCf____@@______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____??______d((zCCf____@@______d((zCCf____??______d((zCCf____@@______d((zCCf____??______d(X(CCfd((CCf!!d((CCf!!d(X(CCf!!d(X(CCf!d((CCf00d((CCf00d((CCf00d((CCf00d(X(CCf/dhdd$ddhhhdd((CCfhhhhhdhhhhd(X(CCf=hmhh<<hhmmmhd(X(CCfMd((CCfd((CCfd((CCfd((CCfd(X(CCf]00d((CCfd((CCfd((CCfd((CCfd((CCfd(X(CCf}CCd((CCfd((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d((CCf__d(X(CCfd(n(CCfRRd((CCfRRd((CCfRRd((CCfRRd((CCfRRd((CCfllllRRlllllld((CCfllllRRlllllld((CCfllllRRlllllld((CCfllllSSlllllld((CCfllllRRlllllld((CCfllllSSlllllld((CCfllllRRlllllld((CCfllllRRlllllld((CCfllllRRlllllld((CCfllllSSlllllld((CCfllllRRlllllld(X(CCfccc@@cccd(X(CCfccd(X(CCfd(X(CCf  d((CCfd((CCf__d((CCf``d((CCf``d((CCf__d((CCf__d((CCf__d(X(CCfd((CCfd((CCfd((CCfd((CCfd((CCfd(X(CCfd(X(CCfd(X(CCf00d((CCf____xx______d(X(CCf_`____```_d(X(CCfopooFFoopppod((CCfqqqq$qqqqqqd(X(CCfqzqq$qqzzzqd(X(CCf xxxOOxxxd((CCfxxd(X(CCfxxd((CCfxd((CCfSSd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd((CCfTTd(X(CCf?TTd(X(CCfK d(X(CCfd(n(CCfd(X(CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCf d((CCfd(X(CCfd(X(CCf55d(X(CCf .0..hh..000.d(X(CCfd((CCfd(X(CCfd(;CCfd(X(CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd((CCfd(+CCfd(-CCfd(3CCf{RRARd(X(CCf=TYTTHHTTYYYTd((CCfYYYYYTYYYYd(X(CCfYZYYggYYZZZYd(X(CCf    d((CCfd(X(CCfM   ||    d((CCf         d((CCf          d((CCf          d((CCf          d((CCf          d((CCf          d((CCf          d((CCf          d((CCf          d((CCf% % % % % % % % % % d((CCf% % % % % % % % % % d((CCf% % % % % % % % % % d((CCf% % % % % % % % % % d(X(CCf, - , , ++, , - - - , d((CCf- - - - - , - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - - - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf- - - - //- - - - - - d((CCf  7     d(X(CCfgO x O O 00O O x x x O d(3CCf(O w O w O O O w O O d((CCfb  5     d((CCf$     d(n(CCft(CCfSO d((CCfd(X(CCf V   V V V d(X(CCfoG ] G G G G ] ] ] G d(X(CCfG V G G G G V V V G d(X(CCfG G G G G   G d((CCf5   G   G d(X(CCf   G   G d(X(CCf%  $   d((CCf  --   d(X(CCf  --   d((CCf  ))   d(X(CCf  b   d((CCf     d(X(CCf     d((CCf6  I    d(+CCf       d(-CCf     d((CCf     d(X(CCf  vv   d(X(CCf    d((CCf     d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d((CCf    d(n(CCf          d(n(CCf   NN    d(n(CCf\ ] \ \ &&\ \ ] ] ] ] d(n(CCf    d(X(CCfd(<CCfd(X(CCfd(-CCfd(X(CCfd((CCfd(:CCfd(X(CCfd((CCfhh|t*CCf+!!!!d(CCf!!d((CCfd(3CCf#d(3CCfd(X(CCfQ''d(3CCf&d(3CCfd((CCf]]]]\\]]]]]]d((CCfd((CCfd(X(CCfd((CCf!!!!!!!!!!d((CCf;;;;HH;;;;;;d([CCf$d((CCfDDDDEEDDDDDDd((CCfDDDDEEDDDDDDd((CCfDDDDEEDDDDDDd((CCfDDDDEEDDDDDDd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd((CCfMMMMMMMMMMd(X(CCfQRQQQQRRRQd(X(CCf]d((CCfd((CCfZZd((CCfZZd((CCfZZd((CCfZZd(n(CCfVVd((CCfhhd((CCfddd(X(CCfd((CCfd(X(CCfd(X(CCfddd(X(CCfs   ==   d((CCf d((CCflld((CCflld((CCflld((CCflld((CCflld((CCflld((CCfmmd((CCflld((CCflld(X(CCflld(X(CCf3333d((CCf333333333d((CCf3333333333d((CCf3333333333d((CCf3333333333d((CCf3333333333d((CCf3333333333d((CCf3333333333d((CCf<<<<NN<<<<<<d(X(CCf<E<<NN<<EEE<d(X(CCfWYWW??WWYYYWd((CCfYYYYYWYYYYd((CCfYYYYMMYYYYYYd(3CCf Hd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd((CCfFFFFFFFFFFd(X(CCfFIFFFFIIIFd(X(CCfaad((CCf          d(X(CCfi n i i i i n n n i d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d((CCf    $$      d(X(CCf' 1   $$  1 1 1  d((CCf  [[   d((CCf  ZZ   d((CCf  ZZ   d((CCf  ZZ   d((CCf  ZZ   d(-CCf 0  1 ~   1   d(X(CCf          d,X(PC_C@UUd((PCd(X(QCid((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd((QCd(X(QC''d((QCd((QCOOd((QCOOd((QCOOd((QCOOd((QCOOd((QCOOd((QCOOd((QCOOd((QCOOd(X(QCQeQQQQeeeQd((QCeeeeeQeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((QCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCeeeeeeeeeed((RCd((RC##d(X(RC**d(X(RCd((RCd((RCd((RCd(X(RCd((RCd((RC  d((RCd((RCd((RCd((RCd((RCd((RC  d(X(SCo&ooMMoo&&&od((SC#$&&&o$$$od(X(SC$&$$$o&&&od(;SCJd((SCd(X(TCd((TC{&&&&&&&&&d((TC&'& &&%%%%d(;TC%&%%%%%%%%d(X(TC%1%%%%111%d(X(ID&S--d((ID&d((ID&YYd((ID&YYd((ID&YYd((ID&YYd((ID&YYd((ID&YYd((ID&YYd((ID&YYd((ID&YYd(X(ID&kd((ID&d((ID&@@d((ID&AAd((ID&@@d((ID&@@d((ID&@@d((ID&@@d((ID&@@d((ID&@@d((ID&AAd((ID&@@d((ID&@@d((ID&@@d((ID&@@d((ID&@@d((ID&AAd((ID&AAd((ID&@@d(X(ID&{d((ID&d((ID&<<d((ID&==d((ID&==d(X(JD&d((JD&d((JD&d((JD&d(X(JD&d((JD&                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c e f g h i j k l m n o p q r s t u v w x y z { | } ~  d((JD&  d((JD&d((JD&d((JD&d((JD&d((JD&d((JD&  d(X(JD&PiPPPPiiiPd((JD&ddddddddddd(X(JD&deddddeeedd(X(KD&iiiiiid((KD&id((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d((KD&d(X(KD&~~d(X(KD&_MMd((KD&d(X(KD&d((KD&EEd(X(KD&EEd(X(LD&d(X(LD&JJJJd((LD&JJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&JJJJJJJJJJd((LD&//////////d(X(MD&9HiHHHHiiiHd(X(MD&-H----HHH-d((MD&GGGGGGGGGGd(X(MD&GUGGGGUUUGd((MD&UUUUUGUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd((MD&UUUUUUUUUUd(X(MD&nonnnnooond(-ND&4-a-a---a--d(X(ND&ceccSScceeecd(X(ND&+^++>>++^^^+|u,X(EF?C@--|u((EF|u((EF|u((EFWW|u((EF|u((EFXX|u((EFWW|u((EFWW|u((EFWW|u((EFWW|u((EF##|u(X(EF**|u(X(EFS|u((EF|u((EF|u(X(EF]|u((EF|u((EF  |u((EF|u((EF|u((EF|u((EF|u((EF|u((EF  |u(X(EFs|u((EF|u((EFQQ|u((EFQQ|u((EFQQ|u((EFQQ|u(X(EF|u((EF|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u((EFPP|u(X(EFNONNNNOOON|u(X(EFNaNNNNaaaN|u((EFaaaaaNaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u((EFaaaaaaaaaa|u(X(EFlnllMMllnnnl|u(X(EFlllMMlll|u(X(EFC3l333l|u((EF/0333l333l|u(X(EF3^333l^^^l|u((EF]]]`]]]]]]|u((EFZ^^^5^^^^^^|u((EF___f______|u((EF__________|u(X(EF|u(X(EF0=0000===0|u((EF 111>M111111u((EFu((EFu((EFu(X(EFu(X(EFu((EFu((EF  u((EFu((EFu((EFu((EFu((EFu((EF  u(X(EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu(X(EFu((EFu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu((EFnnu(X(EFNkNNNNkkkNu((EFkkkkkNkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku((EFkkkkkkkkkku(X(EF?vvvMMvvvu((EFLLu(X(EFMMu((EFu(X(EFZZu((EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu((EFu(X(EF,,u((EFu((EF//u((EF//u((EF//u((EF//u((EF//u((EF//u((EF//u((EF//u((EF//u((EF$$$$$$$$$u(X(EF ==   u((EF         u((EF    ^^      \{0(nœE1( (E' \{0(œE\{0(œE\{0(œE\{0(œE\{0(XœE\{0(œE\{0(œE\{0(œE\{0(œE\{0(œE\{0(œE\{0(œE\{0(œE\{0(XœE  \{0(œE\{0(œE$$\{0(XœE;;\{0(XœE \{0(œE''\{0(XœE''\{0(œE\{0(XœE+\{0(œE\{0(œE\{0(XœE9\{0(XœEc99\{0(œE\{0(œE\{0(XœE}\{0(œE\{0(XœE\{0(XœE=B==AA==BBB=\{0(œEABBBB=BBB=\{0(XœEBDBBB=DD^^D=\{0(œEDDDD^^D=DDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD]]DDDDDD\{0(œEDDDD^^DDDDDD\{0(œEDDDD^^DDDDDD\{0(3œEn|1*XEXX]{0(œE:X\{0(3œE\{0(3œE:N:Nu:::N::\{0(3œEf{f{[fff{ff\{0(3œEiiqiiiii\{0(XœE;\{0(œE\{0(3œE $ &w   &  \{0(3œEEn|1*XE;1(XE\{0(œE_{0(0E|]{0*0EkZ_{0(0E|]{0*0EZ\{0(œE\{0(œEr8\{0(œE8888888888\{0(œE888888888\{0(œE\{0(œE}b\{0(œEbbbbbbbbbb\{0(œEbdbbbbbbbb\{0(œEdddddddddd\{0(œEddddddddd\{0(œE\{0(œE\{0(œE\{0(œEO\{0(œE\{0(œEr\{0(XœEff\{0(-œE ?\{0(3œE*888\{0(XœE\{0(;œE\{0(XœEq[\{0(XœE[,,\{0(XœE[44mm\{0(œEG]mm_{0(0E|]{0*0E\\{0(XœE\]]]C]]]\{0(3œEw]]]]]]]\{0(œE\{0(œE\{0(œE\{0(-œE_{0(0E  |]{0*0E!]   \{0(œEDD\{0(œECC\{0(œEDD\{0(œEDD\{0(œEDD\{0(XœE]DD\{0(œE\{0(XœE]``\{0(XœEf]\{0(œEf\{0(œEf\{0(œEf\{0(XœEf]\{0(œEf\{0(œEf  \{0(œEf\{0(œEf\{0(œEf\{0(œEf\{0(œEf\{0(œEf!!\{0(œEf((\{0(œEf\{0(œEf\{0(XœEf^\{0(XœEf ^''''\{0(œEf'''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(œEf''''''''''\{0(XœEf?^;_;;;;___;\{0(œEf^____;___;\{0(XœEf^_l___;lll;\{0(œEfmmm4 mmllll\{0(œEf$$\{0(XœEf^,,\{0(+œEf   ; \{0(XœEf^\{0(œEf\{0(XœEf^\{0(œEf\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(œEf\\\{0(XœEf^6S6666 SSS6\{0(œEfSSSSS6SSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(œEfSSSSSSSSSS\{0(:œEfSTSSSSSSSS\{0(XœEfSTSSSSTTTS\{0(XœEfT]TTTS]]]S\{0(-œEf U^U]UUU]UU\{0(+œEf U^U]UUU]UU\{0(+œEfTTTT\{0(XœEf_]]]II]]]\{0(XœEf_(\\(((\{0(XœEf`%*%%==%%***%\{0(XœEf`(((VV(((\{0(œEf**\{0(XœEfaM**MMM\{0(œEf::::::::::\{0(XœEfb:;::::;;;:\{0(XœEf4544445554\{0(œEf::::::::::\{0(XœEfbLNLLLLNNNL\{0(XœEf!bMpMMMMpppM\{0(œEfmnpppMnnnM\{0(XœEfnqnnnMqqqM\{0(œEfqqqqqMqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqqqqqqqqqq\{0(œEfqrqqqqpppp\{0(œEfppppppoooo\{0(œEfoooooonnnn\{0(XœEfnpnnvvnnpppn\{0(œEf .8.7z...8z..\{0(MœEf\{0(œEf       \{0(MœEf 5@5\555\55\{0(MœEf&$\{0(XœEfoqooooqqqo\{0(;œEfqrqqqoqqqo\{0(XœEfEbqqqqoo\{0(-œEf^\^\^^^\^^\{0(-œEf]n]nh]]]n]]\{0(-œEf5S5S555S55\{0(œEf\{0(œEf\{0(œEf\{0(XœEfb\{0(XœEfb\{0(œEf\{0(œEf  \{0(œEf\{0(œEf\{0(œEf\{0(œEf\{0(œEf\{0(œEf  \{0(XœEf\{0(XœFb    \{0(œF         \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF    II      \{0(œF$$\{0(XœFb,,\{0(XœFb\{0(œF\{0(œF\{0(œF\{0(XœFb\{0(œF\{0(œF  \{0(œF\{0(œF\{0(œF\{0(œF\{0(œF\{0(œF  \{0(XœFb\{0(œF\{0(œF::\{0(œF::\{0(œF;;\{0(œF::\{0(œF::\{0(œF;;\{0(œF;;\{0(œF::\{0(œF::\{0(œF::\{0(XœF c/2////222/\{0(œF//////////\{0(œF//////////\{0(œF//////////\{0(œF//////////\{0(XœFc/9////999/\{0(œF99999/9999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(œF9999vv999999\{0(-œF*:*:***:**\{0(XœF/cEKEEQQEEKKKE\{0(œFKKKKKEKKKK\{0(œFKKKKuuKKKKKK\{0(œFKKKKuuKKKKKK\{0(œFKKKKvvKKKKKK\{0(œFKKKKuuKKKKKK\{0(œFKKKKuuKKKKKK\{0(œFKKKKuuKKKKKK\{0(XœFAcYsYYYYsssY\{0(œFrrrrbbrrrrrr\{0(XœF{crsrrbbrrsssr\{0(œFrssssrsssr\{0(XœFcssssrr\{0(XœFc``\{0(œF\{0(XœFc\{0(-œFEJEKrEEEKEE\{0(XœFc\{0(œF\{0(œF\{0(œF\{0(Xœ Fc    \{0(nœ F\{0(nœ F\{0(Xœ Fd\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(Xœ F",""$$"",,,"\{0(œ F++++++++++++\{0(Xœ Fe+]++++++]]]+\{0(Xœ F}eZ~ZZ88ZZ~~~Z\{0(œ F~~~~~Z~~~~\{0(œ F~~~~kk~~~~~~\{0(œ F~~~~kk~~~~~~\{0(œ F~~~~kk~~~~~~\{0(œ F~~~~kk~~~~~~\{0(œ F\$~~kk~~~~~~\{0(œ F\$~~//~~~~~~\{0(+œ F\#######\{0(Xœ F~~~kk~~~\{0(œ F~~\{0(œ F~~\{0(œ F~~\{0(Xœ Fe~~\{0(Xœ Fe\{0(œ F--\{0(Xœ F;f--\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(œ F\{0(Xœ F\{0(XœFf$$$$\{0(;œF"#\{0(-œF\{0(-œF###\{0(œF"%&%F%%$$$$\{0(XœFg$A$$$$AAA$\{0(œF>?AAA$???$\{0(XœF?B???$BBB$\{0(;œFBCBBB$BBB$\{0(XœFAgB_BBB$___$\{0(œF$$\{0(XœFg,,\{0(XœFg;;\{0(XœFg2222\{0(-œF222\{0(œF\{0(œF\{0(XœFg\{0(œF\{0(œF\{0(œF\{0(œMF!!\{0(œMF""\{0(œMF\{0(XœMFg\{0(œMFp   {      \{0(œMF\{0(œMF \{0(;œMF \{0(XœMFg\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(œMF\{0(XœMFg\{0(XœMFh((\{0(XœtFfh\{0(œtFf))\{0(XœtFf=h))\{0(;œtFfQ\{0(;œtFf\{0(sœtFfI\{0(XœtFfSS\{0(3œtFf&\{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf          \{0(œtFf   \{0(œtFf66\{0(XœtFfEh66\{0(sœtFf>  \{0(XœtFf\{0(-œtFf  6 \{0(œ:tFf""\{0(Xœ:tFfQh((\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(œ:tFf\{0(Xœ;tFfYh\{0(.œ;tFf          \{0(Xœ;tFfwh "    !!! \{0(Xœ;tFfh!4!!! 444 \{0(œ;tFf ! !   !  \{0(œ;tFf((((&&((((((\{0(Xœ@tFfh )  ||  ))) \{0(Xœ@tFf<W<<ff<<WWW<\{0(Xœ@tFfhVVVVVV\{0(XœBtFfeiBBBB\{0(XœBtFf?@??\\??@@@?\{0(œBtFf@@@G@@@@@@\{0(-œBtFfV^V`<VVV`VV\{0(XœCtFfkj>>>YY>>>\{0(œCtFf\{0(XœDtFfqk\{0(XœDtFfk))))\{0(:œDtFf4555\{0(XœDtFfk          \{0(œDtFf          \{0(XœDtFfk                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m o p q r s t u v w x y z { | } ~          \{0(XœEtFfkuauuu\{0(XœEtFflstssssttts\{0(œEtFftttttstttt\{0(XœEtFflVYVVVVYYYV\{0(œEtFfxxxxxxxxx\{0(XœEtFflx{xxxx{{{x\{0(XœGtFflz6zzzz666z\{0(XœGtFfm"(""88""((("\{0(XœGtFfm=@====@@@=\{0(XœGtFfm;<;;;;<<<;\{0(œGtFf<<<<<;<<<<\{0(œGtFf<<<<<<<<<<\{0(œGtFf<<<<<<<<<<\{0(œGtFf<<<<<<<<<<\{0(œGtFf<<<<<<<<<<\{0(œGtFfbb\{0(XœHtFfm./....///.\{0(œHtFf.////.///.\{0(+œHtFf1 = =   =  \{0(XœHtFf<=<<aa<<===<\{0(XœHtFfm=]===<]]]<\{0(XœHtFf=n]a]]]<aaa<\{0(œHtFf`aaaa<aaa<\{0(XœHtFfKnajaaa<jjj<\{0(XœHtFfcnjjjj<<\{0(XœItFfn\{0(œItFf\{0(XœItFfn\{0(œItFf\{0(XœItFf\{0(;œItFf\{0(XœItFf o\{0(XœJtFf;oltllhhlltttl\{0(:œJtFfVVVVVV\{0(XœLtFfQo<I<<xx<<III<\{0(œLtFf          \{0(XœbGfqo\{0(œbGf    \{0(œbGf         \{0(œbGf    PP      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf    QQ      \{0(œbGf\{0(œbGf  ,7( (bGf"$$\{0(XœbGf\{0(:œbGf\{0(XœbGfo\{0(XœbGfo\{0(XœbGfo\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf  \{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf\{0(œbGf         \{0(œbGf\{0(-œbGf\{0(-œbGf  H _{0(0bGf|]{0*0bGfo_{0(0bGf|]{0*0bGf==LL=!>>TT>!\{0(XœPG& s>?>>TT>!??WW?!\{0(XœPG&s?@??WW?!@@__@!\{0(XœPG&s@A@@__@!AAffA!\{0(XœPG&"sABAAffA!BBooB!\{0(XœPG&*sBCBBooB!CCxxC!\{0(XœPG&CDCCxxC!DDD!\{0(XœPG&2sDEDDD!EE E!\{0(XœPG&:sEFEE E!FFF!\{0(XœPG&BsFGFFF!GGG!\{0(XœPG&JsGHGGG!HHH!\{0(XœPG&RsHIHHH!II I!\{0(XœPG&ZsIJII I!JJ&&J!\{0(XœPG&bsJKJJ&&J!KK..K!\{0(XœPG&jsKLKK..K!LL55L!\{0(XœQG&rsLMLL55L!MM88M!\{0(XœQG&zsHIHHHHII II\{0(XœQG&~sIJII IIJJ((JJ\{0(XœQG&sJKJJ((JJKK11KK\{0(XœQG&sKLKK11KKLL99LL\{0(XœQG&sLMLL99LLMMAAMM\{0(XœQG&sMNMMAAMMNNIINM\{0(XœQG&sNONNIINMOOPPOM\{0(XœQG&sOPOOPPOMPPSSPM\{0(XœQG&sPQPPSSPMQQZZQM\{0(XœQG&sQRQQZZQMRRccRM\{0(XœQG&sRSRRccRMSSllSM\{0(XœQG&sSTSSllSMTTooTM\{0(XœQG&sTUTTooTMUUxxUM\{0(XœQG&sUVUUxxUMVV~~VM\{0(XœQG&sVWVV~~VMWWWM\{0(XœQG&sWXWWWMXXXM\{0(XœQG&sXYXXXMYYYM\{0(XœQG&sYZYYYMZZZM\{0(XœQG&sZ[ZZZM[[[M\{0(XœQG&s[\[[[M\\\M\{0(XœQG&t\]\\\M]]]M\{0(XœQG&t]^]]]M^^^M\{0(XœQG&t^_^^^M___M\{0(XœQG&t_`___M```M\{0(XœQG&&t`a```MaaaM\{0(XœQG&.tabaaaMbbbM\{0(XœQG&6tbcbbbMcccM\{0(XœQG&cdcccMdddM\{0(XœQG&>tdedddMeeeM\{0(XœQG&FtefeeeMfffM\{0(XœQG&Ntdeddddee ee\{0(XœQG&Rtefee eeffff\{0(XœQG&Vtfgffffgggf\{0(XœQG&^tghgggfhh!!hf\{0(XœQG&fthihh!!hfii((if\{0(XœQG&ntijii((ifjj11jf\{0(XœQG&vtjkjj11jfkk99kf\{0(XœQG&~tklkk99kfll<<lf\{0(XœQG&tlmll<<lfmm??mf\{0(XœQG&tmnmm??mfnnBBnf\{0(XœQG&tnonnBBnfooIIof\{0(XœQG&topooIIofppRRpf\{0(XœQG&tpqppRRpfqq[[qf\{0(XœQG&tqrqq[[qfrr^^rf\{0(XœQG&trsrr^^rfssaasf\{0(XœQG&tstssaasfttddtf\{0(XœQG&ttuttddtfuukkuf\{0(XœQG&tuvuukkufvvttvf\{0(XœQG&tvwvvttvfww{{wf\{0(XœQG&twxww{{wfxxxf\{0(XœQG&txyxxxfyyyf\{0(XœQG&tyzyyyfzzzf\{0(XœQG&tz{zzzf{{{f\{0(XœQG&t{|{{{f|||f\{0(XœQG&u|}|||f}}}f\{0(XœQG&u}~}}}f~~~f\{0(XœQG&u~~~~ff\{0(XœQG&uff\{0(XœQG&&uff\{0(XœQG&.uff\{0(XœQG&6uff\{0(XœQG&>uff\{0(XœQG&Fuff\{0(XœQG&Nuff\{0(XœQG&Vuff\{0(XœQG&^uff\{0(XœQG&fuff\{0(XœQG&nuff\{0(XœQG&vuff\{0(XœQG&~uff\{0(XœQG&uff\{0(XœQG&uf!!f\{0(XœQG&u!!f**f\{0(XœQG&u**f--f\{0(XœQG&u--f66f\{0(XœQG&u66f??f\{0(XœQG&u??fGGf\{0(XœQG&uGGfOOf\{0(XœQG&uOOfXXf\{0(XœQG&uXXf[[f\{0(XœQG&u[[fbbf\{0(XœQG&ubbfkkf\{0(XœQG&ukkfttf\{0(XœQG&uttf}}f\{0(XœQG&u}}ff\{0(XœQG&uff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&&vff\{0(XœQG&.vff\{0(XœQG&6vff\{0(XœQG&>vff\{0(œQG&ff\{0(XœQG&Fv!!f))f\{0(XœQG&Nv))f,,f\{0(XœQG&Vv,,f33f\{0(XœQG&^v33f<<f\{0(XœQG&fv<<fEEf\{0(XœQG&nvEEfHHf\{0(XœQG&vvHHfQQf\{0(XœQG&~vQQfYYf\{0(XœQG&vYYf\\f\{0(XœQG&v\\f__f\{0(XœQG&v__fggf\{0(XœQG&vggfoof\{0(XœQG&voofvvf\{0(XœQG&vvvf}}f\{0(XœQG&v}}ff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&vff\{0(XœQG&wff\{0(XœQG&wff\{0(XœQG&wff\{0(XœQG&wff\{0(XœRG&&wff\{0(XœRG&.w\{0(XœRG&2w\{0(XœRG&:w\{0(XœRG&Bw\{0(XœRG&Jw\{0(XœRG&Rw\{0(XœSG&Zw  \{0(XœSG&bw  \{0(XœSG&\{0(XœSG&\{0(XœSG&jw \{0(XœSG&rw \{0(XœSG&zw\{0(XœSG&w\{0(XœSG&w''\{0(XœSG&w''00\{0(XœSG&w0088\{0(XœSG&w88@@\{0(XœSG&w@@HH\{0(XœSG&wHHKK\{0(XœSG&wKKRR\{0(XœSG&wRR[[\{0(XœSG&w[[dd\{0(XœSG&wddmm\{0(XœSG&wmmpp\{0(XœSG&wppww\{0(XœSG&www\{0(XœSG&w\{0(XœSG&w\{0(XœSG&x\{0(XœSG& x\{0(XœSG&x\{0(XœSG&x\{0(XœSG&"x\{0(XœSG&*x\{0(XœSG&2x\{0(XœSG&:x\{0(XœSG&Bx\{0(XœSG&Jx\{0(XœSG&Rx\{0(XœSG&Zx\{0(XœSG&bx\{0(XœSG&jx\{0(XœSG&rx\{0(XœSG&zx\{0(XœSG&x\{0(XœSG&x\{0(XœSG&x\{0(XœSG&x\{0(XœSG&x""\{0(XœSG&x""%%\{0(XœSG&x%%))\{0(XœSG&x))11\{0(XœSG&x1188\{0(XœSG&x88@@\{0(XœSG&x@@GG\{0(XœSG&xGGOO\{0(XœSG&xOOWW\{0(XœSG&xWWZZ\{0(XœSG&xZZcc\{0(XœSG&xccll\{0(XœSG&ylluu\{0(XœSG& yuu}}\{0(XœSG&y}}\{0(XœSG&y\{0(XœSG&"y\{0(XœSG&*y\{0(XœSG&2y\{0(XœSG&:y\{0(XœSG&By\{0(XœSG&Jy\{0(XœSG&Ry\{0(XœSG&Zy""\{0(XœSG&by ""  ++ \{0(XœSG&jy    ++   44 \{0(XœSG&ry    44   == \{0(XœSG&zy    ==   @@ \{0(XœSG&y    @@   GG \{0(XœSG&y   GG PP\{0(XœSG&yPPYY\{0(XœSG&yYY\\\{0(XœSG&y\\dd\{0(XœSG&yddkk\{0(XœSG&ykktt\{0(XœSG&ytt}}\{0(XœSG&y}}\{0(XœSG&y\{0(XœSG&y\{0(XœSG&y\{0(XœSG&y\{0(XœSG&y\{0(XœSG&y\{0(XœSG&y\{0(XœSG&z\{0(XœSG& z\{0(XœSG&z\{0(XœSG&z    \{0(XœSG&"z !   !!!\{0(XœSG&*z!"!!!"""\{0(XœSG&2z"#"""###\{0(XœSG&:z!"!!!!""""\{0(XœSG&>z"#""""####\{0(XœSG&Bz#$####$$$#\{0(XœSG&Jz$%$$$#%%%#\{0(XœSG&Rz%&%%%#&&&#\{0(XœSG&Zz&'&&&#'''#\{0(XœSG&bz'('''#(((#\{0(XœSG&jz()(((#)))#\{0(XœSG&rz)*)))#***#\{0(XœSG&zz*+***#+++#\{0(XœSG&z+,+++#,,,#\{0(XœSG&z,-,,,#--""-#\{0(XœSG&z-.--""-#..++.#\{0(XœSG&z./..++.#//44/#\{0(XœSG&z/0//44/#00770#\{0(XœSG&z0100770#11>>1#\{0(XœSG&z1211>>1#22GG2#\{0(XœSG&z2322GG2#33JJ3#\{0(XœSG&z3433JJ3#44SS4#\{0(XœSG&z4544SS4#55[[5#\{0(XœSG&z5655[[5#66^^6#\{0(XœSG&z6766^^6#77ff7#\{0(XœSG&z7877ff7#88mm8#\{0(XœSG&z8988mm8#99pp9#\{0(XœSG&z9:99pp9#::ss:#\{0(XœSG&z:;::ss:#;;zz;#\{0(XœSG&{;<;;zz;#<<<#\{0(XœSG& {<=<<<#===#\{0(XœSG&{=>===#>>>#\{0(XœSG&{>?>>>#???#\{0(XœSG&"{?@???#@@@#\{0(XœSG&*{@A@@@#AAA#\{0(XœTG&2{ABAAA#BBB#\{0(XœTG&:{BCBBB#CCC#\{0(XœTG&B{CDCCC#DDD#\{0(XœTG&J{DEDDD#EEE#\{0(XœTG&R{EFEEE#FFF#\{0(XœTG&Z{FGFFF#GGG#\{0(XœTG&GHGGG#HHH#\{0(XœTG&HIHHH#III#\{0(XœTG&:;::::;;;:\{0(;œTG&HI;;;:;;;:\{0(XœTG&HIHHHHIIIH\{0(XœTG&IJIIIHJJJH\{0(:œTG&JKJJJHJJJH\{0(XœTG&b{JKJJJHKKKH\{0(XœTG&j{KLKKKHLL LH\{0(XœTG&r{LMLL LHMMMH\{0(XœTG&z{MNMMMHNNNH\{0(XœTG&{NONNNHOO$$OH\{0(XœTG&{OPOO$$OHPP,,PH\{0(XœTG&{PQPP,,PHQQ33QH\{0(XœTG&{QRQQ33QHRR66RH\{0(XœTG&{RSRR66RHSS??SH\{0(XœTG&{STSS??SHTTGGTH\{0(XœTG&{TUTTGGTHUUPPUH\{0(XœTG&{UVUUPPUHVVWWVH\{0(XœTG&{VWVVWWVHWW``WH\{0(XœTG&{WXWW``WHXXiiXH\{0(XœTG&{XYXXiiXHYYqqYH\{0(XœTG&{YZYYqqYHZZttZH\{0(XœTG&{Z[ZZttZH[[ww[H\{0(XœTG&{[\[[ww[H\\zz\H\{0(XœTG&\]\\zz\H]]]H\{0(XœTG&]^]]]H^^^H\{0(XœTG&{^_^^^H___H\{0(XœTG&{_`___H```H\{0(XœTG&|`a```HaaaH\{0(XœTG& |abaaaHbbbH\{0(XœTG&|bcbbbHcccH\{0(XœTG&|cdcccHdd&&dH\{0(XœTG&"|dedd&&dHee..eH\{0(XœTG&*|efee..eHff11fH\{0(XœTG&2|bcbbbbcccc\{0(XœTG&6|cdccccdd&&dd\{0(XœTG&:|dedd&&ddee//ee\{0(XœTG&>|efee//eeff88ff\{0(XœTG&B|fgff88ffgg;;gf\{0(XœTG&J|ghgg;;gfhhBBhf\{0(XœTG&R|hihhBBhfiiKKif\{0(XœTG&Z|ijiiKKifjjTTjf\{0(XœTG&b|jkjjTTjfkk]]kf\{0(XœTG&j|ghgg;;gghhCChh\{0(XœTG&n|hihhCChhiiLLii\{0(XœTG&r|ijiiLLiijjSSjj\{0(XœTG&v|jkjjSSjjkk\\kk\{0(XœTG&z|klkk\\kkllcclk\{0(XœTG&|lmllcclkmmffmk\{0(XœTG&|mnmmffmknnoonk\{0(XœTG&|nonnoonkoowwok\{0(XœTG&|opoowwokppzzpk\{0(XœTG&|pqppzzpkqqqk\{0(XœTG&|qrqqqkrrrk\{0(XœTG&|rsrrrksssk\{0(XœTG&|stsssktttk\{0(XœTG&|tutttkuuuk\{0(XœUG&|uvuuukvvvk\{0(XœUG&|vwvvvkwwwk\{0(XœUG&|wxwwwkxxxk\{0(XœUG&|xyxxxkyyyk\{0(XœUG&|yzyyykzzzk\{0(XœUG&|z{zzzk{{{k\{0(XœUG&|{|{{{k|||k\{0(XœUG&}|}|||k}}}k\{0(XœUG& }}~}}}k~~~k\{0(XœUG&}~~~~kk\{0(XœUG&}kk\{0(XœUG&"}kk\{0(XœUG&*}k  k\{0(XœUG&2}  kk\{0(XœUG&:}kk\{0(XœUG&B}k  k\{0(XœUG&J}  k''k\{0(XœUG&R}''k00k\{0(XœUG&Z}00k99k\{0(XœUG&b}99kBBk\{0(XœUG&j}BBkEEk\{0(XœUG&r}EEkLLk\{0(XœUG&z}LLkUUk\{0(XœUG&}UUk\\k\{0(XœUG&}\\kcck\{0(XœUG&}cckllk\{0(XœUG&}llkwwk\{0(XœUG&}wwkk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&}kk\{0(XœUG&~kk\{0(œUG&kk\{0(XœUG& ~kk\{0(XœUG&~k%%k\{0(XœUG&~%%k..k\{0(XœUG&"~..k66k\{0(XœUG&*~66k 99k\{0(XœUG&2~99kBBk\{0(XœUG&:~BBkIIk\{0(XœUG&B~IIkLLk\{0(XœUG&J~LLkSSk\{0(XœUG&R~SSk\\k\{0(XœUG&Z~\\k__k\{0(XœUG&b~__kggk\{0(XœUG&j~ggkjjk\{0(XœUG&r~jjkqqk\{0(XœUG&z~qqkxxk\{0(XœUG&~xxkk\{0(XœUG&~kk\{0(-œUG&dldn<dddndd\{0(œG \{0(œG \{0(XœG~ \{0(œG\{0(XœG~\{0(XœG~\{0(œG\{0(œG\{0(œG  \{0(œG\{0(œG\{0(œG\{0(œG\{0(œG\{0(œG(!!!I!!!!!!\{0(œGf!!!!!!!!!\{0(œG!!!!!!!!!!\{0(œG!!!!!!!!!!\{0(œG!"!!!!    \{0(XœG&~''\{0(œG&\{0(œG&\{0(XœG&~\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(XœG&~\{0(XœG&      \{0(œG&  \{0(XœG&~  \{0(œG&\{0(XœG&~\{0(XœG&V')'''')))'\{0(XœG&`'+''''+++'\{0(XœG&n'+''''+++'\{0(œG&+++++'++++\{0(œG&++++;;++++++\{0(œG&++++;;++++++\{0(œG&++++<<++++++\{0(œG&++++;;++++++\{0(œG&++++;;++++++\{0(XœG&|+.++;;++...+\{0(œG&4444nn444444\{0(œG&4444nn444444\{0(œG&4444nn444444\{0(œG&4444nn444444\{0(œG&4444nn444444\{0(œG&4444nn444444\{0(œG&4444oo444444\{0(œG&4444oo444444\{0(XœG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(XœG&\{0(XœG&[[\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(XœG&8DDDD\{0(œG&CCCCCCCCCC\{0(XœG&CCCCCC\{0(œG&\{0(XœG&@\{0(XœG&~\{0(œG&,,\{0(XœG&++\{0(XœG&    \{0(œG&\{0(XœG&    \{0(XœG&\{0(XœG& AA   \{0(œG&    TT      \{0(XœG&   TT   \{0(XœG&ւ$$$$\{0(œG&$$$$$$$$$\{0(œG&$$$$$$$$$$\{0(XœG&\{0(œG&\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(œG&""\{0(XœG&xx\{0(œG&\{0(XœG&${{$$$\{0(XœG&$%$$$%%%\{0(œG&%%%%%%%%%\{0(œG&%%%%VV%%%%%%\{0(œG&%%%%VV%%%%%%\{0(œG&%%%%VV%%%%%%\{0(œG&%%%%VV%%%%%%\{0(XœG&[\[[[[\\\[\{0(œG&mmmm<<mmmmmm\{0(XœG&,7,,,,777,\{0(XœG&܃aaaaaa\{0(XœG&$vvvvvv\{0(œG&\{0(XœG&\{0(œG&\{0(XœG&ʄ\{0(XœG&҄\{0(œG&88\{0(XœG&88\{0(XœG&J\{0(œG&\{0(XœG&b6666\{0(œG&L666~666666\{0(œG&6666666666\{0(œG&6666666666\{0(œG&6666666666\{0(œG&6666666666\{0(XœG&RR\{0(XœG&FPPPPPP\{0(œG&\{0(XœG&R\{0(œG&PPPPPPPPPP\{0(œG&PPPPPPPPPP\{0(XœG&z\{0(œG&\{0(-œG&8nnnnnnn\{0(+œG&8nnnnnnn\{0(œG&!!!!!!!!!!\{0(XœG&kk\{0(;œG&\{0(XœG&\{0(XœG&\{0(XœG&66\{0(œG&\{0(XœG&\{0(œG&\{0(XœG& ::\{0(.œG& XbXcXXXcXX\{0(œG&ii\{0(œG&ii\{0(œG&ii\{0(œG&ii\{0(œG&ii\{0(œG&ii\{0(œG&ii\{0(XœG&??????\{0(XœG&    \{0(XœG& \{0(XœG&??\{0(œG&TT\{0(XœG&TT\{0(XœG&dd\{0(XœG&ć\{0(XœG&·\{0(XœG&ևcccccc\{0(XœG&V\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(œG&\{0(XœG&^\{0(XœG&j\{0(XœG&t77\{0(œG&\{0(œG&MM\{0(œG&MM\{0(œG&MM\{0(œG&MM\{0(XœG&\{0(œG&\{0(XœG&\{0(œG&\{0(XœG&))))\{0(XœG&.PSPPPPSSSP\{0(œG&SSSSSPSSSS\{0(œG&SSSSSSSSSS\{0(œG&SSSSSSSSSS\{0(œG&SSSSSSSSSS\{0(œG&SSSSSSSSSS\{0(XœG&:Y^YYYY^^^Y\{0(XœG&J""""\{0(œG&"""""""""\{0(œG&""""""""""\{0(XœG&X"#""""###"\{0(XœG&`22\{0(œG&\{0(XœG&\{0(œG&Z[|W*XG&\\\\\\\\]{0(œG&[\\\\\\\\\{0(œG&  \\\\\\\\\{0(œG&  \\\\\\\\\{0(œG&  \\\\\\\\\{0(XœG&\]\\\\]]]\\{0(œG&FG\{0(XœG&\{0(œG&IIIIIIII\{0(XœG&IJIIIIJJJI|W*XG&HHHHHHHHI]{0(œG&IHHHHHHHH\{0(œG&HHHHHHHHHH\{0(œG&\{0(œG&[[[[[[[[[[\{0(œG&\{0(œG&gh\{0(XœG&z|W*XG&jjjjjjjj]{0(œG&ijjjjjjjj\{0(œG&jjjjjjjj\{0(œG&jjjjjjjj\{0(XœG&`jkjjjjkkkj|W*XG&hmmDDmmmmDDmmj]{0(œG&@jmmDDmmmmmm\{0(XœG&Fmrmmmmrrrm\{0(-œG& mwmwkmmmwmm\{0(+œG& mwmwmmmwmm\{0(XœG&Vqrqqbbqqrrrq\{0(XœG&^stssjjssttts\{0(3œG&\{0(3œG&6{{m{{{{{\{0(XœG&f&&&&\{0(XœG&;;\{0(œG&\{0(XœG&\{0(XœG&rurrrruuur\{0(XœG&==\{0(œG&\{0(XœG&doddddoood\{0(œG&ooooodoooo\{0(œG&oooooooooo\{0(œG&oooooooooo\{0(œG&oooooooooo\{0(œG&oooooooooo\{0(XœG&uvuuuuvvvu\{0(XœKHf\{0(œKHf\{0(œKHf\{0(œKHf  \{0(œKHf\{0(œKHf\{0(œKHf\{0(œKHf\{0(œKHf\{0(XœKHf \{0(œKHf\{0(œKHfzY\{0(œKHfyy\{0(œKHf{{\{0(œKHfvv\{0(œKHfww|`y*KHf\{0(œKHfII\{0(XœKHf\{0(XœKHf\{0(œKHf\{0(œKHfYY\{0(œKHfYY\{0(œKHfYY\{0(œKHfYY\{0(œKHfXX\{0(œKHfXX\{0(œKHfYY\{0(œKHfYY\{0(œKHfXX\{0(œKHfXX\{0(œKHfXX\{0(œKHfXX\{0(XœKHf','''',,,'\{0(œKHf,,,,,',,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(œKHf,,,,::,,,,,,\{0(XœKHfQoQQqqQQoooQ\{0(œKHfoooooQoooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(œKHfooooHHoooooo\{0(XœKHf{{{DD{{{\{0(œKHf{{{\{0(XœKHf{{\{0(œKHf\{0(XœKHfC\{0(XœKHfrr\{0(œKHf\{0(œKHf\{0(œKHf\{0(XœKHfc!!ccc\{0(+œKHf~cc                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  c\{0(œKHfccc=cccccc\{0(œKHfccc_cccccc\{0(œKHfcccr>cccccc\{0(œKHfcccccccccc\{0(œKHfcccccccccc\{0(œKHfcccccccccc\{0(XœKHf # "  ### \{0(XœKHf\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(œKHfrr\{0(XœKHfrr\{0(XœKHfD\DDDD\\\D\{0(XœKHfS_j____jjj_\{0(œKHfjjjjj_jjjj\{0(XœKHfojkjjPPjjkkkj\{0(œNH33\{0(XœNHw33\{0(œNH..\{0(XœNH..\{0(XœNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH  \{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(œNH\{0(XœNH\{0(œNH\{0(XœNH #$$EE$$###\{0(XœNHHSHHHHSSSH\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(œNH____GG______\{0(XœOH_m__GG__mmm_\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyPPyyyyyy\{0(œOHyyyyQQyyyyyy\{0(œOHyyyyQQyyyyyy\{0(XœPHyyyQQyyy\{0(œPHs\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPH\{0(œPHOOOOOOOOOO\{0(œQH@@\{0(œQH@@\{0(œQH??\{0(œQH@@\{0(œQH@@\{0(œQH@@\{0(œQH@@\{0(œQH@@\{0(XœQH ??\{0(XœH 33\{0(œH\{0(œH77\{0(XœH 77\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(XœH# \{0(œH\{0(XœHA \{0(XœHI \{0(XœHQ !+!!!!+++!\{0(œH+++++!++++\{0(œH++++\\++++++\{0(œH++++\\++++++\{0(œH++++\\++++++\{0(XœHk DTDDDDTTTD\{0(œHSSSSSSSSSS\{0(XœH S^SSSS^^^S\{0(œH^^^^^S^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(œH^^^^^^^^^^\{0(XœH jjjQQjjj\{0(œHjj\{0(XœH1 jj\{0(œHjj\{0(XœH[ jj\{0(œHjj\{0(XœH wjwwwj\{0(œHvwwwwjwwwj\{0(XœH wwwwjj\{0(XœH# \{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(XœH+ $$\{0(œH\{0(œH<<\{0(XœH7 <<\{0(XœH? \{0(œH\{0(œH\{0(XœHU \{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(XœH\{0(œH\{0(XœH \{0(œH11\{0(XœH 11\{0(XœH \{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH  \{0(œH  \{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(œH\{0(XœH ))))\{0(œH)))))))))\{0(œH))))mm))))))\{0(œH))))mm))))))\{0(œH))))nn))))))\{0(œH))))nn))))))\{0(œH))))nn))))))\{0(œH))))mm))))))\{0(œH))))mm))))))\{0(œH))))mm))))))\{0(œH))))mm))))))\{0(XœH BgBBBBgggB\{0(œHgggggBgggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(œHgggggggggg\{0(XœH1 sssQQsss\{0(XœH \{0(œH\{0(œHTE\{0(XœH\{0(œH\{0(œHVV\{0(œHUU\{0(œHVV\{0(œHVV\{0(œHVV\{0(œHVV\{0(œHVV\{0(œHUU\{0(œHVV\{0(œHVV\{0(œHVV\{0(œHVV\{0(œHVV\{0(XœH;||\{0(XœHO I    III \{0(œHHIIII III \{0(XœHIOIII OOO \{0(œHNNNNllNNNNNN\{0(XœHNTNNllNNTTTN\{0(œHTTTTTNTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTT TTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(œHTTTTTTTTTT\{0(XœHTWTTTTWWWT\{0(XœHWWWWTT\{0(XœHu\{0(œH==\{0(XœH==\{0(XœH\{0(XœH88\{0(œH\{0(œH\{0(œH,,,,yy,,,,,,\{0(œH,,,,yy,,,,,,\{0(œH :,,yy,,,,,,\{0(XœH,-,,xx,,---,\{0(;œH:;---,---,\{0(œH8888888888\{0(XœH <=<<<<===<\{0(XœHCDCC++CCDDDC\{0(œHCCCC++CCCCCC\{0(XœHCDCC++CCDDDC\{0(œzHFEE\{0(XœzHF!EE\{0(œzHF88\{0(XœzHF)88\{0(œzHF\{0(XœzHF1\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(œzHF\{0(Xœ{HF9\{0(œ{HF\{0(Xœ{HFO\{0(Xœ{HFW\{0(œ{HF\{0(œ{HFTT\{0(œ{HFSS\{0(œ{HFTT\{0(œ{HFTT\{0(œ{HFTT\{0(œ{HFTT\{0(œ{HFSS\{0(œ{HFTT\{0(œ{HFTT\{0(œ{HFTT\{0(œ{HF\{0(œ{HF\{0(œ{HF\{0(œ{HF\{0(œ{HF\{0(œ{HF\{0(Xœ{HFi\{0(XœHF{DSDDllDDSSSD\{0(XœHFR\RRRR\\\R\{0(XœHFT`TTTT```T\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiicciiiiii\{0(œHFiiiibbiiiiii\{0(XœHFiniiiinnni\{0(œHFmnnnninnni\{0(XœHFnonnnioooi\{0(XœHF{{{QQ{{{\{0(œHF{{\{0(XœHFU{{\{0(XœHFgdd\{0(XœHF\{0(XœHFjj\{0(œHF\{0(XœHFYYYY\{0(XœHFaa\{0(XœHFZ]ZZZZ]]]Z\{0(XœHF[[[ [[[\{0(œHF++\{0(XœHF||\{0(œHF\{0(œHF\{0(œHF\{0(XœHF\{0(œHF\{0(XœHF\{0(œHFqq\{0(XœHFqq\{0(œHFn\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(œHF\{0(XœHF\{0(œHF\{0(œHF\{0(XœHF\{0(XœHF-;;;;\{0(œHF;;;;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;SS;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;SS;;;;;;\{0(œHF;;;;SS;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;TT;;;;;;\{0(œHF;;;;SS;;;;;;\{0(œHF;;;;TT;;;;;;\{0(XœHF;L;;TT;;LLL;\{0(œHFLLLLL;LLLL\{0(œHFssssssssss\{0(œHFssssssssss\{0(XœHF}s}ssss}}}s\{0(XœHFaLLaaa\{0(XœHF!\{0(XœHF)JKJJ,,JJKKKJ\{0(œHF````!!``````\{0(XœHF1`a``!!``aaa`\{0(œHF77\{0(œHF\{0(œHFOO\{0(œHFOO\{0(œHFOO\{0(XœHF9OO\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(Xœ1IfC\{0(œ1IfNN\{0(Xœ1If_NN\{0(œ1IfAA\{0(Xœ1IfgAA\{0(Xœ1Ifo\{0(œ1If\{0(œ1If\{0(œ1If  \{0(œ1If  \{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(Xœ1If\{0(Xœ1If!!!!\{0(œ1If!!!!!!!!!\{0(œ1If!!!!<<!!!!!!\{0(œ1If!!!!<<!!!!!!\{0(œ1If!!!!<<!!!!!!\{0(œ1If!!!!;;!!!!!!\{0(œ1If!!!!<<!!!!!!\{0(œ1If!!!!<<!!!!!!\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(œ1IfUUUUUUUUUU\{0(Xœ1Ifnnnnnn\{0(œ1Ifn\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(Xœ1IfQQ\{0(œ1IfWW\{0(Xœ1IfoXX\{0(Xœ1Ife\{0(Xœ1Ifwxxwww\{0(Xœ1Ifoooooo\{0(œ1IfA\{0(œ1If2\{0(œ1If\{0(œ1IfO\{0(œ1Ifh\{0(œ1If\{0(œ1If\{0(Xœ1If\{0(Xœ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If  \{0(œ1If  \{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If  \{0(Xœ1If ))))\{0(œ1If)))))))))\{0(œ1If))))pp))))))\{0(œ1If))))pp))))))\{0(œ1If))))pp))))))\{0(œ1If))))oo))))))\{0(Xœ1If)QQ\{0(œ1If\{0(Xœ1Ifi\{0(œ1If\{0(Xœ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1If\{0(œ1IfW\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œ1IfQQQQQQQQQQ\{0(œVdIFKK\{0(XœVdIFKK\{0(XœWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF  \{0(œWdIF  \{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(œWdIF\{0(XœWdIF""""\{0(œWdIF"""""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""BB""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""BB""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(œWdIF""""AA""""""\{0(XœXdIFoooooo\{0(XœXdIFG{{{oo{{{\{0(œXdIF{\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF++\{0(œXdIF,,\{0(œXdIF,,\{0(œXdIF,,\{0(XœXdIF,,\{0(XœYdIFQQ\{0(œw$Jfqq\{0(œw$Jfrr\{0(Xœw$Jf\{0(œw$Jf\{0(Xœw$Jf\{0(œw$Jf\{0(Xœw$Jf\{0(œw$Jf\{0(œw$Jf\{0(œw$Jf  \{0(œw$Jf  \{0(œw$Jf\{0(œw$Jf\{0(œw$Jf\{0(œw$Jf\{0(œw$JfBB\{0(Xœw$JfBB\{0(Xœx$Jf\{0(œx$Jf\{0(œx$Jfcc\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfcc\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfcc\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(œx$Jfdd\{0(Xœx$Jf(((}}(\{0(œx$Jf((((}}(((((\{0(œx$Jf((((((((((\{0(œx$Jf((((((((((\{0(œx$Jf((((((((((\{0(œx$Jf((((((((((\{0(œx$Jf((((((((((\{0(Xœx$Jf (7((((777(\{0(Xœx$Jf1mm\{0(œx$Jf\{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(œx$Jf  \{0(Xœy$Jf[QQ\{0(œy$Jf\\\{0(Xœz$JfX]]XXX\{0(œz$JfXXXEXXXXXX\{0(Xœz$Jf3\{0(Xœ{$Jfa\{0(Xœ{$Jf(BF|*BFi(BFr|*BFr(BF(BF(XBF (XQBF,QQQQQ(*JBFJJJJ(;PBFOPPP,0(QBFCQQQQQQQQQ(QBFQQQQQQQQQQ(QBFQQQQQQQQQQ(QBFQQQQQQQQQQ(QBFQQQQQQQQQQ(XBF6(WBFWWWWWWWWW(XBFWXWeWWVVVV(XBFVVVVV (XBF2 (BF(XBF8!(BF(BF  (-BFVVVVVVV(;BF;;;;;;;;;;(X<BF@!;<;;;;<<<< T(.gBFVgVgcVVVgVV(3gBFVgVgVVVgVV,0(jBFjjjjoojjjjjj(XkBFH!jkjjoojjkkvvkk(BFII(XBFP!HHLL(XBFX!(XEBF`!EEEEE(DBFDDDD&&DDDDDD(XJBFh!DJDD&&DDJJ))JJ(IBFIIIICCIIIIII(XdBFz!IdIICCIIddIIdd(HBFHHHHqqHHHHHH(RBFRRRRRRRRRR(XSBF!RSRRRRSSSS(X{BF!c{cccc{{{{(X=BF!=====(X=BF@"<=<<tt<<=={{==(<BF<<<<tt<<<<<<(XWBFH"<W<<tt<<WW{{WW(VBFVVVVVVVVVV(XsBF"VsVVVVssss(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(kBFkkkkkkkkkk(XBF"zz(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y { | } ~  (BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(XBF"jjjjj(BF (XBF"(XBF#(XBF#(X&BF#&33&&&&(XPBF8$PPPPP(XJBF$EJEEEEJJJJ(JBFJJJJJJJJJJ(JBFJJJJJJJJJJ(JBFJJJJJJJJJJ(JBFJJJJJJJJJJ(XpBF$QpQQ))QQpp00ppA(XBF$nnn[[nnggs(~BF~~~~~~~~~~(XBF%~~~~~  (BF w  (XBF,%(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(IBFIIIIIIIIII(XBFn%*(XBFv%007(XBF%  (((BF(((XBF%(XBF%eell(XBF@&(XBFX&(XDBFd&D??DDMMDDW(CBFCCCCiiCCCCCC(XBF'CCCiiCCqq(BF``(XBF'``ll(BFTT(XBFAA(BF(BFyy(XBF((XBF(IIRRa(BF(XBF((XBF(   ZZ  ``r(BF``(BFgg(BFhh(BFhh(BFhh(BFhh(BFgg(BFgg(BFgg(BFhh(BFhh(BFhh(BFhh(BFhh(BFgg(BFhh(BFhh(BFgg(BFgg(BFhh(BFgg(BFgg(BFhh(BFgg(BFhh(XBF(hh(XBF((BF(BF(BF(XBF(&(XBF)JJSSb(BF(XBF()(BF(BF(BF(XBF8)(BF(BFuu(BFuu(BFtt(BFtt(BFuu(BFuu(BFuu(BFuu(X,BFV)*,**rr**,,,,(,BF,,,,,,,,,,(,BF,,,,,,,,,,(X,BF^)*,**rr**,,yy,,(,BF,,,,yy,,,,,,(,BF,,,,,,,,,,(XcBFh)ZcZZZZcccc(XBF)(BF(BF(BF(XBF)(BF!!(BF!!(BF!!(BF  (BF!!(BF  (BF!!(BF!!(BF!!(BF!!(BF!!(BF!!(XBF)%%+(BF%%(BFWW(BFXX(BFWW(BFXX(BFXX(BFXX(BFXX(BFXX(XBF)   ww  (BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(XBF  8(XBF)\\iit(XBF)44(XBFB*FF^(BF(X+BFd*+++++)(+BF++++++++++(+BF++++++++++(+BF++++++++++(+BF++++++++++(+BF++++++++++(+BF++++++++++(+BF++++++++++(XBF*.....(XBF*wwwww(BF(BFNN(BF(BF(BF(BF(BF(BF(BF(BFUU(BF(XBF+ (XdBF +adaaaadddd(cBFcccccccccc(XBF,+ccccc(XBF|+zzzzz(BF(XBF+tt(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(XBF+(XUBF+QUQQQQUUUU(RBFQRUUUUUUUU(X\BF+U\UUUU\\00\\([BFU[\\00\\\\\\(XBF+\\\\\(XBFv,(BF(BF(BF(BF(BFee(BF(BF(BF(BFee(BF(BF(BF(BF(BF(BF(BF(BF(BFee(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BF(BFee(BF(BF(BF(BF(BFee(BF(BF(BF(BF(BF(XBF,ee }(BF (XBF,(BF(MBF VVVVVV|+ c(nCFjjjjj|*CF,(nCFV0(*CF9jjjjjjj(*CF9(XCFN5599(CF99(XCFN(CF(XCFNDDF(X8CFJO888,,88(8CF8888,,888888(8CF8888EE888888(8CF8888DD888888(8CF8888EE888888(8CF8888EE888888(8CF8888EE888888(8CF8888888888(XCFO(CF(XCFO(=CF===7======(X>CF=>====>>>>(XCFO  (CF(XCFO(3CF*<(XCF P(XCF6P(XCFdP(XCCF|P C  ss  CCCC(CCFCCCCCCCCCC(CCFCCCCCCCCCC(CCFCCCCCCCCCC(CCFCCCCCCCCCCc(s$CF5jjjj|*$CFPjjjjjj(sCFVjjjjjj(CF\\(X`CFrU`UUeeUU``hh``v(XCFs##&&4(CF&&(CF&&(XDCF sCDCCCCDDDD(DCFDDDDDDDDDD(CF(X6 CF3 6 3 3 3 3 5 5 5 5 |(;6 CF5 6 5 5 5 5 5 5 5 5 (XF CF(s5 F 5 5 5 5 F F F F c (nDFwwwww|QX*DFPswwwwwwww!(nwDF!VwwwwwwwwwD(wDFwwwwwwwwww(XDF''8(XyDF`wywwAAwwyyHHyyR(zDFzyyHHyyyyyy(+zDFzzz(*zDFzzz(DFyyHHyyyyyy(* DF V V VVV VV(+ DF V V VVV VV(XDFj(DF(DF(DF(X DF     (XDF$(XDF!(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DF(DFc (s$DF2|QX*$DF!(DF(XDF (XDF"6699G(DF99(XDF.CCII(XDF6 (DF(DF(DF(DF(XDF> (DF(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(DF<<(XADFT>A>>pp>>AAttAA(XODF`JOJJJJOOOO(ODFOOOOOOOOOO(ODFOOOOOOOOOO(ODFOOOOOOOOOO(ODFOOOOOOOOOO(ODFOOOOOOOOOO(X\ DFpT\TTTT\\\\(X DF{{{DD{{LL(X!DFc (s$"DFR77|QX*$"DFX("DF(X,"DFt+,++++,,,,'(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,(,"DF,,,,,,,,,,("DFVV("DFVV("DFWW("DFVV("DFVV("DFWW("DFVV("DF(X=#DF|%=%%%%====(=#DF==========(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(=#DF====XX======(XE#DF=E==XX==EE__EEi(L#DFLLLLLLLLLL(XV$DFMVMMMMVVVV(V$DFVVVVVVVVVV(V$DFVVVV--VVVVVV(V$DFVVVV--VVVVVV(V$DFVVVV--VVVVVV(Xi$DFbibbppbbiissii(i$DFiiiissiiiiii(i$DFiiiiiiiiii(X%DF (%DFb(%DF(.&DFI|ZXPX(X&DF(&DF(X&DF(X&DF '(&DF(&DF--(X&DF--77>(Xr{F(Xr{F(X&( ( ( 0(ڷ"A 3l (Xڷj:;::::;;;;(Xڷrm n m m MMm m n n n n h|(XCڷzn n n n n   (Xڷ  QQ   (Xڷ  QQ   (Xڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (Xڷ{ | { { { { | | | | (Xڷ  ``   (Xڷ  55   (Xڷ   66   (Xڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (Xڷ     (Xڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (Xڷ:  77   (Xڷ     (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  ii   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  ii   (ڷ  hh   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  ii   (ڷ  ii   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (ڷ  hh   (Xڷp   KK     (Xڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (ڷ          (sڷ      U   (Xڷ: L : : : : L L L L (XڷK r K K K K r r r r K (Xڷr r r r r r r r r r (ڷr r r r 99r r r r r r (Xڷ:r s r r ::r r s s s s (Xڷ  (     (XڷB     (XڷY       (Xڷ  }}   (Xڷ`(Xڷ(Xڷ -  BB  ----(Xڷ2(Xڷ||(XڷU(ڷ&(ڷ(ڷ(ڷ(ڷ(ڷ(Xڷ*qq****(XLڷ*<****<<<<$(Xڷ!3!!!!3333(Xڷ3333333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333>>333333(ڷ3333==333333(ڷ3333MM333333(ڷ3333MM333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333MM333333(ڷ3333MM333333(ڷ3333MM333333(ڷ3333MM333333(ڷ3333MM333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(ڷ3333==333333(Xڷ(XڷMS(Xڷ(Xڷ }}(Xڷ(k}kkkk}}}}(Xڷ||||||||||(XڷR||||||(3Xڷ!dd_eedee]A~(33ڷ!ddeedee(Xڷ~fffff(Xڷ@(Xڷ(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷbb(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(ڷaa(Xڷl"$""""$$$$(Xڷvaa(Xڷ(ڷ(ڷ(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvkkvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(ڷvvvvjjvvvvvv(Xڷ(Xڷ y     y y y y (Xڷy y y y y   y (Xڷ     (Xڷ  @     (ڷ     (ڷ     (ڷ     (Xڷ  <   (Xڷ     (ڷ     (ڷ     (ڷ     (Xڷ,z z z z z   (Xڷp     (Xڷx     (Xڷ     h|(XCڷ  BB   (Xڷ     (ڷ  rr   (ڷ  yy   (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ     (ڷ      (ڷ     (ڷ     (ڷ     (ڷ  $$   (Xڷd}ddoodd}}}}(Xڷ y|yy]]yy||||y(Xڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(ڷ||||||||||(Xڷ;;(Xڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(XڷF(Xڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(Xڷf(Xڷ          (Xڷ~AAAAA(XڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(ڷAAAAAAAAAA(sڷ""" (Xڷ     (Xڷ(Xڷ5]5555\\\\(XڷS`SSXXSS````(XڷiiiBBii(Xڷ6A6666AAAA6(XڷAAAAAAAAAA`(X8ڷABAAyyAABBBB7}(Xڷ(Xڷ(Xڷ(ڷaa(ڷaa(ڷaa(ڷ``(ڷaa(ڷaa(ڷbb(ڷaa(ڷ``                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  (ڷaa(ڷaa(ڷaa(ڷaa(ڷ``(Xڷ(Xڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(ڷ(sڷ  (Xڷ%%(Xڷ"(Xڷ.^^(Xڷ(Xڷ(Xڷ(Xڷ(Xڷ     (;ڷ     1\(;ڷvY Y Y Y Y Y Y Y Y (Xڷabaaaabbbb(Xڷ(Xڷ(Xڷ) < 7 87 A~(ڷffffffffff(ڷffffffffff(ڷffffffffff(ڷffffffffff(ڷffffffffff(Xڷ6yyy}}yy(sڷ12(Xڷn(Xڷ(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn(ڷnn`(X8ڷnn7}(Xڷ(ڷss(ڷss(Xڷ0(ڷaa(Xڷ   (Xڷ     (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (ڷ  nn   (Xڷ " nn """"(3Xڷ+++]A~(-3ڷ !!s!(Xڷ#'####''''(Xڷ4K4444KKKK(XڷKKKKK(-Xڷ  "|"(.-ڷ  ""(XCڷ(Xڷ (ڷj (ڷM(ڷ6(-ڷ   m ]A~(--ڷ7H7J777J77]A~(--ڷdididddidd1\(--ڷx~x~xxx~xx(--ڷ(--ڷ{1 (nڷLLLLL|*ڷZLLLLLLLL5}(n7ڷLLLLLLLLL(+nڷ(*+ڷ(*ڷ6(sڷ6D66(Xڷ: 6=66++66====(XڷLLLLLLLLLL(ڷP(Xڷ(Xڷ  (ڷ  (ڷKKKKKKKKKK(ڷwwwwwwwwww(ڷ(ڷ(ڷ(ڷ</(ڷJ   A~(:ڷ?@!@!!!@!!1\(nڷ!.!!!!....(XڷN +.++XX++....(Xڷ..........(ڷ....jj......(ڷ-!M..kk......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(ڷ....QQ......(+ڷ!0!0!!!0!!(-+۷!0!0!!!0!!1\(X۷Z G]GGGG]]]](X۷ \\\;;\\(X۷(۷pp(۷pp(X۷D pp(3X۷!4!5!!!5!!(X۷T tt(X۷x tt}0(X۷(۷XX(۷YY(۷XX(۷YY(۷YY(۷XX(۷YY(۷YY(۷XX(۷XX(۷YY(۷XX(۷YY(۷XX(۷YY(X۷ YY(X۷ (X۷(۷(X۷ 00000(X۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(۷0000000000(-۷]A~(-۷//////////(X۷6 KSKKhhKKSSSS(X۷L KKKiiKK(X۷4?????(X۷?????????(۷ ???KO??????(۷M?????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷??????????(۷>>>>>>>>>>( ۷[111111A~(X ۷11(X ۷\111111A~( ۷(X ۷(X ۷ dh|(XC ۷>>>>>(X ۷II(X ۷(X ۷ww(X ۷bbbbb(X۷LsLLLLssss(X^ݷLVLLLLVVVV(X^ݷ LUVVVVVVVV(X_ݷVWVVVVWWWW(X_ݷ~~~~~~~~~(_ݷ~~~~~~~~~~(_ݷ~~~~~~~~~~(_ݷ~~~~~~~~~~(X_ݷ     (X_ݷ`(X8_ݷSSSSS7}(X`ݷ-@----@@@@(X`ݷ@@@@@@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(`ݷ@@@@  @@@@@@(X`ݷNcNNssNNcccc(Xaݷmm(Xaݷ#(aݷ(aݷ(aݷ(Xaݷ$(Xaݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(aݷ(Xbݷ\:X::}}::XXXX(-X^%r]A~(X_(X_(_ee(_ee(_ff(_ee(_ee(_ee(_ee(_ff(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ff(_ee(_ee(_ee(_ee(_ff(_ee(_(_ee(_ee(_ee(_ee(_ee(_ee(_ee(_ff(_ee(_ff(_ee(_ee(_ee(_ee(_ee(X`ee(X`<<(X`(`EE(`DD(-a^x^x^^^x^^1 (nb h     h h h h (nbijFFFFFFFF (b8 9         h|(XCb          (Xb          (b          (b          (b          (Xc) X ) ) ) ) X X X X (XdHP P P P P   4P((XDQeH #  88 # # # # 4h|(XCe" . " " ''" " . . . . (Xe" " " " ''" " " " " " (e" " " " ''" " " " " " (e" " " " ((" " " " " " (e" " " " ))" " " " " " (e" " " " ))" " " " " " (e" " " " &&" " " " " " (e" " " " ''" " " " " " (Xf' ' ' MM' '   (XfH      (ng     (Xh     (Xh        (-XhR          (--hR          ]A~(*-hR          (+*hR          (Xi| ;   @@  ; ; ; ; (Xi7 ; 7 7 7 7 ; ; ; ; (Xj: : : : :   (Xj2     (Xj     (j  ,,   (j  ++   (j  ++   (j  ++   (j  ++   (j  ++   (XkD  ''   (Xk  ??   `(X8k +  >> + + + + 7}(XmH P     P P P P (XmC D C C BBC C D D D D (XmC C C C BBC C C C C C (XnC a C C BBC C a a a a (Xna a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a (na a a a a a a a a a h|(XCna a a a a   (Xnl l l l YYl l l l l l (XpV_  _ _ _ _     (Xq\ 5    5 5 5 5 (Xr3 3 3 ..3 3   (Xr      (r     (Xs      (Xs     (Xs     (Xt     (Xt  CC (Xt(t(t(t(t(t(Xt(XuDTDD__DDTTTT(XuSSSSSSSSSSh|(XCuSXSSSSXXXX(XuWWWWWWWWWW`(X8wWlWWWWllll7}(XzNlmllllmmmm(Xz++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(z++++++++++(XzVXmXXXXmmmm(Xzmwmmmmwwww(Xz mwwwwwxxxx(Xzx{xxxx{{{{(Xzzzzzzzzzzz`(X8{zzzzz7}(X{GG(XT(Xn(Xdd`(X8dd7}(X(XBB(BB(CC(BB(BB(X(X..(XQ(X (X(X     (X          (X     (X`(X87}(X BB(Xj!zz(Xr!}}(Xz! ~~    (X!||(X((X!cc(X((((((((((((((((((X"'}}''''(X''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''`(X82"'(''''((((7}(X:"(X((((X";;(XJ#2322223333(X3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(3333333333(XR#3433334444 (XUUUUJJUUUUUU(UUUUJJUUUUUU(UUUUKKUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(UUUUKKUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(UUUUJJUUUUUU(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(oooooooooo(XZ#(Xb#(Xv#YY(X(,,(,,(,,(,,(,,(,,(,,(,,(,,(--(,,(,,(,,(,,(,,(,,(,,(X@(X(X(n(n\\(X#]](X  \\   h|(XC#  ]]   (X     (     h|(XC#     (X,$A D A A A A D D D D (XD D D D D D D D D D (D D D D D D D D D D (D D D D 22D D D D D D (0000000000(\\(X8$]]7}(n33333(X@$!$$!!!!(XrLLLLLLLLL(LLLLLLLLLL(    WW      (XGG(XCCCCCCCCCC(XNN(X`$(X$NN(X(SS(X$^^(X$(X$dd(X     (n     (n\\`(X8$]]7}(n(X$PPPPP(XMMMMyyMMMMMM(MMMMyyMMMMMM(MMMMzzMMMMMMh|(XC4%MMMyyMM(XXX`(X8%7}(X`(X8&7}(XF&(X(((((Xn&ss(X&(X&((((((X''''''''''`(X8>''*''''****7}(XJ'(;((((;;;;(X;;;;;;;;;;(;;;;;;;;;;(;;;;;;;;;;(;;;;;;;;;;(Xr';@;;;;@@@@(X?@@@@@@@@@\(X'@D@@@@DDDD(XCDDDDDDDDD\(X'DrDDDDrrrr(Xrrrrrrrrrr(rrrrxxrrrrrr(rrrryyrrrrrr(rrrryyrrrrrr(rrrrxxrrrrrr(rrrrxxrrrrrr(rrrrxxrrrrrr(rrrrxxrrrrrr(rrrryyrrrrrr(rrrrxxrrrrrr(rrrryyrrrrrr(rrrryyrrrrrr(rrrryyrrrrrr(rrrryyrrrrrr(rrrrxxrrrrrr(rrrryyrrrrrr(X'  (X(SS(X2(tt(X n(XL((XV(tt(X((X((((((((((((((((X)88(X$)mm(X8)``(XL)DDDDD(X):>::::>>>>(X*PPPPP(X@@@@''@@@@@@(@@@@''@@@@@@(@@@@''@@@@@@(Xt*HzHHZZHHzzzz(Xzzzzzzzzzz(zzzzzzzzzz(zzzzzzzzzz(zzzzzzzzzz(zzzzzzzzzz(X*(X((((`(X8*7}(X*(X*(X((X+(XRRRRssRRRRRR(X +RSRRssRRSSSSR(X+(X(X+>N>>88>>NNNN(X((((k(44(XB+#E####EEEE(XEEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(EEEEEEEEEE(X+(X+WXWWWWXXXX(-Xororoooroo]A~(--  A \9(--9=9=999=99]A~(X+(X((nPuPPPPuuuu(nuuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(uuuuuuuuuu(tttttttttt(tttttttttt(tttttttttt(tttttttttt(tttttttttt(tttttttttt(tttttttttt(tttttttttt(n(n\\`(X8+]]7}h|(XC+(X(X,(X(X,(X((X(n(n\\(Xt-]](X\((X(-X(n(n\\(X|-]](X -99999(X!-66666(X!(X!v.(X!(X!.(X!(X"R/(X"^/bb(X"v/(X"(X"/(X"(X"/(X"00h|(XC#/00000(X#0%O%%%%OOOO(X#OOOOONNNN(X$t0bcbbbbcccc(X$cccccccccc(X$|0     (X$         h|(XC%0 "    """"(X%0*9****9999(X&(n&98888(n&X\(&XXh|(XC&0XX(X'0(X'1(X'J(X'1(X(t(X((n((n(\\(XT(1]](XC31(X31(X3(X41ooooo(X4nnnnnnnnnn(X52nnnnn(X5(5(5(X73NzNN))NNzzzz(X7z3(X7 (X73(X73   gg  (X84*****(X8*,****,,,,(X904.9....9999(X9L4(X9(9(9(9(9(9(9(9(X:v4(X:4(X:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(:(X;4     (MX@; (X@4      (XA 5 {    {{{{(XA5{{{{{(XB 6>H>>__>>HHHH(XBHHHHHHHHHH(BHHHHHHHHHH(BHHHHHHHHHH(BHHHHHHHHHH(BHHHHHHHHHH(BHHHHHHHHHH      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdeghijklmnopqrstuvwxyz{|}~(BHHHHHHHHHH(BHHHHHHHHHH(XC$6qqqqq(XE*7[[[[[(XE4444444444(XF7?????(XG8(XI8*****(XIF9$%$$55$$%%%%(XI%%%%%%%%%%(XIN9*>**``**>>>>(XJ|9>d>>>>dddd(XJ98988889999(XJ9999999999(XK9ddddd(XK \(XK:(XK:(XK:(XK;v(XL(;7}(XL;(XM;#E####EEEE(XM><(XM\(XMZ<(XM\(XM<.(XM`(X8N<7}(XN(NBB(NAA(XN<(XN<(XN(N  (XO=  (XO=(XO(O(O(O(O(O(O(O(O(O(O(O(O(O(O(O(XOD=),)))),,,,7}(XO,,,,,,,,,,(O,,,,,,,,,,(O,,,,,,,,,,(O,,,,,,,,,,(XPP=,E,,,,EEEE(XPtFFFFFFFFF(P(XP=CECCQQCCEEEE(XPEEEEEEEEEE(PEEEEZZEEEEEE(PEEEE[[EEEEEE(PEEEEZZEEEEEE(PEEEEZZEEEEEE(QmEEEEEEEEE(XR=EIEEZZEEIIIIE(XRIIIIIIIIII`(X8T=IJIIzzIIJJJJ7}(XT=^f^^^^ffff(XV=(XX=(XX~>NN(XX(XY>GGGGG(XYR?(XY[HHHHHGGGG(Y(XZZ?-<----<<<<(nZ(nZOO(ZOO(ZOO(ZOO(ZOO(ZOO(XZ~?0600ff006666(X[?lmllllmmmm(X\?[[(X\(X\8@\\\\\(X\gggggggggg(X\@ghgggghhhh (n]UmUUUUmmmm(X^@,,(X^ A(X^(X^,A@@(X^(X_4A     (X_(_(_(_(_(_(_(_(_(_----yy------(_----yy------(_----xx------(_----yy------(_----xx------(_----yy------(X_PAdkddddkkkk(X`&ddddddd(X`dA(n`(n`))(`))(a))(a))(a))(a))(nbh|(XCbA(Xb(XbAe(Xb(bh|(XCbA(Xb(XbA(sb+C1C11*(sb**********(b**********(b**********(c**********(c**********(c**********(c**********(c**********(XcA0:0000::::(XcA(Xc(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c(c{{(Xe(B(Xe1111>>>>(Xx==========(XyG=k====kkkk(XyGXiXX__XXiiii(Xyhhhhhhhhhh(XyGhthhhhtttt(Xytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(ytttttttttt(Xz     (nz h    gggg(nzff(XzGff(n\!\!\!\!\!|*G\!\!\!\!\!\!\!\!5}(n7B\!\!\!\!\!\!\!\!\!(n&&&&&|*o&&&&&&&&5}(n7n&&&&&&&&&(*n ))&)(+* )))(XZ:::::(X9999999999`(X89?9999????7}(X=B====BBBB=(-X41\(-XX(X–AAA  AA(XN(Xx  (X$ ZZ$ $ $ $ (X$ $ $ ; $ $ $ $ $ $ ($ $ $ $ $ $ $ $ $ $ ($ $ $ $ $ $ $ $ $ $ ($ $ $ $ $ $ $ $ $ $ (X  xx   (X     (  <<   (  <<   (     (     (     (     (     (     (     (     (     (     (X?!Q!?!?!?!?!Q!Q!Q!Q!(X!!!!00!!!!!!(!!!!00!!!!!!(!!!!00!!!!!!(!!!!0!!!!!!(##########(####0######($$$$cc$$$$$$h|(XC$ $$$cc$$ $ $ $ $(X )$*$)$)$)$)$*$*$*$*$(X)$)$)$)$)$)$)$)$)$)$(X()$-$)$)$)$)$-$-$-$-$(X-$-$-$-$-$-$-$-$-$-$`(X86-$.$-$-$-$-$.$.$.$.$7}(X>O$U$O$O$ggO$O$U$U$U$U$(XP$$$$$$$$$$(X$$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$(X''''''''''(X~'(''ff''(((((X(4(((%%((4(4(4(4((X/(A(/(/(77/(/(A(A(A(A((X 7(@(A(A(A(A(A(A(A(A((XA(V(A(A(A(A(V(V(V(V((X֚E(N(E(E(E(E(N(N(N(N((XN(N(N(N(N(N(N(N(N(N((N(N(N(N(  N(N(N(N(N(N((N(N(N(N(  N(N(N(N(N(N((N(N(N(N(  N(N(N(N(N(N((N(N(N(N(  N(N(N(N(N(N((XY!b!Y!Y!Y!Y!b!b!b!b!(Xb!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(b!b!b!b!b!b!b!b!b!b!(Xb!c!b!b!b!b!c!c!c!c!8(X !  !!!!(X !!!!! ! ! ! !(X> ! ! ! ! ! ! ! ! ! !(XR(R(R(c(R(R(R(R(R(R((XR(S(R(R(R(R(S(S(S(S(R((XFo(s(o(o(o(o(s(s(s(s(h|(XCTl(o(l(l(l(l(o(o(o(o((Xo(o(o(o(o(o(o(o(o(o((o(o(o(o(o(o(o(o(o(o((o(o(o(o(o(o(o(o(o(o((o(o(o(o(o(o(o(o(o(o((X`o(p(o(o(o(o(p(p(p(p((X))))0))))))())))))))))())))))))))())))))))))())))))))))(Xh))))__))))))(X)))*))))))(s$%e%%e%e%$>%$$(s$$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$(s4$0%$%0%$%$%$%$$(s0%%0%]%0%0%%%%%(s/%%0%k%k%k%%%%%(s/%/%/%/%--/%/%/%/%/%/%(/%/%/%/%--/%/%/%/%/%/%(X|/%0%/%/%DD/%/%0%0%0%0%(X.%/%.%.%@@.%.%/%/%/%/%.%(X/%/%/%/%/%/%/%/%/%/%(/%/%/%/%DD/%/%/%/%/%/%(X/%2%/%/%DD/%/%2%2%2%2%(Xu$$u$u$u$u$$$$$(X$$$$$$$$$$($$$$SS$$$$$$($$$$SS$$$$$$($$$$SS$$$$$$(X$$$$$$$$$$(X$$$$$$$$$$($$$$>>$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$??$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$($$$$$$$$$$(X% %%%%% % % % %(s%$%%%%%$$$$(X$%$$$$%%%%(sF$?%-%?%?%?%$ %$$(X % % % %33 % % % % % %(s-B%o%D%o%D%D%B%m%B%B%(s?%?%?%?%?%?%?%?%?%?%(ip%p%p%%p%p%p%p%p%p%(p%p%p%p%p%p%p%p%p%p%(n%n%n%n%n%n%n%n%n%n%(n%n%n%n%n%n%n%n%n%n%(X$n%x%n%n%n%n%x%x%x%x%(X>w%%w%w%KKw%w%%%%%w%(X%%%%%%%%%%(X%%%%||%%%%%%(X%%%%%%%%%%(%%%%%%%%%%(%%%%%%%%%%(%%%%++%%%%%%(%%%%++%%%%%%(%%%%%%%%%%(%%%%%%%%%%(%%%%%%%%%%(%%%%//%%%%%%(%%%%//%%%%%%(XCD%%%%%%%%%%%`(X8%%%%%%%%%%7}(X%%%%%%%%%%(%%%%**%%%%%%(X%%%%**%%%%%%%(X%%%%%%%%%%(X%%%%%%%%%%(%%%%%%%%%%(%%%%%%%%%%(%%%%%%%%%%(%%%%%%%%%%(X&&&&&&&&&&(s/%&&&&&%%%%(s%%%%%%%%%%(s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b([([(##[([(b(b(b(b((Xb(b(b(b(b(b(b(b(b(b((b(b(b(b(33b(b(b(b(b(b((b(b(b(b(33b(b(b(b(b(b((b(b(b(b(33b(b(b(b(b(b((Xȝb(c(b(b(33b(b(c(c(c(c((XНp(u(p(p(p(p(u(u(u(u((Xu(u(u(u(u(u(u(u(u(u((u(u(u(u(u(u(u(u(u(u((u(u(u(u(u(u(u(u(u(u((p(p(p(p(p(p(p(p(p(p((p(p(p(p(p(p(p(p(p(p((p(p(p(p(p(p(p(p(p(p((p(p(p(p(p(p(p(p(p(p((p(p(p(p(p(p(p(p(p(p((p(p(p(p(p(p(p(p(p(p((X(((((((((((X(((((((((((X !! ! ! ! !!!!!(X%%%%%%%%%%(X%%%%%%%%%%(X&%&&&<<&&%&%&%&%&(X* && & &@@ & &&&&& &(X&&&&NN&&&&&&(&&&&OO&&&&&&(&&&&NN&&&&&&h|(XC l'{'l'l'qql'l'{'{'{'{'(X{'{'{'{'{'{'{'{'{'{'({'{'{'{'{'{'{'{'{'{'({'{'{'{'{'{'{'{'{'{'({'{'{'{'{'{'{'{'{'{'(XD''''''''''(X''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(''''''''''(d(d(d()d(d(d(d(d(d((X!&R&!&!&DD!&!&R&R&R&R&(XR&R&R&R&R&R&R&R&R&R&`(X8R&S&R&R&R&R&S&S&S&S&7}(X&&&&&&&&&&(X&&&&&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(&&&&NN&&&&&&(''''''''''(''''''''''`(X8''''''''''7}(X'(''77''(((((X(((((((((((((((DD(((((((((((EE(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((EE(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((EE(((((((((((EE(((((((((((DD(((((((((((EE(((((((((((EE(((((((((((DD(((((((((((EE(((((((Xpu((u(u(u(u((((((X''''''''''(X~((~(~(MM~(~((((((X(((((((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((((((QQ(((((((X^(_(^(^(^(^(_(_(_(_((X_(_(_(_(_(_(_(_(_(_((_(_(_(_(_(_(_(_(_(_((_(_(_(_(_(_(_(_(_(_((_(_(_(_(_(_(_(_(_(_((_(_(_(_(_(_(_(_(_(_((X_(`(_(_(_(_(`(`(`(`((XȠ{(({({(MM{({((((((X,(((((((((((X:(((((((((((XB(((((((((((X((((((((((((((((((((((X((((__(((((((s&(&'&&'(''(X''''((''''''(X&&&&&&&&&&(Xơ5N5555NNNN(XCGCC**CCGGGG(XGGGGGGGGGG(GGGGHHGGGGGG(X GHGGHHGGHHHH(X) ))))) ) ) ) )(n )>* ) ) ) )>*>*>*>*(n))))aa))))))h|(XC))))aa))))))(X)C)))))C)C)C)C)(Xx?))?)?)?)?)))))(X~))))))))))(X))))))))))())))))))))(X))))))))))(X))))))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))())))dd))))))(X))))dd))))))a(XģV)Z)V)V)V)V)Z)Z)Z)Z)(X))))))))))(Xң))))))))))(X))))))))))())))))))))())))))))))())))))))))(X))))))))))(X))))99))))))(X * * * * * * * * * *( * * * * * * * * * *(Z*Z*Z*%+Z*Z*Z*Z*Z*Z*(M * * *[* * * * * * *(X)p)))))p)p)p)p))(Xm)m)m)m)m)m)m)m)m)m)(m)m)m)m)m)m)m)m)m)m)(XФ))))))))))(X))))))))))())))))))))())))))))))())))))))))(l)l)l)l)@@l)l)l)l)l)l)(Xk)l)k)k)<<k)k)l)l)l)l)(Xl)l)l)l)l)l)l)l)l)l),nf*G1S@f*f*f*f*G1G1G1G1|*G1G1G1G1G1G1G1G15}(nf*G1G1G1G1G1G1G1G1G1(nf*,f*f*f*f*****(*n*t1*t1***t1**(-**t1*t1***t1**(--*t1*t1***t1**(+-t*s1t*s1ur1r1t*s1r1r1(+!u*u*u**u*u*u*u*u*u*(q*q*q*q*aaq*q*q*q*q*q*`(X8fq*r*q*q*aaq*q*r*r*r*r*7}(Xn{,|,{,{,{,{,|,|,|,|,(Xv,,,,,,,,,,(X,,,,,,,,,,(,,,,FF,,,,,,(,,,,FF,,,,,,(,,,,FF,,,,,,(,,,,FF,,,,,,(,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( 5,,,,F,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,( ,,,,FF,,,,,,`(X8 ,,,,FF,,,,,,7}(X0s,s,s,s,s,s,s,s,s,s,(0s,s,s,s,s,s,s,s,s,s,(0s,s,s,s,s,s,s,s,s,s,(0s,s,s,s,s,s,s,s,s,s,(0s,s,s,s,s,s,s,s,s,s,(X1,,,,,,,,,,(X1,,,,,,,,,,,(X1,,,,,,,,,,`(X82P,8-,,,,8-8-8-8-7}(s2d,8--7---,,,,(X2,,,,,,,,,,(X2,,,,,,,,,,(X2,,,,TT,,,,,,,(X3,,,,,,,,,,(X3----------(s3D -Q-8-Q-8-8- -&- - -(X3" -- - -@@ - -----(X30*-I-*-*-*-*-I-I-I-I-(X3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_abcdefghijklmnopqrstuvwxyz{|}~3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(3I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4I-I-I-I-I-I-I-I-I-I-(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,,,,,,,(4,,,,AA,,,,,,(4,,,,,,,,,,(X4t,,,,,,,,,,,(X4?;-;-;-z-;-;-;-;-;-;-(X5|----mm------(X5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5----------(5---.@------(5----00------(5----00------(5----00------(6----00------(6^,^,^,_,0_,_,^,^,^,^,(X6^,_,^,^,^,^,_,_,_,_,(X6----0------(X6-----------(X7;-~-;-;-ZZ;-;-~-~-~-~-;-(X7~-~-~-.~-~-~-~-~-~-(X8 -+S+-+-+vv-+-+S+S+S+S+(X8rS+T+S+S+S+S+T+T+T+T+(X8T+T+T+T+T+T+T+T+T+T+(X9z++++++++++(X9 ++++++++++y(X9++++++++++(X9++++++++++(9++++pp++++++(9++++qq++++++(9++++qq++++++(9++++qq++++++(9++++pp++++++(9++++qq++++++(9++++qq++++++(X9,,,,,,,,,,(X9,,,,,,,,,,(9,,,,,,,,,,(X:&-(-&-&-&-&-(-(-(-(-(X:(-(-(-(-(-(-(-(-(-(-(X;,,,,ZZ,,,,,,(X;---/------(X@U+W+U+U+uuU+U+W+W+W+W+(XA-+f+-+-+vv-+-+f+f+f+f+(XAf+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(Af+f+f+f+f+f+f+f+f+f+(XA(f+n+f+f+f+f+n+n+n+n+f+(XA>i++i+i+i+i+++++(XA++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(A++++++++++(XB|++|+|+55|+|+++++(XB----------(nB-.----....(XB----------(XC----------(C----------(XC----------(XC----aa------(XD----aa------8 (XE- .---- . . . .-(XE.G.....G.G.G.G.(XEj.#...66..#.#.#.#.(XFQ.S.Q.Q.Q.Q.S.S.S.S.(XGR..R.R.R.R.....R.(XCG2-.----....-(XG..........`(X8G...............7}(XG .. . . . .....(XG=.?.=.=.=.=.?.?.?.?.(XI....cc......(XL..........(XL..........(XM..........(XM ..........`(XN".#/....#/#/#/#/(XN..........(XN..........(XN..........(XN..........(XO,/8/,/,/,/,/8/8/8/8/(XO,/:/,/,/,/,/:/:/:/:/,/(XO9/9/9/9/9/9/9/9/9/9/(XO9/c/9/9/9/9/c/c/c/c/(XO Y/a/c/c/c/c/b/b/b/b/`(X8Ptb//b/b/b/b/////7}(XP=/=/=/=/!!=/=/=/=/=/=/(P=/=/=/=/!!=/=/=/=/=/=/(P / / / / > > > > (XF> > > > > > > > > > (F> > > > II> > > > > > (F> > > > > > > > > > (F> > > > > > > > > > (F> > > > ##> > > > > > (XF"' 9     9 9 9 9 (XF9 9 9 9 9 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (F9 9 9 9 669 9 9 9 9 9 (F9 9 9 9 779 9 9 9 9 9 (XFz'9 = 9 9 9 9 = = = = (3XF,r r r r r r r ]A~(X0F'` d ` ` ` ` d d d d 6(XFd d d d d d d d d d (Fd d d d d d d d d d (Fd d d d d d d d d d (Fd d d d d d d d d d (XF'n n n n n   (XF'     (XF'     (XF'        (XF( #     # # # # (XF# # # # # # # # # # (F# # # # # # # # # # (F# # # # # # # # # # (F# # # # # # # # # # (F# # # # # # # # # # (XF# % # # # # % % % % # (XFH(m m m  m m   (XFt(  ,,   (XF     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (F     (XF(   (XFu u u u ''u u u u u u (XF(++(XF0//(XF(XF(XF(6D6666DDDD(XFDDDDDDDDDD(FDDDDDDDDDDDD(FDDDDEEDDDDDD(XF)6N6666NNNN(XFNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(FNNNNNNNNNN(XCFJ)NONNNNOOOON(XFOOOOOOOOOO(FOOOOOOOOOO(FOOOOOOOOOO(FOOOOOOOOOO(FOOOOOOOOOO(FOOOOOOOOOO(XFR)ddddd(XF(Ftt(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(F(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Ftt(Fss(Fss(Fss(Fss(Fss(Fss(Fss(Fss(F(Fss(Ftt(Fss(Fss(Fss(Fss(Fss(F(XF)CC(XF)(XF(F==(F==(F==(XF);C;;;;CCCC(XFCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(FCCCCCCCCCC(XF*<U<<<<UUUU(XF(XF (XF>*oooLLoo(XFj*XX(XF*     ,(XF          (F    FF      (F    FF      (F    FF      (F    FF      (XF*   GG  7}(XF*ENEEEENNNN(XF{{{{TT{{{{{{(XF*(XF8+(XF(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(XFn+(XF(XF|+(XF+FF(XF,(XF",(XF*,(XF:,     (XFL,(XFT,(XF(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F::`(X8F\,::7}(XF(F(FCCCCCCCCCC(FsDDDDDDDDD(FDDDDDDDDDD(XFd,(XFv,    (XF&&&&&&&&&&(sF(sF(XF~,(XF(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(XF,(XF(F??(F>>(F>>(F>>(XF,tt(XF(F(F(F(F(XF*-(XF8-~~(XFJ-^b^^cc^^bbbb(XFbbbbbbbbbb(Fbbbbzzbbbbbb(Fbbbb{{bbbbbb(F(XFX-(XF(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(F(XFp-66(XFx-(XF-;;(XF(FTT(FUU(FUU(XF-44444(XF(XF-^^(XF(F(F(F(F(F(F(F(F(XF-11111(sFWp0ZpZZ(sFe)u)f)f)f)f)f)f)f)f)(XF,4-,,,,3-3-3-3-(XF,,,,,,,,,,(XF.,-,,ww,,----,(XFf.,,,,^^,,,,,,(XF.,,,,,,,,,,(XF,,,,,,,,,,`(X8F.,-,,,,----7}(XF,,,s-,,,,,,(F,,,,,,,,,,(F,,,,,,,,,,(F,,,,,,,,,,(XF..........(XF//////////(nF/1////1111|*F.111111115}(n7F|/111111111(sFA0000000000(s F0000000000( F0000000000( F1111111111( F 8889888888(X0 FU68D868686868D8D8D8D8D(X0 FV9889898..98988888D(X F68886868686888888888(s F8o99p9998 988(X FW8888bg8888gg88(X F8888gg888888( F8888gg888888(X FW8888gg888888(X F8888888888( F8888888888( F8888888888( F8888888888( F8888888888( F8888888888( F8888888888( F8888888888( F8888888888( F8888888888(X0 FNW8888888888D(XFZW8988jj889999(XFW9999999999(XF9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdeghijklmnopqrstuvwxyz{|}~F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F9999999999(F8888888888(F8888888888(F8888888888(F8888==888888(XFW(XF(F@@(F@@(F@@(F??(F@@(F??(F@@(F@@(F@@(FSSSS^^SSSSSS(X:FW     (X:F          (X:FX    ??      (X:FX, 1 , , TT, , 1 1 1 1 (X:FF F F F F F F F F F 0(Fkzf0000000000(Fzf0000000000(Fzf0000000000(Fzf0000000000(FXzf X(FXzf(FXzfDX:??::::(FXzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fzf3333333333(Fszf      (FXzfXg p g g %%g g p p p p g (FXzfp p p p p p p p p p (FXzfXg h g g $$g g h h h h (FXzfg h h h h h h h h h 70(FXzfXs z s s s s z z z z (FXzfX  [[   (FXzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (FXzfXAA(Fzf     (FXzfX     (FXzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (Fzf     (FXzfY     (FXzf     (FXzfY     (FXzfY(FXzf&Y(FX7)|f4Y-@----@@@@-(FX|f@@@@@@@@@@(F|f@@@@@@@@@@(FX|f`Y@A@@@@AAAA(FX|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(F|fAAAAAAAAAA(n˹FUUUUU|*˹FhYUUUUUUUU9f(nX;˹Fe UUUUUUUUU(n˹F(X˹F3933339999(X˹F <<<(˹F(-˹F2&X&X&&&X&&#(--˹F(--˹FH(X˹F5655  5566665(X˹FȀhkhh]]hhkkkk(X˹Fkkkkkkkkkk(˹Fkkkkttkkkkkk(˹Fkkkkttkkkkkk(X˹FԀklkkttkkllll(X˹FYYYYYYYYYY(X˹F܀YZYYYYZZZZY(3X˹Fttt]A~(33˹F(-3˹Fimimiiimii(X˹F:A::::AAAA(X˹F^^^^ ^^^^^^(˹FAAAA AAAAAA(˹FAAAAAAAAAA(˹F-B-B-B-B-B-B-B-B-B-B(˹F-B-B-B-B-B-B-B-B-B-B(˹FBBBBBBBBBB(˹FBBBBBBBBBB(˹F+BBBBBBBBBB(˹F7777777777(˹F7777777777(X˹F.909.9.9.9.909090909(X˹F (˹F(X7)˹F(X˹F,X˹FC@(X˹F(˹Fii(˹F(X˹F"(X˹FH9339999(X˹FFOFF>>FFOOOO(X˹F\x\\\\xxxx\(X˹Fxxxxxxxxxx(˹Fxxxxxxxxxx(˹Fxxxxxxxxxx(X˹F|||||(X˹F(˹F(˹F(X˹F(X˹F|||||(X˹F(˹F(˹F(˹F(X˹F (X˹F%%(˹F%%(˹F%%(˹F%%(˹F%%(˹F&&(˹F%%(˹F&&(X˹F,X˹F$3G@3333(X˹F)))))(X˹F))))))))))(˹F))))**))))))(˹F))))))))))))(˹F))))**))))))(˹F))))))))))))(˹F))))**))))))(˹F))))**))))))(˹F))))))))))))(˹F))))))))))(˹F))))**))))))(X˹F2M22ee22MMMM2(X˹FMMMMMMMMMM(˹FMMMM**MMMMMM(˹FMMMM))MMMMMM(˹FMMMM))MMMMMM(˹FMMMM))MMMMMM(˹FMMMM**MMMMMM(˹FMMMM**MMMMMM(X˹Fނhkhhhhkkkkh(X˹F8l(˹F66666666660(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹(۹0(f .4(XfF(Xf(f(f(f(f(f(f(f00(f00(Xf`(Xfp(Xf#(Xft(f(f(f//(f00(f(f,X fC@ (Xf(Xf(f(f(f(f(f(f(f(f(Xfă(Xf70(f(f(f(f(f(Xf̃2<2222<<<<2(Xf@H@@@@HHHH@(Xf====mm======(Xf=>==mm==>>>>=(nf"""""|*f9e(n8f(Xf(Xf(ftt(ftt(ftt(Xfܫtt (Xf(Xf(f<<(f<<(f<<(Xf<<(Xf(Xf(f(f(f(f(Xfpqppppqqqq(Xfqqqqqqqqqq(fqqqqqqqqqq(f(Xf$(Xf(fAA(f@@(f@@(fAA(f@@(fAA(f@@(fAA(f@@(fAA(fAA(f@@(fAA(XfR(Xf(Xf66 (Xf(Xf22 (Xf(Xf]](Xfnn(Xfoo (Xfܬ11(Xf(f(f(f(f(f(f(f(Xf*-****----(Xf^^(Xf(f(f(f(f(f(Xf(Xf(f(f(f(f(f(f(f(f(f(f(f(f(f(f(f(f(Xf.     (XfH$)$$$$))))(XfX>E>>''>>EEEE(XfEEEEEEEEEE(fEEEEZZEEEEEE(fEEEEZZEEEEEE(fEEEEZZEEEEEE(fEEEEYYEEEEEE(fEEEEZZEEEEEE(fEEEEZZEEEEEE(XflEFEEZZEEFFFF(Xftcncc&&ccnnnn(Xfm}mm mm}}}}"(Xf}}}}}}}}}}(fkkkkXXkkkkkk(XfT d T T T T d d d d (Xfd d d d d d d d d d (fd d d d ddd d d d d d (fd d d d eed d d d d d (fd d d d d d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (fd d d d ddd d d d d d (Xfܭ     (Xf     (f     (f  yy   (f  yy   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (f  xx   (Xf"#""""####"(Xf##########(f####xx######(f####yy######(f####yy######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(f####xx######(Xf(####xx######(Xf0{:`@S#e#S#S#K#K#K#K#(Xf[#\#[#[#[#[#\#\#\#\#(Xf%%%%%%%%%%(Xf,&-&,&,&,&,&-&-&-&-&(Xf""""""""""(Xfį!!!!rr!!!!!!(Xf̯    SS      (Xf(f(f(f(f(f(f(Xfԯ  AA   (Xf1111K`1111KK11(Xfܯ2222222222(Xf75857575757585858585(XfR8S8R8R8R8R8S8S8S8S8(Xfd@e@d@d@d@d@e@e@e@e@(Xfe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@(fe@e@e@e@e@e@e@e@e@e@( f!888;888888( f8888888888( f8888aa888888(X f8888aa8888888(X f_:e:_:_:CC_:_:e:e:e:e:(X fe:e:e:e:e:e:e:e:e:e:( fe:e:e:e:uue:e:e:e:e:e:( fe:e:e:e:tte:e:e:e:e:e:( fe:e:e:e:uue:e:e:e:e:e:( fe:e:e:e:tte:e:e:e:e:e:( fe:e:e:e:uue:e:e:e:e:e:(X fe:f:e:e:uue:e:f:f:f:f:(n#f2222222222|*#f22222222(X#f2222222222(X#f2222222222(X#f2222222222(#f2222222222(#f2222222222(#f2222222222(#f2222222222(n$f5d65555d6d6d6d6|*$fd6d6d6d6d6d6d6d6($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555($f5555555555(%f5555555555(%f5555555555(n%f5555555555(n%f5556l555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(X%fX5555555555 (X%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(X%f`5555555555(X%f5555555555(%f5555555555(%f5555555555(%f5555555555(%f5555555555(X%fv5555555555 (X&f~5655556666(s&f56h66h6h65%655(s&f8%6%6%6\6t%6%6%6%6%6%6(&f5555  555555(&f5555  555555(&f5555  555555(X'fP6Q6P6P611P6P6Q6Q6Q6Q6(X'fO6O6O66O6O6O6O6O6O6(X'fO6Q6O6O6O6O6P6P6P6P6O6(X*fVAXAVAVA@@VAVAWAWAWAWA0(ki(ni(X j (sjt77(Xj(Xj(Xj  (Xj(j(j(j(j(j(j(j(Xk(Xk(+k+===(Xkff(Xk(-Xk]A~(Xk&#8##OO##8888(XlV#+##OO##++++#(Xl(Xll (slK^B^BB<X<<(sm6666666666(m6666666666(m6666666666(m6666666666(m6666666666(m6666666666(smN`R`RR (sm     (Xmvzzzzz(Xmyyyyyyyyyy(XmL`c````cccc(Xn(XnXEGEEEEGGGG(XnS%wGGGGGGGG(+n!!!!!!!(XoGHGGGGHHHH(Xobl0(Cp 6(CdG(C----------(C----------(C5555555555(XC7 !!7 7 7 7 (XCn6x6n6n6IIn6n6x6x6x6x6n6(XCx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(Cx6x6x6x6x6x6x6x6x6x6(nC6666666666(nC6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<666666(C6666<<6666660(FkSf//////////(FnTf//////////|*NTf////////(FnTfi`//////////(FXTf2+//////////(FXTf`/0////////(n& |*&:+ |*&~+9e(n:&(n& (& (&(&(+&'ZZZZZZZ(*+&(n&|*&S|*&TS9e(n:&(n&W|*&zW!` X!N &bjbj\\ &>>`>>XXX<$$$$D<0ګ $&&&&&&h&X&?,l:X$$JX `Ѷ$ k<Xt n.(&&^<<<syD!<<<y<<< 973-251-5968 FLEET BANK FAX October 6, 1997 TO: MARILYN FOGARTY, SENIOR SALES REPRESENTATIVE 973-251-5807 FR: JOSEPH J. PISANO RE: CREDIT CARD REGISTRATION MESSAGE: MARILYN, WE AER HAVING SOME DIFFICULTY WITH THE REGISTRATION PROCESS REQUIRED IN ORDER TO USE THE SOFTWARE TO VERIFY AND TO PROCESS CREDIT CARD ORDERS. WE GET AS FAR AS THE STEP REQUIRING US TO DIAL 1-800-569-9629. WE ARE FINDING THAT THE 800 NUMBER JUST KEEPS RINGING. WITHOUT ANY ANSWER, WE ARE UNABLE TO REGISTER OUR SOFTWARE AND TO PROCESS OUR CREDIT CARD ORDERS. PLEASE ADVISE ANY INSTRUCTIONS WE CAN FOLLOW SO THAT WE CAN REGISTER THE SOFTWARE AND PROCESS THE ORDERS WE HAVE AT THIS TIME. THANKS __________________________ PRICE SHEET FOR SEQUENTIALLY NUMBERED NCR RX FORMS NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72 NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72 NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72 NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72 NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72 PRICE SHEET FOR SEQUENTIALLY NUMBERED NCR RX FORMS Prices include UPS shipping but not 6% tax. NCR Sequential Numbers#RxsPRICE500$0.00 1000$81.24 2000$134.30 3000$188.90 4000$241.91 5000$284.15 10000$530.72   Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 Lincoln Park, New Jersey 07035 (973) 335-7832 ( FAX (973) 335-1591  ''njpbsN su'providing the the program 'i'easily opyour and at the same time, use R.ncrease your s TO: Sylvio FR: Joe RE: PLAIN AND PRE-PRINTED NJPBs MESSAGE: Sylvio, thank you for speaking with me about using Rx PROvisions, Inc. as a vendor to supply selected Schering physicians with pre-printed and plain NJPBs (New Jersey Prescription Blanks). NJPBs can be used as a value added strategy to help you build a stronger relationship with important and hard to see physicians who can help you to make your product sales budgets. NJ physicians must use these new Rx forms, so pre-printed NJPBs will be an easy way physicians can prescribe your products. And as an additional incentive to support Schering Products, you can supply the plain forms the physicians must use every day, which will add value to the service you are already providing. Schwarz Pharma products among your targetted physicians. First, the new Rx forms can only be provided by an approved vendor and Rx PROvisions, Inc. is an approved vendor. So we are in a position to recommend to you and to execute for you the Program we discussed, within the regulations established by the State of NJ. In addition, there are additional programs that can help your sales representatives build a perpetual, productive relationship with their physicians. Listed below is a quick review of the background issues followed by a description of the NJPB Program we discussed and two other options Background NJPB ISSUES: There are seven NJPB (New Jersey Prescription Blanks). Each form is for a different type of Healthcare provider. The NJPB that your physicians will use is enclosed so that you can see the colors on the front and on the back. The NJPBs are all supplied in pads of 100 Rx forms. Each form is printed on the back with a green PMS color with reversed out State Logos that bleed to all edges, and is trimmed to 4 x 5 . The front of the form has seven different copy variations printed in a Blue color with positive State seals that again bleed to all four sides. The personalized information on the form is printed in black ink. Rx PROvisions, Inc. is responsible for keeping a database for every healthcare provider and their re-order history, with all verification from the receipt of a signed order form, to the verification of delivery. Each form has a unique Batch number that changes each day. All NJPBs must be delivered to the healthcare providers address we have received from the State of NJ. If there are any address discrepancies, Rx PROvisions, Inc. will notify the healthcare provider. Then the healthcare provider notifies the medical examiners board. So the healthcare provider always knows where their Rx forms will be mailed. The mailing address does NOT have to be the same address we print on the Rx forms Pre-printed NJPB Program BUDGET: SCHWARZ PHARMA PAYS $23.10 plus 6% Tax ($1.39) = $24.49 for 500 Pre-printed Rx forms (5 Rx Pads of 100 Rxs per pad). Please refer to our NJPB Price list enclosed. SCHWARZ PHARMA will be charged $24.49 for each pre-printed order. The Pre-printed NJPB ORDER IS SENT DIRECTLY TO THE PHYSICIAN in accordance with the NJ State Law. INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount , will be sent to the Schwarz Pharma home office for payment. Payment for the invoice will be due within 30 days of the invoice date, payable to : Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 Each order will cost $24.49 which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order. All orders are sent directly to the NJ physician via UPS. Enclosed is an agreement for your review and comments. Lets discuss the above and the enclosures as soon as you are able. Were looking forward to providing this service for SCHWARZ PHARMA and we appreciate your business. Kindest regards, Joseph J. Pisano President jc. AGREEMENT 1. Rx PROvisions, Inc. will print on a demand basis, personalized preprinted NJPBs in pads of 100 Rx forms. The quantity of prescription forms will be a minimum of 500 Rx forms per order. 2. Each prescription form will be pre-printed with the Schwarz Pharma product logo selected by the Schwarz Pharma Sales Representative. 3. The Sales Representative will complete the NJPB Pre-printed Rx Pad Order Form. The order form and a voided Rx form from the physicians office will be enclosed in an envelope addressed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07082 4. Rx PROvisions, Inc. will print 500 personalized, preprinted NJ prescription forms per order (5 pads of 100 Rx forms/pad). 5. An order will be the receipt by Rx PROvisions, Inc., of an order for pre-printed prescription pads and a voided Rx form the physician is currently using. Orders from the sales representatives will be filled and shipped to each PHYSICIAN via UPS. DESCRIPTION: Rx PROvisions, Inc. will use black ink to print personalized, preprinted prescription forms. The front will also be printed in PMS 300 Blue and the back will be printed in PMS 333 Green in accordance with NJPB specifications. The PORTRAIT forms will be trimmed to 4 x 5 . Each Rx form will be personalized by using the physicians practice information on the voided prescription form AFTER IT HAS BEEN VERIFIED with the information in the NJ State database. The physicians license number and a unique BATCH number will be added to the personalization. Two physician names can appear on one Rx form. Any additional physician names will be determined by the size of the font. The State of NJ does not recommend font sizes below 8 points. The physicians DEA number DOES NOT have to appear on the NJ Rx Form, however; the physicians LICENSE NUMBER MUST appear on the NJ Rx Form. 6. Orders printed with incorrect information will be the responsibility of Schwarz Pharma. Orders printed incorrectly using correct information will be replaced at no cost to Schwarz Pharma. INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount, will be sent to the Schwarz Pharma home office for payment. Payment for the invoice will be due within 30 days of the invoice date, payable to: Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 Each order will cost $24.49, which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order. All orders are sent directly to the NJ physician via UPS. TERM and TERMINATION: This agreement shall be effective from _________________ and shall continue in effect until _________________, unless terminated by either Schwarz Pharma or by Rx PROvisions, Inc. effective thirty days after written notice to either party. The current price of $24.49 per order will remain in effect during the calendar year 1998 unless extraordinary costs have increased and can be verified by Rx PROvisions, Inc. Additional information required for the program is as follows: 1. Camera ready copy for the SCHWARZ PHARMA products and information Rx PROvisions, Inc. will use to pre-print each physicians prescription, in response to orders from the sales representatives. 2. The sales representatives name, address, city, state, zip, telephone number, territory number and the physicians name must be on all order forms sent by the sales representatives to Rx PROvisions, Inc. 3. The physicians Rx form must be enclosed with the order form. 4. A suggested sales representative order form appears on the following page of this letter. ______________________________ Joseph J. Pisano Date Rich Vossler Date President District Manager for Rx PROvisions, Inc. for SCHWARZ PHARMA (Suggested Order form for SCHWARZ PHARMA Sales Representatives) SCHWARZ PHARMA NJPB Preprinted Rx Pad Order Form Sales Representative Name and Complete Mailing Address (print or Stamp)  Name  Street Address  City State Zip Territory Number: ________________________________ Physician Name * (Print) _________________________________________ * If more than one physician name appears on the enclosed Rx form, print the physicians name that appears first. PRE-PRINT one of the following SCHWARZ PHARMADuring our recent telephone conversation, we discussed the use the New Jersey Prescription Blanks as a tactic to help your Sales reps build a stronger relationship with important healthcare providers and at the same time increase the use of Schering products among your targetted physicians. stronger relationship with important and hard to see physicians who can help you to make your product sales budgets. NJ physicians must use these new Rx forms, so pre-printed NJPBs will be an easy way physicians can prescribe your products. And as an additional incentive to support Schering Products, you can supply the plain forms the physicians must use every day, which will add value to the service you are already providing. First, the new Rx forms can only be provided by an approved vendor and Rx PROvisions, Inc. is an approved vendor. And we are also a vendor for Schering. So we are in a position to recommend to you and to execute for you the Program we discussed, within the regulations established by the State of NJ. In addition, there are additional programs that can help your sales representatives build a perpetual, productive relationship with their physicianstheir stronger relationship with physicians build aIn addition, there are additional programs that can help your sales representatives. and two other options There are seven NJPB (New Jersey Prescription Blanks). Each form is for a different type of Healthcare provider. The NJPB that your physicians will use is enclosed so that you can see the colors on the front and on the back. The NJPBs are all supplied in pads of 100 Rx forms. Each form is printed on the back with a green PMS color with reversed out State Logos that bleed to all edges, and is trimmed to 4 x 5 . The front of the form has seven different copy variations printed in a Blue color with positive State seals that again bleed to all fourThe front of the form has seven different copy variations printed in a Blue color with positive State seals that again bleed to all four sides. The personalized information on the form is printed in black ink. Rx PROvisions, Inc. is responsible for keeping a database for every healthcare provider and their re-order history, with all verification from the receipt of a signed order form, to the verification of delivery. Each form has a unique Batch number that changes each day. All NJPBs must be delivered to the healthcare providers address we have received from the State of NJ. If there are any address discrepancies, Rx PROvisions, Inc. will notify the healthcare provider. Then the healthcare provider notifies the medical examiners board. So the healthcare provider always knows where their Rx forms will be mailed. The mailing address does NOT have to be the same address we print on the Rx forms Pre-printed NJPB Program BUDGET: SCHERING PAYS $23.10 plus 6% Tax ($1.39) = $24.49 for 500 Pre-printed Rx forms (5 Rx Pads of 100 Rxs per pad). Please refer to our NJPB Price list enclosed. SCHERING will be charged $24.49 for each pre-printed order. The Pre-printed NJPB ORDER IS SENT DIRECTLY TO THE PHYSICIAN in accordance with the NJ State Law. INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount , will be sent to the Schering home office for payment. Payment for the invoice will be due within 30 days of the invoice date, payable to : Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 Each order will cost $24.49 which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order. All orders are sent directly to the NJ physician via UPS. Enclosed is an agreement for your review and comments. Lets discuss the above and the enclosures as soon as you are able. Were looking forward to providing this service for SCHERING and we appreciate your business. Kindest regards, Joseph J. Pisano President jc. AGREEMENT 1. Rx PROvisions, Inc. will print on a demand basis, personalized preprinted NJPBs in pads of 100 Rx forms. The quantity of prescription forms will be a minimum of 500 Rx forms per order. 2. Each prescription form will be pre-printed with the Schering product logo selected by the Schering Sales Representative. 3. The Sales Representative will complete the NJPB Pre-printed Rx Pad Order Form. The order form and a voided Rx form from the physicians office will be enclosed in an envelope addressed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07082 4. Rx PROvisions, Inc. will print 500 personalized, preprinted NJ prescription forms per order (5 pads of 100 Rx forms/pad). 5. An order will be the receipt by Rx PROvisions, Inc., of an order for pre-printed prescription pads and a voided Rx form the physician is currently using. Orders from the sales representatives will be filled and shipped to each PHYSICIAN via UPS. DESCRIPTION: Rx PROvisions, Inc. will use black ink to print personalized, preprinted prescription forms. The front will also be printed in PMS 300 Blue and the back will be printed in PMS 333 Green in accordance with NJPB specifications. The PORTRAIT forms will be trimmed to 4 x 5 . Each Rx form will be personalized by using the physicians practice information on the voided prescription form AFTER IT HAS BEEN VERIFIED with the information in the NJ State database. The physicians license number       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~and a unique BATCH number will be added to the personalization. Two physician names can appear on one Rx form. Any additional physician names will be determined by the size of the font. The State of NJ does not recommend font sizes below 8 points. The physicians DEA number DOES NOT have to appear on the NJ Rx Form, however; the physicians LICENSE NUMBER MUST appear on the NJ Rx Form23.10 plus 6% Tax ($1.39) . and = $24.49 for 500 Pre-printed Rx forms rThe price for the pre-printed Rx pads i(5 Rx Pads of 100 Rxs per pad). Please refer to our NJPB Price list enclosed. PAYS 24.49pre-printed [ahome office for payment.Each order will cost $24.49 which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). sALESSEnclosed is an agreement for your review and comments. LLets discuss the above and the enclosures as soon as you are able. Lets discuss the above and the enclosures as soon as you are able. Were looking forward to providing this service for SCHERING and we appreciate your business. Kindest regards, 500 Rx forms and/500 (5 pads of 100 Rx forms/pad). pre-printed INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount, will be sent to the Schering home office for payment. Payment for the invoice will be due within 30 days of the invoice date, payable to: Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 Each order will cost $24.49, which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order. All orders are sent directly to the NJ physician via UPS. 24.49per order Additional information required for the program is as follows: The physicians Rx form must be enclosed with the order form. 4. A suggested sales representative order form appears on the following page of this letter. Rich Vossler5COLYTE COLYTE FLAVORED EDEX LEVBID NASCOBAL  NIFEREX-150 NIFEREX-150 FORTE PROCTOCREAM 2.5 HC  UNIVASC-hOUR  CLARITIN d 24 Hour d7. AMEX MASTERCARD VISA DISCOVER 7. Charge Order to my credit card: AMEX MASTERCARD VISA DISCOVER AMEX MASTERCARD VISA DISCOVER AMEX MASTERCARD VISA DISCOVER Charge Order to my credit card: 7. FAX 973-927-2797 TO: Sylvio FR: Joe RE: PLAIN AND PRE-PRINTED NJPBs MESSAGE: Sylvio, thank you for speaking with me about using Rx PROvisions, Inc. as a vendor to supply selected Schering physicians with pre-printed and plain NJPBs (New Jersey Prescription Blanks). NJPBs can be used as a value added strategy to help you build a perpetual, productive relationship with your important and hard to see physicians who can help you to make your product sales budgets. NJ physicians must use these new Rx forms, so pre-printed NJPBs will be an easy way physicians can prescribe your products. And as an additional incentive to support Schering Products, you can supply the plain forms the physicians must use every day, which will add value to the service you are already providing. First, the new Rx forms can only be provided by an approved vendor and Rx PROvisions, Inc. is an approved vendor. And, we are also a vendor for Schering. So we are in a position to recommend to you and to execute for you the Program we discussed, within the regulations established by the State of NJ. Listed below is a quick review of the background issues followed by a description of the NJPB Program we discussed: Background NJPB ISSUES: There are seven NJPB (New Jersey Prescription Blanks). Each form is for a different type of Healthcare provider. The NJPB that your physicians will use is enclosed so that you can see the colors on the front and on the back. The NJPBs are all supplied in pads of 100 Rx forms. Each form is printed on the back with a green PMS color with reversed out State Logos that bleed to all edges, and is trimmed to 4 x 5 . The front of the form has seven different copy variations printed in a Blue color with positive State seals that again bleed to all four sides. The personalized information on the form is printed in black ink. Rx PROvisions, Inc. is responsible for keeping a database for every healthcare provider and their re-order history, with all verification from the receipt of a signed order form, to the verification of delivery. Each form has a unique Batch number that changes each day. All NJPBs must be delivered to the healthcare providers address we have received from the State of NJ. If there are any address discrepancies, Rx PROvisions, Inc. will notify the healthcare provider. Then the healthcare provider notifies the medical examiners board. So the healthcare provider always knows where their Rx forms will be mailed. The mailing address does NOT have to be the same address we print on the Rx forms Pre-printed NJPB Program BUDGET: The price break on the enclosed order form we use with physicians is enclosed. The price per pad at the 10,000 Rx level, less the 10% discount amounts to $1.88 per pad of 100 Rx forms. SCHERING will pay $1.88 per pad of 100 Rx forms per pad. The price includes everything (packing, handling, UPS postage, 6% Tax). The minimum number of Rx pads per order is 20 Rx pads. Pre-printed Rx pads are provided at no additional cost. SCHERING will be charged $37.60 for each order. The Plain and/or Pre-printed NJPB ORDER IS SENT DIRECTLY TO THE PHYSICIAN in accordance with the NJ State Law. INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount , will be sent to the appropriate Schering manger you designate. Payment for the invoice will be due within 30 days of the invoice date, payable to : Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order if you wish. All orders are sent directly to the NJ physician via UPS. PAYMENT OPTION Sales Representatives may pay for their orders with their Credit Cards if the budget has been delegated to the Regional level. Lets discuss the above and the enclosures as soon as you are able. Were looking forward to providing this service for SCHERING and we appreciate your business. Joseph J. Pisano President jc. AGREEMENT 1. Rx PROvisions, Inc. will print on a demand basis, personalized preprinted NJPBs in pads of 100 Rx forms. The quantity of prescription forms will be a minimum of 20 Rx pads per order. 2. Each prescription form will be plain or pre-printed with the Schering product logo selected by the Schering Sales Representative. 3. The Sales Representative will complete the NJPB Pre-printed Rx Pad Order Form. The order form and a voided Rx form from the physicians office will be enclosed in an envelope addressed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07082 4. Rx PROvisions, Inc. will print 20 personalized, plain or preprinted NJ prescription forms per order. 5. An order will be the receipt by Rx PROvisions, Inc., of an order for a minimum of 20 prescription pads and a voided Rx form the physician is currently using. Orders from the sales representatives will be filled and will be shipped to each PHYSICIAN via UPS. DESCRIPTION: Rx PROvisions, Inc. will use black ink to print personalized, preprinted prescription forms. The front will also be printed in PMS 300 Blue and the back will be printed in PMS 333 Green in accordance with NJPB specifications. The PORTRAIT forms will be trimmed to 4 x 5 . Each Rx form will be personalized by using the physicians practice information on the voided prescription form AFTER IT HAS BEEN VERIFIED with the information in the NJ State database. The physicians license number and a unique BATCH number will be added to the personalization. Two physician names can appear on one Rx form. Any additional physician names will be determined by the size of the font. The State of NJ does not recommend font sizes below 8 points. The physicians DEA number DOES NOT have to appear on the NJ Rx Form, however; the physicians LICENSE NUMBER MUST appear on the NJ Rx Form. 6. Orders printed with incorrect information will be the responsibility of Schering. Orders printed incorrectly using correct information will be replaced at no cost to Schering. INVOICE: The invoice along with a report to include the name of the sales rep, the date of the order, the name of the physician, the product logos pre-printed on the order, and the dollar amount, will be sent to the Schering home office for payment. Payment for the invoice will be due within 30 days of the invoice date, payable to: Rx PROvisions, Inc. Payment will be mailed to: Rx PROvisions, Inc. PO Box 398 Lincoln Park, NJ 07035 Each order will cost $24.49, which includes everything (printing, packaging, UPS shipping and 6% NJ State Tax). The district managers will receive a copy of the same invoice and report, along with a tear sheet from each physicians Rx Pad order. All orders are sent directly to the NJ physician via UPS. TERM and TERMINATION: This agreement shall be effective from _________________ and shall continue in effect until _________________, unless terminated by either Schering or by Rx PROvisions, Inc. effective thirty days after written notice to either party. The current price of $1.88 per pad will remain in effect during the calendar year 1998 unless extraordinary costs have increased and can be verified by Rx PROvisions, Inc. Additional information required for the program is as follows: 1. Camera ready copy for the SCHERING products and information Rx PROvisions, Inc. will use to pre-print each physicians prescription, in response to orders from the sales representatives. 2. The sales representatives name, address, city, state, zip, telephone number, territory number and the physicians name must be on all order forms sent by the sales representatives to Rx PROvisions, Inc. 3. The physicians Rx form must be enclosed with the order form. 4. A suggested sales representative order form appears on the following page of this letter. ______________________________ Joseph J. Pisano Date Date President District Manager for Rx PROvisions, Inc. for SCHERING (Suggested Order form for SCHERING Sales Representatives) SCHERING NJPB Preprinted Rx Pad Order Form Sales Representative Name and Complete Mailing Address (print or Stamp)  Name  Street Address  City State Zip Territory Number: ________________________________ Physician Name * (Print) _________________________________________ * If more than one physician name appears on the enclosed Rx form, print the physicians name that appears first. PRE-PRINT one of the following SCHERING product LOGOS on each of the 20 Rx pads (100 Rxs per pad) in the order:   CLARITIN D 24 Hour CLARITIN SYRUP 5. Signature of person authorized to order NJPBs:  6. Print Name 7. Charge Order to my credit card: AMEX MASTERCARD VISA DISCOVER ACCOUNT NUMBER EXPIRATION DATE 8. The order(s) will be shipped via UPS to the Healthcare Providers mailing address. Mail this completed form along with the physicians prescription form in an envelope addressed to  Rx PROvisions, Inc. PO Box 398 Lincoln Park, New Jersey 07035 Joseph J. Pisano President (973) 335-7832 ATTACH ONE PRESCRIPTION FORM to this ORDER fORM RXP112297  Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 Lincoln Park, New Jersey 07035;cCOMPANY FAX TO FAX FAX FAX TO :fForFAX TO:_______________________ Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 FAX FAX :_________________________Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 Lincoln Park, New Jersey 07035 (973) 335-7832 ( FAX (973) 335-1591   TO FAX #___________________________ TO FAX #____TO FAX #_________________ TO FAX # ( _) _____________ # ( _)# ( _)# ( _)_) ____________) ____________) ___________) ____________c C_m COVER PLUS ALL PAGESTOTAL PAGES FAXED TOTAL PAGES FAXED Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 (973) 335-7832 ( FAX (973) 335-1591 __________________________________________________________ __________________________________________________________ ___________________________________________________________ _________________________________________________________ ______________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ _________________________________________________________ ______________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ _________________________________________________________ ______________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ _ ________________________________________________________ ______________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ ________________________________________________________ ______________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ ________________________________________________________ _ _____________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 Lincoln Park, New Jersey 07035 (973) 335-7832 ( FAX (973) 335-1591 )___________________:_______________________ _______________________:_____________________ COMPANY u_________________________________________MESSAGE:________________________________________________ _____________________________________________________________________________________________________________________________________________________________________________ ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ MESSAGE MESSAGE 'u w7722687316Liz ImmedicenterrDept. Cons. Affairs0p(rot.in order to keep letter The order for NJPBs is scheduled for delivery today. Tracking number is: 1Z E89 1E2 03 1002 130 9. UPS phone number is: 1-800-742-5877. As a contingency, an additional 1,000 NJPB forms will be printed for Dr. Schran for each office location and will be shipped on Monday March 9, 1998. ...... 51 Rob FreebergSchering Tracey Sears, Doug Conetta, Derek Kish MESSAGE: Thank you for meeting with me today to discuss the action required to get the 1998 One to One Program and the Pre-printed Program started. The following 4 pages is a summary of the meeting and the action (as I understand it) that needs to be taken in order to move ahead. I know you will be travelling quite a bit so I will follow up with you when you are available. Thanks again for your continued interest and support! Regards.. ____________________ ____________ MESSAGE: MESSAGE: ( 908) 298-4690 [...Please...Joseph Pisam 4March 16, 1998 Robert M. Raleigh, Jr.Braintree Laboratories Preprinted Program Proposal follows Let me have your comments at your earliest Regards. MESSAGE: ___________ MESSAGE: MESSAGE: MESSAGE: ___________: 1 _1____________________________________________rvthr 270 Centre Street Holbrook, MA 02343 to arrange for hip the orders we havRob, thank you for speaking with me about the remaining orders we have in process that we received prior to February 25th. You requested that we complete these orders and when they are completed, you want us to call Rick Landers at 1-800-874-6756 for him to arrange pick up of these orders. I understand that Rick is located at: BRAINTREE Laboratories 270 Centre Street Holbrook, MA 02343 A copy of my last invoice follows on the next page. An invoice for the orders referenced above will follow under separate cover along with any orders we have not completed. You requested that we complete these orders and when they are completed, you want us to call Rick Landers at 1-800-874-6756 for him to arrange pick up of these orders. I understand that Rick is located at: BRAINTREE Laboratories 270 Centre Street Holbrook, MA 02343 A copy of my last invoice follows on the next page. An invoice for the orders referenced above will follow under separate cover along with any orders we have not completed. 270 Centre Street Holbrook, MA 02343 270 Centre Street Holbrook, MA 02343 1: 2 : 2 ocessif the following invoice ain... R. RaleighBRAINTREE Labs781-843-7932 2L. FetherbaystrdStu, thanks for speaking with me today about the production work I will need. The following is a Confidentiality Agreement for your review. When we meet next week on Wednesday April 1st or on Friday April 3rd, lets sign the agreement and proceed to address the production I will need. now and possiblySpaces have beenfor re Rob, thank you for speaking with me today about the remaining orders we have in production that we received prior to February 25th. You requested that we complete these orders and when they are completed, you want us to call Rick Landers at 1-800-874-6756 for him to arrange pick up of these orders. I understand that Rick is located at: BRAINTREE Laboratories 270 Centre Street Holbrook, MA 02343 A copy of my last invoice follows on the next page. Please let me know when the invoice will be paid. An invoice for the orders referenced above will follow under separate cover along with any orders we have not completed. You can call me at any time. Regards g'sc. ...Im looking forward to meeting the owner of The Georgian Press who you may use to produce some or all of my production needs. Thanks again and I look forward to speaking with you soon. Regards 212-255-5303 7March 27, 1998S. DiamondGeorgian PressK. Olendervscvausecenters 'responded to su''. request padded and shorderStu, thanks for speaking with me today about the production work I will need. The following is a Confidentiality Agreement for your review. When we meet next week on Wednesday April 1st or on Friday April 3rd, lets sign the agreement and proceed to address the production I will need. I will bring with me a Completed Confidentiality Agreement with the blanks filled in. Im looking forward to meeting the owner of The Georgian Press who you may use to produce some or all of my production needs. T MESSAGE: We recently processed 9 orders for Bryna Edgington and 7 orders for Ron Cure. Bryna called recently because her physicis had not received their pre-printed Rx pads. So I called production and they told me everything had been printted but that the porders had not yet been shipped. Aparently our finance department put a hold on shipping because no payments had been received yet from Schwarz Pharma. Our company is divided into three areas , each with equal business influence. These three areas of responsibility keep the company in balance. I have not left a voice mail message for Bryna yet because you may wish to advise your NJ Sales Representatives that their orders are being processed and printed but are on hold until the company pays Rx PROvisions. Let me know if you need any other information. Ill let you know when we receive payment and when the orders have shipped, Ill have tear sheets for you for the March report and invoice. hanks again and I look forward to speaking with you soon. Regards ____________ Thanks again and I look forward to speaking with you soon. Regards ____________ Let mepMESSAGE: We recently processed 9 orders for Bryna Edgington and 7 orders for Ron Cure. Bryna called recently because her physicians had not received their pre-printed Rx pads. So I called production and they told me everything had been printted but that the orders had not yet been shipped. Apparently our finance department put a hold on shipping because no payments had been received yet from Schwarz Pharma. Our company is divided into three areas , each with equal business influence. These three areas of responsibility keep the company in balance. I have not left a voice mail message for Bryna yet because you may wish to advise your NJ Sales Representatives that their orders are being processed and printed but are on hold until the company pays Rx PROvisions. Let me know if you need any other information. Ill let you know when we receive payment and when the orders have shipped, Ill have tear sheets for you for the March report and invoice. t . Tc ,irfor the Month of Ill sendto have tear sheets for you for the March report An invoice anand invoice.# 732-919-1425 1Schwarz Pharma 5. VosslerCC: ntq00td... We recently processed 9 orders for Bryna Edgington and 7 orders for Ron Cure. Bryna called recently because her physicians had not received their pre-printed Rx pads. So I called production to follow up for her and they told me everything had been printed but that the orders had not yet been shipped. Apparently our finance department put a hold on shipping because no payments had been received yet from Schwarz Pharma. Our company is divided into three areas, each with equal business influence and these three areas of responsibility keep the company in balance. I have not left a voice mail message for Bryna yet because you may wish to advise your NJ Sales Representatives that their orders are being processed and printed but are on hold until the Company pays Rx PROvisions. Let me know if you need any other information. Ill let you know when we receive payment and when the orders have shipped. When our production department provides the tear sheets for my department, we will prepare a monthly report for you to reflect order activity for the month of March. Then an invoice will be sent to the home office for the orders we have processed since our last report. Thanks again and I look forward to speaking with you soon. Regards lcifpte April 6, 1998 4908-298-4690Rob Freeberg4071eringPayment for the Re-Orders sent to Claritin PhysiciansJune 8, 1998 # SP-980608MESSAGE:eRob, thanks for speaking with me this afternoon about the payment for the Re-Orders we sent to Claritin Physicians at the request of Tracey Sears and Shaun Urban. The signed contract from Tracey Sears, the PO from Compas and the Invoice dated February12, 1998 follow. for your help. If you can, please let us know when the check will be sent to Rx PROvisions, Inc. thanks H Thanks and best regards 2Suzanne Schuetze x5445Schwarz Pharma'Invoice # SP-980608 dated June 8, 1998thtoeanother order for anSuzanne, just a message to remind you to send the invoice to Evelyn for payment. Evelyn has not received it yet. Hope you are feeling better. If this ' rosays The order will ship via UPS and UPS tells us that there is a one day turn around So I felt that a written appology was necessary. is 414-238-0961July ne 23, 1998 pe201-439-1208115LaurenDr. M. De AntoniocOrder for NJPBsmMLetter Dated July 29, 1998 and Enclosure ...Lauren, thank you for your follow up call yesterday. Your order was sent to production on Friday, June 19th. So when you called last week for the status of your order, I contacted the production manager who told me all of the orders had been shipped. During a meeting today, I learned that your order was packed and ready for shipment today. So I felt that a written apology was necessary. The order will ship via UPS today, and UPS tells us that their service gives us a one day turn around time. I will enter a complimentary order for your office so that you will always have an extra supply of Rx forms in inventory the next time you order. Please let me know if this offer is acceptable because I need approval from you in order to have NJPBs printed. erithourwe July 29, 1998Melanie FaganW. B. Saunders Company FROM: J. Pisano COMPANY: Rx PROvisions, Inc. Our Telephone conversation this morning Melanie, three pages follow 'dclient please send/fax any information you can provide about the exclusive marketing rights for the purposes that Rx PROvisions, Inc. intends to pursuei.and cdprinting 73-215-238-84959cCraig BarbaroC. B. Printing and Graphics4201-847-0899Confidentiality Agreementyou needCraig, a confidentiality agreement follows for your review and approval. Lets try to meet at the Phoenix Diner in Oakland next week to discuss the production that my business requires. next our Dave CorbyACTION Graphics3SICPA Thermal sensitive InkDave, see the attached info on SICPA, 800 number etc. Let me know if I can provide any other assistance. Please call me with any questions you may have and I look forward to hearing from you soon to confirm our next meeting. Thanks and best regards2872-9494d'us 973-335-609411Diane.Order Form for NJPBsfndaa''itha that I wanted to sDiane, your phone was busy this morning when we returned your call. We will continue to try to reach you today. We will be in the office until 12 noon and then back again by 1pm if you get a chance to call us as well. S peak with you soon. ...alotvTheres more to it Kurt GravesASTRAndOnAdditional Thoughts fa'aKurt, just had some additional thoughts about Prilosec to share with you. I will call you on Friday Oct 2nd @ 10:15am to discuss page 2. There is also another new medium that I will share with you soon that may allow you to promote to consumers while they are in the waiting room and at the same time allow them to interact with the promotion and to build consumer contacts. It can do a lot more and Im getting more info that I will share with you later. '>ccAstra Contacts: Astra Contacts: Astra Contacts: Astra Contacts: Astra Contacts: ' Solutions Partners = Promotion Managers Solutions Partners = Promotion Managers Solutions Partners = Promotion Managers Solutions Partners = Promotion Managers ____________ ____________610-695-1162September 29, 1998ptfMeeting 1pm Friday Oct.2nd (Willys)...aMike, I spoke with John and he said he is available on Friday to meet with us. If I made contact with Astra on Friday morning and I have answers to the questions I sent to you and John Ill bring them with me. I will also bring my One to One box and perhaps we can discuss a little more about your service so that I can ask the right questions and begin to open some doors for you as well. John said we can meet at Willys. Is that ok with you? Let me know. Thanks and best regards Astra Contacts: GI 1. Marianne Jackson Commercial Team Leader for H199 2. Mark Mallon Commercial Team Leader for Prilosec 3. Randy Price Commercial Team Leader for Prilosec OTC 4. Sharon Debbaco Prilosec OTC Patient Program Leader Other Rick Skelly Bextra Josh Tarnoff Plendil ? Atacand Rick Fanto Respiratory Solutions Partners = Promotion Managers 92973-884-2487bENMatt McKennaThomas Ferguson Assoc.SPECIFICATIONS b......Matt, the specifications you requested follow on the next page. When the new production material is ready, please send it to our address above Regards. If you need anything else, just call.Regards. 410-672-32934 13Ben OcasioINFORMATION iw... or should wprint the locationofficeBen, three pages follow. Just let me know how I can help. If you need anything else, just call. Kindest regards ________ p I864-292-3883 1October 22, 1998 DATE: February 23, 1999 TO: Vickie Currin COMPANY: NOVO NORDISK TVickie CurrinNOVO NORDISKrRegional Diabetes'rxprov@aol.com... HYPERLINK mailto:rxprov@aol.com rxprov@aol.com HYPERLINK mailto:rxprov@aol.com rxprov@aol.comDATE: February 23, 1999 TO: YUHAS Graphics COMPANY: FROM: Joe Pisano COMPANY: Rx PROvisions, Inc. RE: Colyte Flavor Packs Logos MESSAGE: Thank you for sending the Colyte Flavored Logos on the Mac Formatted 100mb disk. However, we use PCs and we cannot read the disk with our equipment. Please e-mail the two logos with a .bmp file extension to our e-mail address:  HYPERLINK mailto:rxprov@aol.com rxprov@aol.com Thank you __________ wWe use PCVickie, no problem. Your order was formatted but not printed yet. We called the Practice to find out if William F. Price had a title. There is no professional designation after his name. When we called, there was a recording that also mentioned the change in office location. Do you want us to format the prescription exactly the way it is? Let us know when you can. Thanks and kindest regardsJoe. February 23, 1999 YUHAS GraphicsDr. Manoukian ' Packs LogoseThank you for sending the Colyte Flavored Logos on the Mac Formatted 100mb disk. However, we use PCs and we cannot read the disk with our equipment. Please e-mail the two logos with a .bmp file extension to our e-mail address:  HYPERLINK mailto:rxprov@aol.com rxprov@aol.com 414 - 475-7327 3 t DATE: March 3, 1999 TO: Dr. Manoukian COMPANY: FROM: Joe Pisano COMPANY: Rx PROvisions, Inc. RE: Pre-printed Colyte Flavored NJPBs MESSAGE: We called yesterday and requested that you fax your current NJPB to us so that we can reproduce your practice information correctly. When we receive your current NJPB, we will format your prescription and then we will fax it to you for final approval before we go to press. The request we received from you appears below. Thank you Thank you 1- 732-235-7792 1March 3, 1999Dr. Manoukian Pre-printed Colyte Flavored NJPBssto Lewis tthvwWe called your office yesterday and requested that you fax your current NJPB to us so that we can reproduce your practice information correctly. When we receive your current NJPB, we will format your prescription and then we will fax it to you for final approval before we go to press. The request we received from you appears below. ...Thank you DATE: April 19, 1999 TO: Candance COMPANY: Parkstone Medical Information Systems, Inc. FROM: Joe Pisano COMPANY: Rx PROvisions, Inc. RE: April 15, 1999 Meeting with Glenn Parker and Lewis Stone MESSAGE: Candance, the following letter addressed to Glenn was sent via e-mail last week. Thank you for the information you faxed to us in advance of our meeting. I was very thoroutgh and helpful. Kindest regards t.954475-20922April 19, 1999CandanceedediParkstone Medical Information Systems, Inc. April 15, 1999 Meeting with Glenn Parker and Lewis StoneCandance, i cJoseph J. Pisano President address the following letter addressed to Glenn was sent via e-mail last week. Thank you for the information you faxed to us in advance of our meeting. I was very thorough and helpful! Kindest regards 0Nicole FoardaNGELATarget Marketing 1856482-6053Tel Con request for information1/21/24""'kbedrugphyThese forms are p x Nicole, thank you for taking my phone call. I had a conference call with your father this morning and he said to call you for a copy of the CON Indicia. The Indicia is needed to determine the number of physicians in various specialties, which will be used to prepare proposals for his clients. And, if you can send a sample of a For the Record pad, please send it to my attention at the above address. ...Thanks and best617) 577-31012September 22, 1999Angela Computer Ready NJPBsth'ut'...asso Ill let yoNoAngela, the 8 x 11 sheet on the following page is perforated to produce four 4 x 5 NJPBs. The white margin on the left and on the right is perforated and tears off. The prescribing area where the health care provider will print prescription information is below the address line and above the Substitution Permissible type near the bottom of the form. Hope this helps Kindest regards, pst The school will look like a small college campus when they are finished I saw the plans The You may want Idemolition January 31, 3COPY OF 1/31/00 LETTER TO REBECCA OBERUC Thanks rcompetitive information was providedinIf you have any additional questions or if you need to discuss anything, just call any time. The letter we just sent to Rebecca this morning follows on the next two pages. I am scheduled to meet with Neil Potter on Feb.8th @ 9am, and I will keep you informed of the outcome. My initial meeting with Norm went well and it was Norm who said should follow up with Neil. 'bIm stillThanks again for calling and as always , PS: Mo Beard started their renovation project and Grant Hall no longer exists. Grant Hall and other buildings scheduled for removal or renovation will be completely restored. The project is fully funded and the plans call for a complete face-lift with additional structures to be built. I saw the plans and the school will look like a small college campus when they are finished. , Any feedback will be appreciated. 12598-69504February 2, Matthew McKennasSudler & HennesseyCOMPARISON DATALet us know wheMatt, thank you for calling today. The comparison data on the next three pages was requested by one of our clients. They also provided the competitive data and we organized it for them, as requested. We often get very close to getting business at the client you mentioned today, but for some unknown reason we come in second. Any help in the future will always be appreciated. Im always grateful for your continued support!!! 201994-183223xLisa GinooaTO: Pat DeMarzo COMPANY: NJ Div. Of Medical AssistanceFerndale Pharma TO: Pat DeMarzo COMPANY: NJ Div. Of Medical AssistanceFerndale Pharma Ferndale Pharma'COPY FOR PRAMOSONE and ANALPRAM Commiteeoom on fileLisa, the revisions you provided today appear on the following page. When you have final approval from your physicians, just fax your comments to us. 588-3543Pat DeMarzoNJ Div. Of Medical Assistance NJPBs and Two Primary Addresses thAfter attending One to One "! Exclusive EISAI, Inc./Janssen Pharmaceutica ACIPHEX Sales Force Driven Physician Office Program Situation: The ACIPHEX Sales Representatives need programs that will forge a strong brand identity built around product differentiation. And, they need a competitive share of voice, preferably a 100% Share of Voice from programs for their chosen physicians that will get their physicians to prescribe ACIPHEX. In order to provide the differentiation required, the Program must be exclusive to the ACIPHEX Sales Representatives and must be exclusively sponsored by ACIPHEX advertisements. The program must also satisfy the physicians needs and must be a service the physicians can and will use. The program must be flexible to allow the Sales Representatives to select the receptive physicians in their territories who they feel will be most responsive to the Program. Objective: To differentiate the ACIPHEX Sales Representatives with a Program that they can precisely target to a select and receptive physician target audience. The One to One "! Sales Representative Program will: Maximize ACIPHEX prescribing through continuous point of prescription advertising exposures to a select and receptive physician target audience. Provide the physicians with a continuous, exclusively sponsored ACIPHEX supply of prescription pads provided exclusively by the ACIPHEX Sales Representatives. Deliver the ACIPHEX ad exposures at the precise time the ad exposures are needed during the post-launch promotional period. Insure that the One to One "! Program is delivered and used exclusively by the select and receptive physician target audience. Key Strategies were presented and then e-mailed to me. Our One to One Programs are tactical and support the Key ACIPHEX"!Strategies defined by the marketing team.After reviewing the StHere During the Vendors Fair last August, the ACIPHEX"! Key Strategies were presented and then e-mailed to me. Our One to One Programs are tactical and support the Key ACIPHEX"!Strategies defined by the marketing team.After reviewing the StHere One to One "! During the Vendors Fair last August, the ACIPHEX"! Key Strategies were presented and then e-mailed to me. Our One to One Programs are tactical and support the Key ACIPHEX"!Strategies defined by the marketing team.After reviewing the StHere One to One "! After reviewing the StHere One to One "! Sales Force Driven Physician Office Program to the Sales Representatives and must be exclusively sponsored by ACIPHEX advertisements. rand to tarexSales Representatives to select the receptive physicians in their territories who they feel will be most responsive to the Program. pmme Thet s are tactical in nature and that will Key for some background a as defined by the marketing team.to us further prepared tactical Our andsupport the ACIPHEX"! Strategies.10(6) Aand give a brief overview of the additional So, Key Ithpr will give the Onea full presentation. However, the information that follows will begin to show Rob (and Jose) how our One to One Program will ... Situation: The ACIPHEX Sales Representatives need programs that will forge a strong brand identity built around product differentiation. And, they need a competitive share of voice, preferably a 100% Share of Voice from programs for their chosen physicians that will get their physicians to prescribe ACIPHEX. In order to provide the differentiation and maximum share of voice required, the Program must be customized and exclusive to ACIPHEX. The program must also be customized to satisfy the physicians needs and must be a service the physicians can and will use. The program must be flexible to allow the ACIPHEX Marketing Team to select the physicians they want to target and to adjust their target in response to their changing market. exclusive to ACIPHEXThe program must also be customized to satisfy the physicians needs and must be a service the physicians can and will use.TTo differentiate the ACIPHEX Sales Representatives with a Program that they can precisely target to a select and receptive physician target audience. The One to One "! Sales Representative Program will: provided the Sales Representatives.Insure that the One to One "! Program is delivered and used exclusively by the select and receptive physician target audience. One to One "! to the precise physician target audienceExclusive EISAI, Inc./Janssen Pharmaceutica ACIPHEX Sales Force Driven Physician Office Program Situation: The ACIPHEX Sales Representatives need programs that will forge a strong brand identity built around product differentiation. And, they need a competitive share of voice, preferably a 100% Share of Voice from programs for their chosen physicians that will get their physicians to prescribe ACIPHEX. In order to provide the differentiation required, the Program must be exclusive to the ACIPHEX Sales Representatives and must be exclusively sponsored by ACIPHEX advertisements. The program must also satisfy the physicians needs and must be a service the physicians can and will use. The program must be flexible to allow the Sales Representatives to select the receptive physicians in their territories who they feel will be most responsive to the Program. Objective: To differentiate the ACIPHEX Sales Representatives with a Program that they can precisely target to a select and receptive physician target audience. The One to One "! Sales Representative Program will: Maximize ACIPHEX prescribing through continuous point of prescription advertising exposures to a select and receptive physician target audience. Provide the physicians with a continuous, exclusively sponsored ACIPHEX supply of prescription pads provided exclusively by the ACIPHEX Sales Representatives. Deliver the ACIPHEX ad exposures at the precise time the ad exposures are needed during the post-launch promotional period. Insure that the One to One "! Program is delivered and used exclusively by the select and receptive physician target audience. Pat, please let me know when the NJPB Committee makes its decision regarding the use of two primary addresses on the physicians NJPB. I will keep the NJPB Destruction Form you faxed to me today, on file. Kindest regards& Phone: 1-888-479-7768 FAX: 1-888-479-7828 _____________ ACIPHEX"! Key Strategies were presented and then e-mailed to us here at Rx PROvisions, Inc. (see next page). We reviewed the ACIPHEX"! Key Strategies and sent our proposal and six mock-ups of the ACIPHEX"! One to One"! Program to David Fabbri for distribution to the Team, as requested. So the meeting on March 24th and the presentation to Rob and Jose is actually a continuation of the interest Eisai and Janssen have expressed in using the One to One Program"! to support their ACIPHEX"! Strategies. Let me know if you have any questions and I am grateful to you for arranging the meeting. Kindest regards& ________________ Exclusive EISAI, Inc./Janssen Pharmaceutica ACIPHEX"! One to One"! Program Situation: The ACIPHEX Sales Representatives need programs that will forge a strong brand identity built around product differentiation. And, they need a competitive share of voice, preferably a 100% Share of Voice from programs for their chosen physicians that will get their physicians to prescribe ACIPHEX. In order to provide the differentiation and maximum share of voice required, the Program must be customized and exclusive to ACIPHEX. The program must also be customized to satisfy the physicians needs and must be a service the physicians can and will use. And, the program must be flexible to allow the ACIPHEX Marketing Team to select the physicians they want to target and to adjust their target in response to their changing market. Objective: Maximize ACIPHEX prescribing through continuous point of prescription advertising exposures to a select and receptive physician target audience. Provide the physicians with a continuous, exclusively sponsored ACIPHEX supply of prescription pads sponsored exclusively by ACIPHEX. Deliver the ACIPHEX"!accomplish the support the strategiesaccomplish the f...Moaccomplish the support the strategiesaccomplish the Recommendation: An exclusively sponsored ACIPHEX One to One Program for your chosen physicians will address the ACIPHEX Strategies and will accomplish the Objectives, above. A brief One to One Program Overview follows on the next eight pages. An exclusively sponsored ACIPHEX One to One Program for your chosen physicians will address the ACIPHEX Strategies and will accomplish the Objectives, above. A brief One to One Program Overview follows on the next eight pages. ecommendation: Page 3. March 8, 2000 Page 3. 1FAXED:FAXED:: 11: 11"!"! "!"! The Sales Representatives they .Sfor their chosen sirpreferably a 100% Share of Voicethat will An exclusively will Implement an exclusively8.Loretta Rathert EISAI Inc.MEETING with Rob Fahey and Jose Fojas March 24, 2000 at 2PM at Janssen11609730-2148... Rx PROvisions, Inc. 4 Beaverbrook road, Suite 127 Lincoln Park, NJ 07035 rLoretta, as requested here is some background information for Rob (and Jose) to review before our meeting on March 24th. During the Vendors Fair last August, the ACIPHEX"! Key Strategies were presented and then e-mailed to us here at Rx PROvisions, Inc. (see next page). We reviewed the ACIPHEX"! Key Strategies and sent our proposal and six mock-ups of the ACIPHEX"! One to One"! Program to David Fabbri for distribution to the Team, as requested. So the meeting on March 24th and the presentation to Rob and Jose is actually a continuation of the interest Eisai and Janssen have expressed in using the One to One Program"! to support their ACIPHEX"! Strategies. Let me know if you have any questions and I am grateful to you for arranging the meeting. Kindest regards& ________________ March 8, 2000 Page 3. Exclusive EISAI, Inc./Janssen Pharmaceutica ACIPHEX"! One to One"! Program Situation: ACIPHEX"! needs programs that will forge a strong brand identity built around product differentiation. And, ACIPHEX"! needs a competitive share of voice, preferably a 100% Share of Voice from programs that will target a select and receptive physician audience to get these physicians to prescribe ACIPHEX"!. In order to provide the differentiation and maximum share of voice required, the Program must be customized and exclusive to ACIPHEX"!. The program must also be customized to satisfy the physician s needs and must be a service the physicians can and will use. And, the program must be flexible enough to allow the ACIPHEX"! Marketing Team to select the physicians they want to target and to adjust their target in response to their changing market. Objective: Maximize ACIPHEX"! prescribing through continuous point of prescription advertising exposures to a select and receptive physician target audience. Provide the physicians with a continuous, exclusively sponsored ACIPHEX"! supply of prescription pads sponsored exclusively by ACIPHEX"!. Deliver the ACIPHEX"! ad exposures to the precise physician target audience at the precise time the ad exposures are needed during the post-launch promotional period. RECOMMENDATION: Implement an exclusively sponsored ACIPHEX"! One to One"! Program for your chosen physicians that will address the ACIPHEX"! Strategies and accomplish the Objectives, above. A brief One to One"! Program Overview follows on the next eight pages& . March 31, Samantha Karr, RPhMOPN248858-6718pADDRESS TO SEND LOGO'issmustSamantha, please send the diskette and a print out of the logo we should open, to:ivOur fax # is: Please fax his license number to us at: 973-335-1591April 3, 108213-1218NancyMal B. Isaac, D.O.RLicense # Needed to Print Complimentary NJ Rx Forms Pre-printed with Colyte Flavor PacksA bINancy, please fax Dr. Isaacs NJ license number to us. We need it to print the complimentary NJ Rx pads for him. These NJ Rx forms are paid for by Schwarz Pharma. Please fax his license number to us at: 973-335-1591. Our address, also shown above is: Joseph J. Pisano Rx PROvisions, Inc. 4 Beaverbrook Road, Suite 127 Lincoln Park, NJ 07035 Thanks Rx forms are 973383-6929Bill SiscoSUNRISE HOUSENJPB (RxPAD) ORDERSuithere is you need.Fill in the License Number for the physician. However, fill in the DEA Number only if you want us to print the number on the Rx forms. Any questions just call us. e DATE: May 2, 2000 TO: LINDA GREGORY COMPANY: FLEET BANK FROM: Joseph Pisano COMPANY: Rx PROvisions, Inc. RE: FIRST PAGE OF 1999 TAX RETURN MESSAGE: Linda, the following page is the information you requested. Let me know if you need any additional information. Bill, please complete the following form for each order. Kindest regards __________ 781778-1024 2 RcATHY Dear Cathy, We received the following six orders on May 17th and May 18th from the internal sales reps. I am faxing them back to you so the reps can make the appropriate changes in order for production of the orders to take place. Dear Cathy, We received the following six orders on May 17th and May 18th from the internal sales reps. I am faxing them back to you so the reps can make the appropriate changes in order for production of the orders to take place. W' internal sales reps. Polly Raymond (ISR7):Donna Maechtle (ISR5): Order for Jitendra Parmar, M.D. has two addresses listed. The address at 1601 West Okmulgee is missing the city, state, zip code, and phone number. Debbie Roering (ISR4Donna Maechtle (ISR5 Debbie Roering (ISR4Debbie Roering (ISR4): J. Doris Beamon (ISR1):Please have the sales reps fax the orders back to me with ENLARGED Rx Sincerely, Joseph Pisano  Polly Raymond (ISR7): Order for James P. Culley, M.D. is too small to read. Please have rep enlarge the script. Donna Maechtle (ISR5): Order for Jitendra Parmar, M.D. has two addresses listed. The address at 1601 West Okmulgee is missing the city, state, zip code, and phone number. Debbie Roering (ISR4): The DEA # on the order for Jeffrey M. Cryan, M.D. is not legible, please further enlarge the script. Debbie Roering (ISR4): On the order for John F. Sallstrom, PA-C, should only this doctors name appear on the script, or should all five doctors be included? John F. Sallstroms name is highlighted, but it is not specified if only his name should appear. Debbie Roering (ISR4): On the orders for S. Keith Smith, M.D., Edward T. Plyer, M.D., Shelli E. Cannon, M.D., and John F. Sallstrom, PA-C, there is a discrepancy with the zip codes and the area codes listed. Please have rep send the correct zip code and area code for Morganton, NC. Also, these four scripts are too small to be read accurately. Please have rep place only one script on a page and enlarge each one. J. Doris Beamon (ISR1): Order for Bruce Riger, M.D. is too small to read. Rep wrote out DEA #, but the phone number, license number, and city are not clear. Please have rep enlarge script. Please have the sales reps fax the orders back to me with ENLARGED Rx forms as soon as possible (see next page). Lastly, please ask J. Doris Beamon to specify the credentials of the doctors (M.D. or D.O) when she writes the orders by hand. Her omission of this information forces us to simply print Dr. before the doctors name. Thank you for your attention to these small but important matters. Call me with any questions at (973) 335-7832. MESSAGE: forms as soon as possible (see next page). (973) 335-7832 ( FAX (973) 335-1591 PAGE 1  (973) 335-7832 ( FAX (973) 335-1591 PAGE 1 PAGE 1isrS'262238-0961419 Cathy Race'MESSAGE: Dear Cathy, We received the following six orders on May 17th and May 18th from the ISRs. I am faxing them back to you so the reps can make the appropriate changes in order for production of the orders to take place. Polly Raymond (ISR7): Order for James P. Culley, M.D. is too small to read. Please have rep enlarge the script. Donna Maechtle (ISR5): Order for Jitendra Parmar, M.D. has two addresses listed. The address at 1601 West Okmulgee is missing the city, state, zip code, and phone number. Debbie Roering (ISR4): The DEA # on the order for Jeffrey M. Cryan, M.D. is not legible, please further enlarge the script. Debbie Roering (ISR4): On the order for John F. Sallstrom, PA-C, should only this doctors name appear on the script, or should all five doctors be included? John F. Sallstroms name is highlighted, but it is not specified if only his name should appear. Debbie Roering (ISR4): On the orders for S. Keith Smith, M.D., Edward T. Plyer, M.D., Shelli E. Cannon, M.D., and John F. Sallstrom, PA-C, there is a discrepancy with the zip codes and the area codes listed. Please have rep send the correct zip code and area code for Morganton, NC. Also, these four scripts are too small to be read accurately. Please have rep place only one script on a page and enlarge each one. J. Doris Beamon (ISR1): Order for Bruce Riger, M.D. is too small to read. Rep wrote out DEA #, but the phone number, license number, and city are not clear. Please have rep enlarge script. Please have the sales reps fax the orders back to me with ENLARGED Rx forms as soon as possible (see next page). Lastly, please ask J. Doris Beamon to specify the credentials of the doctors (M.D. or D.O) when she writes the orders by hand. Her omission of this information forces us to simply print Dr. before the doctors name. Thank you for your attention to these small but important matters. Call me with any questions at (973) 335-7832. _________________ 1May 31, 2000 nURIAIRWIN GOLDSTEIN, M.D.CORRECTED PHONE NUMBER ON NJPBs (Rx Forms) MESSAGE: MESSAGE: May 31, 2000 TO: Nuria Swaby FR: Joseph Pisano RE: PRE-PRINTED RX PAD ORDER FORM km ...c./oor p colleguesFaxquestioinsinformationFAX : Nuria, thank you for calling us today regarding your need for pre-printed Rx Forms. We print Rx forms for all healthcare providers, not only in New Jersey but also in every other State. So if you and your colleagues need any Rx forms, just complete the Order Form on the following page and mail or FAX it to us. We would appreciate enlarged Rx Forms if you fax them to us, especially non-NJ Rx forms. If you have any other questions or if you need any additional Information please call me at any time. Kindest regards PRE-PRINTED RX PAD ORDER FORM 973696-5104May 31, 20002732972-5334Nuria SwabynjpPRE-PRINTED RX PAD ORDER FORMRE: NJPB ORDER Nuria, ,'ATara,pLEASEPleasep.below vUPS The price for your order will be $94.95 plus 6% tax. There is no charge for UPS shipping. The price for your order will be $94.95 plus 6% tax. There is no charge for UPS shipping. The price for your order will be $94.95 plus 6% tax. There is no charge for UPS shipping. pLEASEPleasep,ON ACCOUNT HOWEVER THE CARD DATE HAS EXPIRED. Please provide an u .c AMEX372847990361002 alling us today regarding your need for pre-printed Rx Forms. We print Rx forms for all healthcare providers, not only in New Jersey but also in every other State. So if you and your colleagues need any Rx forms, just complete the Order Form on the following page and mail or FAX it to us. We would appreciate enlarged Rx Forms if you fax them to us, especially non-NJ Rx forms. If you have any other questions or if you need any additional Information please call me at any time. Kindest regards ___________________________________ ... 1OCEAN CITY FAMILY PRACTICE ( 22TO: Tara OCEAN CITY FAMILY PRACTICE FR: Joseph Pisano RE: NJPB ORDER MESSAGE: Tara, thank you for your order for 5,000 NJPBs for Darlene Flamini, RN, MSN, NP-C. Please review the copy on the following page, and fax to us your comments/approval. We will use your approved copy to print your order. The price for your order will be $94.95 plus 6% tax. There is no charge for UPS shipping. We have the following AMEX CARD on file, however the date has expired. Please provide a current Card and/or expiration date we can keep on file: 372847990361002 Thanks and kindest regards _____________________________ Rx PROvisions, Inc. Rx PROvisions, Inc. (609) 399-15720 TO FAX:_201-871-4005________________ TOTAL PAGES FAXED: 1 June 14, 2000 TO FAX:_201-871-4005________________ ________________TO FAX:_201-871-4005 _ TOTAL PAGES FAXED: 1 June 14, 2000 TO FAX: 201-871-4005June 14, 2000 1 201-871-4005 TO: Alice Kosterich eIf rmn MESSAGE:a r.physiciansphysicians , so 'TO: Alice Kosterich, MEDICIS FR: Joseph Pisano RE: Pre-printed Rx Pads MESSAGE: Alice, thank you for calling us today for information about ordering pre-printed Rx pads for your physicians. Our order form follows on the next page. The order form is for both New Jersey and Non-New Jersey physicians. The SAMPLE on page 3 shows an example of the layouts we do in both portrait and landscape. The signature line at the bottom of the Rx form is for New York. Since we provide pre-printed Rx pads for Sales Representatives and their physicians nation wide, we have the appropriate Rx signature line for each state. We print most of our Rx forms on white paper and have on occasion printed Rx forms on yellow and on pink stock. However, the turn around time increases as the number of order variables increases. 'th... Since we provide pre-printed Rx pads for Sales Representatives and their physicians nation wide, we have the appropriate Rx signature line for each state. We print most of our Rx forms on white paper and have on occasion printed Rx forms on yellow and on pink stock. However, the turn around time increases as the number of order variables increases. Since we will be off next week, lets try to speak with each other the week of June 26th to discuss the service you need. Kindest regards July 12ne 14, 2000 3TOTAL PAGES FAXED: July 12, 2000 6565212-717-9634TO: Alice Kosterich, MEDICIS FR: Joseph Pisano, President RE: Pre-printed Rx Pads MESSAGE: Alice, thank you for calling us today for information about ordering pre-printed Rx pads for your physicians. Our order form follows on the next page. The order form is for both New Jersey and Non-New Jersey physicians. The SAMPLE on page 3 shows an example of the Rx form layouts we do in both portrait and landscape. The signature line at the bottom of the Rx form is for New York. Since we provide pre-printed Rx pads for Sales Representatives and their physicians nation wide, we have the appropriate Rx signature line for each state. We print most of our Rx forms on white paper and have on occasion printed Rx forms on yellow and on pink stock. However, the turn around time increases as the number of order variables increases. Since we will be off next week, lets try to speak with each other the week of June 26th to discuss the service you need. Kindest regards ____________________ TOTAL PAGES FAXED: 1 July 12, 2000 July 12, 2000908-688-3161 5201-994-1832 29973-450-93953908-688-31611 NJPB LO' F THE FORMRDMESSAGE;173402-0508TO: LORI UTTER FR: JOSEPH PISANO RE: REQUEST FOR NJPB ORDER FORM MESSAGE; LORI, THANK YOU FOR REQUESTING AN ORDER FORM FOR NJPBS FOR DR. KEATING AND FOR DR. STACK. OUR ORDER FORM FOLLOWS ON THE NEXT PAGE. PLEASE COMPLETE THE FORM FOR EACH PHYSICIAN AND FAX THE FORM TO US AT: 973-335-1591. KINDEST REGARDS... PS: YOUR PRACTICE NAME ACKNOWLEDGEMENT FORM FOLLOWS ON THE 3RD PAGE OF THIS FAX. 71473-5958'fRARYga MALZONE I serve with Rx pads.forms printed with drtbS . Rx pads with the , and edrc and the are the same with my 2-color fingerprint logo on the Rx pad covers. i..LSteve, the following quote is for one of my group practices. The want special Rx Pads printed with their 2-color logo (MOPN) on the Rx forms in each pad AND on their Rx pad covers. They have 550 physicians in the group and each physician will receive 24 personalized Rx pads. I will also need sample MOPN Rx pads featuring the 2-color Rx form. All of the MOPN sample Rx pads will be personalized with the same name. I will also need sample One to One pads in both portrait and landscape format. These sample pads have my 2-color logo on the front cover and Rx forms printed with black ink. The 4-color ads for the on the inside front cover are the same ads that run as ad inserts in all of the Rx pads. I have all of the production material and I m waiting for final approval of the Rx form layout from the Chairman of the MOPN physician group. The program is funded and I want to proceed at least with the printing of the 4-color work now. I need your quote on the following specs. Please call me. I can discuss this on the phone or in person. Kindest regards... Steve, the following quote is for one of my group practices. The want special Rx Pads printed with their 2-color logo (MOPN) on the Rx forms in each pad AND on their Rx pad covers. They have 550 physicians in the group and each physician will receive 24 personalized Rx pads. I will also need sample MOPN Rx pads featuring the 2-color Rx form. All of the MOPN sample Rx pads will be personalized with the same name. I will also need sample One to One pads in both portrait and landscape format. These sample pads have my 2-color logo on the front cover and Rx forms printed with black ink. The 4-color ads for the on the inside front cover are the same ads that run as ad inserts in all of the Rx pads. I have all of the production material and I m waiting for final approval of the Rx form layout from the Chairman of the MOPN physician group. The program is funded and I want to proceed at least with the printing of the 4-color work now. I need your quote on the following specs. Please call me. I can discuss this on the phone or in person. Kindest regards... ' One to Oneon the r for the inside front cover are tthat eth and I will also need sample MOPN Rx pads featuring their 2-color Rx form. All of the MOPN sample Rx pads will be personalized with the same name. I have all of the production material. I m just waiting for final approval of the Rx form layout from the Chairman of the MOPN physician group. The program is funded and I want to proceed at least with the printing of the 4-color work now. So I need your quote on the following specs. Please call me. I can discuss this on the phone or in person. Gary/SteveGary/Steveall in the landscape formatOne to One pads in both portrait and landscape format.tseach 575-33771 (973) 335-7832 FAX (973) 335-1591 PAGE 1 0f 3 July 29, 2000GARY / STEVEQUOTATIONsANDInAND August 9, 2000 TOTAL PAGES FAXED: 3 TO : Sandi FR: JOSEPH PISANO RE: REQUEST FOR PRE-PRINTED INFORMATION REVIEW MESSAGE: Sandi, pre-printed information for PLEXION, DYNACIN and TRIAZ follow on the next two pages for Dr. Masessa to review. Please fax your comments / approval of the pre-printed information to us at: 973-335-1591. Kindest regards... Gary / Steve, the following quote is for one of my group practices. They want special Rx Pads printed with their 2-color logo (MOPN) on the Rx forms in each pad AND on their Rx pad covers. They have 550 physicians in the group and each physician will receive 24 personalized Rx pads all in the landscape format. Im not sure about the re-order rate yet. I will also need sample MOPN Rx pads featuring their 2-color Rx form. All of the MOPN sample Rx pads will be personalized with the same name. I will also need sample One to One pads in both portrait and landscape format. These sample pads have my 2-color logo on the front cover and Rx forms printed with black ink on bright white paper. There are five (5) 4-color ads. The 4-color ads are the same for all of the Rx pads for MOPN and for all of the sample pads. The ad on the inside front cover will rotate among the 5 ads. The same 5 ads will run as ad inserts in all of the Rx pads. Ad inserts will be placed after every fifth (5th) Rx form in all of the Rx pads. I have all of the production material. I m just waiting for final approval of the Rx form layout from the Chairman of the MOPN physician group. The program is funded and I want to proceed at least with the printing of the 4-color work now. So I need your quote on the following specs. Please call me. I can discuss this on the phone or in person. Kindest regards... K93973-208-8106 3TO : SandiINFORMATION REVIEWSandi, pre-printed information for PLEXION, DYNACIN and TRIAZ follow on the next two pages for Dr. Masessa to review.Please fax your comments / approval of the pre-printed information to us at: 973-335-1591 as soon as you are able. Thanks and kindest regards... RREQUESTS18770-682-70450BilldREQUEST FOR ALTERNATE PRE-PRINTED COLYTE SCRIPTS't''just e HERE ARE SOME EXAMPLES OF ALTERNATE PRE-PRINTED COLYTE SCRIPTS WE HAVE CREATED IN THE PAST. WE CAN ADD ANY MEDICATIONS THE DOCTOR WANTS. JOE WILL BE BACK IN THE OFFICE MONDAY MORNING, 8/21. I WILL LEAVE HIM A MESSAGE TO CONTACT YOU REGARDING THIS REQUEST. HAVE A NICE WEEKEND! REBECCAf2 973-402-0508 Lori UtterNJPB ORDER FOR DR. FILLION Lori, thank you for calling us for an order form to order NJPBs for Dr. Fillion. The price for '#35.68 (please see next page). Just comasplete the form on the second page and fax it to us. Also, if there are any changes you want to make on Dr. Fillions NJPB, fax those changes to us as well. Fax# 973-335-1591 _____________ _412732-683-02536Chris PenzatRACEYLUXIQ Information On File'''dAND'a e Rx padsChris, we have the copy, below, on file from other CONNETICS sales representatives who use us for their pre-printed Rx Pads. Our price for 1,000 Single NJPBs is $37.60 and our price for NCR (2-part) NJPBs is $72.33. Please review the pre-printed information above and fax to us your comments / approval to proceed with your order for Dr. L. Robert Smith. wEWyo Kindest regards r irc August 2973208-81063Tracey cc: Al FuchsPre-printed Spironolactone, Plexion and Dynacin NJPBsf ceed to faxOne Tracey, thank you for ordering pre-printed Spironolactone NJPBs for each office. The price for 10 pre-printed NJPB Rx Pads (1,000 NJPBs) is $35.68 plus tax, which includes printing packaging, handling and UPS delivery. With approved pre-printed copy from you, we will print one order for your Newfoundland Office and one order for your Rockaway Office. We will send our invoice for both orders to Al Fuchs at your Rockaway office. Please review the copy for Spirolactone on page 2 of this fax and please review the DYNACIN and PLEXION copy on page 3 of this fax. The DYNACIN and PLEXION NJPBs are compliments of MEDICIS. We will produce your orders as soon as we receive approval from Dr. Masessa. Kindest regards... 212-717-9634 Alicea'Alice, our peoplehad a difficult time reading the information on the fax you sent recently. So, before we print the three orders you sent to us, please review and correct the copy. The telephone and DEA numbers were especially difficult to read. If you can, please mail an original Rx form to us. Or, if you prefer to fax orders to us, perhaps the copy can be enlarged and darkened before you send it.. Please fax to us your corrections and comments so we can produce your orders for you. begin to 6973-359-0158William DelfsApproved CDSPRE-PRINTED RX COPY FOR REVIEW 2208-81062September 12, 2000 Sandi DEA Number for Mark EvansrSandi,Bill, the following page contains the copy you requested for review by Dr. Berlin. As soon as you have Dr. Berlins comments / approval, please contact us again so that we can set up your account with us and to process our order. Rx PROvisions, Inc. Four Beaverbrook Road, Suite 127 Lincoln Park, New Jersey 07035 (973) 335-7832 FAX (973) 335-1591 PAGE 1 of 1 TO FAX: 973-428-5390 POLICIES AND PROCEDURES FOR THE PRODUCTION OF CALIFORNIS SECURITY PRESCRIPTIONS VENDOR APPLICATION FOR October 4, 2000 TOTAL PAGES FAXED: 1 TO: Eduardo Arriagada COMMERCE BANK FR: JOSEPH PISANO RE: Request for ORIGINAL DOCUMENTS MESSAGE: Eduardo, I need the original documents I gave you when we opened our checking account this afternoon. Please call me to let me know how the documents will be returned. Kindest regards... Joseph Pisano Rx PROvisions, Inc. Phone: 973-335-7832 Fax# 973-335-1591 VENDOR APPLICATION FOR October 4, 2000 TOTAL PAGES FAXED: 1TO: Eduardo Arriagada COMMERCE BANK FR: JOSEPH PISANO RE: Request for ORIGINAL DOCUMENTS MESSAGE: Eduardo, I need the original documents I gave you when we opened our checking account this afternoon. Please call me to let me know how the documents will be returned. Kindest regards... Joseph Pisano Rx PROvisions, Inc. Phone: 973-335-7832 Fax# 973-335-1591 _____________ aseGeneral Statement: supporting documentation addressing each of the vendor requirements on the Policies and Procedures section of the security printer application are enclosed with the application SGeneral StatementGeneral Statementsoonmb.m on the follows the guidelines and corresponds to the with the applicationproividesrionaphysiciianswein the 200 in TrcvNJ Prescription Blan rsSupporting documentation ing therequired , . are enclosed. enclosed requirements Rx for toprovide Opn applied for a license and was approved otfisaclfrom the Treasury DepartmentIn June 1996, practitionersGeneral Statement: Rx PROvisions, Inc. is a privately held company that serves the healthcare industry. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms , diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients, and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. Rx PROvisions, Inc was incorporated on August 15, 1995. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms , diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients, and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. Rx PROvisions, Inc was incorporated on August 15, 1995. ""safety.fRx PROvisions, Inc. is a company that provides medical documents used by practitioners nation wide during the practice of medicine. aAn example of the NJ Rx form is enclosed. the Rx PROvisions, Inc. is a privately held company that serves the healthcare industry. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms , diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients, and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. An example of our original security Rx form printed with blue thermal sensitive ink is enclosed. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. ,, General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. An example of our original security Rx form printed with blue thermal sensitive ink is enclosed. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. An example of our original security Rx form printed with blue thermal sensitive ink is enclosed. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. When the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled, and general public assistance programs. The supporting documentation required for this application is similar in scope to the NJ Prescription Blank Program, and addresses each of the vendor requirements outlined in the Policies and Procedures section of the enclosed security printer application. The documentation is stated in numbered paragraphs, which correspond to the numbered guidelines provided by the California State Board of Pharmacy. _________________ General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. At the heart of any document of value lies trust. In this context the counterfeiter undermines not just monetary worth but fundamental public confidence. Rx PROvisions, Inc. uses unique interactive thermal sensitive ink to produce healthcare providers personalized prescription forms. The unique ink protects the prescriptions from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. An example of our original security Rx form printed with blue thermal sensitive ink is enclosed. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. When the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled, and general public assistance programs. The supporting documentation required for this application is similar in scope to the NJ Prescription Blank Program, and addresses each of the vendor requirements outlined in the Policies and Procedures section of the enclosed security printer application. The documentation is stated in numbered paragraphs, which correspond to the numbered guidelines provided by the California State Board of Pharmacy. _________________ the we lies trust.At the heart of any document of value is our trustoA is.. In this context worthproduction process to produce healthcare providers personalized prescription formss to produce.unique The unique ink sthe s Information printed on the prescription forms with thermal sensitive ink, will not reappear on a photocopy and cannot be scanned into a computer. to change color permanently 1W CALIFORNIA SECURITY PRESCRIPTIONS General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and uses the Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms used and consumed by healthcare providers when they are treating patients; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. Our trust is at the heart of any document of value, which the counterfeiter undermines not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save the healthcare industry hundreds of millions of dollars annually. An example of our original security Rx form printed with blue thermal sensitive ink is enclosed. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled, and general public assistance programs. The supporting documentation required for this application is similar in scope to the NJ Prescription Blank Program, and addresses each of the vendor requirements outlined in the Policies and Procedures section of the enclosed security printer application. The documentation is stated in numbered paragraphs, which correspond to the numbered guidelines provided by the California sState Board of PharmacyVENDOR APPLIPolicies and Procedurevendor applications section of the enclosed security printer application., which correspond to the numbered guidelinesrequired for this application is similar in scope to the NJ Prescription Blank Program, and addresses each of the vendor requirements outlined in the AHCA Vendor Application. The documentation is stated in numbered paragraphs beginning on page five (5) hbrequired for this application is similar in scope to the NJ Prescription Blank Program, and addresses each of the vendor requirements outlined in the AHCA The documentation of the provided by the Florida Agency for Health Care Administration. Another formulation of the thermal sensitive ink used by Rx PROvisions, Inc. can also be used to print prescription product labels and OTC product labels. Rx PROvisions, Inc. can produce product labels for prescription and OTC stock packages and for prescription and OTC product samples. The ink, used to print product labels, can be calibrated to change color permanently when a compromising temperature for that specific product has been reached. The permanent color change will insure that excessive temperatures have not compromised the potency of prescription products dispensed as samples to patients, or products used to fill prescriptions, or products purchased by the consumer as an OTC product. approval letter is enclosed POLICIES AND PROCEDURES FOR THE PRODUCTION OF FLORIDA SECURITY PRESCRIPTIONS r. uses several security features . uses several security features . Our security stock is produced theoriginal The supporting documentation is stated in numbered paragraphs that correspond to the sixteen (16) numbered paragraphs beginning on page five (5) of the AHCA Vendor Application. ________________________________the uses thewhen they are treating patients;s, which we produce Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Our security stock is produced exclusively for our use in the production of prescription forms. Wthey have been when we have approved.Our security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The inks reactive qualities also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. Currently, we are working on additional prescription validity features which we will announce to you at a later date. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions (see enclosed copy). An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. , Currently, we are working on additional prescription validity features which we will announce to you at a later date. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions (see enclosed copy). An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The inks reactive qualities also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title ____________________________________ inks as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions (see enclosed copy)enclosed copy) 6General Statement: Rx PVendor Name: ROvisionsVendor Name: Vendor Name:Vendor Name:was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The reactive qualities of thermal sensitive ink also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title ____________________________________ Vendor Name:Business Address:City:State:ZIP:Federal Tax ID:Name of Company: Rx PROvisions, Inc. Founded: 1995 Address: 166 Main Street, Suite 3 City: Lincoln Park State: NJ Zip: 07035 Telephone: 973-305-8105 FAX: 973-305-8108 Name of Media Produced: Medical Office Forms and Services. Contact Person: Joseph J. Pisano, President. BRIEF DESCRIPTION OF SERVICES The Rx PROvisions, Inc. One to One"! Prescription Pad Programs are sponsored with pharmaceutical advertising and are offered as physician exclusive programs to pharmaceutical marketers. Several products from the same pharmaceutical company can sponsor the same physician at no additional cost. One price is paid per physician. All One to One"! Rx Pads sent to each targeted physician are sponsored with 4-color ads. Rx forms are reproduced in either the portrait or the landscape layout as directed by the physician. The information on the Rx form is reproduced with the same practice logos, logotype and design preferred by the physician or by the practice. Rx pads are perfect bound with a wrap around cover. The cover is printed as directed by the client or by the physician practice. Rx Formats are printed on safety non-copy able stock, 2-part stock, regular and colored stock. The Rx PROvisions, Inc. Pre-printed Rx Pad Program is designed to respond to any Sales Representative who requests pre-printed Rx Pads for their physicians. Not all physicians use pre-printed Rx pads so the program is directed by the Sales Representatives who can pre-qualify the physician. The pre-printed Rx pad program is designed to: Facilitate the prescribing of specific treatment modalities among targeted physicians. Build a relationship between called on physicians and the sales representatives who are providing a value added service for the physician. Enable the pharmacist to understand the prescription, to dispense it properly and to encourage the pharmacist to dispense the prescription as written. Vendor Name: Rx PROvisions, Inc. Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 Federal Tax ID: 22-3390483 Name of Company: Rx PROvisions, Inc. Founded: 1995 Address: 166 Main Street, Suite 3 City: Lincoln Park State: NJ Zip: 07035 Telephone: 973-305-8105 FAX: 973-305-8108 Name of Media Produced: Medical Office Forms and Services. Contact Person: Joseph J. Pisano, President. BRIEF DESCRIPTION OF SERVICES Vendor Name: Rx PROvisions, Inc. Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 Federal Tax ID: 22-3390483 Name of Company: Rx PROvisions, Inc. Founded: 1995 Address: 166 Main Street, Suite 3 City: Lincoln Park State: NJ Zip: 07035 Telephone: 973-305-8105 FAX: 973-305-8108 Name of Media Produced: Medical Office Forms and Services. Contact Person: Joseph J. Pisano, President. BRIEF DESCRIPTION OF SERVICES Name of Company: Rx PROvisions, Inc. Vendor Name: Rx PROvisions, Inc. Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 Federal Tax ID: 22-3390483 Founded: 1995 Address: 166 Main Street, Suite 3 City: Lincoln Park State: NJ Zip: 07035 Name of Media Produced: Medical Office Forms and Services. Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 Federal Tax ID: 22-3390483 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. 1.Paragraph 2. BRIEF DESCRIPTION OF SERVICES BRIEF DESCRIPTION OF SERVICESParagraph 2. Paragraph 2. . physician exclusiveWe offer severaOs are sponsored withThe program serves as a medium to deliver pharmaceutical advertising and are offered as physician exclusive programs to pharmaceutical marketers. Several phyfor the and are offered as physician exclusive programs to pharmaceutical marketers. Several products from the same pharmaceutical company can sponsor the same physician at no additional cost. One price is paid per physician. All One to One"! Rx Pads sent to each targeted physician are sponsored with 4-color ads. The forms are provided as a complimentary service to the practitioner who sees prescription drug messages as the forms are used. Rx forms are reproduced in either the portrait or the landscape layout as directed by the physician. The information on the Rx form is reproduced with the same practice logos, logotype and design preferred by the physician or by the practice. Rx pads are perfect bound with a wrap around cover. The cover is printed as directed by the client or by the physician practice. Rx Formats are printed on safety non-copy able stock, 2-part stock, regular and colored stock. The forms are provided as a complimentary service to the practitioner who sees prescription drug messages as the forms are used. Rx forms are reproduced in either the portrait or the landscape layout as directed by the physician. The information on the Rx form is reproduced with the same practice logos, logotype and design preferred by the physician or by the practice. Rx pads are perfect bound with a wrap around cover. The cover is printed as directed by the client or by the physician practice. Rx Formats are printed on safety non-copy able stock, 2-part stock, regular and colored stock. Our Rx forms cretreivedrevised and reproduced. iin accordance with that client or by the physician practice. non-copy able stock, One to One"! Prescription Pad Program.either the portrait or the landscape layout as atsPre-printed Rx Pad Program The if the oa ffrom the Pre-printed Rx Pad Program is designed to respond to any Sales Representative who requests pre-printed Rx Pads for their physicians. Not all physicians use pre-printed Rx pads so the program is directed by the Sales Representatives who can pre-qualify the physician. The pre-printed Rx pad program is designed to: In 1996, the first order for prescription pads came from a pharmaceutical company In 1996, the first order for prescription pads came from a pharmaceutical company In 1996, the first order for prescription pads came from a pharmaceutical company In 1996, the first order for prescription pads came from a pharmaceutical company thesforTmfraud in the passed into law durin.svia retreivesisceWemthe features used in fradulentrrfive a unique batch number that to tr five feature five The forms we havother Rx formso""; on the front side on the front, and on the back, on the backon the back. statement provides the date, 22 the 3We continue to enhance our counterfeit resistant Rx forms by adding features to stop the fraudulent use of prescription forms. Our Rx forms currently have the following features on the front side; a void pattern appears if copied, a thermal sensitive ink Rx in the corner, a micro print signature line that will not copy, a six quantity check box to confirm the quantity prescribed, and a unique batch number that identifies the production date, the prescriber and the order number. On the back we have the following features; a description of safety features, thermal sensitive ink in our logo and a security watermark 4be mewith t f, ""followed by the productiothe invoice and to the each s ;sThe An actual 2practiceproduction dadate Follo. and a unique batch number that identifies the production date, the prescriber and the order number. On the back we have the following features; a escriberRXPyymmdd1234 practice or pract itioner 5e,The batch number methodology is used to identify and to track every prescription form we produce. The State of New Jersey requires that all Rx forms have a unique batch number. We also print a unique batch number on all Rx forms we 6We currently provide our services to pharmaceutical companies and to health care providers. We receive payment from the pharmaceutical companies by check and we also accept American Express, MasterCard, Visa and Discover credit cards for our health care provider accounts. 6"""" xbased upon If any other si reWe currently provide our services to pharmaceutical companies and to health care providers. We receive payment from the pharmaceutical s" 8sPWe will offer several counterfeit-proof prescription blanks. Our standard single sheet form is trimmed to 4.25 x 5.5. It is available as a single sheet and as a 2- 9'uAn existanceare and are also provided to the security Additional comments about the security of our facilities is. That ,controllsacontrolliBy aA is provided by ing Securifeatures of our facility are provided belooverview ofSamples of prototype prescription blanks are enclosed. the stock production process from the actual prescription form production process by facility and distance, dividOt The request for stock is forwarWhen stockhas the sole responsibility and is dedicated to stock tCen. Those there As the counterfeit-proof stock As the stock Ii cwe need stock to produce counterfeit-proof we need facility that will use the stock to produce prescriptions neddedThen torders for pare then sent to the production facility is notified by us to send stock to the , ra tear sheet taken fro , tracking number and shipped. Each order is given a tracking number. A shipping label and tracking number and t. The is sent C ouand are delivered. 0Rx PROvisions, Inc. uses UPS to ship security Rx forms to the Prescriber. Rx forms are printed, shrunk wrapped and packed in plain brown boxes. The dominant label on the outer box is the white UPS bar code label. All orders are delivered with a signature required feature to confirm the receivers signature, the date and the time of delivery. B. These delivery data are captured electronically and two copies are printed. One copy is sent with the invoice to confirm delivery and the other remains with the original order on file. Order records are kept for five years. A. Upon receipt of an order for prescription forms, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by Practitioner. The entry includes the order date, practice address, phone (fax if applicable) payment method (check, credit card), the quantity ordered, the type of prescription form and the assignment of a unique RXP number or Batch Number, that corresponds to each order. B. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. C. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 8 years. Electronic data is secured with a scheduled back up. Two back up copies are produced and kept in two different secure locations. The hard copy (order forms and shipping confirmation) is scanned and stored electronically with the backed up electronic data. The original order form and the shipping confirmation are also kept as bound hard copy, filed by physician, for 5 years. These records are kept in a secure dry site. The original order form received by Rx PROvisions, Inc. from the health care provider and the shipping information for that order will be made available as hard copy on demand as requested by law enforcement. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). The records can be produced within 24 hours. A. Upon receipt of an order for prescription forms, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by Practitioner. The entry includes the order date, practice address, phone (fax if applicable) payment method (check, credit card), the quantity ordered, the type of prescription form and the assignment of a unique RXP number or Batch Number, that corresponds to each order. B. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. C. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 8 years. Electronic data is secured with a scheduled back up. Two back up copies are produced and kept in two different secure locations. The hard copy (order forms and shipping confirmation) is scanned and stored electronically with the backed up electronic data. The original order form and the shipping confirmation are also kept as bound hard copy, filed by physician, for 5 years. These records are kept in a secure dry site. The original order form received by Rx PROvisions, Inc. from the health care provider and the shipping information for that order will be made available as hard copy on demand as requested by law enforcement. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). The records can be produced within 24 hours. Rx PROvisions, Inc. uses UPS to ship security Rx forms to the Prescriber. Rx forms are printed, shrunk wrapped and packed in plain brown boxes. The dominant label on the outer box is the white UPS bar code label. All orders are delivered with a signature required feature to confirm the receivers signature, the date and the time of delivery. B. These delivery data are captured electronically and two copies are printed. One copy is sent with the invoice to confirm delivery and the other remains with the original order on file. Order records are kept for five years. In our twelve years of existence we never had any security breech of any kindA. Upon receipt of an order for prescription forms, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by Practitioner. The entry includes the order date, practice address, phone (fax if applicable) payment method (check, credit card), the quantity ordered, the type of prescription form and the assignment of a unique RXP number or Batch Number, that corresponds to each order. B. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. C. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 8 years. Electronic data is secured with a scheduled back up. Two back up copies are produced and kept in two different secure locations. The hard copy (order forms and shipping confirmation) is scanned and stored electronically with the backed up electronic data. The original order form and the shipping confirmation are also kept as bound hard copy, filed by physician, for 5 years. These records are kept in a secure dry site. The original order form received by Rx PROvisions, Inc. from the health care provider and the shipping information for that order will be made available as hard copy on demand as requested by law enforcement. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). The records can be produced within 24 hours. Rx PROvisions, Inc. uses UPS to ship security Rx forms to the Prescriber. Rx forms are printed, shrunk wrapped and packed in plain brown boxes. The dominant label on the outer box is the white UPS bar code label. All orders are delivered with a signature required feature to confirm the receivers signature, the date and the time of delivery. B. These delivery data are captured electronically and two copies are printed. One copy is sent with the invoice to confirm delivery and the other remains with the original order on file. Order records are kept for five years. In our twelve years of existence we never had any security breech of any kindnThe following addresses the methodology lyA. Upon receipt of an order for prescription forms, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by Practitioner information needsre.lyA. Practitioner.B. C. 8aE, faxesscanned and retreivedsent ordered, the type of prescription form practitoner be re, can als UPS B. two copies are printed. One copy is sent with the invoice to confirm delivery and the other remains with the original order on file. Order records are kept for five years. In our twelve years of existence we never had any security breech of any kind electronically with the backed up electronic data. The original order form and the shipping confirmation are also kept as bound hard copy, filed by physician, for 5 yearsare also kept as bound hard copy, filed by physician, for 5 years electronically with the backed up electronic data. The original order form and the shipping confirmation. These records are kept in a secure dry site. data. The original order form and the shipping confirmation. These records are kept in a secure dry site. electronically with the backed up electronic. ,.are different and shipping confirmationstored for a moving 5 years as bound bound and stored for a moving 5 years as hard copy, filed by physician These records are kept in a secure dry site,electronically with the backed up electronic data. The original order form and the shipping confirmation . orderform yrand to the AHC any data (electronic and or hard copy) relating to any order from any Florida health care provider. dThe original order form received by Rx PROvisions, Inc. from the health care provider and the shipping information for that order will be made available as hard copy on demand as requested as requested to the AHC as requested dThe original order form received by Rx PROvisions, Inc. from the health care provider and the shipping information for that order will be made available as hard copy by law enforcement. in plain brown boxes. box UPSlabel ' AnyThe Electronic dataRx PROvisions, Inc. uses DHL and to ship security Rx forms to the Prescriber. Rx forms are printed, shrunk wrapped and packed. The dominant label on the outer shipper is the white bar code label. All orders are delivered with a signature required feature to confirm the receivers signature, the date and the time of delivery. These delivery data are captured electronically and stored. Tbeen sentt in an electronic format or any other crican also be retrieved and provided on demand. and e.The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). All electronic records can be produced within 24 hours. Reports will be produced on demand in an electronic format to reflect the practitioner, order dates, prescription form quantities ordered, tracking number information and any additional information we have in our database from orders received from Florida healthcare providers. , 1 nare produced the The following are used successfully for the last twelve years to comply with operational requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwide. addresses the record keeping and database methodology Rx PROvisions, Inc has sonow ,A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. Rx PROvisions, Inc. will use the web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify the practitioners license status by completing the information requested on the license search page on the site. The order for prescriptions will be processed further if the practitioners license is approved as Clear, Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. The DEA database contains over 1.2 million records and is updated monthly by the DEA. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. been A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. Rx PROvisions, Inc. will use the web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify the practitioners license status by completing the information requested on the license search page on the site. The order for prescriptions will be processed further if the practitioners license is approved as Clear, Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. The DEA database contains over 1.2 million records and is updated monthly by the DEA. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. been A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. Rx PROvisions, Inc. will use the web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify the practitioners license status by completing the information requested on the license search page on the site. The order for prescriptions will be processed further if the practitioners license is approved as Clear, Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. The DEA database contains over 1.2 million records and is updated monthly by the DEA. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. been A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. Rx PROvisions, Inc. will use the web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify the practitioners license status by completing the information requested on the license search page on the site. The order for prescriptions will be processed further if the practitioners license is approved as Clear, Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. The DEA database contains over 1.2 million records and is updated monthly by the DEA. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. Rx PROvisions, Inc. has been A. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. Our order process also requires the name and phone number of the person who is placing the order for security prescriptions on behalf of the Prescriber, if applicable. The information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. Rx PROvisions, Inc. will use the web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify the practitioners license status by completing the information requested on the license search page on the site. The order for prescriptions will be processed further if the practitioners license is approved as Clear, Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. The DEA database contains over 1.2 million records and is updated monthly by the DEA. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. Rx PROvisions, Inc. has been A. 2web site  HYPERLINK "http://www.dca.ca.gov" www.dca.ca.gov to verify will sprovides the current license number for each healthcare provider and will be used to verify license Tof provides the current license number for each healthcare provider of provides the current license number for and tHby completing the Specifically, tinformation requested on the license search page on the site. approved as Clear,Renewed/Current or Active. If the search results reveal anything other than Clear, Renewed/Current or Active, Rx PROvisions, Inc. will call the appropriate licensing board to verify that the practitioner is permitted to practice and write controlled substance prescriptions. B. The order for prescriptions will be processed further if the practitioners license is confirmed. Authority to Prescribe Controlled Substances (DEA Registration) Rx PROvisions, Inc. will use the DEA on line look up to verify the Practitioners DEA number. .conterfeitsecurityThe information provided on the order form for prescriptions is verified against the States prescribing practitioner License database. An additional numerical identifier, the Practitioners UPIN is used by Rx PROvisions, Inc. In response to recent HIPAA regulations, the UPIN number is going to be replaced by a 10-digit National Provider Identifier, or NPI, that will identify all providers who bill electronically, not just Medicare providers. Unfortunately at this time the new NPI and the DEA are not linked and must be used independently. and to use tformat 3d couterfeittoshippmentto The current handle an additional 100,000 physicians. 2 oOur prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. We also request their current prescription form which is also used Our production capacity is designed to be perfectly scalable to satisfy demand. We receive an average of two or more orders each year from over 100,000 physicians in our database. We have additional plant capacity right now to produce counterfeit-proof prescriptions for an additional 10,000 physicians each month. The average time from receipt of order to shipment of the product is from 24 hours to 48 hours. Our current business model is designed to handle up to 200,000 healthcare providers. 4f'sOur current business model is designed to handle up to 200,000 healthcare providers. Our production capacity is designed to be perfectly scalable to satisfy demand. We receive an average of two or more orders each year from over 100,000 physicians in our database. 5Paragraph 16. Listed below are references for you to contact for our companys experience and qualifications with the production of fraud resistant prescriptions. Paragraph 16. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The reactive qualities of thermal sensitive ink also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title ____________________________________ ; and product labels for the pharmaceutical manufacturers to use to protect the integrity and potency of their prescription and OTC products and samples. security features including interactive thermal sensitive ink as partfeatures including interactive thermal sensitive ink as partRx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our counterfeit-proof security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The reactive qualities of thermal sensitive ink also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title Rx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our counterfeit-proof security stock is our design and is produced exclusively for our use in the production of prescription forms. Our trust is at the heart of any document of value, which the counterfeiter tries to undermine not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. uses several security features including interactive thermal sensitive ink as part of the healthcare providers personalized prescription form production process. Reactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. The reactive qualities of thermal sensitive ink also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. I certify that the foregoing information provided in the above responses is true and accurate. _______________________________________ ____________________ Name Date Title any snfor their physicians. Build a relationship between called on physicians and the sales representatives who are providing a value added service for the physician. Build a relationship between called on physicians and the sales representatives who are providing a value added service for the physician. encourage the pharmacist to dispense the prescription as written.uspecific and 'Tgoes forms to promote printed entirely with thermal sensitive inksThe . . During the last ten years we have been We can retrieve current or hwe prescriptions have Rx forms for at least the last 10 years.counterfeit resistant copyhave the on the left uo. The quality of the fThe t raud resistant paper isa The Rx PROvisions, Inc. Pre-printed Rx Pad Program is designed to respond to Pharmaceutical Sales Representatives who request pre-printed Rx Pads in response to approval from the physician. Not all physicians use pre-printed Rx pads so the program is directed by the Sales Representatives who can pre-qualify the physician. The pre-printed Rx pad program is designed to: Facilitate the prescribing of frequently used and or complicated treatment modalities among targeted physicians. Enable the pharmacist to understand the prescription, to dispense it properly and to facilitate the pharmacists directions to the patient. opaque offset white 60# offset opaque by entirely and that the to The assigned and very addresses via mail fax or e-mail, the record keeping and database methodology Rx PROvisions, Inc has used successfully for the last twelve years to comply with operational requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwide. Upon receipt of an order for prescription forms Paragraph 13. ['However, the health care providers NPI, which will be used for billing purposes may replace both the License number and the DEA number in the future. INTERNAL MEDICINE ASSOCIATES OF NJ 1777 Hamburg Turnpike, Suite 302 Wayne, NJ 07470 ATTN: LORI Office Manager 973-831-9222 Ms. Denise Conte, Representative Medicis Pharmaceutical Corporation 8125 North Hayden Road Scottsdale, AZ 85258 908-342-2002 Princeton Orthopaedic Associates, PA Jo Donnelly, Office Manager 325 Princeton Avenue Princeton, NJ 08540 609-924-8131 x4333 Princeton Orthopaedic Associates, PA Jo Donnelly, Office Manager The reactive qualities of thermal sensitive ink also serve as a quick validity test for the dispensing pharmacist. An example of our security Rx form printed with blue thermal sensitive ink on the front side and on the reverse side is enclosed with this application. are continuReactive ink properties help to protect original prescription forms from fraudulent use, which can save our healthcare industry hundreds of millions of dollars annually. . which can industry hundreds of millions of dollars annually. are continuReactive ink properties help to protect original prescription forms from fraudulent use, our physicians OsThe and diaserves on the back with a State logo "copied,lightened,.The company Our Rx forms currently use the following features on the front side; a void pattern appears if copied, a thermal sensitive ink Pharmacy Rx Symbol in the corner, a micro print signature line that will not be legible if Rx form is copied, a six quantity check box to confirm the quantity prescribed, and a unique batch number that identifies the production date, the practitioner or health care facility and the order number. On the back we have the following features; a description of the safety features, thermal sensitive blue ink in our One to One"! logo and a security watermark that is seen at an angle. A representative sample of our current product is enclosed. Our trust is at the heart of any document of value, which the counterfeiter undermines not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. produces paper stock with several tamper proof features which are listed below. Our security features help to protect original prescription forms from fraudulent use, which can save the healthcare system hundreds of millions of dollars annually. In 1996, we worked in collaboration with the NJ Department of Health and Human Services to develop ways to protect prescriptions in response to the departments concern over Medicaid Fraud in NJ. Since 1997, the paper we have used and continue to use to produce tamper proof prescriptions is made by Rx PROvisions, Inc. Our tamper proof paper starts with 60# opaque white stock and then the following is applied to the front side of the paper; 1. A latent "VOID" pattern is applied to paper. This pattern will appear when the prescription is copied or faxed. 2. A second screened "blue" color ink is applied over the "VOID" pattern. This ink coat covers the "VOID" pattern and also serves to identify erasures and chemical alterations. 3. A third ink is applied to the paper. This is the "thermochromic" blue ink that serves as a validity test for the pharmacist. The blue thermochromic ink will fade to colorless when touched and will reappear when cooled. 4. Under the "Address" line we print, "Rx illegal if not thermal sensitive blue Rx square in corner. VOID appears when copied. On back, hologram copy appears and blue thermal Rx will fade to colorless when warmed". 5. The "signature line" on the front of the prescription is printed in "microprint" with the words" Rx PROvisions, Inc. Security". The microprint is too small to remain legible if copied. 6. Our name "Rx PROvisions, Inc." and a "unique" batch number, beginning with the letters "RXP" are printed in the bottom corner. The "batch" number identifies the production date, the prescriber and the order that generated the prescription. On the back of the paper, we apply the following: 1. First we apply the "hologram" copy that is faint but can be seen at an angle. 2. A second printing pass applies our phone number, our name, a list of the security features that make the prescription tamper proof and our thumb print "One to One logo which also represents Prescription Security as the core of our mission. 3. A third press pass applies the "thermochromic RX" with blue ink that is part of our patented logo and serves as an additional validity test for the pharmacist. The features listed above make our prescription forms tamper proof and these features meet and exceed the state Medicaid tamper-poof requirements. Our trust is at the heart of any document of value, which the counterfeiter undermines not just in monetary terms but also in fundamental public confidence. To preserve that trust, Rx PROvisions, Inc. produces paper stock with several tamper proof features which are listed below. Our security features help to protect original prescription forms from fraudulent use, which can save the healthcare system hundreds of millions of dollars annually. In 1996, we worked in collaboration with the NJ Department of Health and Human Services to develop ways to protect prescriptions in response to the departments concern over Medicaid Fraud in NJ.Since 1997, the paper we have used and continue to use to produce tamper proof prescriptions is made by Rx PROvisions, Inc. Our tamper proof paper starts with 50 or 60# opaque white stock and then the following is applied to the front side of the paper; 1. A latent "VOID" pattern is applied to paper. This pattern will appear when the prescription is copied or faxed. 2. A second screened "blue" color ink is applied over the "VOID" pattern. This ink coat covers the "VOID" pattern and also serves to identify erasures and chemical alterations. 3. A third ink is applied to the paper. This is the "thermochromic" blue ink that serves as a validity test for the pharmacist. The blue thermochromic ink will fade to colorless when touched and will reappear when cooled. 4. Under the "Address" line we print, "Rx illegal if not thermal sensitive blue Rx square in corner. VOID appears when copied. On back, hologram copy appears and blue thermal Rx will fade to colorless when warmed". 5. The "signature line" on the front of the prescription is printed in "microprint" with the words" Rx PROvisions, Inc. Security". The microprint is too small to remain legible if copied. 6. Our name "Rx PROvisions, Inc." and a "unique" batch number, beginning with the letters "RXP" are printed in the bottom corner. The "batch" number identifies the production date, the prescriber and the order that generated the prescription. On the back of the paper, we apply the following: 1. First we apply the "hologram" copy that is faint but can be seen at an angle. 2. A second printing pass applies our phone number, our name, a list of the security features that make the prescription tamper proof and our thumb print "One to One logo which also represents Prescription Security as the core of our mission. 3. A third press pass applies the "thermochromic RX" with blue ink that is part of our patented logo and serves as an additional validity test for the pharmacist. The features listed above make our prescription forms tamper proof and these features meet and exceed the state Medicaid tamper-poof requirements. Paragraph 5. The batch number methodology is used to identify and to track every prescription form we produce. The State of New Jersey requires that all Rx forms have a unique batch number. We also print a unique batch number on all Rx forms we distribute nationwide. The batch number starts with three letters, RXP that identifies Rx PROvisions, On the back of the paper, we apply the following: Our tamper proof paper starts with 50 or 60# opaque white stock and then the following is applied to the front side of the paper; Our tamper proof paper starts with 50 or 60# opaque white stock and then the following is applied to the front side of the paper; is "Rx illegal if not thermal sensitive blue Rx square in corner. VOID appears when copied. On back, hologram copy appears and blue thermal Rx will fade to colorless when warmed". on all Rx forms(01) Title ____________________________________ Rx On , h. Happears s and for presc. Our standard large Rx forms are trimmed to 5.5 x 8.5. It is available as a single sheet and as a 2-part set. Florida health care provider. In the event of a recall or any other emergency, these data can be used to reach all healthcare providers who have received prescription forms from Rx PROvisions, Inc. Reports will be produced on demand in an electronic format to reflect the practitioner, order dates, prescription form quantities ordered, tracking number information and any additional information we have in our database from orders received from Florida healthcare providers. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). All electronic records can be produced within 24 hours. Paragraph 12. Rx PROvisions, Inc. has been producing prescription forms for the past twelve years. If the sample prototype is acceptable by AHA, Rx PROvisions, Inc. is ready to produce counterfeit-proof prescriptions for Florida healthcare providers. Orders will be entered as described above and prescription forms can be produced in 24 hours. Paragraph 13. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. We also request their current prescription form which is also used to verify, update and to format their prescription form. Our order process also requires the name and phone number of the person who is placing the order for counterfeit-proof prescriptions on behalf of the Prescriber, if applicable. Rx PROvisions, Inc. uses the internet to verify the practitioners license status The Floridahologram Rx PROvisions, Inc Sehologram""copy XThe features listed above make our prescription forms tamper proof and these features meet and exceed the "Manner of Issuance of Written, Typed or Computer Generated Prescriptions". (Chapter 6, Section 4, WY Controlled Substance Act, Rules and Regulations). . spoofproof. requirements.TsWspracticefraud counterfeit-proofor for counterfeit-proofCounterfeit-proofCounterfeit-proof counterfeit-proof stock, 2-part stock, regular and colored stock, as directed by the physician. Rx PROvisions, Inc. also receives prescription pad orders directly from health care providers. The practice completes an order form and mails or faxes the order form to us. If the order is new, a proof is sent to the practice for approval before the order is produced. If the order is for Rx forms we have done before and there are no changes, the order is entered into our database and then it is sent to production for printing and shipping. Paragraph 3. Rx PROvisions, Inc. has been in business since 1995. In 1996, the first order for prescription pads came from a pharmaceutical company that wanted to use our Rx pads as a medium to deliver advertising for a product used to treat diabetes. In 1996, our Rx forms were printed entirely with blue thermal sensitive ink that reacted to touch and served as a test for validity. In 1997, Rx PROvisions, Inc was approved to provide the new security Rx form in New Jersey which was initiated to address Medicaid prescription fraud (approval letter enclosed). These Rx forms are printed in blue with a State logo on the front and in green with a State logo on the back (see blank NJ Prescription Blank, enclosed). All of these forms must be produced and shipped with a tracking number to prove delivery directly to the practitioner. Rx PROvisions, Inc. has been providing these Rx forms to health care providers in New Jersey for the last ten years. Historical data on any physician orders for prescriptions produced and shipped by Rx PROvisions, Inc. can be provided on demand. Paragraph 4. We continue to enhance our counterfeit-proof Rx forms by adding features to stop the fraudulent use of prescription forms. Our Rx forms currently use the following features on the front side; a void pattern appears if copied, a thermal sensitive ink Pharmacy Rx Symbol in the corner, a micro print signature line that will not be legible if Rx form is copied, a six quantity check box to confirm the quantity prescribed, and a unique batch number that identifies the production date, the practitioner or health care facility and the order number. On the back we have the following features; a description of the safety features, thermal sensitive blue ink in our One to One"! logo and a security watermark that is seen at an angle. A representative sample of our current product is enclosed. Since 1997, the paper we have used and continue to use to produce tamper proof prescriptions is made by Rx PROvisions, Inc. Our tamper proof paper starts with 50# or 60# opaque white stock and then the following are applied to the front side of the paper; 1. A latent "VOID" pattern is applied to paper. This pattern will appear when the prescription is copied or faxed. 2. A second screened "blue" color ink is applied over the "VOID" pattern. This ink coat covers the "VOID" pattern and also serves to identify erasures and chemical alterations. 3. A third ink is applied to the paper. This is the "thermochromic" blue ink that serves as a validity test for the pharmacist. The blue thermochromic ink will fade to colorless when touched and will reappear when cooled. 4. Under the "Address" line we print, "Prescription illegal if not blue background with thermal sensitive blue Rx square in corner. Resists erasures or alterations. VOID appears on front when copied. Security features listed on back with watermark copy and blue thermal Rx that will fade to colorless when warmed". 5. The "signature line" on the front of the prescription is printed in "microprint" with the words" Rx PROvisions, Inc. Security". The microprint is too small to remain legible if copied. 6. Our name "Rx PROvisions, Inc." and a "unique" batch number, beginning with the letters "RXP" are printed in the bottom corner. The "batch" number identifies the production date, the prescriber and the order that generated the prescription. On the back of the paper, we apply the following: 1. First we apply the "watermark that is faint but can be seen at an angle. 2. A second printing pass applies our TOLL FREE phone number, our name, a list of the security features that make the prescription tamper proof and our thumb print "One to One logo which also represents Prescription Security as the core of our mission. 3. A third press pass applies the "thermochromic Rx" letters with blue ink that is part of our patented logo and serves as an additional validity test for the pharmacist. The features listed above make our prescription forms tamper resistant and these features meet and exceed the "Manner of Issuance of Written, Typed or Computer Generated Prescriptions" (Chapter 6, Section 4, WY Controlled Substance Act, Rules and Regulations) and the Federal guidelines for State Medicaid tamper-resistant prescription forms. Paragraph 5. The batch number methodology is used to identify and to track every prescription form we produce. Several States, including the State of New Jersey require that all Rx forms have a unique batch number. Actually, we also print a unique batch number on all Rx forms we distribute nationwide. The batch number starts with three letters, RXP that identifies Rx PROvisions, Inc as the producer of the document. The RXP is followed by six digits that represent the year, month and day (yymmdd), or the order date. The order date is followed by four digits (1234) that refer to the practitioner or health care facility and serve as a locator number for our database. The last two digits (01) refer to the number of orders produced for the healthcare provider so far that year. Paragraph 6. We currently provide our services to pharmaceutical companies and to health care providers. We receive payment from the pharmaceutical companies by check and we also accept American Express, MasterCard, Visa and Discover credit cards for our health care provider accounts. Paragraph 7. The paper stock used by Rx PROvisions, Inc. for tamper resistant prescriptions is 50# or 60# offset opaque white stock. Paragraph 8. We will offer several tamper resistant prescription blanks for both single product entry and for multiple entries (samples enclosed). Our standard single sheet Rx form is trimmed to 4.25 x 5.5. Our computer sheets are 8.5 x 11. We will respond to and produce any other custom size for any client that orders them from us. Paragraph 9. Samples of prototype prescription blanks for the State of Wyoming are enclosed. Paragraph 10. In our twelve years of existence we never had any security breech of any kind. A convenient flow diagram of the companys operational processes and safeguards for manufacturing our tamper resistant stock is provided below. Additional comments about the security of our facilities are also provided. Tamper resistant stock is produced exclusively at one facility and that facility has the original printing plates, thermal sensitive ink and electronic files used in the counterfeit-proof stock production process. The facility is protected by external and internal security systems and alarm that monitor and protect the building and the safety of the stock we produce. One person at that facility has the authorization to access the printing plates, the thermal sensitive ink and the production material needed to produce our counterfeit-proof stock. Tamper resistant stock inventory is produced and stored exclusively at this facility. When counterfeit-proof stock is needed to produce prescriptions, the contact person at Rx PROvisions, Inc. is notified via e-mail from the prescription form production facility. We use separate facilities to provide additional security and control. Each plant is physically separated by communication, location and distance. Our on-demand production process controls the use, inventory and security of the stock we produce. Orders for prescription forms from our clients are received by our Main Street location where the orders are processed and sent to our prescription form production facility. Orders for counterfeit-proof stock required to produce these prescriptions are directed to our Main Street office. Then, the counterfeit-proof stock production facility is notified to provide the required inventory for the prescription production facility where the prescription pads are printed and packed. Then the tracking numbers and shipping labels are affixed to each order. Orders are picked up at the end of each day at this facility for delivery to our clients. The prescription form production facility sends the shipping information to our Main Street office where the orders are closed out and invoiced. Paragraph 11. The following describes, the record keeping and database methodology Rx PROvisions, Inc has used successfully for the last twelve years to comply with operational requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwide. Upon receipt of an order for prescription forms via mail fax or e-mail, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by healthcare provider. The entry includes the order date, practice name and practitioner, complete address, phone (fax if applicable) payment method (check, credit card), the prescription form quantity and type and the assignment of a unique RXP number or Batch Number, that corresponds to each order. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 10 years. All electronic data is secured with a daily scheduled back up. Two back up copies of the electronic back-up data are produced and kept in two separate secure locations. The hard copy (order forms from clients) is filed by physician, bound and stored for a moving 5 years as hard copy. These records are kept in a secure dry site Rx PROvisions, Inc. will make available on demand to the AHC any and all data (electronic and or hard copy) relating to any order from any WYOMING health care provider. In the event of a recall or any other emergency, these data can be used to reach all healthcare providers who have received prescription forms from Rx PROvisions, Inc. Reports will be produced on demand in an electronic format to reflect the practitioner, order dates, prescription form quantities ordered, tracking number information and any additional information we have in our database from orders received from WYOMING healthcare providers. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est). All electronic records can be produced within 24 hours. Paragraph 12. Rx PROvisions, Inc. has been producing prescription forms for the past twelve years. If the sample prototype is acceptable by AHA, Rx PROvisions, Inc. is ready to produce counterfeit-proof prescriptions for WYOMING healthcare providers. Orders will be entered as described above and prescription forms can be produced in 24 hours. Paragraph 13. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. We also request their current prescription form which is also used to verify, update and to format their prescription form. Our order process also requires the name and phone number of the person who is placing the order for counterfeit-proof prescriptions on behalf of the Prescriber, if applicable. Rx PROvisions, Inc. uses the internet to verify the practitioners license status The WYOMING Medical License search will be used to verify the license numbers for each healthcare provider who orders prescription forms. Rx PROvisions, Inc also uses DEA Lookup.com to verify DEA numbers. The DEA database contains over 1.2 million records and is updated monthly by the DEA. Paragraph 14. Our current business model is designed to handle up to 200,000 healthcare providers. Our production capacity is designed to be perfectly scalable to satisfy demand. We receive an average of two or more orders each year from over 100,000 physicians in our database. We have additional plant capacity right now to produce counterfeit-proof prescriptions for an additional 10,000 physicians each month. The average time from receipt of order to shipment of the product is from 24 hours to 48 hours. Paragraph 15. Listed below are references for you to contact for our companys experience and qualifications with the production of fraud resistant prescriptions. INTERNAL MEDICINE ASSOCIATES OF NJ 1777 Hamburg Turnpike, Suite 302 Wayne, NJ 07470 ATTN: LORI Office Manager 973-831-9222 Ms. Denise Conte, Representative Medicis Pharmaceutical Corporation 8125 North Hayden Road Scottsdale, AZ 85258 908-342-2002 Jo Donnelly, Office Manager Princeton Orthopaedic Associates, PA 325 Princeton Avenue Princeton, NJ 08540 609-924-8131 x4333 Paragraph 16. General Statement: Rx PROvisions, Inc was incorporated on August 15, 1995 and created and patented our Rx Fingerprint trademark to communicate our security position in the marketplace. Rx PROvisions, Inc. is a privately held company that serves the healthcare industry nationwide. The products produced by Rx PROvisions, Inc. include; personalized fraud resistant prescription forms, diagnostic forms and other office practice forms that are used and consumed by healthcare providers in conjunction with patient care. In 1997 when the State of New Jersey adopted a security prescription law to reduce prescription fraud, Rx PROvisions, Inc. completed and submitted a vendor application. On July 14, 1997, our firm was approved (see copy of approval letter) as a licensed vendor to provide New Jersey uniform prescription blanks in response to the new law requiring physicians to use security prescriptions. An example of the NJ Rx form is enclosed. The fiscal impact of the new law was highlighted in an earlier report in June 1996 by the NJ Department of the Treasury X!X!X!X!X!X!X!Z!Z![! [!%[!+[!?[!G[!N[!W[!^[!g[!n[!w[!~[![![![![![![![![![![![![![![![![![![![![![![!\!\!\!\!\!\!\!\! \!!\!'\!0\!1\!2\!5\!ּhSDB*hphhSD5B*hphhSDB*OJQJhphhSD5B*OJQJhphhSD hSD5CJ hSDCJjhSDCJUmHnHuhSDCJmHnHuhSD56CJ:Z!Z!Z![![![![! [!%[!+[!,[! $$Ifa$Ukd$$IfF     4  $$Ifa$$If$ x@a$ ,[!-[!1[!8[!9[!:[!?[!G[!H[!JUkd$$IfF     4  $$Ifa$Ukdj$$IfF     4 H[!I[!N[!W[!X[!Y[!^[!g[!h[!JUkd$$IfF     4  $$Ifa$Ukd6$$IfF     4 h[!i[!n[!w[!x[!y[!~[![![!JUkdh$$IfF     4  $$Ifa$Ukd$$IfF     4 [![![![![![![![![!JUkd4$$IfF     4  $$Ifa$Ukd$$IfF     4 [![![![![![![!D; $$Ifa$Ukd$$IfF     4  $$Ifa$$IfUkd$$IfF     4 [![![![![![![![!AUkd$$IfF     4 Ukdj$$IfF     4  $$Ifa$ $$Ifa$[![![![![![![![![!JUkd$$IfF     4 Ukd6$$IfF     4  $$Ifa$[![![!\!\!\!\!\!\!JUkdh$$IfF     4 Ukd$$IfF     4  $$Ifa$\!\!\! \!!\!'\!0\!1\!2\!JUkd4$$IfF     4 Ukd$$IfF     4  $$Ifa$2\!3\!4\!5\!L\!M\!N\!O\!T\!Z\![\! $$Ifa$Ukd$$IfF     4 $If $$Ifa$ 5\!N\!O\!T\!Z\![\!\\!h\!i\!n\!v\!w\!x\!}\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!\!]!]! ]!]!]!]!]!]!]!$]!-]!.]!/]!4]!=]!>]!?]!D]!M]!N]!O]!U]!^]!_]!`]!c]!Ӹ㨸ɨɨɨɨɨɨɨɨhSDB*CJOJQJhph!hSD5B*CJOJQJhphhSDB*hphhSDB*CJ$OJQJhphhSD5B*hph!hSD5B*CJ$OJQJhphB[\!\\!`\!g\!h\!i\!n\!v\!w\!JUkdj$$IfF     4  $$Ifa$Ukd$$IfF     4 w\!x\!}\!\!\!\!\!\!\!JUkd6 $$IfF     4  $$Ifa$Ukd$$IfF     4 \!\!\!\!\!\!\!\!\!JUkd $$IfF     4  $$Ifa$Ukd $$IfF     4 \!\!\!\!\!\!\!\!\!JUkd $$IfF     4  $$Ifa$Ukdh $$IfF     4 \!\!\!\!\!\!\!\! $$Ifa$Ukd4 $$IfF     4  $$Ifa$$If\!\!\!\!\!]!]! ]!]!JUkd $$IfF     4  $$Ifa$Ukd $$IfF     4 ]!]!]!]!]!]!$]!-]!.]!JUkd $$IfF     4  $$Ifa$Ukdj $$IfF     4 .]!/]!4]!=]!>]!?]!D]!M]!N]!JUkd $$IfF     4  $$Ifa$Ukd6 $$IfF     4 N]!O]!U]!^]!_]!`]!a]!b]!c]!JUkdh$$IfF     4  $$Ifa$Ukd$$IfF     4 c]!z]!{]!|]!}]!]!]!]! $$Ifa$Ukd$$IfF     4  $$Ifa$$Ifc]!|]!}]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]!]^!w^!|^!^!^!^!^!^!^!^!^!^!^!^!^!^!^!^!^!^!^!_!己Ƿ$hSD56>*B*CJ$OJQJph hSDCJjhSDCJUmHnHu hSDCJ hSDB*hphhSDB*OJQJhphhSD5B*hphhSD5B*OJQJhph7]!]!]!]!]!]!]!]!]!JUkd$$IfF     4  $$Ifa$Ukd8$$IfF     4 ]!]!]!]!]!]!]!]!]!JUkdj$$IfF     4  $$Ifa$Ukd$$IfF     4 ]!]!]!]!]!]!]!]!]!JUkd6$$IfF     4  $$Ifa$Ukd$$IfF     4 ]!]!]!]!]!]!]!]!]!JUkd$$IfF     4  $$Ifa$Ukd$$IfF     4 ]!^! ^!!^!/^!0^!1^!]^!t^!u^!v^!w^!|^!^!^! $$Ifa$Ukdh$$IfF     4  $$Ifa$$If$ x@a$^!^!^!^!^!^!^!^!^!JUkd8$$IfF     4  $$Ifa$Ukd$$IfF     4 ^!^!^!^!^!^!^!^!^!JUkd$$IfF     4  $$Ifa$Ukd$$IfF     4 ^!^!^!^!^!^!^!^!^!JUkd$$IfF     4  $$Ifa$Ukdj$$IfF     4 ^!^!^!^!^!_!*_!K_!s_!u_!_!_!_!_!_!$a$ $ $ a$$ x@a$ x@ $$Ifa$Ukd6$$IfF     4 _!_!*_!K_!\_!]_!^_!r_!s_!t_!_!_!b!=c!Lc!6e!Le!Ze!_e!e!e!Rf!ff!~f!f!f!f!f!g!>g!Hg!h!h!j!j!j!{t{ojjjjjjjjaZ hSD5>*hSD5>*CJ hSD>* hSD5 hSD>*CJ hSDCJhSD hSDCJ jhSDCJUmHnHu hSD>*CJhSD>*CJOJQJ' j8hSD:>*B* CJ OJQJphhSD6>*CJOJQJhSD56B*OJQJph!hSD56B*CJOJQJph!hSD56B*CJ$OJQJph#_!_!_!`!`!`!`!b! c! c!d!d!d!d!5e!6e!Pe!e!4f!f!g!h!j!j!j!Rk!L & FLL$a$ L & F L   x@j!j!j!j!j!k!k!k!k!k!k!k!k!l!l!}m!~m!m!m!n!n!o!o!p!p!r!Dr!Er!s!s!s!x! x!x!x! y! y!y!y!y!y!z!z!z!{!|!|!|!8}!}!}! ~!4~!~!~!~!~!~!~!~!-!.!/!0!!亩!jhSD>*CJUmHnHu hSD>*CJ hSD6>* hSD6hSD5>*CJ hSD6CJ hSD5CJ hSDCJ hSD5>* hSD5hSD hSD>*@Rk!k!k!k!l!l!~m!m!m!m!$n!n!n!n!co!do!o!o!o!o!o!o!o!o! ] L L & FL & FL & FLL$a$L & Fo!p!p!p!Lq!Mq!r!#r!.r!Er!r!r!ds!s!s!s!s!t!t!u!v!Gw!x! x! x! x!x! & FM NOPL$a$x! y!y!y!y!y!7z!z!z!z!{!{!|!|!|!|!|!}!}!~!~!~!~!-!.!L & F & Fh^h` hL & FL & FL$a$L & F.!/!O!!!!!!M!N!!!!!!!!Հ!! !M!!!! <]<LL & FLh`hL$h`ha$ & F$a$  ^` !+!M!N!O!!!!!!!!!!0!Q!!!DŽ!Ȅ!! !:!`!!!!7!* hSD>* hSD>*CJhSD5CJOJQJjhSDUmHnHuhSDjhSDCJUmHnHu hSDCJ hSD>*CJhSD56CJ A!!DŽ!Ȅ!!!!!-!!!Ԉ!/!?!!!!!!O!P!Z!L!я!!L & FL & FL & FLL$a$ L & F  x@ Џ!я!!!8!9!H!R!P!!!!!!!!!Ι!!!-!1!_!f!g!Y!Z!ݝ!ޝ!!!F!G!۟!!!!M!n!v!!! ! !!! !!!>!@!A!E!H!!!ľĮğđđđ hSD5CJjhSDUmHnHujhSD5UmHnHujhSDCJUmHnHu hSDCJ hSDCJ hSD6>* hSD>*CJ hSD5CJ hSDCJ hSD5>* hSD6 hSD5hSD hSD>*6!!!w!!9!;!!!!!'!(!)!:!D!H!R!!!!!P!d!o!$a$ ] L LL & FL & FL$a$o!!!!!!!!!!&!@!!F!!!!j!k!! !!! ! L LL & FL & FL & F & FM NOP$a$ !i!Z!ޝ!!!!! !G!!ԟ!՟!3!4!!! !! !>!@!H!k!$<]<a$ <h-]<^h`-<]<L & FL & FL$a$L & FLk!!!ա!!!! !-!.!9!A!c!d!,!-!2!3!b!c!ئ!!e!֧!! L & F L  $ x@a$ x@L & FL!!!!.!f!u!ئ!!!!!s!!!! !*CJ hSD6CJ hSD5>* hSD6 hSD5CJhSD5>*CJ hSD>*CJ hSDCJ hSD>* hSDCJ hSDCJhSD hSD5D!l!|!,!-!F!P! !ĭ!!,!!!!!&!:!E!]!!+!:!!!^!L & FL & FL & FL & FL & FL & FLL$a$ L & F ^!_!p!z!~!!D!E!ʳ!˳!!!!ô!-!.!ѵ!6!7!D!E!'!Z!t!0! & FM NOPL$a$ ] L 0!!q!r!s!t!~!o!!!!*!!"!\!]!s!t!_! ! !K!L! ! & F & Fh^h` hL & FL & FL$a$L & FL & FK!P!!!+!t!!!!!"!#!)!G!H!R!!!!!h!q!!!!!!!!!!!!|!}!!!!!!!!!!!!!!!!E!G!j!!!jhSD5CJUmHnHu hSD5CJ hSD5 hSDCJhSD5OJQJjhSDUmHnHu hSD>*CJhSD56CJ jhSD>*UmHnHu hSD>*CJ hSDCJhSD@OJQJ hSD>*hSD5 ! !!!"!#!!!!!!!&!'!(!)!*!+!,!-!.!h!!!! & F$a$  ^` & Fh^h`L!!!!!!!!N!O!!!!}!!!!!!!!E!j!$<]<a$ <h-]<^h`- & F<]<<]<LL & FLh`hL$h`ha$j!!#!%!9!D!l!!!!!!!!!!!!!!!!!!!!! x@ $ ]a$L$a$$a$L!!"!#!$!9!f!!!!!!!!!!!!!! ! !!!!!!!!!/!0!R!r!yhW!hSD56B*CJOJQJph!hSD56B*CJ$OJQJph$hSD56>*B*CJ$OJQJphjhSDCJUmHnHuhSDB*hphhSD5B*hph hSDCJ hSDCJhSD56>*$hSD56>*B*CJ OJQJphjhSD5UmHnHuhSD56B*OJQJphhSD hSD5!!!!!!!!!!!!!!!!!!!! $$Ifa$$If x@!!!!!!!!AUkd$$IfF     4  $$Ifa$ $$Ifa$Ukd$$IfF     4 !!!!!!!!!JUkd$$IfF     4 Ukdl$$IfF     4  $$Ifa$!!!!!! ! ! !JUkd$$IfF     4 Ukd8$$IfF     4  $$Ifa$ ! ! !!!!!!!JUkdj$$IfF     4 Ukd$$IfF     4  $$Ifa$!!!!!!!!JA$ x@a$Ukd6$$IfF     4 Ukd$$IfF     4  $$Ifa$!!0!R!|!}!!!!!!!!!!!*!L!n!!!!!!!!x!$ x@a$ x@$a$ $ $ a$r!|!}!!!!!!!!!!!!!)!*!L!M!m!n!!!!!!!̹̈ylXMlF hSD>*CJhSD>*CJOJQJ' j8hSD:>*B* CJ OJQJphhSD6>*CJOJQJhSD56B*OJQJphhSD56B*OJQJph!hSD56B*CJOJQJph!hSD56B*CJ$OJQJph$hSD56>*B*CJ$OJQJph'jhSDB*CJUmHnHphuhSD56CJ hSD6CJ hSDCJ hSD hSDCJ!!!!!!!!!!!!!!"!+!-!K![!^!`!d!e!q!!!!!!!!ȿȵϵϥp\OhSD6>*CJOJQJ'jhSDB*CJUmHnHphu!hSD56B*CJOJQJph!hSD56B*CJ$OJQJph$hSD56>*B*CJ$OJQJph hSD5CJhSD56CJhSD56>*CJhSD5>*CJ hSD>*CJ hSDCJhSD6B*CJOJQJphhSDCJmHnHujhSDCJUmHnHux!!!!!!J!!!!!!!!!!!!! x@ x@$d &d N P  x@$d &d N P  x@&d P  x@$a$ $ $ a$$ x@a$!!!!!!!!!!!!!3!4!E!F!G![!®yj[N:/NhSD>*CJOJQJ' j8hSD:>*B* CJOJQJphhSD6>*CJOJQJhSD56B*OJQJphhSD56B*OJQJph!hSD56B*CJOJQJph!hSD56B*CJ$OJQJph$hSD56>*B*CJ$OJQJph'jhSDB*CJUmHnHphuhSD hSDCJ hSD>*CJhSD6>*CJOJQJhSD>*CJOJQJ' j8hSD:>*B* CJ OJQJph!!!!!!!!!!!!!!}}}t x@dh x@d x@ x@d$d &d N P  x@d$d &d N P  x@d$d &d N P  x@xx x@xx$d &d N P  !!!!!!!!!!!!!!! x@dh$d  &d N  P  x@dh$d &d N P  x@dh$d &d N P L x@dh x@dh$d &d N P  x@dh x@!!!!!4!!!!.!/!0!!!!!!!t!u!!$ x@a$L x@ x@$d &d N P  x@$a$ $ $ a$L x@dh x@dh[!x!!!!!!!5!|!}!!!!!!!!!!"!!!!!!!!!!!!!#!/!1!=!!!!!!! !_","8"9";"k""d"f"{"}"!""""i""" "# ") " "P "_ "` "w""""""""" "" hSDCJH*hSD5CJH*hSD56>*CJ hSD5 hSD5CJhSD hSDCJhSD56CJN!!P!Q!!6!7!m!n!z!{!|!!!!!!!!~!!!!!! x@&d P  x@&d P $ x@a$ x@!!!!!!!!!!!!"!5!!!!!!!!!!!$ x@&d P a$$ x@&d P a$ x@&d P $ x@a$!!!!!!!!!!!!!!!!!!!! !`! ! !$ x@a$$ x@&d P a$ x@&d P $ x@&d P a$ !0"B"U"V"6"7"^"_"","9"!""""""""""h"i"" x@&d P $ x@a$$ x@&d P a$"""""" " "H "I "" "# " " "_ "o "~ " """"")"*" x@$ x@a$$ x@a$ x@&d P $ x@&d P a$*"p"x"y"z"{"|"}"~""""""""""""""""""" x@&d P  x@$ x@a$""""&""""""V""""K"L"""M"""""""/"W" N  x$ x@a$ x@""""9"E"X"e"""("*"/"W""/"X"e"~"h"""""""""""""|"~" "3!"4!"7!"8!"_!"`!"a!"!"!"!"!"!"!"""""-""/""9""&$"%"%"%"%"%"%"%"&"&"&"&"&"}'"~'"'"'"'" ("(" ("jhSDCJU hSD6>*hSD5CJH*hSDCJOJQJhSD hSDCJH* hSD5CJ hSDCJhSD56>*CJIW"t"u"A"B"C"""f"g"h"""" """" " " "!"!"#!" ^` ^``$ x@a$ x@#!"3!"5!"6!"7!"8!"`!"a!"!"!"!"!"!"!"#"#"#"#" $" $"&$"6$"9$"o$" ^` @ ^@ `$ x@a$$ x@a$ x@ p^p`o$"$"$"%"%"3%"J%"V%"n%"%"%"%"%"q&"&";'"a'"b'"s'"t'"}'"~'"'"'"'"'" N @$ x@a$ x@ ^` ("A("B("C("Q("R("S("t("u("v("("("("(")")")"*"*" *".*"/*"+"+"+"+"+"+"+"","/,"-"-"9-"IJΨċyrycYhSDB*CJ phjhSDB*CJ Uph hSD5CJ hSDCJ hSD0JKB*CJph"jhSDB*CJUph hSD5CJhSDhSD0JKB*ph"j[hSDB*CJUphhSDB*CJphjhSDB*CJUph hSD0JKjhSDCJUjhSDCJU hSDCJ!'"("("("("("(" )" )")")"0*"1*"<*"=*">*"I*"m+"n+"+"+"+"+"+"+" x@&d P $ x@a$$ x@a$L N  x@+"+"+"+"+"+"",",","K-"\-"^-"_-"`-"a-"b-"c-"w-"x-"-"-"-"-"-"-"$ x@a$L N  x@&d P  x@$ x@a$9-":-";-"I-"J-"K-"[-"]-"b-"c-"-"-"H/"S/"U/"V/"X/"i/"/"/"/"/"/"1" 1"1"1"1"-1"21"J1"S1"~1"1"1"1"1"1"2"2"2"2"13"i3"P4"ͽͲͬùwwýp hSD5CJhSD@OJQJ hSD5CJ hSD5'jhSDB*CJUmHnHphuhSDCJmHnHu hSDCJ hSD5CJ hSD hSDCJhSD56>*CJ hSDCJ hSD0JKB*CJ phjhSDB*CJ Uph"jhSDB*CJ Uph,-"}."~." /" /"=/"H/"S/"T/"U/"I0"J0"0"0" 1"1"1"-1".1"1"1"1"1"1"1"Q2"$ x@a$L N  x@&d P E x@Q2"R2"2"2"2"2"2"13"3"3"3"O4"P4"a4"4"6"6"o6"6"6"@7"A7"H8"I8"Z8"[8"l8"L N  x@&d P  x@P4"a4"4"4"4"6"6"6"6"6"m8"o8"p8"8"8" 9"-:"/:"r<"s<"<"<"<"<">">"?"?"P@"X@"@"@"A"B"B"B"B"B"D"E"lF"vF"wF"G"G"H"H"LH"\H"pI"~I"J"J"J"K"K"K"K"K"ƿݿٝ٘ٓٓٓٓٓٝ hSD>* hSD5 hSD6 hSD56 hSD>*CJ hSDCJhSD56CJ hSD5CJhSD6B*CJph hSDCJH*hSD hSD5CJhSD56>*CJ hSDCJhSD@CJOJQJ:l8"m8"n8"o8"p8"9"9":":":"r<"s<"t<"<"="="m>"n>">">"?"t?"?"O@"P@"w@"@" x@^ x@&d P  x@@"@"@"B"B"bB"B"B"B"D"D"kF"lF"JH"LH"pI"J"K"N"P"R"^R"R"R"` L & F  L & F F L n^`n$a$ x@K"K"K"L"N"N"O"P"P"xP"zP"Q"R"R"BR"XR"^R"R"R"R"T"T"7V"8V"V"V"V"X"X"Y"Y"_Z"Z"["\"\"\"\"\"\"\"\"]"]"]"]"]"_^"`^"l^"_" `"fa"pa"qa"b",b".b"2b"zb"b"c"c"nd"ud"d"d"d"d"d"e"f"f"f"i"i" j" j"j" hSD6 hSD>*CJ hSD56 hSD>* hSD5CJhSD6B*CJph hSDCJ hSD5hSDNR"T"3V"V"V"V"V"V"V"V"V"V"V"V"V"V"V"V"X"X"X"X"Y"J\"]"]" ^" L n^`n$a$` ^",^"G^"`^"_"_"ea"fa"xb"zb"c"nd"d"g"g"`h"bh"h"h"h"h"h"h"h"h" x@L & F L & F F L n^`n$a$h"h"i":k"l"m"m"m"m"m"m"m"m"m"m"m"n"Ln"`n"n"n"|p"}p"q"q"6r"7r"$a$$`a$`$ x@a$j"j"nk"rk"m"Zn"\n"tn"vn"n"n"n"p"q"q"7r"Ar"Br"Cr"Kr"r"r"[s"bs"t"t"fv"Jw"Kw"cw"w"w"w"w"w"x"x"x"x"x"x"&y"fy"z"z"z"z"z"|"|"}"}"p~"t~""","""ā"Ɓ"ށ""N"""ݮݮݮhSD6B*CJphhSD56>*CJ hSD>*hSD hSD6 hSD56 hSD>*CJhSD5>*CJhSD56CJ hSD5CJ hSDCJH* hSDCJ hSD5@7r"Cr"r"[s"lt"u" v"fv"w"Jw"Kw"Zw"bw"cw"dw"w" x"x"y"z"&z"Dz"[z"z" x@$a$$a$`L & F L & F F L n^`nz"|"<~""""""""""""","B"""ā"Ɓ"@"B"P"R"Ƈ"ȇ"L$a$$`a$`""L"H"ȇ"܇"އ""""""$"Z"""Ҋ"b"d""""܋"ދ"""x"z"""l"n"p""ȍ"""""Ž"""̏"""""ʐ"""ё""K""""(")"*"n"p"{"}"["]"h"j""궿꿬ڧڧڧڧ hSDH*hSDCJOJQJhSD56CJhSD56>*CJ hSD5CJ hSD5 hSD>*hSD hSD6 hSD56 hSDCJ hSD>*CJhSD5>*CJAȇ""""b"d"""ތ"l"n"p"r""$"ˏ"̏"""&"7"K"i"""$a$ x@`L & F L & F F L n^`n""g"h""""ё"" "B"C"""""""" " " """"""$a$$ x@a$L N  x@"")"+"2"3"?"@""" ","-" " " "";""""""'"("՗"֗"S"d\$d\$@& x@"""ʖ"("<"֗""T"i"W"m""""" " """"Ý""""""">"?"@"t"u"~""""""""""""""" "¢옏{{ hSDH* hSD5\hSDOJQJhSD56CJhSD56>*CJ hSD6hSD6B*CJOJQJphhSDCJmHnHu hSDCJ j8hSD:>*B* ph hSD6>*hSD@OJQJ hSD>*hSDjhSDCJUmHnHu0S"T"V"W""""" " "~"""""u"""" """ţ""ԥ"F"G"H"e"` x@$a$ """ "5"""8"ţ"ܣ""ʤ"ˤ""f"g"Ħ"ͦ"ڦ"!"0"1"T"Y"i"""""""թ"""""i"j"Ī"ƪ"Ǫ"!"""r"s""""""""ح"٭"ڭ"ݭ"߭""""")"*"ᩜ j8hSD:B* ph hSD6hSD:CJ^JaJhSD:CJ^JaJhSDCJOJQJhSD56>*CJhSD5CJ\ hSDCJ hSD5\hSD56CJ hSD>*hSD=e"f"t""Ħ"ͦ"ڦ"""!"0"1"2"3"Z"""""0"X"i""" ""i"j"$ 87$8$H$a$@&j"Ū"ƪ"Ǫ"""s"t"u"v"w"x"y"z"{"|"}"~"""<"="""W"""""$a$$ 87$8$H$a$"""""""")"*"""""n"o"""""/"0"1"O"P"Q"U"$ x@a$$a$*"4"9":"""""O"P"Q"T"U"V"W"j"k"n"o"p""""""а"Ѱ"߰""")"*"+","A"B"R"i"w"""ȸظ~uuhuuuhSD56CJOJQJhSD56CJhSDCJOJQJhSD56B*CJ$phhSD56>*B*CJ$ph'jhSDB*CJUmHnHphujhSDCJUmHnHuhSD6B*CJOJQJphhSDCJmHnHuhSD56>*CJhSD hSDCJhSD5CJ\(U"k""""""Ѱ""*","-"B"Q"R"w""""""ȱ""""";"@& x@$ x@a$ $ $ a$""""ϱ"""!"""""""""","-"="["""ٺ"ۺ"%"&"'">"L"N"["u"y"""""""""ϻ"" "8":"Q"S"["D"|"աա✌ hSDH* hSD5jhSDCJUmHnHu hSD\hSD5CJ\hSD56>*CJhSD5CJOJQJ\hSD56CJOJQJ hSDCJH* hSDCJ hSD5\hSDhSD5CJ]hSD56CJ hSDCJ]3;"""""i""""","-"["{""""""""""%"&"'"="L" x@$a$@&$ x@a$L"h"v""""ϻ"""g"ټ"""""M"N"O"P"Q"#"$"""""d" x@$a$@&$ x@a$d"e"""""0"1"D"["\""" " """""(")"h"i"|"}"~""""" x@|"}"""""""/"7"8"v"w"""""""""a"~"""V"o"y""I"K"l"""""""""""/"1"=">"""""""&"("*"+"8"ν󘏘ӘӘۘhSD5CJ\ hSD5CJhSDCJH*\hSD6>*CJ\]hSD>*CJ\ hSD5\ hSDCJhSD hSD6hSD56\hSD56CJhSD6CJ\] hSD\ hSDCJ\ hSD58"T"U"V"W"X"Y"""""""""""""" "+">"$ x@a$$a$ vx@ x@ x@ 8x@ 8x@ x@ v@>"n"o"""L"M"`"a""V""l"""""""""%"&"""L vx@L x@ v@ v8x@L v@ x@"""""","Z"[""""""%"&"""""""""""Y"Z""$ x@a$ x@"""""d"e"f"g"h"i"j"""W"X"-"."""<"="P"Q"R"`"" ""$ x@a$ x@8"""""""R"_"`"a"b"n""""""""""" ","-"k"l""""O""H"wlh\huWhSD5CJ\hSDhSD56B*phhSD56B*phhSD56B*CJphhSD56B*CJ$phhSD56>*B*CJ$ph'jhSDB*CJUmHnHphujhSDCJUmHnHu hSD6hSD56>*CJhSD56\hSD56CJhSD5CJ\ hSD5CJ!""W"X""@"A""" "-""""""" "O"P""""""Q"R""$ x@a$$a$ x@"""""""""""""""""I"J"""""""""""$ x@a$ x@H""""""""""1"2"3"G"""""^"o"r"","/"?"""W""""p""""""0""""4"_"`""""""R"`""("D"d""""""H"J"ξξξξξξh/hSD>*CJh/hSDCJ hSD>*CJhuWhSD6>*CJ hSDCJhuWhSD6CJhuWhSDCJhuWhSD5CJ\ hSD5CJhSD hSDCJ\huWhSD5CJ<""""C"D"""""""""""W""""""""""J"""gdSD x@J"["^""""""""H""""@"o"p"q""""""""" """""V"X"Y""#####6#####B##### # ########ǽǽǽDZǩǠǽǽǽǽǽDZho0CJaJh/hCJaJhCJaJh5CJaJ>*CJ h/>*CJCJ h/CJ huWCJhuW6>*CJ hSDCJh/hSDCJhuWhSDCJhuWhSD6>*CJ:      !"#$%&'()*+,-./01234>789:;<=ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~""""" """Y""#####\#]# # # # #z #{ ######$ x@a$QR x@gdSD######7#_### # # # # # ##(#U#^#z#"###4#e#####$###Y####L#q#########$#d#e#p#w###<#>#?#@#D#E#N#O#ɺhuW5CJ\ 5CJ\hM->*CJaJ hM->*hM-hM-CJaJ hM->*CJ hM-CJhM-6>*CJ huWCJ h7>*CJ h/CJCJ h/>*h/ho0CJaJ<#L#M############=#@#A#B#C#D#E#g#h#i##C"#D"#"#$ x@a$ x@QO#i#z#####\#j###### #+ #Q #T #] #b #g #o # # # # # # ##!#7!#8!#X!#`!#i!#u!#|!#!#!#####%#%#t&#&#)#)#)#)#)#)#*#*#+#5+#+#+#+#+#+#',#-#-#.# /# /#;/#C/#Z/#[/#\/#b/#|/#/#/#h.n>*CJaJ >*CJaJ 5CJ\hN%6CJaJCJaJhM->*CJaJhM-CJaJhM-6>*CJaJhuW5CJ\H"#"#%#%#%# %# %# %#&#&# (# (#),#*,#,#,#.#.#.#.#.#.# /#Z/#|0#}0#~0#0#$ x@a$ x@/#/#/#0#z0#{0#~0#0#0#0#0#0#0#0#0#1#1#+1#41#G1#J1#S1#X1#]1#e1#1#1#1#1#1#1#1# 2#=2#2#2#V3#W3#[3#3#3#3#3#3#3#3#3#3#3#3# 4#4#=4#G4#h4#i4#x4#4#4#4#4#4#5#)5#,5#j5#5#6#@6#K6#a6#b6#6#6#6#@8#T8#W8#8#9#9#9#9#9#9#9#n:#o:#hM->*CJaJ >*CJaJh.nCJaJCJaJhM-CJaJW0#2#c6#6#6#8#8#9#9#9#9#9#9#o:#p:#q:#r:#s:#=#=#>#>#/@#B#C#C#C#C#D#$a$ x@Qo:#q:#s:#:#:#:#;#;#;#<#'<#0<#Z<#{<#<#<#=#=#|>#>#>#>#?#@#/@#@#@#@#@#@#@#@# A# A#A#A#A#'A#FA#^A#pA#A#A#A#A#A#A#5B#=B#FB#RB#YB#}B#B#B# C#kC#C#C#C#C#C#C#D#D#D#3E#UE#VE#WE#hE#oE#}E#E#ߺ6>*CJaJ 5CJ\ >*CJaJh.nCJaJhM->*CJaJhM-CJaJhM-6>*CJaJhuW5CJ\CJaJID#D#D#`D#mD#sD#tD#uD#D#VE#&H#'H#I#I#JK#KK#M#N#N#N#N#JO#KO#LO#O#O#O#O#$a$Q$ x@a$ x@E#E#E#E#E#E#F#G#G#G#8G#AG#kG#G#G#G#%H#0H#H#I#I#I#K# K#IK#JK#KK#K#K#K#K#K# L#L#%L#(L#1L#6L#;L#CL#bL#zL#L#L#L#L#L#L#M#QM#YM#bM#nM#uM#M#M#M#PN#N#N#N#N#N#N#N#O#O#O#O#P#P#P#+P#޻ 6>*]5\h| CJaJ >*CJaJh.nCJaJhM->*CJaJCJaJhM-CJaJh| 56CJaJh| 6CJaJHO#O#O#O#JP#lP#P#P#P#Q#2Q#3Q#RQ#SQ#sV#WW#XW#YW#}X#X#Y#Y#(Z#JZ#Q & Fh`h`$da$dd\$$ x@a$ x@+P#*CJ\]^JCJ^J>*^J 5\^J 56\]^Jh h\ 6>*]5\6]:JZ#KZ#wZ#xZ#Z#Z#Z# [#/[#][#y[#[#[#[#[#\#\#8\#9\#e\#f\#\#\#\#\#]#K]#g]#$da$dd\$QZ#Z#Z#Z#Z#Z#Z#Z#[#[# [# [#[#.[#/[#4[#F[#L[#Q[#U[#][#g[#w[#x[#y[#}[#[#[#[#[#[#\#\#"\##\#$\#9\#J\#f\#k\#z\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#ȽȬȬȬȬȬh*CJ]aJh*]5\CJaJh| 5CJaJhM-CJaJ6\#]#]#]#"]#4]#:]#?]#C]#K]#U]#e]#f]#g]#k]#z]#]#]#]#]#^#^#^#^#)^#:^#F^#G^#H^#]^#n^#^#^#^#^#^#^#^#^#^#^#^#ɻxiɘh*CJOJQJ]^JaJh_#?_#A_#}_#~_#_#_#_#Q$da$dd\$^#^#^#^# _# _#_##_#)_#._#2_#:_#;_#@_#A_#X_#~_#_#_#_#_#_#_#_#_#_#_#`#`#`#&`#5`#S`#T`#c`#d`#`#`#`#`#`#`#`#`#`#οߵߦߦߦߦߦߙ~{w{q 5\^J>*^J^JhACJaJh*CJOJQJ]^JaJ,_#&`#S`#T`#d`#`#`#`#c#c#Vd#Ke#/f#0f#1f#2f#f#g#h#h#j#j#l#l#h`h`dxd x@$da$dd\$`#`#"a#Qa#da#a#a#a#a#b#b#c#c#c#Vd#/f#f#h#h#i#j#6j#j#j#k#6k#l#l#m#am#m#n#+o#,o#.o#0o#3o#4o#5o#q#q#r#r#r#s#s#s#|vvv 5CJaJh*CJ\]^JCJ^J56>*CJ\]^J 56\]6] hA\^J hA^J 5\^J^J.l#l#m#am#m#n#7n#8n#+o#,o#/o#0o#4o#q#q#q#q#q#q#r#r#s#s#t#t#t#u#u#u#dd\$Qs#s#t#t#t#u#u#u#u#u#Kv#Lv#z#z#l{#n{#R|#T|#}#}#}#}####ƒ# #'#e#g#$#&###p####$#b#d#!#####m######hEM5CJOJQJ^JaJ 5^JaJhEMCJOJQJ^JaJhEM>*CJOJQJ^JhEMCJOJQJ^JhEM5CJOJQJ^J h?>*CJ h7.[5CJ h e5CJCJhA5CJaJh0z-5CJaJCJaJ 5CJaJ2u#Kv#jw#:x#y#y#y#z#z#j{#k{#R|#}#}######c#d#"###_#`#.###p# @Qp#`#a## #\#]#+###m#ɘ# ##ҙ# #!#ќ#Ҝ#g#h#####M####Q @###########ɘ#ט##### #"#ҙ## #!# ##=#>#p#y#####М#Ҝ#*#+#i#j###ž#Ϟ#ў######ǟ###D#E#f#n#ݠ#ޠ#E#####٣#ڣ###̤#ڤ###!### hF5CJ 5CJaJhC i^JaJCJaJhEMCJaJhEM5^JaJhEMCJOJQJ^JaJhEM^JaJ^JaJH##ף###̤##k#####>##մ#ִ#ȶ#%#l#### #S##### # x@ @####9#:#]#^#_#m#n#j#l#n##٪##"############ # #0#1#2#@#A#=#?#A#####f#g#ӿ߱|nh9 U0JKB*CJaJph&jYh9 UB*CJUaJph^JaJ hF5CJh>CJaJhPJhF5CJaJh9 U0JB*CJaJph&jh9 UB*CJUaJphh9 UB*CJaJph jh9 UB*CJUaJphh!CJaJCJaJCJ+g#r#Դ#մ#ִ#۴#ݴ#ȶ######'#(#&#(#M#N###p\MChHOJQJ^JhH5CJOJQJ^JaJ'hH0JKB*CJOJQJ^JaJph2jhHB*CJOJQJU^JaJph#hHB*CJOJQJ^JaJph,jhHB*CJOJQJU^JaJphhHCJOJQJ^JaJhHCJOJQJ^JhH5CJOJQJ^JhHOJQJ^JaJ^JaJh>CJaJCJaJh!CJaJ#»##ڽ#۽######4#5########־yne`TH:hHCJOJQJ^JaJhHCJOJQJ^JhHOJQJ^JaJ^JaJhA5CJaJhH5OJQJ^J*hH0JK5B*CJOJQJ^JaJph5jhH5B*CJOJQJU^JaJph&hH5B*CJOJQJ^JaJph/jhH5B*CJOJQJU^JaJphhH5CJOJQJ^JaJhH5CJOJQJ^JhH5OJQJ^JaJ#######4#5##########׽雑ysy\J0\2j] hHB*CJOJQJU^JaJph#hHB*CJOJQJ^JaJph,jhHB*CJOJQJU^JaJph 5CJaJhHCJOJQJ^JaJhHCJ^JaJhHOJQJ^JhHCJOJQJ^JaJ'hH0JKB*CJOJQJ^JaJph2jhHB*CJOJQJU^JaJph#hHB*CJOJQJ^JaJph,jhHB*CJOJQJU^JaJph #S#### ######## #!#"########p#q#'#(#)#*#+# x@ @#####################"## #!#"###)#*#.#/#9#;#=#>#######5#M#8#h#ƾ|shM->*CJaJCJaJhM-CJaJhM-6>*CJaJhuW5CJ\ 5CJ\ hH5aJhA5CJaJ 5CJaJ^JaJhH^JaJhHCJOJQJ^JaJ,jhHB*CJOJQJU^JaJph'hH0JKB*CJOJQJ^JaJph-+#,#-#.#>##########:#;###>#J#K#L#M######$a$ x@ @h#i#y#########[#y##:#{#####(#)#-#Q#Y#k#t############:#;#J#}########<###'#2#H#I#J#L#"#+#,#-#.#3#A####### #I#######hb[>*CJaJhuW5CJ\^JaJ >*CJaJh.nCJaJCJaJhM->*CJaJhM-CJaJN####,#-##>#?###b#c######u#v#w#######v#$a$Q @ x@####H##/###1#8#a#b#c#####"#4#=#P#S#\#a#f#n##### ##F#|########{######### #=#>#N#L#v#U#V#W#s####̸̽̽̽CJaJ^JCJ^Jhb[CJaJ^JaJhb[>*CJOJQJ^JaJhb[CJOJQJ^JaJhb[CJaJh.nCJaJhM->*CJaJCJaJhM-CJaJ?v#w###########A#N#T#U#V###O####W##h`hdd\$h^h & F @$a$Q x@####+#E#W#/#F########$#0##C#D#N#P#R#S###########t#v#w####(#)#*#.#/#6#ijĘہ}\^J 5\^JhUF>*CJaJh(CJaJhb[CJaJ hS^JhS;OJQJ\^JhSOJQJ^J hH5aJ^JaJhEM^JaJ 5CJaJ>*^J^Jhm6>*CJ\]^JCJ^JCJaJhA5CJaJ.########D#S#T#######5#E#m#n#o######7$8$H$ @Q x@ & F####0#E#Z#m###########$6$$$x$y$$$$j$ed~Xed~XQ @6#=#$$$$$+$>$6$$$b$u$$$$$ $ $ $ $ $ $<$$$U$&$9$`$f$$˽󬠬󬠬{o^oUoB*^JaJph h`96>*B*]^JaJphh`9B*^JaJph h`96>*B*CJ]aJphh`9B*CJaJph6CJ]aJ56>*CJ\]aJ5CJ\aJ6>*CJ]aJ6>*B*CJ]aJphB*CJaJphh`9B*aJphhJjCJ\aJhJj6CJ\]aJCJaJ hA\^J j$$$ $ $ $ $ $ $ $ $ $ $<$U$$<$=$$$$4$$$$]$R$S$dd[$\$Qed~X$$$$S$V$k$$s$$$$$$$F$I$i$j$m$$$$$$$g$$$$$W$f$j$k$v$мzqhzd\hb[^JaJ5\h`9\^JaJh`95^JaJh`9^JaJh`956>*\]^JaJh`95\^JaJh`9CJaJhDM5CJaJ 5CJaJhA5CJaJCJaJh`96B*]^JaJphh`9B*^JaJph&h`956>*B*\]^JaJphh`95B*\^JaJph#S$$$$$r$s$$$$$$$j$$$$g$$$W$k$l$m$n$o$p$q$$a$$da$ x@Qq$w$$$$$$$$$$$$# $$ $3 $~!$!$!$"$"$z#${#$ %$ %$%$dd\$ @$ x@a$$ @a$ x@v$$$$$$$$$$$9$$$$$$" $$ $. $0 $3 $!$!$!$!$!$!$G"$"$"$"$-#$>#$y#${#$#$#$#$#$#$#$#$#$#$#$$$p$$ %$%$%$%$'%$*%$%$%$'$'$赮ӞCJ^Jh`9CJaJh`9^JaJhH^JaJ hH5aJhA5CJaJhEM^JaJhE^JaJCJaJ >*^JaJh`9>*^JaJ 5CJ\ 5CJaJ^JaJhM-CJaJCJaJ9%$'$'$'$($($-)$.)$z*${*$j+$k+$+$+$+$y,$z,$0$0$0$0$1$1$1$D2$$3$b4$ 5$6$Q x@'$'$'$'$>($($($($($+$+$+$+$z,$2/$F/$H/$0$0$0$0$0$0$0$0$0$0$0$0$1$1$K3$L3$Y3$h3$}3$3$3$3$3$Ѷtkekekeke >*^JaJh`9>*^JaJh`96>*\]^JaJ \^JaJh`9\^JaJ^JaJh`96>*]^JaJh`9^JaJh`9B*^JaJphh`9B*aJph hJj\aJhJj6\]aJaJ >*CJaJhUF>*CJaJhqCJaJCJaJhA5CJaJ 5CJaJ'3$3$ 4$ 4$4$84$=4$b4$6$6$.6$H6$a6$k6$6$6$<7$I7$7$7$7$7$8$8$8$h9$}9$9$9$9$9$ :$(:$v:$:$:$:$:$;$ ;$;$;$;$;$[<$_<$<$<$蹰 5CJaJh-5CJaJhDM5CJaJh`95CJaJh`9>*CJaJCJaJh`95CJaJh`9CJaJh`96]^JaJ^JaJh`96>*\]^JaJh`9\^JaJh`9^JaJ >*^JaJh`9>*^JaJ/6$6$H6$I6$6$7$C8$D8$9$9$9$:$:$E;$F;$<$<$<$<$<$<$=$=$=$a>$b>$q>$?$?$ x@Q<$<$<$<$=$=$=$=$b>$m>$n>$q>$?$?$?$?$@$#@$&@$)@$H$H$H$H$H$H$H$H$H$I$J$J$J$|J$J$J$J$*K$*^JaJh~^JaJ^JaJhEM^JaJCJaJ 5CJaJhA5CJaJN?$?$@$@$)@$y@$z@$WA$XA$C$C$C$C$D$D$E$E$4F$5F$H$H$H$H$H$I$I$K$K$dM$ @Q x@dM$eM$AO$BO$P$P$Q$Q$R$R$R$T$T$#T$[U$\U$V$V$V$V$W$W$W$W$W$X$X$Y$Y$ x@ @T$ T$"T$#T$T$YU$ZU$\U$U$U$ V$V$&V$'V$,V$?V$aV$1W$W$W$W$W$W$W$Y$Y$Y$Y$Y$3Z$Z$Z$ [$"[$[$[$[$[$[$[$]$@]$A]$Q]$]$O_$y_$_$%%%%ĻUhb[>*^JaJhb[^JaJhb[>*CJaJhb[CJaJhM-CJaJhM-6>*CJaJhuW5CJ\ 5CJ\^JhS;\^J hS^J^JaJhH^JaJ hH5aJhA5CJaJ 5CJaJ3Y$Y$2Z$3Z$VZ$wZ$Z$Z$Z$Z$Z$ [$#[$0[$1[$M[$r[$[$[$[$[$[$]$]$y_$z_$%%Q7$8$H$ @ x@. The report estimated that the NJ security prescriptions would save the State approximately $1.5 million annually by reducing fraud in the Medicaid, Pharmaceutical Assistance to the Aged and Disabled (PAAD), and general public assistance programs. Our counterfeit-proof safety estsecurity Paragraph 15. Listed below are references for you to contact for our companys experience and qualifications with the production of fraud resistant prescriptions. INTERNAL MEDICINE ASSOCIATES OF NJ 1777 Hamburg Turnpike, Suite 302 Wayne, NJ 07470 ATTN: LORI Office Manager 973-831-9222 Ms. Denise Conte, Representative Medicis Pharmaceutical Corporation 8125 North Hayden Road Scottsdale, AZ 85258 908-342-2002 Jo Donnelly, Office Manager Princeton Orthopaedic Associates, PA 325 Princeton Avenue Princeton, NJ 08540 609-924-8131 x4333 6fraud AHA,The Board maintains a which includes a listing of practitioners duly uses confirm practitioners who are registered with the Board to prescribe controlled substances in Wyoming.internet to verify the practitioners license status confirm practitioners who are registered with the Board to . internet The WYOMING Medical License search will be used to verify the license numbers for each healthcare provider who orders prescription forms. Federal Tax ID: 22-3390483 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. elephone: 973-305-8105 Vendor Name: Rx PROvisions, Inc. Founded: 1995 Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 TOLL FREE Number1-888-921-1211 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. Federal Tax ID: 22-3390483 1-888-921-1211 Vendor Name: Rx PROvisions, Inc. Founded: 1995 Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 TOLL FREE Number: 1-888-921-1211 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. E-mail: jpisano@rxproinc.com Federal Tax ID: 22-3390483 Vendor Name: Rx PROvisions, Inc. Federal Tax ID: 22-3390483 Founded: 1995 TOLL FREE Number: 1-888-921-1211 Telephone: 973-305-8105 FAX: 973-305-8108 Founded: 1995 Vendor Name: Rx PROvisions, Inc. Federal Tax ID: 22-3390483 Business Address: 166 Main Street, Suite 3 City: Lincoln Park State: New Jersey ZIP: 07035 TOLL FREE Number: 1-888-921-1211 Telephone: 973-305-8105 FAX: 973-305-8108 Contact Person: Joseph J. Pisano, President. E-mail: jpisano@rxproinc.com Wyoming are enclosed. Paragraph 10. In our twelve years of existence we never had any security breech of any kind. A convenient flow diagram of the companys operational processes and safeguards for manufacturing our tamper resistant stock is provided below. Additional comments about the security of our facilities are also provided. Tamper resistant stock is produced exclusively at one facility and that facility has the original printing plates, thermal sensitive ink and electronic files used in the tamper resistant stock production process. The facility is protected by external and internal security systems and alarm that monitor and protect the building and the safety of the stock we produce. One person at that facility has the authorization to access the printing plates, the thermal sensitive ink and the production material needed to produce our tamper resistant stock. Tamper resistant stock inventory is produced and stored exclusively at this facility. When tamper resistant stock is needed to produce prescriptions, the contact person at Rx PROvisions, Inc. is notified via e-mail from the prescription form production facility. We use separate facilities to provide additional security and control. Each plant is physically separated by communication, location and distance. Our on-demand production process controls the use, inventory and security of the stock we produce. Orders for prescription forms from our clients are received by our Main Street location where the orders are processed and sent to our prescription form production facility. Orders for tamper resistant stock required to produce these prescriptions are directed to our Main Street office. Then, the tamper resistant stock production facility is notified to provide the required inventory for the prescription production facility where the prescription pads are printed and packed. Then the tracking numbers and shipping labels are affixed to each order. Orders are picked up at the end of each day at this facility for delivery to our clients. The prescription form production facility sends the shipping information to our Main Street office where the orders are closed out and invoiced. Paragraph 11. The following describes, the record keeping and database methodology Rx PROvisions, Inc has used successfully for the last twelve years to comply with operational requirements for work we have done for the State of New Jersey, our pharmaceutical clients and for healthcare providers nationwide. Upon receipt of an order for prescription forms via mail fax or e-mail, Rx PROvisions, Inc. enters the order data into a password protected electronic database, by healthcare provider. The entry includes the order date, practice name and practitioner, complete address, phone (fax if applicable) payment method (check, credit card), the prescription form quantity and type and the assignment of a unique RXP number or Batch Number, that corresponds to each order. The RXP prefix identifies Rx PROvisions, Inc. as the producer of the prescription forms. The unique RXP number is printed on every prescription form printed for that order. Each unique RXP number has 12 digits. The first 6 digits provide the date the order was produced. The next four numbers refer to the actual order in the database. The last 2 digits are the number of orders placed by the healthcare provider during the calendar year. The prescription form database is perpetual and holds prescription order records and financial transactions by physician for a moving 10 years. All electronic data is secured with a daily scheduled back up. Two back up copies of the electronic back-up data are produced and kept in two separate secure locations. The hard copy (order forms from clients) is filed by physician, bound and stored for a moving 5 years as hard copy. These records are kept in a secure dry site Rx PROvisions, Inc. will make available on demand to the AHC any and all data (electronic and or hard copy) relating to any order from any WYOMING health care provider. In the event of a recall or any other emergency, these data can be used to reach all healthcare providers who have received prescription forms from Rx PROvisions, Inc. Reports will be produced on demand in an electronic format to reflect the practitioner, order dates, prescription form quantities ordered, tracking number information and any additional information we have in our database from orders received from WYOMING healthcare providers. The contact person for such information is Joseph J. Pisano, President, Rx PROvisions, Inc. 166 Main Street, Suite 3, Lincoln Park, NJ 07035 or by calling 973.305.8105 Monday thru Friday, 9am to 5pm (est.). All electronic records can be produced within 24 hours. Paragraph 12. Rx PROvisions, Inc. has been producing prescription forms for the past twelve years. If the sample prototype is acceptable by the Wyoming Board of Pharmacy, Rx PROvisions, Inc. is ready to produce tamper resistant prescriptions for WYOMING healthcare providers. Orders will be entered as described above and prescription forms can be produced in 24 hours. Paragraph 13. Our prescription form order process requests information from the healthcare provider that we use to verify their identity and authority as a Prescriber or licensed healthcare facility. We also request their current prescription form which is also used to verify, update and to format their prescription form. Our order process also requires the name and phone number of the person who is placing the order for tamper resistant prescriptions on behalf of the Prescriber, if applicable. Rx PROvisions, Inc. will use the Wyoming Board of Pharmacy website (http://pharmacyboard.state.wy.us), to verify the practitioners license status to prescribe controlled substances in Wyoming "Manner of Issuance of Written, Typed or Computer Generated Prescriptions" (Chapter 6, Section 4, WY Controlled Substance Act, Rules and Regulations) and the Pharmacy http://pharmacyboard.state.wy.usAHC Rx PROvisions, Inc. will make available on demand to the Department of Professional/Financial Regulation Rx PROvisions, Inc. will make available on demand to the Department of Professional/Financial Regulation any and all data (electronic and or hard copy) relating to any order from any MAINE health care provider. In the event of a recall or any other emergency, these data can be used to reach all healthcare providers who have received prescription forms from Rx PROvisions, Inc. Rx PROvisions, Inc. One Sixty Six Main Street, Suite 3 Lincoln Park, New Jersey 07035 (973) 305-8105 f& FAX (973) 305-8108 (973) 305-8105 f& FAX (973) 305-8108 Rx PROvisions, Inc. One Sixty Six Main Street, Suite 3 Lincoln Park, New Jersey 07035 (973) 305-8105 f& FAX (973) 305-8108 Rx PROvisions, Inc. One Sixty Six Main Street, Suite 3 Lincoln Park, New Jersey 07035 (973) 305-8105 f& FAX (973) 305-8108Rx PROvisions, Inc. Rx PROvisions, Inc. One Sixty Six Main Street, Suite 3 Li%%$%.%0%2%3%%g%%%%E%F%G%M%N%R%%%%%%%7%o%r%t% % % %%'%1%@%D%S%b%%%%%%%սլլդ|||s|nCJaJhuW5CJ\h*CJaJ 5CJ\^JhS;\^J hS^J^JaJ hH5aJ 5CJaJhA5CJaJhb[CJaJhEM^JaJ+%3%%%% %%E%F%g%%%%%%%%%2%E%F%% % %'%S%%dxQx7$8$H$ @ x@%%%%/%N%z%%%% %7%j%%%%%&%e%s%t%%%.%m%%%% x@dxQx%%%%%%%%%%%%%%%%$%(%/%0%N%X%g%k%z%%%%%%%%%%%ŻŮҗŇ~xodZhCJ^JaJh5CJ\aJhuW5CJ\ 5CJaJh5CJaJ5CJ\aJh*CJ]^JaJh*CJ]^JaJh6CJ]^JaJh5CJ\^JaJhCJ^JaJh6CJ^JaJh56CJ^JaJh5CJ^JaJ*d%e%m%n%r%s%t%u%%%%%%%%%%% %(%)%-%.%:%;%<%O%Q%`%ŽxlcXOH h5aJh6^JaJh56^JaJh5^JaJh6>*]^JaJh6]^JaJ^JaJh^JaJh5\^JaJ CJ\aJhCJ\aJ5CJ\aJh5CJ\aJ5\^JaJhuW5CJ\h6>*CJ]^JaJh6CJ]^JaJh5CJ\^JaJhCJ^JaJ`%l%m%~%%%%%%%%%%%%%% %%%-%J%K%h%i%%%%%%%%%"%,%1%M%Y%<%k%l%%%%"%B%%%%%%Ĺ򲮲h~^JaJ^JaJhEM^JaJ 5CJaJhA5CJaJCJaJ5aJ h5aJh5\^JaJh h5CJ hCJ5CJ h5CJhCJaJh5CJaJh^JaJ haJ2%i%%%%%%%%%%@%A%%%%%%%r%s%%%%;%<% %% @ x@Qdx%%O%Q%Z%_%%%%%%%%,%C%D%K%O%Z%c%w%y%%%%%%%%%%%'%)%,%%%%%%%%%Y%%%%?%P%%%%%%%% %M%N%%%%C%M%T%%%% B*CJOJQJ\^JaJphh`9^JaJhH^JaJ hH5aJ 5CJaJhA5CJaJhE^JaJ^JaJhEM^JaJhEM>*^JaJC%%%%%%%%%%%,%%%%%%%%%%%%%0%x%%%$a$ x@ @%%%%%%%.%0%x%%%%%%%%.%0%2%6%^%`%%%%%0%8%`%b%%%%%2%4%6%:%ŶztzŶkckŶzh#LCJaJh#L6CJaJ 5CJ\h0>YCJaJh0>Y6hg-6@B*CJaJph3hg-6@B*CJaJph3hg-6B*CJ aJ ph3hg-6>*B*CJ aJ ph3+jhg-B*CJ UaJ mHnHph3uB*OJQJ\^JaJph B*CJOJQJ\^JaJph^JaJ&% % %%%^%%%%`%%%%%%%> & & & & & &H &J &L &N &$a$$ x@a$:%`%b%%%%%%%% &> &\ &^ &` &d & & & & & & & & & & &ʴwuwqiqe]eLD]e]ej!hSDU jA7 hSDUVmHnHujhSDUhSDh0>YCJaJh0>YUhg-6@B*CJaJph3hg-6@B*CJaJph3hg-6B*CJ aJ ph3hg-6>*B*CJ aJ ph3+jhg-B*CJ UaJ mHnHph3uhQ6B*CJ aJ ph3hQ6>*B*CJ aJ ph3+jhQB*CJ UaJ mHnHph3u6ncoln Park, New Jersey 07035 (973) 305-8105 f& FAX (973) 305-8108  EMBED Word.Picture.8   EMBED MS_ClipArt_Gallery   EMBED MS_ClipArt_Gallery  & & & & & &@ &B &D &F &N &j-hSDUhSDjhSDUj!hSDU j7 hSDUVmHnHu (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#8$8% (/ =!"#$% ObjectPool`Ѷ_936642369  F`Ѷ`Ѷ1Table6CompObj h [$@$NormalmH <A@<Default Paragraph Font  l,b$uCq;KGkx @n( ̙3f̙ 6   AB S  ?e4@0+p@GTimes New Roman5Symbol3& Arial"hgfhf!r0/ Joe Pisano Joe PisanoObjInfoWordDocument @SummaryInformation( DocumentSummaryInformation8kG bjbjَ ] UUUikkkkkk$ZNRU3"UUUiMiiiU iUiiiii @Sɼ_ i  jUmHN N!$"$#$$$%n|xuCq;KGkPNG  IHDRqqgAMAPLTE3f3333f333ff3fffff3f3f̙3f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙333333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffffff3fffffff3fff̙ffff3fffff3f̙3333f33̙3ff3ffff̙f3f̙3f̙̙3f̙3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3f (((555CCCPPP]]]kkkxxx pHYs;,;5` IDATxKr#,%>8|÷;B8Ì 3n34Up2)RU>}JEHd|<<C)5Ox&^9j_׷XMӐ%ͣhWb%P3ۯL{F#]H<~\xRs8YIo[|rP^EX"tNbIp9 8 _ax5Sw߲8Jő'2;֍,OlOoaX rn@+fvaj=ei9sWvtp^,\27oHfü|?{=/[|@ܪ3Pn< @A#?ۍq<WH"G⿙caoasCXR7&ܼYY#l끓!=|{/Z;UV%t{̼q[ё y k_xbHcܩW(Eng87[K Xv*1{>3M!ښ;SkLcehc䃁[v}nb."mh!+3_~,o` gNh& e"% [gOi4ggd>,~U`H.U'38K(*ѬlG9 :]/,~ūx@6=OvP34omVLÅ*ߣ\k]><Э|k fƊLCkfJʛ >n[wRcr)=}tVv沰PXxcFzP837Sf8~8N$;ɫ͙WZbV:A~4H:f趁\WFwe*eP۝ɡޤV׼mbix@@t.voctw#(?f|͖ԨvuYѥ7ڟ8J g9GWlDx0ϝB@55teY—{q{@KώyK_|iܼ^/<|g,n๸'vZAn9LX5 yf(tCӫQ|\ʬЬX3 \OOqx 8-v?g zӇ%zhZZ/6;@Td#U qt/:)\f7b~j>ߙ->O%M46eM:Q8f#B7;mrp o?i<~BWMV/8,ׂs h񈴰"]X C "lvJu < ,>l]SbVŝA~ /閏,n5KPg%_ZȃV Lf)FKX*TVYF~嵧9ӌ7GGU?ހKۥ\!B0 )#zl:!Z oG_X>Pb&~VVR1 yekYqj?#RQh)L2tdq<f)s"R5:y8?@.R%sFhY$b߁'̺7V?^\pܘD d:œou]}l:,KbQ_c,XRp0懻w-CaOzAbh'p8Zɴ{-\GYf=D~a9?YtOyW)=ՐD>dlQaՠW8Qګsqf|NZBID+١@ppx+!~z"{/Lˤo>eg*Vኳ<'5-?IP pq߳8lPBd~v2PioԒH W2 }Xc~G FACE*epg~vv"[@(fOٚmIZӘS `\+zA" w~ڸyGw,>1CbV'+L;IhR-= ]#(F95'Gqǽw#aEI5r'.?ZmBߔ™S#J$xV:y)a<\LƵE Ei/{eu<_yבm\gh"yqDӋG`ި $>mb^yqz`wB/ˈ)aepCzq~P1E0:+>;o=cOW  OGu:Ӽ3%=b_)$9bO-"df*hS X=ˎϗ\\i3^dNgf W6ꪝ9*t]n d5cc  %m^?gXxjnNy:込8nsHBz7!~%˧޶PPiEq_"USS Xq`reu+#_*lg*H隗8+l[~-pG bhn,NЪ̐LA5W\R|1i3*-7ѷpW=( r7dGTq-'sȯ)ޮhglzɊ q }|8?|߲8aZKVxfa<1z:B~X+M\% aqKz!m k3νP= yc?¦yPzxԜN䄟l [*c>eYP]yNpN3$k$N--txbq䢧ryמhSz~;x<Gj/u+oZ&>-~DU[:vk>mj )Q4#KT.)jSf:ts*~JJ`܍niP7n&9oEABdȔ"DqwƘg 95^V-TEML.;MX*R֯Wn+Wd'dء%SϋqcKR.8HH[RHI$G沷iɞ,2}4|N~}Y']c úÜ<|ZΤ ̩5L{2 ~\{o}4[/8ѵ 10cN8tX{9)j[>7\'mb& &(H秖u?YOӕ)]/gP1oLri'i)ӵ8eapo (q.w~Gr*,9|Q}MG/il&8 ~(ģ'@7]} Űq)͓ߗrO%,k1Lz_T ᅃ&5ʲz1:^LQx;xu1uvum . l(aīd087K-(mXT .G^sjG?UhDFq^znwtPwݜOhklcoZ’<,&dɇ%@wCvȌtER鋱*Ocm."|9pU;"< ݆SkJ?Jz sf2`!Ĺ!"mE/dBRnЖa洋-P$SH.x:&ZBܽx[DY,65ȓ@4KFcwէ˒+\͈;]߶8&(0awqq\ٷ-qPlfJ!el%.=_afן&C#,r+R>'\!х!O7A|r g2+mcQ 剭Kt>]D(=)?]}:/_#`egm~ZO'U鯞zw/Y4{11"4.Ic*)Gدr~R]`hnv6j7eez-ޯ<1{_1#L&6lPz~}8}>77=>V(vXBjQҭ&h\M}&3ԦnfnO& X=s쉵:khRSI_6`"3oV@*8s&Z\E ~f)D\Ev΅4k)}r]UJIdеrbqΨ'k߯wn_zy4ڛ~/sO%BJGxB`IY<6ɛqPhtlI~U{3_r֟?_nhe}Fn4?T`TilXżp,x)\>]q+i<; y<=jDȾWO+o]$ V=5[?wػ_rݷ$PO;~CU|mBJjdJ!.v3?*c6F)k u(u~] QCtEșr;ZڦfJtq7q[|89iPVM#Vv0K%$?r] ɎpONm^D,V LJU-)H ǠfrrL%X|_p@N2}1% xH)r'R[Pcq9e#SFv!vb"i(ϊap$n@J,G眕dnK<9: |Rهu~oqاkZ*omZG'r@&&'sz?7tu.xM:P}YgT}OZ׹5g-lv 8cj4&zL Wjo;Bl6r{F%mD2៘jMMY* [1 õM!G9f>']gy@!0x^ɧ4 1.x_YJn86>8O&4>nv)(IgT4W= en7CܠY]W *"BIbPeombCS+NU8EaazB?;޳x~Bđ7P/WԂ-~:y4 FfN2Z[6R³y0¶H~KjO]GN) V,l khKc ͓ agQ폌m p]ybJ7{,Yρ4ӟ+f!T&=$de*O}' $E|4WZAL  "_;w.c.ŸV腏&,PcaÒ`9/#?]yIrKBxa&a L}Q@5B(!1.շ6sBwOBBcߺF;5]7{j}>N0#k+AɓOHHI\vqkx6kȒRڌϩM=HR8nv}PR-q, R$EoJU7J_g_uuMSSBg;ʏ+$nln_w#\<8 U kqv,~}*1x#j*X^2-9üڞ.B1^‡Gbjxe`wMUI#Zt gxK3hz2cc%X-. IDAT'In (IG[IsQ^# ]yJkmpxf^㵖X~,~%UGkfp +?L߯:ᅬ&Zڡ! LƦ\N5+կQr\ء0*[>헇!uMd#>-1lv1<.5SU,MmznW[P,uܚkAfjJ9Ӧ]y㬁Lv]X9lP8=Xu r@˩-@5m%G Kʙ7Zrѫf] ȸIK P&ԇqh%M~B5ʛB+x ي#T͢/hg։F>|jc]:ˤSt39 />ƗDra~7c&, Y{뫓 n'1td ;脆 50'x.7vD stPUm[mK5t}X d TI[E1\_q9i᱐ALjgJC%JJ2P97zXU—Ƅͭ t I\]نY6o`cy!iuu,,no918y%iN'4E6 Ql SFdEm'Tx䳳YaLV<`W5F:4Wqe}9ޮ .:)eGE'(oQ]j{_Fgmq ෳ=BWMArk >E`t݅f&Y+\r'|RJN^sC>Դ yz13;P§IvUDt⑽AZZAvr-+OBy>@H-aƭ]k}nHI͍_32ji/k?x y4iNReJ͐İ@7$s"Yk_9"ʭD"k.kjR#Je@"Ĵy8y|m6'WݭtDK őRglR=1AJZS,ǤZJ;):hA)bѐnqѝ&ԺC&$_[fӝM||AEA\J KŴ r*T!Q:,^fjH\yCU#E^䚝/8S?5klB?ZCJc[c#d5-MBRO 2-omgՎOpO$Bd! tKh#n4gX^acnc*,By'F:x텤 2""V$cYCW+Sѡ'Mv{ʫ"'Ѭ;J$D'<r\>ߴdNOӪ}}9 ^^avȓ"zٗ,~[ۦ^Rg-(ŠDzx+JM.xdXT`LWm. ഠ Ȑaf=68r;ZtoQE_ɛksz) h$(O-,1jaH(.򄺷ɣ7Ⱥ%ߨ8=Zi&]RO\|: >Bs,fx,O:s[g6Fiι1xHI`Folj=_HA jQ7a*(P|!{ ވkj{kvw(6`}O2kz|oQyϬxwp4+JLf2g&Qݵ&{TO,Fwg* G9&m)Kr C%x㦬BL:XgwqBmTӭ8sTPt^$τg! +O,JWT߯F$|jƞ$}1KpV[^.^>m;|1Ɖ\uk/N r{1:ߖac A3qgA۳U*mnY}½`!ZC m!zrݵ8+?*:RXA-|=U`(̓7M!@%a^INv&W!`a닒^[D 0; ~~\x@xN_zZk{BjĘnNz|scF#2lrKtC%K晊f>*m EVu<ϟ~S^3n;C ܎Ct$Pp.I0ah4\$rz  aS=w56!U 9(sԱڴqtsz-uO΋nT Seh*7_f#.e eqM(nh.8ޔkV(J&RM:p9-ӟZV8.YiB/\K~=|> Fk HVBɇUa)*/ o]5vhV~NeV!C'gfk5+}9G mfks:\\Lag/i #-c'8k͓c^\SE͞)R5KQ4#\'|K=$ E!b7i.`bc'&D+]zb%IC+pfQk*np:HTJNxo"ݶp$tT!c(!XZ$_ʴpXy>.{@F(`Zm{v3d(H) STknMr1TՓ2[%v99Ym덩;b{D"l#gg$7Ĭ,}mN©o$pGB\!@.;w;2tk44t{UuAa}xی}d9*Ӿ**[٬Lpf$5ȇgNAC8P1U\5yJ37PCL*kl%w,6\CpQ׋;gq<x5rw>C%3^0kY:Cb1c { 9RQ9:~PoLXr(`#W'&v-N# j0C ΎMbI‰MWV5Ykm]-J*y8]Q rM0*0r)&Hh$ڔ?C瘙۴Lriq8a|y~:G?C[sV"s%%AOQU .W9c3\A}ނ ΡI%"@ :GaTprQg:GѫUy}-Z&@zsjOok!Eթ}dH aM@~Aٺ8.P2}觤tԻx|Fbpes6*WrAEho,Z^sףM79%>VkD8iYL+gHIp-ŝPRMKTg2ԲJ&ċy2b ] *FLwn{koXVdSx]E-BUhmܬ0F2h(>JUi@+BtAVҾ,^PSF`=CeSlʦ[>uߏ#f} LBP. d`)|A136!Nr kJ:9z'(;~^hh-O&#q[bRSO$J5+~>D=i{grcC m7'-ed&#[mĨbѯt6,A|cyb D.3DgЈxwjW92yUSpIv_gBeviB"@$EĻ׸8О ~ "HMըr0IXN`i;T:՚'9 Μ8;a97JԺ[|Ԡ|xv$Ĩ JM*AM㸻C Y<^w, JRTOdeN/PPķ 6Ȳ늀 @acO$[$:5{{}1C2tISڤMܵ58qcH.Q&'4*L PV?"'V'Ck >egE;BkeJ*cɅG=4F"4)dG!C*xة=\7YݣTZ5[Qlr27Lr*Eq0  _(tQS [Wm%l 175]l S0'd-.fr7>i4Wykxozkr9oXG9MAAWM7^я`~CMg_6I`QQ :,N nr nhZeDXO~u7a-fl›fD$us%N͒L ϩ@Bvn~!mo O VKĔ%sW ʺX0y xMҚUf<L]?hTUyIUaT 55K<*m?*.`(5״dαVU=fYM9K"u˹ ׭ .rfe[Oi;h 2x @ fqق`P፨Y[~eUhmKCJ/ i2X >tlt2ojO ʶShX-?Sķ Ҏ`r547{(,{;H83{>RhxSѮ"DZ^pprueߗ}[衴egaM?k%5 <s͡cdkyϞjasmҭ=JNNt;Kf>[r.`nȤw76p|~sg)%QnҬ(>'mqԨ*)b󬶄Q1LՖIJ| ͱ$3lucod{RsH{v,&DS=U6WBiَl{E-.ONkafœ /qE ۚJ!S!bU4žOa2N|.SC"*ͣp,]3JD`OG`tySf b~ƛK˱\6{\I͓Sa֜>G x86TuoU!(@/.vCE,Hv搯 rP 8xsv88pĂj [a%WN싯b?eO=gl*uCP.cNT0#8]nqsO^fz4j݂eg[5xkٜ*|pI챶:˭\;6B::vUs ] 8R"t'Plg 2nG yBU8̄`&guھ Ѡp_5 sǹ%źSkH\NXIkv9gşKA1G(bifnqrL{/Xa˴עl+e ;8U(LBAG)Gtrj@WYI4u}`K˳W\2O[3X:*p8I: UTc9̡PCTx!'Z]$2Ȉb[$ae7&^fVL ڴ)MaRt|=')뤤XzD,/]cŕkD$쟓gzvR"9mw ') G|cqJ 9ƃ5H{};YN)YNwzv0 ʭ y8R@#mCt߷jzttY |+I0ESe:^{ZF^gd7mӳi7KB7`ƭP}D8T#v+*.,hvTRP.zل9zw苫Inj{ƉUHq;;S& lQLIBA^[<a;h^` k,?3Y4<㪽|1ig)ʷw1Ng{hN]G=Xb&* *du~ &m h0UÏ;- qȢrbEE|%%.~tt"m튅_\RH ?]ΔAP}?>(pEͳ08vκgJʖtHiApn]l5^[/<d)b Ih3%],ˍ-_y6l{{E>~? ǭ#PcAaPymq~7$_,q|Px Vfr&Sݹi\zE=roϸ4t3v&MS \1 dE;S6yd=-jk@˺DCN\0q-ZD d7G1o67˞/ךuX 3ϔO#N,.<ωܙ$=-}>F0Bd6,YeYX͍in+!c AL|yyegJ:܊ٻ?/FW|Z<]ꃆ*گ jt8@!Y'TL|4 B*G7'HlN I= цe/油 V7bo|I{`g/Ld J=0sJ~h`X+wiHV nq ]TȔʕ5Td-#`f8׏skJ|^޷H%nc܏PËGFp,/%jwU3~i w頹e{=nmf凘 R ~i3^A>kV&p |t*d3r@hY .s%Y8-;qTn^ۑVim$wc/~jK h@/}6h >˃rG~ޙw>ʫwB_ !dwk,/gZF'j?(kak t3̡:{v8g0`ǃtRDjQ؋TFJ>V>HYyEG*Ŧ#ƦyG|vܐ>[K0ZLRևy0O$-Ĵ;ۋDT^ ;͖&͡@S;l{J-xomUCK TZB G,H5hQ'lgh8s?H/'PKo'O\[*t>9];W`Z^Y E7CN4ExоhXUDB|r:Nikܑ¥w:o\ nUr>P(+ݖZY%_W QB4vaP <¶ZUcNڂ*$Ì|0E7 I10qСvY^B%,Uͨ:3|G=i*")%'PşBk8?2YZ>5w!PGd\3έ?rVbVod[ٖ=91*iKFCihICM^mXmus[muЬ <>JdJdjkM@ o=JO+ۙmqBh 9RkJy So=ӭ#3`f q0Gn= 7FD"luˉ ##p8 al,BB&Ht6SGlvr؆ s~ - }kOOȣOGnEvOϰumsvتJ8j㰋O{u@q]h"t,>2rS&BgpcUPG"a,O`xM8"N{nwm0w7?%)a)jد/֓P$qR"gM*8Wz*[Wbʔs 0yvҩ֙v,/J+8bNVs U[ץ'9} ؁%#;Q˲ȱݏ\i"!4;N2#5r<ܷ7IZ2wY݈+o>gqbf "@Jz6Vc ]z5OY$<ס  O{۱NjD4ÒÎF ZdYֺ8AʂD[mRdqK[JDg"‰^w^֝Za/vv>96"&忳p`SN|‚ǚIX $ -A ɝ؛WU'Hv>h~|Q'!FB';ݝ\aSt#dž]C0|ksGZxd9ч;i"}N jmH4$1Cku=Ֆ; <&B*Bwo%|Wea ըPyޏ>mq$'dNq$ID Q?f́܎wd3o<HCBP:fany؆-FtW"lBZ̅+j\f'Y8Ui,kbme:oA?Ό^M[nD]M~\,;͟yUqDr[Y*E|GG.>Ϥ=OjEblY<fRK(H3sJoɃJJGg~Fo>;T@z+Cv YF]cF 'c]j>)<ʦwݽEt %l=DC؉[|v+~OYlnyhce]TpC p**U<*NIw$'ke+-7[JN?ncydH]fxz|ԕJ21WTdW?./߳W,>eq6J[.^#X i t[,"Y=@ !EA wS.?}2_xAHs8\jw)<),W>$}l8BfZN#7h cC~YH С}|0PxLr adv^'.g'qP˛>ś9pI RFө-?$ 5AH%I*vZKr,;oU:ARȚIFf m`n%mewYH7!f5G/>B0#_]bq)`a*)I >AQ{q3b}P R`X~DƄDNrYIgawԡw 89ʠg⛙˙[Kz?WׯY%uK={ϳf=jSOww31ޙ>l3?bs)V-Mo9ɼ#hKesP OSQibI[H瑾x3,C29z"/Oh d5HdeQO47G,8 "o,\1hQ1ə a"gB{rb*ghN'kΖБYkh`}(_ƿcя_ #q}X*sBnDދ.TN͙oyt/N@wbe'y{SSOp\+ ¯, g'JzV8M4`hn><Թ'@ZÝn4'PrJ{F;^'%[d<&__zAE$˓Lx=Ěş8T [y~ x+D&\;N{'>̽h7LjDGs2*u y|DNgn:áyFoA׎5WPCx:W೯םtzcR-&[޲a#W &g4وpz;pv$~Ep>ЇwN`o$Cl ^7vCED58שaO<\Zݷ߰xt7R2ɏGnx:i!1%y}@Fxbd9pASv ӭ3ND>Rf5g⇲M wxj[jXhru=2GhRN+% m:q% ~@wi*EAֆ0nʼnc说781WcW! aV8t!P&V9aKЂ*Œd sU2]6F~$8t?KG7,\(Fx6Ϊ̳MҔv9ٛek\<dmyN]nt a F-*rF:KÜ{},I 3DL=:vş&-7VI{ m5s]A;DO;֙d@Aܝ" eMšr 9 {7G7*7"o~oZܡC@%D]cB0$rE{pfU)`g7dAa^;w`'=I7oxt% N8,iq U[;1T=YS>'sB챵>]Ĕb8 {n1>1HwFkؚ!YT-k+[eU[s[ܳۊf^\ 9$YG׎TZH%.A8 im'HrÖ4>کd'MdC ۽9O"DEI4%WPOahKC4y|&L-PSHH\t~Btʦ㍽Q:rMzk"9 \c{0 -ȁ۽3YR_{N 1s+_Cw'aTqbhk9",eϥ7Jdt4πp@``>-nnPM%jfΌx&E?S:+=*jNnZOs>q003Jx:-X Ƹ͘c{>7RH, d(R8;d*Ykw-rʕTy+Us+( CHꙢߐG>MACTۉ cq=a2[jW|ȡ Tz _c7i2NJ2?MDҖEBL&19ݙ mRDeJ9=OW!7pa*>c`2y a6?lP;mP"?#+,'KQ$xe=&+F_1Nʭ0X9-;ԞKAu[] (>.KӶ?Tjobҝ< @c0Paa@g=i7G 4Ɩ,~vCF?:) N8۩9Dw-JA8$Jrp. 3Bh磶XNcu!p*:a}N@!iv_ NSMuxg]ľ@r.@a|Z #"!rVVnЕxnF``c[xd֭-ͺ7p= ,mJ.Veb^.8ހ`n.mCyŭ7? VLh% cاaOpX3ncC{8Y%ZBZVTCb#<4@lQϖ(V XcK[D~Pi}4#M-n>7ALqqUmAl)y{ T|n _\*.^p̎r8Ed ӆ8;DJPFNqKf&DX}OV{b^9?Ѱ(L[oIjhg~\3}–\",AI30g3F?c;ҬQj0i5z:E#p.ju]8=S7,{x5:<' H 0m P9±lI(u^OOK*~f-U`gm8,B8( M(&='/d y:0\"?il (XJ"UTCG$Qh%};1μ鶛3:*u!\X2mOHawp2Ksd@!-I Uǒ ~ƕ@=9"/Z (@g=X.> eKG=u8d$ O<' āp>YC!X]3gKIDAT*tȫ8zN)HS:?AXOX>(p=8U^_aq^=IThD%gQh5"%>!e "Eh  rIg&y ;I E,9A=޷ l(Y7T$T&/8?=|2 H$0f1P 06=+u1(|Vz!=&jB\ 2,i'С/xp\__gY;L_+竸H.}nӈf >3q.hIa'PNZbҴt>"GH]EXyA:s_w}Iv b׵Ri0$ ͘ ~cir#n:Oiyb2"1٪)%** 킾3%^ȧb6wy}g$KyEՉzcUfbtDgGrn eًE><ƘBgc3,-Vk( 8R&\=AYĊWwZ vw0I* 'ʵz=`ld E,Ew/H}guC$W 5Hl0>Z?Ų ]\⦓ LYIDQG*7޿Ϝjؽn(¤PݢDz-esʖ4@"󕯒-oXY&ߪa` ><['_nqd'{.0ٵnD VlWⷠ e'\x[Dtj0lIArPF_ JH-car_oqnh[\7y;YpjZm.}4j!1c?de5LƒU< \6q2Y8`#.>|şֱ0)Hq3pLqXX~B{9g0Khͧ'Ъ>vW"?-g)V 2/OΧ!oOn)oU͖ͦ6hֶN ArqM62K wbAF~Zl7\RGLH-Ě}~>ga^ OiSLA "G͘!V̞x6>*UEڐ0m߇篖4. G$ .! lBL2I*z{\x܊+۞duE86_(/N.׸Z 1(EړVB${\eE `k#[Pb-LvnM;otͣ0vd^i廟 HlC5@}ŹSşwR ƌr\gFOˤvpEOߞ$s*{B!Bab>R(KTl@,NHOմRJAoHI[鄇OIav#/čڱ&-7M0sqg>: B?#;@86:1j8~1W^E }I1y_gfBG3`L Y+\<'WFN_%f!iđVlL?b;{f&͋_)}"}9}|M@3rHj4J45X&ܗ*42/L-rwI8LX7` )$T@,%a~k;; ε RVg<9UZhZμy+5d4׷ 2[po'_C1!?qAs9 P0>T7F)?ҭ|ό:p+rd^f;! l=Y_Q~1(iWw%_OV U(dnfstMnz~9PAW٨UgEb %f$U>U>2:@k5Yp x;8E1xݙp`Lv $gc[/Efx9IG34хqʣfH#;E+#a+ _ZR9B|uB-u8y.Ć df1C c S:~?@Kќ7$Reb^['I7cc((L% eYܬ9[;@q]᪓`Ydۦ(OGLCbd).E[Rу涵G`=0@g>t9$j,[-|oWAP2N345 Pq'mώ>\EV/.ɼp{DTj)Cm~ۗ[|"%Bӟ&ĉ3V"طZN>إ|:z6*dD!AxlB*2UpHȐaR@( <1@{}jP<I( )*5ivq>Nx ࣢-Z7躏6D̕~7OQ|v2Kء1}n_ yt Z\H<.$}|.%Z&FJq\v qOU* <3i'N yyYx=3P@p:`C"|6B*9.8d-MeN8e̖~O1$*|2>dw"iٳ,fKIǝ\eu>Y~[YS_>xt_OjPLf5h3y0/z4go)rQ@vN sWr4%=`̮kdws``ߺ~ qTL2gE `?d qL>:r5ΠJɝO'fOVէp̸ۘmovUR^adfY7'iaTOGSa+}F~`g<-I(s(?HPqcwITJV x&E"ǧI7&g*NY}N*lđÁ)gSI7XH.)ar)#㞏ZMC9VWdEf0 kU"܈]@99@)6!H_HGQڨ$d*8jߪA$䖦a@Bd[*\GXܠ9‚['AYW@mV_ {;Gnk[>HҒB))=Ǔܔ@Gt"-1 B ps=⼨@Q:ؘjwZ쐁T,%t(q=D[SG|(-E׺ T{By5ЄFq F@N %2WN9Ѳ v<sBO /'pˑ!E;[/XbvwXE~,AoQk/߿UsKJwV"3iO#{2q=5 43'*uᩆea6?k4|\\rIl;rv C+FDj&sضN8+4CXkm$~ĝ:v# if$}griy4 WK!Y$ *Ώ三Hef坹N߃…LaKt?oM8x\p!(lMgVq _PID_GUIDAN{9E73B420-3525-11D1-B8ED-00608CC9A71F}_935793866F`Ѷ`ѶCompObjxObjInfo OlePres0001V   D     D .--4$' r _I  ' r [ 2 n      n[ 6 _ P+ =Er-<$' P v  I 9 L' 2j  y n * =v      v y y fE n r-$ ( k+ M 6h( ( -$ m8/'p na eKm8m8-$Qwz,$Ras(/( nUwEhARR-&$ Q0DsZjGa=,P#?̸-$h}Ehh-$ UP0?'PAUPUP$FlC$2h2T0:22-$sAYsPsAsA-l$4.`?F7j 6&b%4[/F6y6#Hn]P:F: :YTZ:k+E G/s^`..X$*m, )USr^^DS,v (bI eL ,4gPkkEmm$$GH=8Q\exTegCK=H,w$[0GHGH"$^=%, J]na>R _QP^=^=4$sy zPh YIX!kn%y`l{{ss8$d{k :k=z6OQC 7E[%m9AddH$"6&;b0K\ Pk TX!q2[e/g7 N3Ni}Z66,$yI5-I rA v   Pr _T 2  j|E#yy$ }Oc}}$%+%%- $ @x;T--$~$ggg$S${8SS($g$rQ`g;n]<:ktKug$g$4$hR R4uSW3@ vlJ!S hh"$Vr^H H8 PVV"$6 R@ u0   @ b r wG , c F6 R6 R>$ ~n [ [ t    3 D ;  3 p_ {  e ;  * 2 5:  1 c u _ W ~ ~"$ ] _ 0   b 9    e *   0$   0 O QT W{ *> 3 *   6  O        >$ _Ey W^y]Xw2xF -Se=!  _ _6$rH7v%*2dtS3W_CR;%CZ~rr0$:*rN\oLrjH!{M >$ 8GLB/@Whnk\? -#$(KB-$ ,66,$ rmtT$(n_WpIEGQfj\X:;FZ{ 3=;k*D &y*XD?_3/n_n_$ _fz\^mR:1r1WD_f_f.$!2BuKq__S@/'! $I I i u 8j iD c" PPu$ ?(?=JvFlrd??$!a&{jhF!!Ole10NativeSummaryInformation(DocumentSummaryInformation8hCompObj"qbb:_b8C.b__bOv v  \]Healthcare & MedicineC:\MSPUB\Clipart\doctor2.wmf $ D P \ ht| Ethan Frome EW/LN/CBh$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ah$$If!vh555#v$V:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 ad$$If!vh555#v:V 544 aDyK rxprov@aol.comyK ,mailto:rxprov@aol.comDyK rxprov@aol.comyK ,mailto:rxprov@aol.comDyK rxprov@aol.comyK ,mailto:rxprov@aol.comDyK rxprov@aol.comyK ,mailto:rxprov@aol.comDyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK www.dca.ca.govyK .http://www.dca.ca.gov/DyK rxprov@aol.comyK ,mailto:rxprov@aol.com Dd0U+p<  C A? 2 sT"fu%w` X `!X sT"fu%wD (Ex-& x} Uo04՘!jdĊʸ˸6Q"Q-iUPd/jF)d4Rae7J(0{οj?owyoy;=h+܏-!Q>r]ӯd*EZ " *ύܠ=c۳^YKֹw<ϊ^U^Sx/f/7`03Iy Ap4PpplTo3x҂3z%7^:+"1ş#QvQc1ϳ܂%]X?LA69Lȵl caH80%~gl`4c~6q\x B:K$\ovݺ?VL)%O#j`KFb4en<k3,u_|nKG#K9.glĪx N:$~;V|b@_J!|F5qX&C dՒ8.l~}@ C:*Z-%K<s֑؊)Yqģ3:ծ=W20[q%Qէ Rt`CqEt'ǭ dp0;h qG4#*)'SWN?-!n tr"Ƕ>̃m(~5zXfwGS 1xhˉBUYWJ^eXuh*o|CankKqdps嶲ˮxUqTSV__% N0Ot>鴚H1?C`>& tptWSv]LO<EB| >V饐`݆dz^a: 腰XpHb6m5Wx~LٛhC\;@߆Z#wk&5>NV7{˸j"g Jn$XR.`3D#~chOAM垔NqmN1I2mr'l+ e2H L$oc8G4-\ݞ3tl\yج2LMh&qMS&OjjrH+j([ERs.<Nu4I)&Y|R9K੺?[ N{u'CrNxSQ&̈́Y)x%Om}Gk4* [QW5e~3 wHm.өz>'=u1]_d}(I7T%3R^H)yD +%+HyAG4\IwM,W77hH6m$~~eo]u_"? t*bkWү,=#이z=WN$qώZ^Η z{uk)B/ȔD3^#Nqj{޿x+z7x[]uap]5;Dy.ؓ MIқjȟmVՋS.2qyL¡.\$33PʩpgiC nD%:ƞF*)UC\``s'6/Q.'F(%{i͍ή#z/N[9YXl6v57l_5KqBʴGoltQi~gl 9^*߀l$ crPm8nب< [}j'< !<Cp Cp GcQ$ sQ qi7a /`.< 0'Η#`3aqa( y2/n gQz53<&1OCd9GJU`6 RLp/$k [[&PͶ*}3UX Z u8բgb0 =GTLHj QPdz]՗P)ε7HoTwWW3u\JUDuVXrZn]?P'A%Η#-⻺97aRJ=8. !UCzAT㵂't nV&FYZ@=^<lvDw @ػ +X&yyG ; P[/ e plZ~P9JZ DB~>k(4#(nИޅ4"Hk!,: ZQPGýp71tvZ{ӡ̀:8_hG;JgխwG/>*9T>H=F-#Hh}?zy}h ΥMXHq+q8Fst5)c؁^th v]0r)QeNxThOY04jK~Emz ps }>)PZkԂ!J ,Dz kP.6vP+̤&octq9r&=O[Gq`;nѮ : +-4+9_y(w9'X sk*o+ڶj'.CΖ#zSM3q'M!vc? pkmr]ӯd*EZ " *ύܠ=c۳^YKֹw<ϊ^U^Sx/f/7`03Iy Ap4PpplTo3x҂3z%7^:+"1ş#QvQc1ϳ܂%]X?LA69Lȵl caH80%~gl`4c~6q\x B:K$\ovݺ?VL)%O#j`KFb4en<k3,u_|nKG#K9.glĪx N:$~;V|b@_J!|F5qX&C dՒ8.l~}@ C:*Z-%K<s֑؊)Yqģ3:ծ=W20[q%Qէ Rt`CqEt'ǭ dp0;h qG4#*)'SWN?-!n tr"Ƕ>̃m(~5zXfwGS 1xhˉBUYWJ^eXuh*o|CankKqdps嶲ˮxUqTSV__% N0Ot>鴚H1?C`>& tptWSv]LO<EB| >V饐`݆dz^a: 腰XpHb6m5Wx~LٛhC\;@߆Z#wk&5>NV7{˸j"g Jn$XR.`3D#~chOAM垔NqmN1I2mr'l+ e2H L$oc8G4-\ݞ3tl\yج2LMh&qMS&OjjrH+j([ERs.<Nu4I)&Y|R9K੺?[ N{u'CrNxSQ&̈́Y)x%Om}Gk4* [QW5e~3 wHm.өz>'=u1]_d}(I7T%3R^H)yD +%+HyAG4\IwM,W77hH6m$~~eo]u_"? t*bkWү,=#이z=WN$qώZ^Η z{uk)B/ȔD3^#Nqj{޿x+z7x[]uap]5;Dy.ؓ MIқjȟmVՋS.2qyL¡.\$33PʩpgiC nD%:ƞF*)UC\``s'6/Q.'F(%{i͍ή#z/N[9YXl6v57l_5KqBʴGoltQi~gl 9^*߀l$ crPm8nب< [}j'< !<Cp Cp GcQ$ sQ qi7a /`.< 0'Η#`3aqa( y2/n gQz53<&1OCd9GJU`6 RLp/$k [[&PͶ*}3UX Z u8բgb0 =GTLHj QPdz]՗P)ε7HoTwWW3u\JUDuVXrZn]?P'A%Η#-⻺97aRJ=8. !UCzAT㵂't nV&FYZ@=^<lvDw @ػ +X&yyG ; P[/ e plZ~P9JZ DB~>k(4#(nИޅ4"Hk!,: ZQPGýp71tvZ{ӡ̀:8_hG;JgխwG/>*9T>H=F-#Hh}?zy}h ΥMXHq+q8Fst5)c؁^th v]0r)QeNxThOY04jK~Emz ps }>)PZkԂ!J ,Dz kP.6vP+̤&octq9r&=O[Gq`;nѮ : +-4+9_y(w9'X sk*o+ڶj'.CΖ#zSM3q'M!vc? pkm_ bo}o~cpsTi/58^CE?kSVW&*&T&~&&&&&&P&z&&&&"&L&v&&&&&H&r&&&&&D&n&&& ,-9:HIXYhixy !12NO[\hiwx./>?NO_`|}vwnnnnnnooooo o o ooooooo){|>?@ABC֮׮ABab$%&'()E+-./01MNgRST^_ !"#=jk *Y=$%XYv &9uFGd'c  67jk*+W0\k`U9:01U){oprstcfg223|}+,  ' (  PQ8()$%MN5/ 0   ##$x$y$%%&&&')3,z,.025M5779;4<>>w@BCkElEmEwGIJkLOOOPPPRRRRSSSTTUUU8V9VVVVVVVVWWWWWWWPZQZ\\t]u]`aaaatauavaaaaaaaabeeff*h+hjkkkk=l>l?lllllnn>p?pqqUtaubucuduuuu vvvvvvQwxxxxzNzzN{O{P{{|| }}}}}}}}}} ~5~6~7~X~{~~~~~~~~ "5Zvwxy|}ef(abֈgA'(zoh+,Q1 ɖD9ޙߙrst֛QӜ Ýם؝ٝڝ۝ܝݝ     lno34uxU#֬׬XYhδ<=!"#$%3EFU;ξݾ"#2EFz{  CD#$3~z{XYZ[ =`w*34WX%&Ijz#$@ezefg-Y!"h`|%){?@FGOPGHabqjk%&WXopyz67IJK`u !Ef"7[|K0܈4 K0K0LK0K0 mes New RoK0  `K0  PYK0YK0K0K0K0I0*+K0TZ1-,4K0Z9<=>K0H23K0@89K0CDK0̮K0 !K0"#<K0$%tK0&'K0()K0*+$K0,-\K0./ĻK001K0234K045lK067K089ܼK0K0:;dK0K0<=)K0K0>?Բ4K0K0@A <K0K0BCDK0K0DE|K0K0FGK0HIXK0JKK0LMȽK0NOK0PQ8K0RSpK0TUK0VWK0XYK0Z[ K0\]DK0^_|K0`aK0bcK0de$K0fg\K0hiK0jkK0lmK0no<#<K0pq\%tK0rs'K0tu̹)K0vw+$K0xy<-\K0z{t/ĻK0|}1K0~34K0K0K0K0K0K0K0K0K0K0K0K0K0K0K0K0K0K0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@0@0@0@0@Q0@Q0@Q0@0@0@Q0@Q0@Q0@0@0@Q0@Q0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@$ 0@$ 0@$ 0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@Q0@0@0@0@Q0@Q0@Q0@0@0@0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K00@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@ 0@0@Q0@Q0@Q0@0@0@0@ 0@ 0@0@0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@Q0@Q0{00~X{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00~XG{00{00@0@0@0@0@0@0{00{00{00{00{00{00{00{00{00{00{00{00{00@Q0@Q0@0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@Q0@Q0@0@Q0@Q0@0@Q0@Q0@0@Q0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@Q0@0@0@Q0@0@Q0@Q0@Q0@0@0@0      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijmlnopqrst@0@0@Q0@Q0@Q0@0@0@0@0@0@0@0@Q0@0@0@0@Q0@Q0@Q0@0@Q0@Q0@0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@Q0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K00 ,-9:HIXYhixy !12NO[\hiwx./>?NO_`|}vwnnnnnnooooo o o ooooooo.77>>kElEkLRSSU9VVWWv}} ~5~6~X~{~~~~~~ "5Zvxef(abֈgA'(zoh+,Q1 ɖD9ޙߙrQӜ Ýδ[=`wIjz$@ezK0Ty K0yK0yK0yK0 4zK0  ns\K0  K0PK0 K0 gK0#K0$K0 s\KK0P KK0  K04%K0 !l%K0"#%K0$%%K0&',CXXK0()dC7}K0*+CK0,-CK0./'K0010(DK023h( p gXK045(!K067(K089)K0:;FK0<=FK0>?GXXK0@A0<GQSXZ_cgoprv~T %,:CZ!,[!H[!h[![![![![![!\!2\![\!w\!\!\!\!\!]!.]!N]!c]!]!]!]!]!]!^!^!^!^!_!Rk!o!x!.!!!o! !k!!^!0! !!j!!!!! !!!x!!!!!!! !"*""W"#!"o$"'"+"-"Q2"l8"@"R" ^"h"7r"z"ȇ"""S"e"j""U";"L"d"">"""""""#"#0#D#O#JZ#g]#_#l#u#p## #+##v###j$S$q$%$6$?$dM$Y$%%%%%N &',/36:=B123456789:;=>?@ABCDEFHIJKLMNOPRTUVWY[\]^`abdefhijklmnqstuwxyz{|}L &(BQRu.:I*&*5*223999@@@GGGLLLXXXXXXXXXX9;>Z\b:::s/'N((((HHH IIIII IAIBICIDIijjjj}l~llllllllEmFm#noooooooLpppppqܔVW1&&8888CC f f`  " CMt XV4 m 4 MM4 MMt MMt $t!h@ t tttct3tx3tttt3tetth tt C"ct $t!h@ t ttHhth tt3t"4(4et334C4 (#4 4Vxt@ smt smt smt smt smt smt (smt Mt!4!HsD4!HsDt!HDt Mt sMt sMt xt!HD t!H t!Htt!$t!Qpt xFt!Qpt xFt!Qpt!!pt!Jt xFt"9t"9t#9t"9t#9t _936642338 OLE_LINK1@tX$uXduXuXuX$vXdvXD(vXD(vXD($wXCu3dwX8 wX8 wX8 $xX8 dxX8 xX8 xX8 $yX8 dyX8 yX8 yXȑ8 $zXɑ8 dzXʑ8 zXˑ8 zXב8 ${Xؑ8 d{Xّ8 {Xڑ8 {Xۑ8 $|Xܑ8 d|X`P8 |X`P8 |X`P8 $}X`P8 d}X`P8 }X`P8}X`P8 $~X`P8 d~X`P8 ~X`P8~X`P8 $X`P8 dX`P8 X`P8 X`P8$X`P8 dX`P8 X`P8 X`P8$X`P8 dX`P8 X`P8 X`P8 $X`P8 dXaP8 XaP8 X)aP8 $X*aP8 dXGaP8 XHaP8 XdaP8 $XeaP8 dXfaP8 XgaP8 X#L $X$L dXRL XSL XTL $XULdXVL XWL XXL $XYLdXZL X[L X\L$X]L dX^L X_L X`L$XaL dXbL XcLXdL $XeL dXfL XgLXmL $XNI dXOI XPI XQI $XRI dXSI XI XI $XI dXI XI XI $XI dXI XhI XiI$XjI dXkIXlI XmI$XnI dXoI XpI XqI $XrI dXsI XtI XuI $XvI dXwI XxI XyI$XzI dX{I X|I X}I$X~I dXI XIXI $XI dXI XIXI $XI dXIXI XI $XI dXIXI XI $XI dXI XI XI $XI dXIXI XI $XI dXIXI XI $XIdXI XI XI $XIdXI XI XI$XI dXI XI XI$XuR dXvRXwR XxR $XyR dXv Xv Xv $XvdXv XvXv $XvdXv Xv Xv $Xv dXv Xv Xv $Xv dXv Xv XܿC $XݿC dX XX $X dX  X X; $X<dX= X> X? $X@dXB XCXD $XE dXF XGX"f"fDfDfSf_fRi tq}}ܥ]]55ss,,hh@@yyoo>SS>>^ss''  &&D'D'kZkZa[a[||}}}}}}~~;~{~{~~~~~~~~  5ggnnll4499 ``wwNNDDNN``jjqt @eezz{{VV  HHPPqquu77[[jv      !"#$%&'()*+,-./0123456789:;<=>?@ABCDFEIGHJKLMPNOQRSTWUVXYZ[\]^_`abcdefghijklmnopqrstuvwyxz|{}~BfBfQf]fdfdfait̂gg??zz66rrJJyy55J]]VVj}}11  &&N'N'uZuZk[k[||}}}}~~ ~ ~G~~~~~~~~  !!>nnuuss??  @@  ,vvXXNNUUeiosyy Iyyaa++RRWWxxYYht{{  !"#$%&'()*+,-./0123456789:;<=>?@ABCDFEHIGJKLMOPNQRSTVWUXYZ[\]^_`abcdefghijklmnopqrstuvwyxz|{}~>*urn:schemas-microsoft-com:office:smarttags PersonName8*urn:schemas-microsoft-com:office:smarttagsdate:*urn:schemas-microsoft-com:office:smarttagsStreet;*urn:schemas-microsoft-com:office:smarttagsaddress8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsState>*urn:schemas-microsoft-com:office:smarttags PostalCode9*urn:schemas-microsoft-com:office:smarttagsplace 3N 101415199519972000478DayMonthYear                     otuxWggKSTtKK`   Ye5%1FRξھ#/ $1)ouxefg!"0}$%IJKTUtKK` [h333333333333333333333\\ooppqqrrsstt_  "011A`{{}}~~ %})KchIIK`otxKSTtKK` SD&@ '''''''',,,,1111 8 8 8 88888llll]]]]`B@`B"`D@`H"`J"`L"`N"`P"`R"`T"`D@`\"`D@`b"`D@`f"`h"`n"`D@`t"`D@`x"`D@`|"`~"`"`"`"`E@`R#`T#`F@`b#`F@`j#`F@`$`H@`.$``H@`K@`%`%` &Unknown Joe PisanoGz Times New Roman5Symbol3& z ArialE& Century Gothic;LibrarianC& CommonBulletsY&Copperplate Gothic Light7Palatia"0h0@P?SD2SL@L Normal$@CJOJQJ_HkHmH sH tH <@< Heading 1 dCJ4@4 Heading 2d:@: Heading 3 h^h@>@> Heading 4 ^@CJ>@> Heading 5 8^8@CJ>@> Heading 6 ^@CJ>@> Heading 7 ^@CJ>@> Heading 8 p^p@CJ> @> Heading 9  ^ @CJDA@D Default Paragraph FontViV  Table Normal :V 44 la (k(No List XOX Heading Base$$$a$@KHOJQJkH>B@> Body Text$da$DOD Footnote Base $dCJ^I@"^ Message Header'$$ @0x^`0a$NO2N Block Quotation$]^<OB< Body Text Keep$8"a8 Captiond6CJ.OR. Picture$VOV Document Labeldx^@CJlHO!"H Message Header First>*> Endnote ReferenceH*4+4  Endnote Text0 @0 FooterXCJDOD Header Base$ !@&@ Footnote ReferenceH*66  Footnote Text,@, HeaderXHOH Lead-in EmphasisCJOJQJkH2(@2 Line NumberCJ4/@"4 List"h^h`0@!2 List Bulletp# & F>T h]^1@!B List Numberp$ & F>T8 h.]^H-RH  Macro Text%$da$ OJ QJ kH2)@2 Page NumberCJ2Oq2 SuperscriptH*=@A List Number 5a(p>T h.^pTOT Message Header Label@CJOJQJkH2L@2 Date*$0$a$:@A List Number 2a+8>T8 h.^8;@A List Number 3a,>T h.^05@!0 List 5 -^04@!0 List 4 .^03@!0 List 3 /8^802@!0 List 2 0^8X@8 EmphasisCJOJQJkH4?@"4 Closing 2$d424  Comment Text3>'A> Comment ReferenceCJDC@RD Body Text Indent 5h^h>@b> Normal Indent 6^ND@!rN List Continue7]^`BE@qB List Continue 2 88^8BF@qB List Continue 3 9^BG@qB List Continue 4 :^BH@qB List Continue 5 ;p^pzOz Company Name0<dM $d %d &d 'd -D@CJ EHOJQJkHjOj Return Address,=$&d /#$0$ P @CJ<O< Enclosure>$$a$JOJ Reference Initials ?$$<@@< Signature@$$LOL Signature Job Title A$a$BOB Signature Name B$a$LO!L Message Header Last C@&dl$@Bl Envelope Address!D@ &+D/^@ 6CJOJQJ>%@R> Envelope ReturnE6<@Ab List Number 4aF>T h.^>9@1r> List Bullet 5 Gp^p>6@1> List Bullet 2 H8^8>7@1> List Bullet 3 I^>8@1> List Bullet 4 J^0U@0 Hyperlink>*B*6P@6 Body Text 2LCJPR@P Body Text Indent 2M h^hHT@H Block TextN @]^PS@P Body Text Indent 3O]`:Q@: Body Text 3 P]\^@\ 5 Normal (Web)Qdd[$\$@B*CJ^JaJphJZ@"J `9 Plain TextR@B*CJ^JaJph8C8C!z z z z z z z: M"&1B;8C}z&9ZGsDET|z8 9 : I 9 : ~   *+$('89RSb !!!! $!$w$x$)%*%!&"&&&((;)<)K)r*s*D,E,-.//[1\1q2r2{3|3344446566677L8M8\888h9i9O:P:^:h<i<>>??|A}AVBWBBBB C9C!!!!!5!5!l!x!x!x!x!x!x!5!5! !!!!!!!!5!5!!!!!!!!!!!5!!!p!!,_!!,_!!!!!!!!!!!!d !!!!!5!!!k!!Ă !!5!5!!!5!!!5!!!5!!!5!!!!!!!!!!!!!!!!!!!5!!!!!!!!!4 !!!!!!5!!!5!!!!!!!!!5!!!!!!!5!<;!!!!!!!!!!!!!!/9ZGsDET|z8 9 : I 9 : ~   *+$('89RSb !!!! $!$w$x$)%*%!&"&&&((;)<)K)r*s*D,E,-.//[1\1q2r2{3|3344446566677L8M8\888h9i9O:P:^:h<i<>>??|A}AVBWBBBB C3C4C5C6C9C00000000Q0Q0Q0Q00000000000000Q0Q0Q0Q0Q0Q0Q0Q0Q0Q00Q0Q000000000000000000000Q00Q0Q0Q0Q0Q0Q000Q0Q00Q0Q00Q0Q00Q0Q00Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q0Q000000000000000000000000000000000000Q0Q00000Q0Q0Q00000000000!*+$('L889C{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00{00@0"@0" d E}X"%(+15;?MCF X!5\!c]!_!j!!Џ!!K!!r!!![!" ("9-"P4"K"j"""" "*""|"8"H"J"#O#/#o:#E#+P#Z#\#^#`#s####g####h###6#$v$'$3$<$T$%%%d%`%%%:% &N &&)*+-.01245789;<>0<GQSXZ_cgoprv~T %,:CZ!,[!H[!h[![![![![![!\!2\![\!w\!\!\!\!\!]!.]!N]!c]!]!]!]!]!]!^!^!^!^!_!Rk!o!x!.!!!o! !k!!^!0! !!j!!!!! !!!x!!!!!!! !"*""W"#!"o$"'"+"-"Q2"l8"@"R" ^"h"7r"z"ȇ"""S"e"j""U";"L"d"">"""""""#"#0#D#O#JZ#g]#_#l#u#p## #+##v###j$S$q$%$6$?$dM$Y$%%%%%N &',/36:=B123456789:;=>?@ABCDEFHIJKLMNOPRTUVWY[\]^`abdefhijklmnqstuwxyz{|}L &(8C"$Ob$ W ytN*b$ @ŭUBZyN|2$sT"fu%w` b$paӜyV@.#(  x " S HA* One2One Logo - ColorB S  ?z    0 A ? ?"\  3 Ԕ8c?"\  3 Ԕ8c?"\  3 Ԕ8c?"\  3 Ԕ8c?"\  3 Ԕ8c?"bB    C D"bB    C D"bB   C D"bB  C D"bB  C D"bB  C D"  c ZA ?6 `&(4HWcA'k*?,?27 7g? 5GOQyPQR~RRF ON"Oq@J?5GKB5GETBE>?72/D\@IcRR`T`Td4Pj+74"  c |A*. `One2One Logo - ColorS`TS`T"   T 3f11? "\  3 Ԕ8c?"\  3 Ԕ8c?"\  3 Ԕ8c?"\  3 Ԕ8c?"bB  C D"bB  C D"bB   C D"bB   C D" !  hZw?FAXArial Black   S HA* One2One Logo - Color" # S HA* One2One Logo - Color8C"9t%)*CS,2 a%,-l.zR{R,}Rl~RRLMLML,N LlNdINeINv,OvlOaP8XaP84XItXIX aP8XaP84X"LtX%LXvLXvLXv,MXvlMXֿCMX׿CMXoaP8,NXpaP8lNXqaP8UraP8U99HTZZz  ''e&e&0'0'(("*"*T2T2q4q477<<y=y=9C      !"#$77FRYYrr  11p&p&;';')),*,*Y2Y2v4v477<<==9C  !"#$:$*urn:schemas-microsoft-com:office:smarttagsStreet;%*urn:schemas-microsoft-com:office:smarttagsaddress8#*urn:schemas-microsoft-com:office:smarttagsCity9"*urn:schemas-microsoft-com:office:smarttagsState>!*urn:schemas-microsoft-com:office:smarttags PostalCode9*urn:schemas-microsoft-com:office:smarttagsplace % %$#"!%$#"""""%$%$%$""""""3C6C9C9Fdk: F 3C6C9C:::::9: I 2C3C9C3C6C9C(u Bom PT/z @B r$! .V(= ?G \=I BnMj0nai s 9) x .x !:xM}} hh^h`OJQJo( hh^h`OJQJo(h88^8`.h^`.h L ^ `L.h  ^ `.hxx^x`.hHLH^H`L.h^`.h^`.hL^`L.hh^h`o(.hh^h`. hh^h`OJQJo( hh^h`OJQJo(hh^h`. hh^h`OJQJo(^`o(. hh^h`OJQJo(@hh^h`. hh^h`OJQJo(hh^h`.^`o(.@hh^h`56>*CJOJQJo(. ss`"s"s#sh#s#s$sp$s$?G@B/z!:xr$!\=I}}.x0naiBom(u9) x.V(=BnMPl"`b@hh^h`." @hh^h`.# @hh^h`.t# 2@hh^h`.# 6@hh^h`.$$` @hh^h`.|$` @hh^h`.$` @hh^h`.         ~Xn4~ R7 wq^3:N%c_FV| '(J+-M-0z-o067Z 8\8`9;G<h?AD[F.G]MI#LDM8P:eR;S@SUgVJVeVuWYb[|`vbX&fMfC iJjm"mZpmn63ofkq"@y%J4N3| on>f =j4ifEMS+Huw1yUF DE p*| }C:]4%i0\M^mFw4dCC3QHX(?uW2 Ethan FromeEthanEW/LN/CB Lan AdminL